{"date": "2025-12-23", "symbol": "LLY", "type": "income_statement_annual", "result": {"error": "max_retries_exceeded", "url": "https://financialmodelingprep.com/stable/income-statement"}}
{"date": "2025-09-30", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2025-09-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2025-10-30", "acceptedDate": "2025-10-30 11:15:28", "fiscalYear": "2025", "period": "Q3", "revenue": 17600800000, "costOfRevenue": 3008300000, "grossProfit": 14592500000, "researchAndDevelopmentExpenses": 4121400000, "generalAndAdministrativeExpenses": 2740700000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2740700000, "otherExpenses": 0, "operatingExpenses": 6862100000, "costAndExpenses": 9870400000, "netInterestIncome": -114600000, "interestIncome": 65000000, "interestExpense": 179600000, "depreciationAndAmortization": 470000000, "ebitda": 7882000000, "ebit": 7412000000, "nonOperatingIncomeExcludingInterest": 318400000, "operatingIncome": 7730400000, "totalOtherIncomeExpensesNet": -498000000, "incomeBeforeTax": 7232400000, "incomeTaxExpense": 1649900000, "netIncomeFromContinuingOperations": 5582500000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 5582500000, "netIncomeDeductions": 0, "bottomLineNetIncome": 5582500000, "eps": 6.22, "epsDiluted": 6.21, "weightedAverageShsOut": 896900000, "weightedAverageShsOutDil": 898800000}}
{"date": "2025-06-30", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2025-06-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2025-08-07", "acceptedDate": "2025-08-07 09:59:55", "fiscalYear": "2025", "period": "Q2", "revenue": 15557700000, "costOfRevenue": 2447800000, "grossProfit": 13109900000, "researchAndDevelopmentExpenses": 3336100000, "generalAndAdministrativeExpenses": 2647600000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2647600000, "otherExpenses": 0, "operatingExpenses": 5983700000, "costAndExpenses": 8431500000, "netInterestIncome": -209000000, "interestIncome": 40000000, "interestExpense": 249000000, "depreciationAndAmortization": 478500000, "ebitda": 7503900000, "ebit": 7025400000, "nonOperatingIncomeExcludingInterest": 100800000, "operatingIncome": 7126200000, "totalOtherIncomeExpensesNet": -349800000, "incomeBeforeTax": 6776400000, "incomeTaxExpense": 1115900000, "netIncomeFromContinuingOperations": 5660500000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 5660500000, "netIncomeDeductions": 0, "bottomLineNetIncome": 5660500000, "eps": 6.3, "epsDiluted": 6.29, "weightedAverageShsOut": 897900000, "weightedAverageShsOutDil": 899793000}}
{"date": "2025-03-31", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2025-03-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2025-05-01", "acceptedDate": "2025-05-01 11:30:18", "fiscalYear": "2025", "period": "Q1", "revenue": 12728500000, "costOfRevenue": 2224200000, "grossProfit": 10504300000, "researchAndDevelopmentExpenses": 2733700000, "generalAndAdministrativeExpenses": 2362200000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2362200000, "otherExpenses": 0, "operatingExpenses": 5095900000, "costAndExpenses": 7320100000, "netInterestIncome": -195400000, "interestIncome": 48300000, "interestExpense": 243700000, "depreciationAndAmortization": 462800000, "ebitda": 4162600000, "ebit": 3699800000, "nonOperatingIncomeExcludingInterest": 1708600000, "operatingIncome": 5408400000, "totalOtherIncomeExpensesNet": -1952300000, "incomeBeforeTax": 3456100000, "incomeTaxExpense": 696800000, "netIncomeFromContinuingOperations": 2759300000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 2759300000, "netIncomeDeductions": 0, "bottomLineNetIncome": 2759300000, "eps": 3.07, "epsDiluted": 3.06, "weightedAverageShsOut": 897989000, "weightedAverageShsOutDil": 900604000}}
{"date": "2024-12-31", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2024-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2025-02-19", "acceptedDate": "2025-02-19 10:10:59", "fiscalYear": "2024", "period": "Q4", "revenue": 13532800000, "costOfRevenue": 2403800000, "grossProfit": 11129000000, "researchAndDevelopmentExpenses": 3022500000, "generalAndAdministrativeExpenses": 2308700000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2308700000, "otherExpenses": 0, "operatingExpenses": 5331200000, "costAndExpenses": 7735000000, "netInterestIncome": -180400000, "interestIncome": 44300000, "interestExpense": 224700000, "depreciationAndAmortization": 484800000, "ebitda": 5748200000, "ebit": 5263400000, "nonOperatingIncomeExcludingInterest": 534400000, "operatingIncome": 5797800000, "totalOtherIncomeExpensesNet": -759100000, "incomeBeforeTax": 5038700000, "incomeTaxExpense": 628900000, "netIncomeFromContinuingOperations": 4409800000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 4409800000, "netIncomeDeductions": 0, "bottomLineNetIncome": 4409800000, "eps": 4.91, "epsDiluted": 4.88, "weightedAverageShsOut": 897538000, "weightedAverageShsOutDil": 903158000}}
{"date": "2024-09-30", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2024-09-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2024-10-30", "acceptedDate": "2024-10-30 11:54:10", "fiscalYear": "2024", "period": "Q3", "revenue": 11439100000, "costOfRevenue": 2170800000, "grossProfit": 9268300000, "researchAndDevelopmentExpenses": 2734100000, "generalAndAdministrativeExpenses": 1984400000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 1984400000, "otherExpenses": 0, "operatingExpenses": 4718500000, "costAndExpenses": 6889300000, "netInterestIncome": -144900000, "interestIncome": 47800000, "interestExpense": 192700000, "depreciationAndAmortization": 466800000, "ebitda": 2247900000, "ebit": 1781100000, "nonOperatingIncomeExcludingInterest": 2768700000, "operatingIncome": 4549800000, "totalOtherIncomeExpensesNet": -2961400000, "incomeBeforeTax": 1588400000, "incomeTaxExpense": 618100000, "netIncomeFromContinuingOperations": 970300000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 970300000, "netIncomeDeductions": 0, "bottomLineNetIncome": 970300000, "eps": 1.08, "epsDiluted": 1.07, "weightedAverageShsOut": 901000000, "weightedAverageShsOutDil": 905000000}}
{"date": "2024-06-30", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2024-06-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2024-08-08", "acceptedDate": "2024-08-08 11:28:54", "fiscalYear": "2024", "period": "Q2", "revenue": 11302800000, "costOfRevenue": 2170200000, "grossProfit": 9132600000, "researchAndDevelopmentExpenses": 2711200000, "generalAndAdministrativeExpenses": 2002900000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 2002900000, "otherExpenses": 0, "operatingExpenses": 4714100000, "costAndExpenses": 6884300000, "netInterestIncome": -146300000, "interestIncome": 37300000, "interestExpense": 183600000, "depreciationAndAmortization": 414400000, "ebitda": 4115200000, "ebit": 3700800000, "nonOperatingIncomeExcludingInterest": 717700000, "operatingIncome": 4418500000, "totalOtherIncomeExpensesNet": -901300000, "incomeBeforeTax": 3517200000, "incomeTaxExpense": 550200000, "netIncomeFromContinuingOperations": 2967000000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 2967000000, "netIncomeDeductions": 0, "bottomLineNetIncome": 2967000000, "eps": 3.29, "epsDiluted": 3.28, "weightedAverageShsOut": 900900000, "weightedAverageShsOutDil": 904200000}}
{"date": "2024-03-31", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2024-03-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2024-04-30", "acceptedDate": "2024-04-30 12:04:51", "fiscalYear": "2024", "period": "Q1", "revenue": 8768000000, "costOfRevenue": 1673500000, "grossProfit": 7094500000, "researchAndDevelopmentExpenses": 2522800000, "generalAndAdministrativeExpenses": 1836100000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 1836100000, "otherExpenses": 0, "operatingExpenses": 4358900000, "costAndExpenses": 6032400000, "netInterestIncome": -133800000, "interestIncome": 45800000, "interestExpense": 179600000, "depreciationAndAmortization": 400600000, "ebitda": 3116300000, "ebit": 2715700000, "nonOperatingIncomeExcludingInterest": 19900000, "operatingIncome": 2735600000, "totalOtherIncomeExpensesNet": -199500000, "incomeBeforeTax": 2536100000, "incomeTaxExpense": 293200000, "netIncomeFromContinuingOperations": 2242900000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 2242900000, "netIncomeDeductions": 0, "bottomLineNetIncome": 2242900000, "eps": 2.49, "epsDiluted": 2.48, "weightedAverageShsOut": 900800000, "weightedAverageShsOutDil": 903800000}}
{"date": "2023-12-31", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2023-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2024-02-21", "acceptedDate": "2024-02-21 11:44:37", "fiscalYear": "2023", "period": "Q4", "revenue": 9353400000, "costOfRevenue": 1788000000, "grossProfit": 7565400000, "researchAndDevelopmentExpenses": 2562700000, "generalAndAdministrativeExpenses": 1809600000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 1809600000, "otherExpenses": 0, "operatingExpenses": 4372300000, "costAndExpenses": 6160300000, "netInterestIncome": -93700000, "interestIncome": 44500000, "interestExpense": 138200000, "depreciationAndAmortization": 387700000, "ebitda": 3034700000, "ebit": 2647000000, "nonOperatingIncomeExcludingInterest": 546100000, "operatingIncome": 3193100000, "totalOtherIncomeExpensesNet": -684300000, "incomeBeforeTax": 2508800000, "incomeTaxExpense": 319100000, "netIncomeFromContinuingOperations": 2189700000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 2189700000, "netIncomeDeductions": 0, "bottomLineNetIncome": 2189700000, "eps": 2.43, "epsDiluted": 2.42, "weightedAverageShsOut": 899379000, "weightedAverageShsOutDil": 903980000}}
{"date": "2023-09-30", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2023-09-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2023-11-02", "acceptedDate": "2023-11-02 11:21:53", "fiscalYear": "2023", "period": "Q3", "revenue": 9498600000, "costOfRevenue": 1860100000, "grossProfit": 7638500000, "researchAndDevelopmentExpenses": 2409100000, "generalAndAdministrativeExpenses": 1688400000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 1688400000, "otherExpenses": 0, "operatingExpenses": 4097500000, "costAndExpenses": 5957600000, "netInterestIncome": -75700000, "interestIncome": 48900000, "interestExpense": 124600000, "depreciationAndAmortization": 411000000, "ebitda": 962800000, "ebit": 551800000, "nonOperatingIncomeExcludingInterest": 2989200000, "operatingIncome": 3541000000, "totalOtherIncomeExpensesNet": -3113800000, "incomeBeforeTax": 427200000, "incomeTaxExpense": 484600000, "netIncomeFromContinuingOperations": -57400000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": -57400000, "netIncomeDeductions": 0, "bottomLineNetIncome": -57400000, "eps": -0.0605, "epsDiluted": -0.0605, "weightedAverageShsOut": 949303000, "weightedAverageShsOutDil": 949303000}}
{"date": "2023-06-30", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2023-06-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2023-08-08", "acceptedDate": "2023-08-08 13:23:19", "fiscalYear": "2023", "period": "Q2", "revenue": 8312100000, "costOfRevenue": 1807400000, "grossProfit": 6504700000, "researchAndDevelopmentExpenses": 2356500000, "generalAndAdministrativeExpenses": 1809800000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 1809800000, "otherExpenses": 0, "operatingExpenses": 4166300000, "costAndExpenses": 5973700000, "netInterestIncome": -74300000, "interestIncome": 46000000, "interestExpense": 120300000, "depreciationAndAmortization": 366300000, "ebitda": 2575500000, "ebit": 2209200000, "nonOperatingIncomeExcludingInterest": 129200000, "operatingIncome": 2338400000, "totalOtherIncomeExpensesNet": -249500000, "incomeBeforeTax": 2088900000, "incomeTaxExpense": 325700000, "netIncomeFromContinuingOperations": 1763200000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 1763200000, "netIncomeDeductions": 0, "bottomLineNetIncome": 1763200000, "eps": 1.86, "epsDiluted": 1.86, "weightedAverageShsOut": 949286000, "weightedAverageShsOutDil": 949286000}}
{"date": "2023-03-31", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2023-03-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2023-04-27", "acceptedDate": "2023-04-27 11:56:56", "fiscalYear": "2023", "period": "Q1", "revenue": 6960000000, "costOfRevenue": 1626700000, "grossProfit": 5333300000, "researchAndDevelopmentExpenses": 1985100000, "generalAndAdministrativeExpenses": 1633400000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 1633400000, "otherExpenses": 0, "operatingExpenses": 3618500000, "costAndExpenses": 5245200000, "netInterestIncome": -68600000, "interestIncome": 34200000, "interestExpense": 102800000, "depreciationAndAmortization": 362300000, "ebitda": 1994800000, "ebit": 1632500000, "nonOperatingIncomeExcludingInterest": 82300000, "operatingIncome": 1714800000, "totalOtherIncomeExpensesNet": -185100000, "incomeBeforeTax": 1529700000, "incomeTaxExpense": 184800000, "netIncomeFromContinuingOperations": 1344900000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 1344900000, "netIncomeDeductions": 0, "bottomLineNetIncome": 1344900000, "eps": 1.42, "epsDiluted": 1.42, "weightedAverageShsOut": 949267000, "weightedAverageShsOutDil": 949267000}}
{"date": "2022-12-31", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2022-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2023-02-22", "acceptedDate": "2023-02-22 10:26:53", "fiscalYear": "2022", "period": "Q4", "revenue": 7301800000, "costOfRevenue": 1548100000, "grossProfit": 5753700000, "researchAndDevelopmentExpenses": 1995900000, "generalAndAdministrativeExpenses": 1550300000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 1550300000, "otherExpenses": 0, "operatingExpenses": 3546200000, "costAndExpenses": 5094300000, "netInterestIncome": -58500000, "interestIncome": 25500000, "interestExpense": 84000000, "depreciationAndAmortization": 375000000, "ebitda": 2555400000, "ebit": 2180400000, "nonOperatingIncomeExcludingInterest": 27100000, "operatingIncome": 2207500000, "totalOtherIncomeExpensesNet": -111100000, "incomeBeforeTax": 2096400000, "incomeTaxExpense": 158700000, "netIncomeFromContinuingOperations": 1937700000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 1937700000, "netIncomeDeductions": 0, "bottomLineNetIncome": 1937700000, "eps": 2.04, "epsDiluted": 2.04, "weightedAverageShsOut": 950182000, "weightedAverageShsOutDil": 950182000}}
{"date": "2022-09-30", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2022-09-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2022-11-01", "acceptedDate": "2022-11-01 11:16:21", "fiscalYear": "2022", "period": "Q3", "revenue": 6941600000, "costOfRevenue": 1579100000, "grossProfit": 5362500000, "researchAndDevelopmentExpenses": 1802900000, "generalAndAdministrativeExpenses": 1521800000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 1521800000, "otherExpenses": 0, "operatingExpenses": 3324700000, "costAndExpenses": 4903800000, "netInterestIncome": -61400000, "interestIncome": 20100000, "interestExpense": 81500000, "depreciationAndAmortization": 362900000, "ebitda": 2009900000, "ebit": 1647000000, "nonOperatingIncomeExcludingInterest": 390800000, "operatingIncome": 2037800000, "totalOtherIncomeExpensesNet": -472300000, "incomeBeforeTax": 1565500000, "incomeTaxExpense": 113800000, "netIncomeFromContinuingOperations": 1451700000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 1451700000, "netIncomeDeductions": 0, "bottomLineNetIncome": 1451700000, "eps": 1.61, "epsDiluted": 1.61, "weightedAverageShsOut": 900700000, "weightedAverageShsOutDil": 903800000}}
{"date": "2022-06-30", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2022-06-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2022-08-04", "acceptedDate": "2022-08-04 11:31:24", "fiscalYear": "2022", "period": "Q2", "revenue": 6488000000, "costOfRevenue": 1430500000, "grossProfit": 5057500000, "researchAndDevelopmentExpenses": 1781900000, "generalAndAdministrativeExpenses": 1530800000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 1530800000, "otherExpenses": 0, "operatingExpenses": 3312700000, "costAndExpenses": 4743200000, "netInterestIncome": -71000000, "interestIncome": 10200000, "interestExpense": 81200000, "depreciationAndAmortization": 348900000, "ebitda": 1521000000, "ebit": 1172100000, "nonOperatingIncomeExcludingInterest": 572700000, "operatingIncome": 1744800000, "totalOtherIncomeExpensesNet": -653900000, "incomeBeforeTax": 1090900000, "incomeTaxExpense": 138400000, "netIncomeFromContinuingOperations": 952500000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 952500000, "netIncomeDeductions": 0, "bottomLineNetIncome": 952500000, "eps": 1.06, "epsDiluted": 1.05, "weightedAverageShsOut": 900300000, "weightedAverageShsOutDil": 902900000}}
{"date": "2022-03-31", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2022-03-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2022-04-29", "acceptedDate": "2022-04-29 11:57:54", "fiscalYear": "2022", "period": "Q1", "revenue": 7810000000, "costOfRevenue": 2072100000, "grossProfit": 5737900000, "researchAndDevelopmentExpenses": 1610100000, "generalAndAdministrativeExpenses": 1464600000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 1464600000, "otherExpenses": 0, "operatingExpenses": 3074700000, "costAndExpenses": 5146800000, "netInterestIncome": -77900000, "interestIncome": 7000000, "interestExpense": 84900000, "depreciationAndAmortization": 435700000, "ebitda": 2574200000, "ebit": 2138500000, "nonOperatingIncomeExcludingInterest": 524700000, "operatingIncome": 2663200000, "totalOtherIncomeExpensesNet": -609600000, "incomeBeforeTax": 2053600000, "incomeTaxExpense": 150700000, "netIncomeFromContinuingOperations": 1902900000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 1902900000, "netIncomeDeductions": 0, "bottomLineNetIncome": 1902900000, "eps": 2, "epsDiluted": 2, "weightedAverageShsOut": 950605000, "weightedAverageShsOutDil": 950605000}}
{"date": "2021-12-31", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2021-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2022-02-23", "acceptedDate": "2022-02-23 11:00:57", "fiscalYear": "2021", "period": "Q4", "revenue": 7999900000, "costOfRevenue": 2050200000, "grossProfit": 5949700000, "researchAndDevelopmentExpenses": 1959400000, "generalAndAdministrativeExpenses": 1519400000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 1519400000, "otherExpenses": 0, "operatingExpenses": 3478800000, "costAndExpenses": 5529000000, "netInterestIncome": -74000000, "interestIncome": 7400000, "interestExpense": 81400000, "depreciationAndAmortization": 445700000, "ebitda": 2367000000, "ebit": 1921300000, "nonOperatingIncomeExcludingInterest": 549600000, "operatingIncome": 2470900000, "totalOtherIncomeExpensesNet": -631000000, "incomeBeforeTax": 1839900000, "incomeTaxExpense": 113800000, "netIncomeFromContinuingOperations": 1726100000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 1726100000, "netIncomeDeductions": 0, "bottomLineNetIncome": 1726100000, "eps": 1.81, "epsDiluted": 1.81, "weightedAverageShsOut": 953653000, "weightedAverageShsOutDil": 953653000}}
{"date": "2021-09-30", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2021-09-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2021-10-27", "acceptedDate": "2021-10-27 09:06:59", "fiscalYear": "2021", "period": "Q3", "revenue": 6772800000, "costOfRevenue": 1430800000, "grossProfit": 5342000000, "researchAndDevelopmentExpenses": 1705300000, "generalAndAdministrativeExpenses": 1505300000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 1505300000, "otherExpenses": 0, "operatingExpenses": 3210600000, "costAndExpenses": 4641400000, "netInterestIncome": -76600000, "interestIncome": 7000000, "interestExpense": 83600000, "depreciationAndAmortization": 382300000, "ebitda": 1711200000, "ebit": 1328900000, "nonOperatingIncomeExcludingInterest": 802500000, "operatingIncome": 2131400000, "totalOtherIncomeExpensesNet": -886100000, "incomeBeforeTax": 1245300000, "incomeTaxExpense": 135200000, "netIncomeFromContinuingOperations": 1110100000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 1110100000, "netIncomeDeductions": 0, "bottomLineNetIncome": 1110100000, "eps": 1.16, "epsDiluted": 1.16, "weightedAverageShsOut": 956589000, "weightedAverageShsOutDil": 956589000}}
{"date": "2021-06-30", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2021-06-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2021-08-03", "acceptedDate": "2021-08-03 12:04:04", "fiscalYear": "2021", "period": "Q2", "revenue": 6740100000, "costOfRevenue": 1953200000, "grossProfit": 4786900000, "researchAndDevelopmentExpenses": 1655000000, "generalAndAdministrativeExpenses": 1614600000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 1614600000, "otherExpenses": 0, "operatingExpenses": 3269600000, "costAndExpenses": 5222800000, "netInterestIncome": -81500000, "interestIncome": 5400000, "interestExpense": 86900000, "depreciationAndAmortization": 369300000, "ebitda": 2050100000, "ebit": 1680800000, "nonOperatingIncomeExcludingInterest": -163500000, "operatingIncome": 1517300000, "totalOtherIncomeExpensesNet": 76600000, "incomeBeforeTax": 1593900000, "incomeTaxExpense": 203700000, "netIncomeFromContinuingOperations": 1390200000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 1390200000, "netIncomeDeductions": 0, "bottomLineNetIncome": 1390200000, "eps": 1.53, "epsDiluted": 1.53, "weightedAverageShsOut": 907300000, "weightedAverageShsOutDil": 910400000}}
{"date": "2021-03-31", "symbol": "LLY", "type": "income_statement_quarter", "result": {"date": "2021-03-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2021-04-30", "acceptedDate": "2021-04-30 09:23:35", "fiscalYear": "2021", "period": "Q1", "revenue": 6805600000, "costOfRevenue": 1878600000, "grossProfit": 4927000000, "researchAndDevelopmentExpenses": 1672100000, "generalAndAdministrativeExpenses": 1502600000, "sellingAndMarketingExpenses": 0, "sellingGeneralAndAdministrativeExpenses": 1502600000, "otherExpenses": 0, "operatingExpenses": 3174700000, "costAndExpenses": 5053300000, "netInterestIncome": -82300000, "interestIncome": 5500000, "interestExpense": 87800000, "depreciationAndAmortization": 350300000, "ebitda": 1914500000, "ebit": 1564200000, "nonOperatingIncomeExcludingInterest": 188100000, "operatingIncome": 1752300000, "totalOtherIncomeExpensesNet": -275900000, "incomeBeforeTax": 1476400000, "incomeTaxExpense": 121100000, "netIncomeFromContinuingOperations": 1355300000, "netIncomeFromDiscontinuedOperations": 0, "otherAdjustmentsToNetIncome": 0, "netIncome": 1355300000, "netIncomeDeductions": 0, "bottomLineNetIncome": 1355300000, "eps": 1.41, "epsDiluted": 1.41, "weightedAverageShsOut": 959482000, "weightedAverageShsOutDil": 959482000}}
{"date": "2024-12-31", "symbol": "LLY", "type": "balance_sheet_annual", "result": {"date": "2024-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2025-02-19", "acceptedDate": "2025-02-19 10:10:59", "fiscalYear": "2024", "period": "FY", "cashAndCashEquivalents": 3268400000, "shortTermInvestments": 154800000, "cashAndShortTermInvestments": 3423200000, "netReceivables": 13275400000, "accountsReceivables": 11005700000, "otherReceivables": 2269700000, "inventory": 7589200000, "prepaids": 8340500000, "otherCurrentAssets": 111400000, "totalCurrentAssets": 32739700000, "propertyPlantEquipmentNet": 17102400000, "goodwill": 5770300000, "intangibleAssets": 6166300000, "goodwillAndIntangibleAssets": 11936600000, "longTermInvestments": 3215900000, "taxAssets": 8000600000, "otherNonCurrentAssets": 5719700000, "totalNonCurrentAssets": 45975200000, "otherAssets": 0, "totalAssets": 78714900000, "totalPayables": 4574900000, "accountPayables": 3228600000, "otherPayables": 1346300000, "accruedExpenses": 11539300000, "shortTermDebt": 5117100000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 7145300000, "totalCurrentLiabilities": 28376600000, "longTermDebt": 28527100000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 0, "otherNonCurrentLiabilities": 7539600000, "totalNonCurrentLiabilities": 36066700000, "otherLiabilities": 0, "capitalLeaseObligations": 1146600000, "totalLiabilities": 64443300000, "treasuryStock": -49500000, "preferredStock": 0, "commonStock": 592400000, "retainedEarnings": 13545000000, "additionalPaidInCapital": 7439300000, "accumulatedOtherComprehensiveIncomeLoss": -4321900000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 14192100000, "totalEquity": 14271600000, "minorityInterest": 79500000, "totalLiabilitiesAndTotalEquity": 78714900000, "totalInvestments": 3370700000, "totalDebt": 33644200000, "netDebt": 30375800000}}
{"date": "2023-12-31", "symbol": "LLY", "type": "balance_sheet_annual", "result": {"date": "2023-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2024-02-21", "acceptedDate": "2024-02-21 11:44:37", "fiscalYear": "2023", "period": "FY", "cashAndCashEquivalents": 2818600000, "shortTermInvestments": 109100000, "cashAndShortTermInvestments": 2927700000, "netReceivables": 11336200000, "accountsReceivables": 9090500000, "otherReceivables": 2245700000, "inventory": 5772800000, "prepaids": 5540800000, "otherCurrentAssets": 149500000, "totalCurrentAssets": 25727000000, "propertyPlantEquipmentNet": 12913600000, "goodwill": 4939700000, "intangibleAssets": 6906600000, "goodwillAndIntangibleAssets": 11846300000, "longTermInvestments": 3052200000, "taxAssets": 5477300000, "otherNonCurrentAssets": 4989900000, "totalNonCurrentAssets": 38279300000, "otherAssets": 0, "totalAssets": 64006300000, "totalPayables": 2598800000, "accountPayables": 2598800000, "otherPayables": 0, "accruedExpenses": 1650400000, "shortTermDebt": 6904500000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 3849200000, "deferredRevenue": 0, "otherCurrentLiabilities": 16139500000, "totalCurrentLiabilities": 27293200000, "longTermDebt": 18320800000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 0, "otherNonCurrentLiabilities": 7528600000, "totalNonCurrentLiabilities": 25849400000, "otherLiabilities": 0, "capitalLeaseObligations": 1107400000, "totalLiabilities": 53142600000, "treasuryStock": -44200000, "preferredStock": 0, "commonStock": 593600000, "retainedEarnings": 10312300000, "additionalPaidInCapital": 7250400000, "accumulatedOtherComprehensiveIncomeLoss": -4327000000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 10771900000, "totalEquity": 10863700000, "minorityInterest": 91800000, "totalLiabilitiesAndTotalEquity": 64006300000, "totalInvestments": 3161300000, "totalDebt": 25225300000, "netDebt": 22406700000}}
{"date": "2022-12-31", "symbol": "LLY", "type": "balance_sheet_annual", "result": {"date": "2022-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2023-02-22", "acceptedDate": "2023-02-22 10:26:53", "fiscalYear": "2022", "period": "FY", "cashAndCashEquivalents": 2067000000, "shortTermInvestments": 144800000, "cashAndShortTermInvestments": 2211800000, "netReceivables": 8558900000, "accountsReceivables": 6896000000, "otherReceivables": 1662900000, "inventory": 4309700000, "prepaids": 2946800000, "otherCurrentAssets": 7300000, "totalCurrentAssets": 18034500000, "propertyPlantEquipmentNet": 10144000000, "goodwill": 4073000000, "intangibleAssets": 7206600000, "goodwillAndIntangibleAssets": 11279600000, "longTermInvestments": 2901800000, "taxAssets": 2792900000, "otherNonCurrentAssets": 4337000000, "totalNonCurrentAssets": 31455300000, "otherAssets": 0, "totalAssets": 49489800000, "totalPayables": 2947800000, "accountPayables": 1930600000, "otherPayables": 1017200000, "accruedExpenses": 8784100000, "shortTermDebt": 1501100000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 475100000, "deferredRevenue": 0, "otherCurrentLiabilities": 3905200000, "totalCurrentLiabilities": 17138200000, "longTermDebt": 14737500000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 87300000, "otherNonCurrentLiabilities": 6751400000, "totalNonCurrentLiabilities": 21576200000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 38714400000, "treasuryStock": -50500000, "preferredStock": 0, "commonStock": 594100000, "retainedEarnings": 10042600000, "additionalPaidInCapital": 6921400000, "accumulatedOtherComprehensiveIncomeLoss": -3844600000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 10649800000, "totalEquity": 10775400000, "minorityInterest": 125600000, "totalLiabilitiesAndTotalEquity": 49489800000, "totalInvestments": 3046600000, "totalDebt": 16238600000, "netDebt": 14171600000}}
{"date": "2021-12-31", "symbol": "LLY", "type": "balance_sheet_annual", "result": {"date": "2021-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2022-02-23", "acceptedDate": "2022-02-23 11:00:57", "fiscalYear": "2021", "period": "FY", "cashAndCashEquivalents": 3818500000, "shortTermInvestments": 90100000, "cashAndShortTermInvestments": 3908600000, "netReceivables": 8127200000, "accountsReceivables": 6672800000, "otherReceivables": 1454400000, "inventory": 3886000000, "prepaids": 2530600000, "otherCurrentAssets": 0, "totalCurrentAssets": 18452400000, "propertyPlantEquipmentNet": 8985100000, "goodwill": 3892000000, "intangibleAssets": 7691900000, "goodwillAndIntangibleAssets": 11583900000, "longTermInvestments": 3212600000, "taxAssets": 2489300000, "otherNonCurrentAssets": 4082700000, "totalNonCurrentAssets": 30353600000, "otherAssets": 0, "totalAssets": 48806000000, "totalPayables": 1797500000, "accountPayables": 1670600000, "otherPayables": 126900000, "accruedExpenses": 1034300000, "shortTermDebt": 1538300000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 126900000, "deferredRevenue": 0, "otherCurrentLiabilities": 10682600000, "totalCurrentLiabilities": 15052700000, "longTermDebt": 15346400000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1733700000, "otherNonCurrentLiabilities": 7518400000, "totalNonCurrentLiabilities": 24598500000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 39651200000, "treasuryStock": -52700000, "preferredStock": 0, "commonStock": 596300000, "retainedEarnings": 8958500000, "additionalPaidInCapital": 6833400000, "accumulatedOtherComprehensiveIncomeLoss": -4343100000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 8979200000, "totalEquity": 9154800000, "minorityInterest": 175600000, "totalLiabilitiesAndTotalEquity": 48806000000, "totalInvestments": 3302700000, "totalDebt": 16884700000, "netDebt": 13066200000}}
{"date": "2025-09-30", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2025-09-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2025-10-30", "acceptedDate": "2025-10-30 11:15:28", "fiscalYear": "2025", "period": "Q3", "cashAndCashEquivalents": 9791900000, "shortTermInvestments": 121600000, "cashAndShortTermInvestments": 9913500000, "netReceivables": 19457200000, "accountsReceivables": 16107400000, "otherReceivables": 3349800000, "inventory": 12180400000, "prepaids": 20248700000, "otherCurrentAssets": 271500000, "totalCurrentAssets": 62071300000, "propertyPlantEquipmentNet": 22316000000, "goodwill": 5898000000, "intangibleAssets": 6446700000, "goodwillAndIntangibleAssets": 12344700000, "longTermInvestments": 2808300000, "taxAssets": 8962700000, "otherNonCurrentAssets": 6432400000, "totalNonCurrentAssets": 52864100000, "otherAssets": 0, "totalAssets": 114935400000, "totalPayables": 4262200000, "accountPayables": 4262200000, "otherPayables": 0, "accruedExpenses": 0, "shortTermDebt": 1633000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 9444400000, "deferredRevenue": 0, "otherCurrentLiabilities": 34245700000, "totalCurrentLiabilities": 40140900000, "longTermDebt": 40873600000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 6293600000, "otherNonCurrentLiabilities": 3776500000, "totalNonCurrentLiabilities": 50943700000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 91084600000, "treasuryStock": -62500000, "preferredStock": 0, "commonStock": 591400000, "retainedEarnings": 22252000000, "additionalPaidInCapital": 7231900000, "accumulatedOtherComprehensiveIncomeLoss": -3206300000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 23793300000, "totalEquity": 23850800000, "minorityInterest": 57500000, "totalLiabilitiesAndTotalEquity": 114935400000, "totalInvestments": 2929900000, "totalDebt": 42506600000, "netDebt": 32714700000}}
{"date": "2025-06-30", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2025-06-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2025-08-07", "acceptedDate": "2025-08-07 09:59:55", "fiscalYear": "2025", "period": "Q2", "cashAndCashEquivalents": 3375900000, "shortTermInvestments": 170100000, "cashAndShortTermInvestments": 3546000000, "netReceivables": 17205600000, "accountsReceivables": 14170400000, "otherReceivables": 3035200000, "inventory": 11013800000, "prepaids": 18019800000, "otherCurrentAssets": 68800000, "totalCurrentAssets": 49854000000, "propertyPlantEquipmentNet": 20529700000, "goodwill": 5770500000, "intangibleAssets": 5908300000, "goodwillAndIntangibleAssets": 11678800000, "longTermInvestments": 3207400000, "taxAssets": 9427400000, "otherNonCurrentAssets": 6225300000, "totalNonCurrentAssets": 51068600000, "otherAssets": 0, "totalAssets": 100922600000, "totalPayables": 12378900000, "accountPayables": 4075700000, "otherPayables": 8303200000, "accruedExpenses": 14537400000, "shortTermDebt": 5723700000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 6958000000, "deferredRevenue": 0, "otherCurrentLiabilities": 6379900000, "totalCurrentLiabilities": 39019900000, "longTermDebt": 34180100000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 0, "otherNonCurrentLiabilities": 9373500000, "totalNonCurrentLiabilities": 43553600000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 82573500000, "treasuryStock": -55400000, "preferredStock": 0, "commonStock": 592000000, "retainedEarnings": 17376200000, "additionalPaidInCapital": 7089300000, "accumulatedOtherComprehensiveIncomeLoss": -3716000000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 18272900000, "totalEquity": 18349100000, "minorityInterest": 76200000, "totalLiabilitiesAndTotalEquity": 100922600000, "totalInvestments": 3377500000, "totalDebt": 39903800000, "netDebt": 36527900000}}
{"date": "2025-03-31", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2025-03-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2025-05-01", "acceptedDate": "2025-05-01 11:30:18", "fiscalYear": "2025", "period": "Q1", "cashAndCashEquivalents": 3093300000, "shortTermInvestments": 127400000, "cashAndShortTermInvestments": 3220700000, "netReceivables": 14003200000, "accountsReceivables": 12036600000, "otherReceivables": 1966600000, "inventory": 9311000000, "prepaids": 14653900000, "otherCurrentAssets": 72400000, "totalCurrentAssets": 41261200000, "propertyPlantEquipmentNet": 18474100000, "goodwill": 5770500000, "intangibleAssets": 6012200000, "goodwillAndIntangibleAssets": 11782700000, "longTermInvestments": 3222700000, "taxAssets": 8573200000, "otherNonCurrentAssets": 6074900000, "totalNonCurrentAssets": 48127600000, "otherAssets": 0, "totalAssets": 89388800000, "totalPayables": 9617700000, "accountPayables": 3442000000, "otherPayables": 6175700000, "accruedExpenses": 11550300000, "shortTermDebt": 4016400000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 6175700000, "deferredRevenue": 0, "otherCurrentLiabilities": 4883700000, "totalCurrentLiabilities": 30068100000, "longTermDebt": 34499500000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 0, "otherNonCurrentLiabilities": 8974400000, "totalNonCurrentLiabilities": 43473900000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 73542000000, "treasuryStock": -49500000, "preferredStock": 0, "commonStock": 592600000, "retainedEarnings": 15099500000, "additionalPaidInCapital": 6910000000, "accumulatedOtherComprehensiveIncomeLoss": -3774600000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 15764800000, "totalEquity": 15846800000, "minorityInterest": 82000000, "totalLiabilitiesAndTotalEquity": 89388800000, "totalInvestments": 3350100000, "totalDebt": 38515900000, "netDebt": 35422600000}}
{"date": "2024-12-31", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2024-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2025-02-19", "acceptedDate": "2025-02-19 10:10:59", "fiscalYear": "2024", "period": "Q4", "cashAndCashEquivalents": 3268400000, "shortTermInvestments": 154800000, "cashAndShortTermInvestments": 3423200000, "netReceivables": 13275400000, "accountsReceivables": 11005700000, "otherReceivables": 2269700000, "inventory": 7589200000, "prepaids": 8340500000, "otherCurrentAssets": 111400000, "totalCurrentAssets": 32739700000, "propertyPlantEquipmentNet": 17102400000, "goodwill": 5770300000, "intangibleAssets": 6166300000, "goodwillAndIntangibleAssets": 11936600000, "longTermInvestments": 3215900000, "taxAssets": 8000600000, "otherNonCurrentAssets": 5719700000, "totalNonCurrentAssets": 45975200000, "otherAssets": 0, "totalAssets": 78714900000, "totalPayables": 4574900000, "accountPayables": 3228600000, "otherPayables": 1346300000, "accruedExpenses": 11539300000, "shortTermDebt": 5117100000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 0, "deferredRevenue": 0, "otherCurrentLiabilities": 7145300000, "totalCurrentLiabilities": 28376600000, "longTermDebt": 28527100000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 0, "otherNonCurrentLiabilities": 7539600000, "totalNonCurrentLiabilities": 36066700000, "otherLiabilities": 0, "capitalLeaseObligations": 1146600000, "totalLiabilities": 64443300000, "treasuryStock": -49500000, "preferredStock": 0, "commonStock": 592400000, "retainedEarnings": 13545000000, "additionalPaidInCapital": 7439300000, "accumulatedOtherComprehensiveIncomeLoss": -4321900000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 14192100000, "totalEquity": 14271600000, "minorityInterest": 79500000, "totalLiabilitiesAndTotalEquity": 78714900000, "totalInvestments": 3370700000, "totalDebt": 33644200000, "netDebt": 30375800000}}
{"date": "2024-09-30", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2024-09-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2024-10-30", "acceptedDate": "2024-10-30 11:54:10", "fiscalYear": "2024", "period": "Q3", "cashAndCashEquivalents": 3369000000, "shortTermInvestments": 149400000, "cashAndShortTermInvestments": 3518400000, "netReceivables": 12051700000, "accountsReceivables": 10294800000, "otherReceivables": 1756900000, "inventory": 7459800000, "prepaids": 8250600000, "otherCurrentAssets": 134600000, "totalCurrentAssets": 31415100000, "propertyPlantEquipmentNet": 16171800000, "goodwill": 5768400000, "intangibleAssets": 6537300000, "goodwillAndIntangibleAssets": 12305700000, "longTermInvestments": 3200200000, "taxAssets": 7392300000, "otherNonCurrentAssets": 5121800000, "totalNonCurrentAssets": 44191800000, "otherAssets": 0, "totalAssets": 75606900000, "totalPayables": 2886500000, "accountPayables": 2886500000, "otherPayables": 0, "accruedExpenses": 1703300000, "shortTermDebt": 2074300000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 3878800000, "deferredRevenue": 0, "otherCurrentLiabilities": 18010000000, "totalCurrentLiabilities": 24674100000, "longTermDebt": 29045400000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 0, "otherNonCurrentLiabilities": 7566700000, "totalNonCurrentLiabilities": 36612100000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 61286200000, "treasuryStock": -32700000, "preferredStock": 0, "commonStock": 593900000, "retainedEarnings": 13627200000, "additionalPaidInCapital": 7339600000, "accumulatedOtherComprehensiveIncomeLoss": -4274800000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 14240000000, "totalEquity": 14320700000, "minorityInterest": 80700000, "totalLiabilitiesAndTotalEquity": 75606900000, "totalInvestments": 3349600000, "totalDebt": 31119700000, "netDebt": 27750700000}}
{"date": "2024-06-30", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2024-06-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2024-08-08", "acceptedDate": "2024-08-08 11:28:54", "fiscalYear": "2024", "period": "Q2", "cashAndCashEquivalents": 3223600000, "shortTermInvestments": 140400000, "cashAndShortTermInvestments": 3364000000, "netReceivables": 13079000000, "accountsReceivables": 11027900000, "otherReceivables": 2051100000, "inventory": 6481500000, "prepaids": 7137600000, "otherCurrentAssets": 142200000, "totalCurrentAssets": 30204300000, "propertyPlantEquipmentNet": 14829400000, "goodwill": 5768200000, "intangibleAssets": 6636100000, "goodwillAndIntangibleAssets": 12404300000, "longTermInvestments": 2924600000, "taxAssets": 6655300000, "otherNonCurrentAssets": 4856900000, "totalNonCurrentAssets": 41670500000, "otherAssets": 0, "totalAssets": 71874800000, "totalPayables": 2924800000, "accountPayables": 2924800000, "otherPayables": 0, "accruedExpenses": 1168300000, "shortTermDebt": 5161600000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 3496600000, "deferredRevenue": 0, "otherCurrentLiabilities": 17866500000, "totalCurrentLiabilities": 27121200000, "longTermDebt": 23730400000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 0, "otherNonCurrentLiabilities": 7387700000, "totalNonCurrentLiabilities": 31118100000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 58239300000, "treasuryStock": -32700000, "preferredStock": 0, "commonStock": 594200000, "retainedEarnings": 13178000000, "additionalPaidInCapital": 7214200000, "accumulatedOtherComprehensiveIncomeLoss": -4378500000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 13562000000, "totalEquity": 13635500000, "minorityInterest": 73500000, "totalLiabilitiesAndTotalEquity": 71874800000, "totalInvestments": 3065000000, "totalDebt": 28892000000, "netDebt": 25668400000}}
{"date": "2024-03-31", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2024-03-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2024-04-30", "acceptedDate": "2024-04-30 12:04:51", "fiscalYear": "2024", "period": "Q1", "cashAndCashEquivalents": 2460200000, "shortTermInvestments": 126100000, "cashAndShortTermInvestments": 2586300000, "netReceivables": 10013500000, "accountsReceivables": 7885600000, "otherReceivables": 2127900000, "inventory": 6101800000, "prepaids": 6348600000, "otherCurrentAssets": 138600000, "totalCurrentAssets": 25188800000, "propertyPlantEquipmentNet": 13624000000, "goodwill": 4939600000, "intangibleAssets": 6762200000, "goodwillAndIntangibleAssets": 11701800000, "longTermInvestments": 3086900000, "taxAssets": 5633900000, "otherNonCurrentAssets": 4708100000, "totalNonCurrentAssets": 38754700000, "otherAssets": 0, "totalAssets": 63943500000, "totalPayables": 2473700000, "accountPayables": 2473700000, "otherPayables": 0, "accruedExpenses": 844200000, "shortTermDebt": 1651500000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 4189400000, "deferredRevenue": 0, "otherCurrentLiabilities": 13628700000, "totalCurrentLiabilities": 18598100000, "longTermDebt": 24559900000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 0, "otherNonCurrentLiabilities": 7888100000, "totalNonCurrentLiabilities": 32448000000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 51046100000, "treasuryStock": -32700000, "preferredStock": 0, "commonStock": 594200000, "retainedEarnings": 12553900000, "additionalPaidInCapital": 7009500000, "accumulatedOtherComprehensiveIncomeLoss": -4299500000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 12812200000, "totalEquity": 12897400000, "minorityInterest": 85200000, "totalLiabilitiesAndTotalEquity": 63943500000, "totalInvestments": 3213000000, "totalDebt": 26211400000, "netDebt": 23751200000}}
{"date": "2023-12-31", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2023-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2024-02-21", "acceptedDate": "2024-02-21 11:44:37", "fiscalYear": "2023", "period": "Q4", "cashAndCashEquivalents": 2818600000, "shortTermInvestments": 109100000, "cashAndShortTermInvestments": 2927700000, "netReceivables": 11336200000, "accountsReceivables": 9090500000, "otherReceivables": 2245700000, "inventory": 5772800000, "prepaids": 5540800000, "otherCurrentAssets": 149500000, "totalCurrentAssets": 25727000000, "propertyPlantEquipmentNet": 12913600000, "goodwill": 4939700000, "intangibleAssets": 6906600000, "goodwillAndIntangibleAssets": 11846300000, "longTermInvestments": 3052200000, "taxAssets": 5477300000, "otherNonCurrentAssets": 4989900000, "totalNonCurrentAssets": 38279300000, "otherAssets": 0, "totalAssets": 64006300000, "totalPayables": 2598800000, "accountPayables": 2598800000, "otherPayables": 0, "accruedExpenses": 1650400000, "shortTermDebt": 6904500000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 3849200000, "deferredRevenue": 0, "otherCurrentLiabilities": 16139500000, "totalCurrentLiabilities": 27293200000, "longTermDebt": 18320800000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 0, "otherNonCurrentLiabilities": 7528600000, "totalNonCurrentLiabilities": 25849400000, "otherLiabilities": 0, "capitalLeaseObligations": 1107400000, "totalLiabilities": 53142600000, "treasuryStock": -44200000, "preferredStock": 0, "commonStock": 593600000, "retainedEarnings": 10312300000, "additionalPaidInCapital": 7250400000, "accumulatedOtherComprehensiveIncomeLoss": -4327000000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 10771900000, "totalEquity": 10863700000, "minorityInterest": 91800000, "totalLiabilitiesAndTotalEquity": 64006300000, "totalInvestments": 3161300000, "totalDebt": 25225300000, "netDebt": 22406700000}}
{"date": "2023-09-30", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2023-09-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2023-11-02", "acceptedDate": "2023-11-02 11:21:53", "fiscalYear": "2023", "period": "Q3", "cashAndCashEquivalents": 2380800000, "shortTermInvestments": 113100000, "cashAndShortTermInvestments": 2493900000, "netReceivables": 10363800000, "accountsReceivables": 8167100000, "otherReceivables": 2196700000, "inventory": 4901400000, "prepaids": 0, "otherCurrentAssets": 5247900000, "totalCurrentAssets": 23007000000, "propertyPlantEquipmentNet": 11863200000, "goodwill": 4085200000, "intangibleAssets": 6781700000, "goodwillAndIntangibleAssets": 10866900000, "longTermInvestments": 2691700000, "taxAssets": 4574800000, "otherNonCurrentAssets": 4911900000, "totalNonCurrentAssets": 34908500000, "otherAssets": 0, "totalAssets": 57915500000, "totalPayables": 4412600000, "accountPayables": 2435100000, "otherPayables": 1977500000, "accruedExpenses": 1233200000, "shortTermDebt": 2244700000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1977500000, "deferredRevenue": 0, "otherCurrentLiabilities": 14107700000, "totalCurrentLiabilities": 21998200000, "longTermDebt": 17923600000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 0, "otherNonCurrentLiabilities": 6686300000, "totalNonCurrentLiabilities": 24609900000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 46608100000, "treasuryStock": -45000000, "preferredStock": 0, "commonStock": 593600000, "retainedEarnings": 10309900000, "additionalPaidInCapital": 7160000000, "accumulatedOtherComprehensiveIncomeLoss": -3784900000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 11220400000, "totalEquity": 11307400000, "minorityInterest": 87000000, "totalLiabilitiesAndTotalEquity": 57915500000, "totalInvestments": 2804800000, "totalDebt": 20168300000, "netDebt": 17787500000}}
{"date": "2023-06-30", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2023-06-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2023-08-08", "acceptedDate": "2023-08-08 13:23:19", "fiscalYear": "2023", "period": "Q2", "cashAndCashEquivalents": 2694500000, "shortTermInvestments": 134600000, "cashAndShortTermInvestments": 2829100000, "netReceivables": 9171400000, "accountsReceivables": 7516100000, "otherReceivables": 1655300000, "inventory": 4798700000, "prepaids": 0, "otherCurrentAssets": 4532400000, "totalCurrentAssets": 21331600000, "propertyPlantEquipmentNet": 11277400000, "goodwill": 4078900000, "intangibleAssets": 6903500000, "goodwillAndIntangibleAssets": 10982400000, "longTermInvestments": 2745100000, "taxAssets": 3805900000, "otherNonCurrentAssets": 4671600000, "totalNonCurrentAssets": 33482400000, "otherAssets": 0, "totalAssets": 54814000000, "totalPayables": 3708000000, "accountPayables": 2474200000, "otherPayables": 1233800000, "accruedExpenses": 867700000, "shortTermDebt": 661600000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1233800000, "deferredRevenue": 0, "otherCurrentLiabilities": 13677700000, "totalCurrentLiabilities": 18915000000, "longTermDebt": 18158400000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 0, "otherNonCurrentLiabilities": 6591300000, "totalNonCurrentLiabilities": 24749700000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 43664700000, "treasuryStock": -45000000, "preferredStock": 0, "commonStock": 593600000, "retainedEarnings": 10368500000, "additionalPaidInCapital": 6948600000, "accumulatedOtherComprehensiveIncomeLoss": -3788700000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 11063800000, "totalEquity": 11149300000, "minorityInterest": 85500000, "totalLiabilitiesAndTotalEquity": 54814000000, "totalInvestments": 2879700000, "totalDebt": 18820000000, "netDebt": 16125500000}}
{"date": "2023-03-31", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2023-03-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2023-04-27", "acceptedDate": "2023-04-27 11:56:56", "fiscalYear": "2023", "period": "Q1", "cashAndCashEquivalents": 3545900000, "shortTermInvestments": 123400000, "cashAndShortTermInvestments": 3669300000, "netReceivables": 9022100000, "accountsReceivables": 7526200000, "otherReceivables": 1495900000, "inventory": 4544800000, "prepaids": 0, "otherCurrentAssets": 3575200000, "totalCurrentAssets": 20811400000, "propertyPlantEquipmentNet": 10546200000, "goodwill": 4073100000, "intangibleAssets": 7087100000, "goodwillAndIntangibleAssets": 11160200000, "longTermInvestments": 2750400000, "taxAssets": 3406700000, "otherNonCurrentAssets": 4488100000, "totalNonCurrentAssets": 32351600000, "otherAssets": 0, "totalAssets": 53163000000, "totalPayables": 3544200000, "accountPayables": 2015900000, "otherPayables": 1528300000, "accruedExpenses": 739700000, "shortTermDebt": 3100000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 1528300000, "deferredRevenue": 0, "otherCurrentLiabilities": 11723000000, "totalCurrentLiabilities": 16010000000, "longTermDebt": 18880500000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 0, "otherNonCurrentLiabilities": 6977600000, "totalNonCurrentLiabilities": 25858100000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 41868100000, "treasuryStock": -45000000, "preferredStock": 0, "commonStock": 593500000, "retainedEarnings": 10639300000, "additionalPaidInCapital": 6793100000, "accumulatedOtherComprehensiveIncomeLoss": -3777300000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 11190400000, "totalEquity": 11294900000, "minorityInterest": 104500000, "totalLiabilitiesAndTotalEquity": 53163000000, "totalInvestments": 2873800000, "totalDebt": 18883600000, "netDebt": 15337700000}}
{"date": "2022-12-31", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2022-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2023-02-22", "acceptedDate": "2023-02-22 10:26:53", "fiscalYear": "2022", "period": "Q4", "cashAndCashEquivalents": 2067000000, "shortTermInvestments": 144800000, "cashAndShortTermInvestments": 2211800000, "netReceivables": 8558900000, "accountsReceivables": 6896000000, "otherReceivables": 1662900000, "inventory": 4309700000, "prepaids": 2946800000, "otherCurrentAssets": 7300000, "totalCurrentAssets": 18034500000, "propertyPlantEquipmentNet": 10144000000, "goodwill": 4073000000, "intangibleAssets": 7206600000, "goodwillAndIntangibleAssets": 11279600000, "longTermInvestments": 2901800000, "taxAssets": 2792900000, "otherNonCurrentAssets": 4337000000, "totalNonCurrentAssets": 31455300000, "otherAssets": 0, "totalAssets": 49489800000, "totalPayables": 2405700000, "accountPayables": 1930600000, "otherPayables": 475100000, "accruedExpenses": 1059800000, "shortTermDebt": 1501100000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 475100000, "deferredRevenue": 0, "otherCurrentLiabilities": 12171600000, "totalCurrentLiabilities": 17138200000, "longTermDebt": 14737500000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 87300000, "otherNonCurrentLiabilities": 6751400000, "totalNonCurrentLiabilities": 21576200000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 38714400000, "treasuryStock": -50500000, "preferredStock": 0, "commonStock": 594100000, "retainedEarnings": 10042600000, "additionalPaidInCapital": 6921400000, "accumulatedOtherComprehensiveIncomeLoss": -3844600000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 10649800000, "totalEquity": 10775400000, "minorityInterest": 125600000, "totalLiabilitiesAndTotalEquity": 49489800000, "totalInvestments": 3046600000, "totalDebt": 16238600000, "netDebt": 14171600000}}
{"date": "2022-09-30", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2022-09-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2022-11-01", "acceptedDate": "2022-11-01 11:16:21", "fiscalYear": "2022", "period": "Q3", "cashAndCashEquivalents": 2617400000, "shortTermInvestments": 124700000, "cashAndShortTermInvestments": 2742100000, "netReceivables": 8324800000, "accountsReceivables": 6715300000, "otherReceivables": 1609500000, "inventory": 3831100000, "prepaids": 2741900000, "otherCurrentAssets": 0, "totalCurrentAssets": 17639900000, "propertyPlantEquipmentNet": 9311300000, "goodwill": 3891600000, "intangibleAssets": 7124100000, "goodwillAndIntangibleAssets": 11015700000, "longTermInvestments": 2574600000, "taxAssets": 2384300000, "otherNonCurrentAssets": 4535700000, "totalNonCurrentAssets": 29821600000, "otherAssets": 0, "totalAssets": 47461500000, "totalPayables": 2368800000, "accountPayables": 1683200000, "otherPayables": 685600000, "accruedExpenses": 984100000, "shortTermDebt": 1744600000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 685600000, "deferredRevenue": 0, "otherCurrentLiabilities": 10555300000, "totalCurrentLiabilities": 15652800000, "longTermDebt": 14143800000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 171900000, "otherNonCurrentLiabilities": 7327100000, "totalNonCurrentLiabilities": 21642800000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 37295600000, "treasuryStock": -50500000, "preferredStock": 0, "commonStock": 594100000, "retainedEarnings": 10006500000, "additionalPaidInCapital": 6829000000, "accumulatedOtherComprehensiveIncomeLoss": -4295800000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 10070100000, "totalEquity": 10165900000, "minorityInterest": 95800000, "totalLiabilitiesAndTotalEquity": 47461500000, "totalInvestments": 2699300000, "totalDebt": 15888400000, "netDebt": 13271000000}}
{"date": "2022-06-30", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2022-06-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2022-08-04", "acceptedDate": "2022-08-04 11:31:24", "fiscalYear": "2022", "period": "Q2", "cashAndCashEquivalents": 2622900000, "shortTermInvestments": 113800000, "cashAndShortTermInvestments": 2736700000, "netReceivables": 7672400000, "accountsReceivables": 6364500000, "otherReceivables": 1307900000, "inventory": 3899400000, "prepaids": 2806700000, "otherCurrentAssets": 0, "totalCurrentAssets": 17115200000, "propertyPlantEquipmentNet": 9128200000, "goodwill": 3891800000, "intangibleAssets": 7497700000, "goodwillAndIntangibleAssets": 11389500000, "longTermInvestments": 2587200000, "taxAssets": 2371900000, "otherNonCurrentAssets": 4471600000, "totalNonCurrentAssets": 29948400000, "otherAssets": 0, "totalAssets": 47063600000, "totalPayables": 1785900000, "accountPayables": 1659300000, "otherPayables": 126600000, "accruedExpenses": 835800000, "shortTermDebt": 2121800000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 126600000, "deferredRevenue": 0, "otherCurrentLiabilities": 10877100000, "totalCurrentLiabilities": 15620600000, "longTermDebt": 14692000000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 862500000, "otherNonCurrentLiabilities": 7229300000, "totalNonCurrentLiabilities": 22783800000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 38404400000, "treasuryStock": -50500000, "preferredStock": 0, "commonStock": 594100000, "retainedEarnings": 8556000000, "additionalPaidInCapital": 6746000000, "accumulatedOtherComprehensiveIncomeLoss": -4287700000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 8544700000, "totalEquity": 8659200000, "minorityInterest": 114500000, "totalLiabilitiesAndTotalEquity": 47063600000, "totalInvestments": 2701000000, "totalDebt": 16813800000, "netDebt": 14190900000}}
{"date": "2022-03-31", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2022-03-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2022-04-29", "acceptedDate": "2022-04-29 11:57:54", "fiscalYear": "2022", "period": "Q1", "cashAndCashEquivalents": 2459200000, "shortTermInvestments": 109100000, "cashAndShortTermInvestments": 2568300000, "netReceivables": 7805700000, "accountsReceivables": 6322500000, "otherReceivables": 1483200000, "inventory": 3893000000, "prepaids": 2697700000, "otherCurrentAssets": 0, "totalCurrentAssets": 16964700000, "propertyPlantEquipmentNet": 9102700000, "goodwill": 3892000000, "intangibleAssets": 7482400000, "goodwillAndIntangibleAssets": 11374400000, "longTermInvestments": 2727300000, "taxAssets": 2464900000, "otherNonCurrentAssets": 4285300000, "totalNonCurrentAssets": 29954600000, "otherAssets": 0, "totalAssets": 46919300000, "totalPayables": 2031600000, "accountPayables": 1433300000, "otherPayables": 598300000, "accruedExpenses": 693100000, "shortTermDebt": 1355900000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 598300000, "deferredRevenue": 0, "otherCurrentLiabilities": 9305400000, "totalCurrentLiabilities": 13386000000, "longTermDebt": 15152900000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1286100000, "otherNonCurrentLiabilities": 7632300000, "totalNonCurrentLiabilities": 24071300000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 37457300000, "treasuryStock": -50500000, "preferredStock": 0, "commonStock": 594100000, "retainedEarnings": 9369400000, "additionalPaidInCapital": 6656300000, "accumulatedOtherComprehensiveIncomeLoss": -4225300000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 9330800000, "totalEquity": 9462000000, "minorityInterest": 131200000, "totalLiabilitiesAndTotalEquity": 46919300000, "totalInvestments": 2836400000, "totalDebt": 16508800000, "netDebt": 14049600000}}
{"date": "2021-12-31", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2021-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2022-02-23", "acceptedDate": "2022-02-23 11:00:57", "fiscalYear": "2021", "period": "Q4", "cashAndCashEquivalents": 3818500000, "shortTermInvestments": 90100000, "cashAndShortTermInvestments": 3908600000, "netReceivables": 8127200000, "accountsReceivables": 6672800000, "otherReceivables": 1454400000, "inventory": 3886000000, "prepaids": 2530600000, "otherCurrentAssets": 0, "totalCurrentAssets": 18452400000, "propertyPlantEquipmentNet": 8985100000, "goodwill": 3892000000, "intangibleAssets": 7691900000, "goodwillAndIntangibleAssets": 11583900000, "longTermInvestments": 3212600000, "taxAssets": 2489300000, "otherNonCurrentAssets": 4082700000, "totalNonCurrentAssets": 30353600000, "otherAssets": 0, "totalAssets": 48806000000, "totalPayables": 1797500000, "accountPayables": 1670600000, "otherPayables": 126900000, "accruedExpenses": 1034300000, "shortTermDebt": 1538300000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 126900000, "deferredRevenue": 0, "otherCurrentLiabilities": 10682600000, "totalCurrentLiabilities": 15052700000, "longTermDebt": 15346400000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1733700000, "otherNonCurrentLiabilities": 7518400000, "totalNonCurrentLiabilities": 24598500000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 39651200000, "treasuryStock": -52700000, "preferredStock": 0, "commonStock": 596300000, "retainedEarnings": 8958500000, "additionalPaidInCapital": 6833400000, "accumulatedOtherComprehensiveIncomeLoss": -4343100000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 8979200000, "totalEquity": 9154800000, "minorityInterest": 175600000, "totalLiabilitiesAndTotalEquity": 48806000000, "totalInvestments": 3302700000, "totalDebt": 16884700000, "netDebt": 13066200000}}
{"date": "2021-09-30", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2021-09-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2021-10-27", "acceptedDate": "2021-10-27 09:06:59", "fiscalYear": "2021", "period": "Q3", "cashAndCashEquivalents": 3788200000, "shortTermInvestments": 37100000, "cashAndShortTermInvestments": 3825300000, "netReceivables": 7025000000, "accountsReceivables": 5914300000, "otherReceivables": 1110700000, "inventory": 3907400000, "prepaids": 3050600000, "otherCurrentAssets": 0, "totalCurrentAssets": 17808300000, "propertyPlantEquipmentNet": 8920400000, "goodwill": 3884100000, "intangibleAssets": 7887700000, "goodwillAndIntangibleAssets": 11771800000, "longTermInvestments": 3350500000, "taxAssets": 2625600000, "otherNonCurrentAssets": 3710400000, "totalNonCurrentAssets": 30378700000, "otherAssets": 0, "totalAssets": 48187000000, "totalPayables": 1770300000, "accountPayables": 1566800000, "otherPayables": 203500000, "accruedExpenses": 836600000, "shortTermDebt": 1563000000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 203500000, "deferredRevenue": 0, "otherCurrentLiabilities": 9512100000, "totalCurrentLiabilities": 13682000000, "longTermDebt": 15522400000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1632500000, "otherNonCurrentLiabilities": 9396000000, "totalNonCurrentLiabilities": 26550900000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 40232900000, "treasuryStock": -52700000, "preferredStock": 0, "commonStock": 598200000, "retainedEarnings": 9639400000, "additionalPaidInCapital": 6758000000, "accumulatedOtherComprehensiveIncomeLoss": -6172700000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 7757000000, "totalEquity": 7954100000, "minorityInterest": 197100000, "totalLiabilitiesAndTotalEquity": 48187000000, "totalInvestments": 3387600000, "totalDebt": 17085400000, "netDebt": 13297200000}}
{"date": "2021-06-30", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2021-06-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2021-08-03", "acceptedDate": "2021-08-03 12:04:04", "fiscalYear": "2021", "period": "Q2", "cashAndCashEquivalents": 3220000000, "shortTermInvestments": 51200000, "cashAndShortTermInvestments": 3271200000, "netReceivables": 6902800000, "accountsReceivables": 5829400000, "otherReceivables": 1073400000, "inventory": 3824900000, "prepaids": 3296600000, "otherCurrentAssets": 0, "totalCurrentAssets": 17295500000, "propertyPlantEquipmentNet": 8855500000, "goodwill": 3884200000, "intangibleAssets": 7985400000, "goodwillAndIntangibleAssets": 11869600000, "longTermInvestments": 3474900000, "taxAssets": 2674900000, "otherNonCurrentAssets": 3638600000, "totalNonCurrentAssets": 30513500000, "otherAssets": 0, "totalAssets": 47809000000, "totalPayables": 2127700000, "accountPayables": 1597800000, "otherPayables": 529900000, "accruedExpenses": 755500000, "shortTermDebt": 1778500000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 529900000, "deferredRevenue": 0, "otherCurrentLiabilities": 10431500000, "totalCurrentLiabilities": 15093200000, "longTermDebt": 14736600000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 1857300000, "otherNonCurrentLiabilities": 9458400000, "totalNonCurrentLiabilities": 26052300000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 41145500000, "treasuryStock": -52700000, "preferredStock": 0, "commonStock": 598100000, "retainedEarnings": 8530100000, "additionalPaidInCapital": 6669200000, "accumulatedOtherComprehensiveIncomeLoss": -6287100000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 6444400000, "totalEquity": 6663500000, "minorityInterest": 219100000, "totalLiabilitiesAndTotalEquity": 47809000000, "totalInvestments": 3526100000, "totalDebt": 16515100000, "netDebt": 13295100000}}
{"date": "2021-03-31", "symbol": "LLY", "type": "balance_sheet_quarter", "result": {"date": "2021-03-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2021-04-30", "acceptedDate": "2021-04-30 09:23:35", "fiscalYear": "2021", "period": "Q1", "cashAndCashEquivalents": 3002400000, "shortTermInvestments": 49000000, "cashAndShortTermInvestments": 3051400000, "netReceivables": 6658600000, "accountsReceivables": 5592800000, "otherReceivables": 1065800000, "inventory": 3660800000, "prepaids": 3233700000, "otherCurrentAssets": 0, "totalCurrentAssets": 16604500000, "propertyPlantEquipmentNet": 8630100000, "goodwill": 3877400000, "intangibleAssets": 8087800000, "goodwillAndIntangibleAssets": 11965200000, "longTermInvestments": 3232400000, "taxAssets": 2649900000, "otherNonCurrentAssets": 3756200000, "totalNonCurrentAssets": 30233800000, "otherAssets": 0, "totalAssets": 46838300000, "totalPayables": 2431200000, "accountPayables": 1639600000, "otherPayables": 791600000, "accruedExpenses": 649900000, "shortTermDebt": 4900000, "capitalLeaseObligationsCurrent": 0, "taxPayables": 791600000, "deferredRevenue": 0, "otherCurrentLiabilities": 8628200000, "totalCurrentLiabilities": 11714200000, "longTermDebt": 16199600000, "capitalLeaseObligationsNonCurrent": 0, "deferredRevenueNonCurrent": 0, "deferredTaxLiabilitiesNonCurrent": 2200600000, "otherNonCurrentLiabilities": 9624600000, "totalNonCurrentLiabilities": 28024800000, "otherLiabilities": 0, "capitalLeaseObligations": 0, "totalLiabilities": 39739000000, "treasuryStock": -52700000, "preferredStock": 0, "commonStock": 599700000, "retainedEarnings": 9181300000, "additionalPaidInCapital": 6579200000, "accumulatedOtherComprehensiveIncomeLoss": -6395600000, "otherTotalStockholdersEquity": -3013200000, "totalStockholdersEquity": 6898700000, "totalEquity": 7099300000, "minorityInterest": 200600000, "totalLiabilitiesAndTotalEquity": 46838300000, "totalInvestments": 3281400000, "totalDebt": 16204500000, "netDebt": 13202100000}}
{"date": "2024-12-31", "symbol": "LLY", "type": "cash_flow_annual", "result": {"date": "2024-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2025-02-19", "acceptedDate": "2025-02-19 10:10:59", "fiscalYear": "2024", "period": "FY", "netIncome": 10590000000, "depreciationAndAmortization": 1766600000, "deferredIncomeTax": -2683100000, "stockBasedCompensation": 645600000, "changeInWorkingCapital": -5385000000, "accountsReceivables": -2155200000, "inventory": -2507400000, "accountsPayables": 2608800000, "otherWorkingCapital": -3331200000, "otherNonCashItems": 3883800000, "netCashProvidedByOperatingActivities": 8817900000, "investmentsInPropertyPlantAndEquipment": -5057800000, "acquisitionsNet": -947700000, "purchasesOfInvestments": -775800000, "salesMaturitiesOfInvestments": 522500000, "otherInvestingActivities": -3042700000, "netCashProvidedByInvestingActivities": -9301500000, "netDebtIssuance": 8901100000, "longTermNetDebtIssuance": 10752900000, "shortTermNetDebtIssuance": -1851800000, "netStockIssuance": -2500000000, "netCommonStockIssuance": -2500000000, "commonStockIssuance": 0, "commonStockRepurchased": -2500000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -4680400000, "commonDividendsPaid": -4680400000, "preferredDividendsPaid": 0, "otherFinancingActivities": -490600000, "netCashProvidedByFinancingActivities": 1230100000, "effectOfForexChangesOnCash": -296700000, "netChangeInCash": 449800000, "cashAtEndOfPeriod": 3268400000, "cashAtBeginningOfPeriod": 2818600000, "operatingCashFlow": 8817900000, "capitalExpenditure": -8403600000, "freeCashFlow": 414300000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-12-31", "symbol": "LLY", "type": "cash_flow_annual", "result": {"date": "2023-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2024-02-21", "acceptedDate": "2024-02-21 11:44:37", "fiscalYear": "2023", "period": "FY", "netIncome": 5240400000, "depreciationAndAmortization": 1527300000, "deferredIncomeTax": -2341000000, "stockBasedCompensation": 628500000, "changeInWorkingCapital": -3055000000, "accountsReceivables": -2451000000, "inventory": -1425000000, "accountsPayables": 4274400000, "otherWorkingCapital": -3453400000, "otherNonCashItems": 2239900000, "netCashProvidedByOperatingActivities": 4240100000, "investmentsInPropertyPlantAndEquipment": -3447600000, "acquisitionsNet": -1044300000, "purchasesOfInvestments": -829000000, "salesMaturitiesOfInvestments": 700300000, "otherInvestingActivities": -2532100000, "netCashProvidedByInvestingActivities": -7152700000, "netDebtIssuance": 8649900000, "longTermNetDebtIssuance": 3958500000, "shortTermNetDebtIssuance": 4691400000, "netStockIssuance": -750000000, "netCommonStockIssuance": -750000000, "commonStockIssuance": 0, "commonStockRepurchased": -750000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -4069300000, "commonDividendsPaid": -4069300000, "preferredDividendsPaid": 0, "otherFinancingActivities": -335000000, "netCashProvidedByFinancingActivities": 3495600000, "effectOfForexChangesOnCash": 168600000, "netChangeInCash": 751600000, "cashAtEndOfPeriod": 2818600000, "cashAtBeginningOfPeriod": 2067000000, "operatingCashFlow": 4240100000, "capitalExpenditure": -7392100000, "freeCashFlow": -3152000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-12-31", "symbol": "LLY", "type": "cash_flow_annual", "result": {"date": "2022-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2023-02-22", "acceptedDate": "2023-02-22 10:26:53", "fiscalYear": "2022", "period": "FY", "netIncome": 6244800000, "depreciationAndAmortization": 1522500000, "deferredIncomeTax": -2185200000, "stockBasedCompensation": 371100000, "changeInWorkingCapital": -800000, "accountsReceivables": -299600000, "inventory": -599700000, "accountsPayables": 1331700000, "otherWorkingCapital": -433200000, "otherNonCashItems": 1633300000, "netCashProvidedByOperatingActivities": 7585700000, "investmentsInPropertyPlantAndEquipment": -1854300000, "acquisitionsNet": -327200000, "purchasesOfInvestments": -707600000, "salesMaturitiesOfInvestments": 463600000, "otherInvestingActivities": -1337400000, "netCashProvidedByInvestingActivities": -3762900000, "netDebtIssuance": -62000000, "longTermNetDebtIssuance": -1560000000, "shortTermNetDebtIssuance": 1498000000, "netStockIssuance": -1500000000, "netCommonStockIssuance": -1500000000, "commonStockIssuance": 0, "commonStockRepurchased": -1500000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -3535800000, "commonDividendsPaid": -3535800000, "preferredDividendsPaid": 0, "otherFinancingActivities": -308900000, "netCashProvidedByFinancingActivities": -5406700000, "effectOfForexChangesOnCash": -167600000, "netChangeInCash": -1751500000, "cashAtEndOfPeriod": 2067000000, "cashAtBeginningOfPeriod": 3818500000, "operatingCashFlow": 7585700000, "capitalExpenditure": -2985300000, "freeCashFlow": 4600400000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-12-31", "symbol": "LLY", "type": "cash_flow_annual", "result": {"date": "2021-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2022-02-23", "acceptedDate": "2022-02-23 11:00:57", "fiscalYear": "2021", "period": "FY", "netIncome": 5581700000, "depreciationAndAmortization": 1547600000, "deferredIncomeTax": -802300000, "stockBasedCompensation": 342800000, "changeInWorkingCapital": -1012600000, "accountsReceivables": -1278300000, "inventory": -235900000, "accountsPayables": -1013800000, "otherWorkingCapital": 1515400000, "otherNonCashItems": 1708700000, "netCashProvidedByOperatingActivities": 7365900000, "investmentsInPropertyPlantAndEquipment": -1309800000, "acquisitionsNet": -747400000, "purchasesOfInvestments": -1013400000, "salesMaturitiesOfInvestments": 847400000, "otherInvestingActivities": -644300000, "netCashProvidedByInvestingActivities": -2867500000, "netDebtIssuance": 501400000, "longTermNetDebtIssuance": 505400000, "shortTermNetDebtIssuance": -4000000, "netStockIssuance": -1250000000, "netCommonStockIssuance": -1250000000, "commonStockIssuance": 0, "commonStockRepurchased": -1250000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -3086800000, "commonDividendsPaid": -3086800000, "preferredDividendsPaid": 0, "otherFinancingActivities": -295900000, "netCashProvidedByFinancingActivities": -4131300000, "effectOfForexChangesOnCash": -205700000, "netChangeInCash": 161400000, "cashAtEndOfPeriod": 3818500000, "cashAtBeginningOfPeriod": 3657100000, "operatingCashFlow": 7365900000, "capitalExpenditure": -1978400000, "freeCashFlow": 5387500000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2025-09-30", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2025-09-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2025-10-30", "acceptedDate": "2025-10-30 11:15:28", "fiscalYear": "2025", "period": "Q3", "netIncome": 5582500000, "depreciationAndAmortization": 470000000, "deferredIncomeTax": 501400000, "stockBasedCompensation": 151100000, "changeInWorkingCapital": 5627100000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": 5627100000, "otherNonCashItems": -3496200000, "netCashProvidedByOperatingActivities": 8835900000, "investmentsInPropertyPlantAndEquipment": -2087700000, "acquisitionsNet": -549400000, "purchasesOfInvestments": -150100000, "salesMaturitiesOfInvestments": 556100000, "otherInvestingActivities": -751500000, "netCashProvidedByInvestingActivities": -2982600000, "netDebtIssuance": 2614500000, "longTermNetDebtIssuance": 6706200000, "shortTermNetDebtIssuance": -4091700000, "netStockIssuance": -708100000, "netCommonStockIssuance": -708100000, "commonStockIssuance": 0, "commonStockRepurchased": -708100000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1345200000, "commonDividendsPaid": -1345200000, "preferredDividendsPaid": 0, "otherFinancingActivities": -30200000, "netCashProvidedByFinancingActivities": 531000000, "effectOfForexChangesOnCash": 31700000, "netChangeInCash": 6416000000, "cashAtEndOfPeriod": 9791900000, "cashAtBeginningOfPeriod": 3375900000, "operatingCashFlow": 8835900000, "capitalExpenditure": -223900000, "freeCashFlow": 8612000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2025-06-30", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2025-06-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2025-08-07", "acceptedDate": "2025-08-07 09:59:55", "fiscalYear": "2025", "period": "Q2", "netIncome": 5660500000, "depreciationAndAmortization": 478500000, "deferredIncomeTax": -1068700000, "stockBasedCompensation": 185100000, "changeInWorkingCapital": -2262900000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -2262900000, "otherNonCashItems": 94400000, "netCashProvidedByOperatingActivities": 3086900000, "investmentsInPropertyPlantAndEquipment": -1697100000, "acquisitionsNet": 0, "purchasesOfInvestments": -171200000, "salesMaturitiesOfInvestments": 204300000, "otherInvestingActivities": -170900000, "netCashProvidedByInvestingActivities": -1834900000, "netDebtIssuance": 824700000, "longTermNetDebtIssuance": -778100000, "shortTermNetDebtIssuance": 1602800000, "netStockIssuance": -692200000, "netCommonStockIssuance": -692200000, "commonStockIssuance": 0, "commonStockRepurchased": -692200000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1347000000, "commonDividendsPaid": -1347000000, "preferredDividendsPaid": 0, "otherFinancingActivities": -30400000, "netCashProvidedByFinancingActivities": -1244900000, "effectOfForexChangesOnCash": 275500000, "netChangeInCash": 282600000, "cashAtEndOfPeriod": 3375900000, "cashAtBeginningOfPeriod": 3093300000, "operatingCashFlow": 3086900000, "capitalExpenditure": -1803900000, "freeCashFlow": 1283000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2025-03-31", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2025-03-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2025-05-01", "acceptedDate": "2025-05-01 11:30:18", "fiscalYear": "2025", "period": "Q1", "netIncome": 2759300000, "depreciationAndAmortization": 462800000, "deferredIncomeTax": -391600000, "stockBasedCompensation": 153700000, "changeInWorkingCapital": -3364200000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -3364200000, "otherNonCashItems": 2045600000, "netCashProvidedByOperatingActivities": 1665600000, "investmentsInPropertyPlantAndEquipment": -1509500000, "acquisitionsNet": 0, "purchasesOfInvestments": -196700000, "salesMaturitiesOfInvestments": 71600000, "otherInvestingActivities": -1717700000, "netCashProvidedByInvestingActivities": -3352300000, "netDebtIssuance": 4612300000, "longTermNetDebtIssuance": 6461000000, "shortTermNetDebtIssuance": -1848700000, "netStockIssuance": -1200000000, "netCommonStockIssuance": -1200000000, "commonStockIssuance": 0, "commonStockRepurchased": -1200000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1346300000, "commonDividendsPaid": -1346300000, "preferredDividendsPaid": 0, "otherFinancingActivities": -686300000, "netCashProvidedByFinancingActivities": 1379700000, "effectOfForexChangesOnCash": 131900000, "netChangeInCash": -175100000, "cashAtEndOfPeriod": 3093300000, "cashAtBeginningOfPeriod": 3268400000, "operatingCashFlow": 1665600000, "capitalExpenditure": -3266500000, "freeCashFlow": -1600900000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2024-12-31", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2024-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2025-02-19", "acceptedDate": "2025-02-19 10:10:59", "fiscalYear": "2024", "period": "Q4", "netIncome": 4409800000, "depreciationAndAmortization": 484800000, "deferredIncomeTax": -966700000, "stockBasedCompensation": 141900000, "changeInWorkingCapital": -2224900000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -2224900000, "otherNonCashItems": 628900000, "netCashProvidedByOperatingActivities": 2473800000, "investmentsInPropertyPlantAndEquipment": -1496000000, "acquisitionsNet": 0, "purchasesOfInvestments": -182100000, "salesMaturitiesOfInvestments": 97200000, "otherInvestingActivities": -339600000, "netCashProvidedByInvestingActivities": -1920500000, "netDebtIssuance": 3042300000, "longTermNetDebtIssuance": 0, "shortTermNetDebtIssuance": 3042300000, "netStockIssuance": -2053900000, "netCommonStockIssuance": -2053900000, "commonStockIssuance": 0, "commonStockRepurchased": -2053900000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1168300000, "commonDividendsPaid": -1168300000, "preferredDividendsPaid": 0, "otherFinancingActivities": -45500000, "netCashProvidedByFinancingActivities": -225400000, "effectOfForexChangesOnCash": -428500000, "netChangeInCash": -100600000, "cashAtEndOfPeriod": 3268400000, "cashAtBeginningOfPeriod": 3369000000, "operatingCashFlow": 2473800000, "capitalExpenditure": -1747200000, "freeCashFlow": 726600000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2024-09-30", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2024-09-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2024-10-30", "acceptedDate": "2024-10-30 11:54:10", "fiscalYear": "2024", "period": "Q3", "netIncome": 970300000, "depreciationAndAmortization": 466800000, "deferredIncomeTax": -429800000, "stockBasedCompensation": 133200000, "changeInWorkingCapital": -9800000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -9800000, "otherNonCashItems": 2581200000, "netCashProvidedByOperatingActivities": 3711900000, "investmentsInPropertyPlantAndEquipment": -1172700000, "acquisitionsNet": 0, "purchasesOfInvestments": -294800000, "salesMaturitiesOfInvestments": 99800000, "otherInvestingActivities": -2637000000, "netCashProvidedByInvestingActivities": -4004700000, "netDebtIssuance": 1875200000, "longTermNetDebtIssuance": 4964600000, "shortTermNetDebtIssuance": -3089400000, "netStockIssuance": -446100000, "netCommonStockIssuance": -446100000, "commonStockIssuance": 0, "commonStockRepurchased": -446100000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1170500000, "commonDividendsPaid": -1170500000, "preferredDividendsPaid": 0, "otherFinancingActivities": -47300000, "netCashProvidedByFinancingActivities": 211300000, "effectOfForexChangesOnCash": 226900000, "netChangeInCash": 145400000, "cashAtEndOfPeriod": 3369000000, "cashAtBeginningOfPeriod": 3223600000, "operatingCashFlow": 3711900000, "capitalExpenditure": -4170800000, "freeCashFlow": -458900000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2024-06-30", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2024-06-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2024-08-08", "acceptedDate": "2024-08-08 11:28:54", "fiscalYear": "2024", "period": "Q2", "netIncome": 2967000000, "depreciationAndAmortization": 414400000, "deferredIncomeTax": -1007600000, "stockBasedCompensation": 211100000, "changeInWorkingCapital": -1399100000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -1399100000, "otherNonCashItems": 280400000, "netCashProvidedByOperatingActivities": 1466200000, "investmentsInPropertyPlantAndEquipment": -1402800000, "acquisitionsNet": -947700000, "purchasesOfInvestments": -157400000, "salesMaturitiesOfInvestments": 213600000, "otherInvestingActivities": 95600000, "netCashProvidedByInvestingActivities": -2198700000, "netDebtIssuance": 2735900000, "longTermNetDebtIssuance": -664200000, "shortTermNetDebtIssuance": 3400100000, "netStockIssuance": 0, "netCommonStockIssuance": 0, "commonStockIssuance": 0, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -1172400000, "commonDividendsPaid": -1172400000, "preferredDividendsPaid": 0, "otherFinancingActivities": -8000000, "netCashProvidedByFinancingActivities": 1555500000, "effectOfForexChangesOnCash": -59600000, "netChangeInCash": 763400000, "cashAtEndOfPeriod": 3223600000, "cashAtBeginningOfPeriod": 2460200000, "operatingCashFlow": 1466200000, "capitalExpenditure": -1402800000, "freeCashFlow": 63400000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2024-03-31", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2024-03-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2024-04-30", "acceptedDate": "2024-04-30 12:04:51", "fiscalYear": "2024", "period": "Q1", "netIncome": 2242900000, "depreciationAndAmortization": 400600000, "deferredIncomeTax": -279000000, "stockBasedCompensation": 159400000, "changeInWorkingCapital": -1751200000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -1751200000, "otherNonCashItems": 393300000, "netCashProvidedByOperatingActivities": 1166000000, "investmentsInPropertyPlantAndEquipment": -986300000, "acquisitionsNet": 0, "purchasesOfInvestments": -141500000, "salesMaturitiesOfInvestments": 111900000, "otherInvestingActivities": -161700000, "netCashProvidedByInvestingActivities": -1177600000, "netDebtIssuance": 1247700000, "longTermNetDebtIssuance": 6452500000, "shortTermNetDebtIssuance": -5204800000, "netStockIssuance": 0, "netCommonStockIssuance": 0, "commonStockIssuance": 0, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -1169200000, "commonDividendsPaid": -1169200000, "preferredDividendsPaid": 0, "otherFinancingActivities": -389800000, "netCashProvidedByFinancingActivities": -311300000, "effectOfForexChangesOnCash": -35500000, "netChangeInCash": -358400000, "cashAtEndOfPeriod": 2460200000, "cashAtBeginningOfPeriod": 2818600000, "operatingCashFlow": 1166000000, "capitalExpenditure": -986300000, "freeCashFlow": 179700000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-12-31", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2023-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2024-02-21", "acceptedDate": "2024-02-21 11:44:37", "fiscalYear": "2023", "period": "Q4", "netIncome": 2189600000, "depreciationAndAmortization": 387700000, "deferredIncomeTax": -506200000, "stockBasedCompensation": 120200000, "changeInWorkingCapital": -3172200000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -3172200000, "otherNonCashItems": 669000000, "netCashProvidedByOperatingActivities": -311900000, "investmentsInPropertyPlantAndEquipment": -1070600000, "acquisitionsNet": -1624800000, "purchasesOfInvestments": -275000000, "salesMaturitiesOfInvestments": 68900000, "otherInvestingActivities": -22800000, "netCashProvidedByInvestingActivities": -2924300000, "netDebtIssuance": 4594400000, "longTermNetDebtIssuance": 0, "shortTermNetDebtIssuance": 4594400000, "netStockIssuance": 0, "netCommonStockIssuance": 0, "commonStockIssuance": 0, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -1018100000, "commonDividendsPaid": -1018100000, "preferredDividendsPaid": 0, "otherFinancingActivities": -31600000, "netCashProvidedByFinancingActivities": 3544700000, "effectOfForexChangesOnCash": 129300000, "netChangeInCash": 437800000, "cashAtEndOfPeriod": 2818600000, "cashAtBeginningOfPeriod": 2380800000, "operatingCashFlow": -311900000, "capitalExpenditure": -1651100000, "freeCashFlow": -1963000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-09-30", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2023-09-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2023-11-02", "acceptedDate": "2023-11-02 11:21:53", "fiscalYear": "2023", "period": "Q3", "netIncome": -57400000, "depreciationAndAmortization": 411000000, "deferredIncomeTax": -844300000, "stockBasedCompensation": 215600000, "changeInWorkingCapital": 793300000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": 793300000, "otherNonCashItems": 1671300000, "netCashProvidedByOperatingActivities": 2189500000, "investmentsInPropertyPlantAndEquipment": -970300000, "acquisitionsNet": 0, "purchasesOfInvestments": -150800000, "salesMaturitiesOfInvestments": 133400000, "otherInvestingActivities": -2092800000, "netCashProvidedByInvestingActivities": -3080500000, "netDebtIssuance": 1595000000, "longTermNetDebtIssuance": 0, "shortTermNetDebtIssuance": 1595000000, "netStockIssuance": 0, "netCommonStockIssuance": 0, "commonStockIssuance": 0, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -1016200000, "commonDividendsPaid": -1016200000, "preferredDividendsPaid": 0, "otherFinancingActivities": -6800000, "netCashProvidedByFinancingActivities": 572000000, "effectOfForexChangesOnCash": 5300000, "netChangeInCash": -313700000, "cashAtEndOfPeriod": 2380800000, "cashAtBeginningOfPeriod": 2694500000, "operatingCashFlow": 2189500000, "capitalExpenditure": -4001200000, "freeCashFlow": -1811700000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-06-30", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2023-06-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2023-08-08", "acceptedDate": "2023-08-08 13:23:19", "fiscalYear": "2023", "period": "Q2", "netIncome": 1763200000, "depreciationAndAmortization": 366300000, "deferredIncomeTax": -431100000, "stockBasedCompensation": 161500000, "changeInWorkingCapital": -840200000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -840200000, "otherNonCashItems": -387800000, "netCashProvidedByOperatingActivities": 631900000, "investmentsInPropertyPlantAndEquipment": -738200000, "acquisitionsNet": 0, "purchasesOfInvestments": -234200000, "salesMaturitiesOfInvestments": 154600000, "otherInvestingActivities": 358700000, "netCashProvidedByInvestingActivities": -459100000, "netDebtIssuance": 0, "longTermNetDebtIssuance": 0, "shortTermNetDebtIssuance": 0, "netStockIssuance": 0, "netCommonStockIssuance": 0, "commonStockIssuance": 0, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -1017800000, "commonDividendsPaid": -1017800000, "preferredDividendsPaid": 0, "otherFinancingActivities": -15600000, "netCashProvidedByFinancingActivities": -1033400000, "effectOfForexChangesOnCash": 9200000, "netChangeInCash": -851400000, "cashAtEndOfPeriod": 2694500000, "cashAtBeginningOfPeriod": 3545900000, "operatingCashFlow": 631900000, "capitalExpenditure": -836300000, "freeCashFlow": -204400000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2023-03-31", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2023-03-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2023-04-27", "acceptedDate": "2023-04-27 11:56:56", "fiscalYear": "2023", "period": "Q1", "netIncome": 1344900000, "depreciationAndAmortization": 362300000, "deferredIncomeTax": -559400000, "stockBasedCompensation": 131200000, "changeInWorkingCapital": 164100000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": 164100000, "otherNonCashItems": 287500000, "netCashProvidedByOperatingActivities": 1730600000, "investmentsInPropertyPlantAndEquipment": -668500000, "acquisitionsNet": 0, "purchasesOfInvestments": -169000000, "salesMaturitiesOfInvestments": 343400000, "otherInvestingActivities": -194700000, "netCashProvidedByInvestingActivities": -688800000, "netDebtIssuance": 2460500000, "longTermNetDebtIssuance": 3958500000, "shortTermNetDebtIssuance": -1498000000, "netStockIssuance": -750000000, "netCommonStockIssuance": -750000000, "commonStockIssuance": 0, "commonStockRepurchased": -750000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -1017200000, "commonDividendsPaid": -1017200000, "preferredDividendsPaid": 0, "otherFinancingActivities": -281000000, "netCashProvidedByFinancingActivities": 412300000, "effectOfForexChangesOnCash": 24800000, "netChangeInCash": 1478900000, "cashAtEndOfPeriod": 3545900000, "cashAtBeginningOfPeriod": 2067000000, "operatingCashFlow": 1730600000, "capitalExpenditure": -903500000, "freeCashFlow": 827100000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-12-31", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2022-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2023-02-22", "acceptedDate": "2023-02-22 10:26:53", "fiscalYear": "2022", "period": "Q4", "netIncome": 1937700000, "depreciationAndAmortization": 375000000, "deferredIncomeTax": 10400000, "stockBasedCompensation": 92900000, "changeInWorkingCapital": -836000000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -836000000, "otherNonCashItems": -300000, "netCashProvidedByOperatingActivities": 1579700000, "investmentsInPropertyPlantAndEquipment": -500700000, "acquisitionsNet": -327200000, "purchasesOfInvestments": -168500000, "salesMaturitiesOfInvestments": 128900000, "otherInvestingActivities": 7000000, "netCashProvidedByInvestingActivities": -860500000, "netDebtIssuance": -243300000, "longTermNetDebtIssuance": 0, "shortTermNetDebtIssuance": -243300000, "netStockIssuance": 0, "netCommonStockIssuance": 0, "commonStockIssuance": 0, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -884400000, "commonDividendsPaid": -884400000, "preferredDividendsPaid": 0, "otherFinancingActivities": -13700000, "netCashProvidedByFinancingActivities": -1141400000, "effectOfForexChangesOnCash": -128200000, "netChangeInCash": -550400000, "cashAtEndOfPeriod": 2067000000, "cashAtBeginningOfPeriod": 2617400000, "operatingCashFlow": 1579700000, "capitalExpenditure": -555600000, "freeCashFlow": 1024100000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-09-30", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2022-09-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2022-11-01", "acceptedDate": "2022-11-01 11:16:21", "fiscalYear": "2022", "period": "Q3", "netIncome": 1451700000, "depreciationAndAmortization": 362900000, "deferredIncomeTax": -1070600000, "stockBasedCompensation": 85100000, "changeInWorkingCapital": 927600000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": 927600000, "otherNonCashItems": 460000000, "netCashProvidedByOperatingActivities": 2216700000, "investmentsInPropertyPlantAndEquipment": -617200000, "acquisitionsNet": 0, "purchasesOfInvestments": -254800000, "salesMaturitiesOfInvestments": 108600000, "otherInvestingActivities": -191900000, "netCashProvidedByInvestingActivities": -955300000, "netDebtIssuance": -375900000, "longTermNetDebtIssuance": 0, "shortTermNetDebtIssuance": -375900000, "netStockIssuance": 0, "netCommonStockIssuance": 0, "commonStockIssuance": 0, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -882200000, "commonDividendsPaid": -882200000, "preferredDividendsPaid": 0, "otherFinancingActivities": -5200000, "netCashProvidedByFinancingActivities": -1263300000, "effectOfForexChangesOnCash": -3600000, "netChangeInCash": -5500000, "cashAtEndOfPeriod": 2617400000, "cashAtBeginningOfPeriod": 2622900000, "operatingCashFlow": 2216700000, "capitalExpenditure": -652100000, "freeCashFlow": 1564600000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-06-30", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2022-06-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2022-08-04", "acceptedDate": "2022-08-04 11:31:24", "fiscalYear": "2022", "period": "Q2", "netIncome": 952500000, "depreciationAndAmortization": 348900000, "deferredIncomeTax": -618400000, "stockBasedCompensation": 92100000, "changeInWorkingCapital": -69900000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -69900000, "otherNonCashItems": 478100000, "netCashProvidedByOperatingActivities": 1183300000, "investmentsInPropertyPlantAndEquipment": -371000000, "acquisitionsNet": 0, "purchasesOfInvestments": -153000000, "salesMaturitiesOfInvestments": 118000000, "otherInvestingActivities": -420500000, "netCashProvidedByInvestingActivities": -826500000, "netDebtIssuance": 767600000, "longTermNetDebtIssuance": -849900000, "shortTermNetDebtIssuance": 1617500000, "netStockIssuance": 0, "netCommonStockIssuance": 0, "commonStockIssuance": 0, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -883700000, "commonDividendsPaid": -883700000, "preferredDividendsPaid": 0, "otherFinancingActivities": -7600000, "netCashProvidedByFinancingActivities": -123700000, "effectOfForexChangesOnCash": -69400000, "netChangeInCash": 163700000, "cashAtEndOfPeriod": 2622900000, "cashAtBeginningOfPeriod": 2459200000, "operatingCashFlow": 1183300000, "capitalExpenditure": -813600000, "freeCashFlow": 369700000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2022-03-31", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2022-03-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2022-04-29", "acceptedDate": "2022-04-29 11:57:54", "fiscalYear": "2022", "period": "Q1", "netIncome": 1902900000, "depreciationAndAmortization": 435700000, "deferredIncomeTax": -506600000, "stockBasedCompensation": 101000000, "changeInWorkingCapital": -34300000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -34300000, "otherNonCashItems": 624300000, "netCashProvidedByOperatingActivities": 2523000000, "investmentsInPropertyPlantAndEquipment": -365400000, "acquisitionsNet": 0, "purchasesOfInvestments": -131300000, "salesMaturitiesOfInvestments": 108100000, "otherInvestingActivities": -649000000, "netCashProvidedByInvestingActivities": -1037600000, "netDebtIssuance": -210400000, "longTermNetDebtIssuance": -710100000, "shortTermNetDebtIssuance": 499700000, "netStockIssuance": -1500000000, "netCommonStockIssuance": -1500000000, "commonStockIssuance": 0, "commonStockRepurchased": -1500000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -885500000, "commonDividendsPaid": -885500000, "preferredDividendsPaid": 0, "otherFinancingActivities": -282400000, "netCashProvidedByFinancingActivities": -2878300000, "effectOfForexChangesOnCash": 33600000, "netChangeInCash": -1359300000, "cashAtEndOfPeriod": 2459200000, "cashAtBeginningOfPeriod": 3818500000, "operatingCashFlow": 2523000000, "capitalExpenditure": -881000000, "freeCashFlow": 1642000000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-12-31", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2021-12-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2022-02-23", "acceptedDate": "2022-02-23 11:00:57", "fiscalYear": "2021", "period": "Q4", "netIncome": 1726100000, "depreciationAndAmortization": 445700000, "deferredIncomeTax": -92500000, "stockBasedCompensation": 75300000, "changeInWorkingCapital": -474500000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -474500000, "otherNonCashItems": 476400000, "netCashProvidedByOperatingActivities": 2156500000, "investmentsInPropertyPlantAndEquipment": -291400000, "acquisitionsNet": 0, "purchasesOfInvestments": -275400000, "salesMaturitiesOfInvestments": 263600000, "otherInvestingActivities": -75800000, "netCashProvidedByInvestingActivities": -379000000, "netDebtIssuance": -2600000, "longTermNetDebtIssuance": -100000, "shortTermNetDebtIssuance": -2500000, "netStockIssuance": -750000000, "netCommonStockIssuance": -750000000, "commonStockIssuance": 0, "commonStockRepurchased": -750000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -773300000, "commonDividendsPaid": -773300000, "preferredDividendsPaid": 0, "otherFinancingActivities": -600000, "netCashProvidedByFinancingActivities": -1526500000, "effectOfForexChangesOnCash": -220700000, "netChangeInCash": 30300000, "cashAtEndOfPeriod": 3818500000, "cashAtBeginningOfPeriod": 3788200000, "operatingCashFlow": 2156500000, "capitalExpenditure": -394200000, "freeCashFlow": 1762300000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-09-30", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2021-09-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2021-10-27", "acceptedDate": "2021-10-27 09:06:59", "fiscalYear": "2021", "period": "Q3", "netIncome": 1110100000, "depreciationAndAmortization": 382300000, "deferredIncomeTax": -296000000, "stockBasedCompensation": 90100000, "changeInWorkingCapital": -666500000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -666500000, "otherNonCashItems": 1011300000, "netCashProvidedByOperatingActivities": 1631300000, "investmentsInPropertyPlantAndEquipment": -336800000, "acquisitionsNet": 0, "purchasesOfInvestments": -208300000, "salesMaturitiesOfInvestments": 100600000, "otherInvestingActivities": -172000000, "netCashProvidedByInvestingActivities": -616500000, "netDebtIssuance": 307700000, "longTermNetDebtIssuance": 505500000, "shortTermNetDebtIssuance": -197800000, "netStockIssuance": 0, "netCommonStockIssuance": 0, "commonStockIssuance": 0, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -770400000, "commonDividendsPaid": -770400000, "preferredDividendsPaid": 0, "otherFinancingActivities": -500000, "netCashProvidedByFinancingActivities": -463200000, "effectOfForexChangesOnCash": 16600000, "netChangeInCash": 568200000, "cashAtEndOfPeriod": 3788200000, "cashAtBeginningOfPeriod": 3220000000, "operatingCashFlow": 1631300000, "capitalExpenditure": -455600000, "freeCashFlow": 1175700000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-06-30", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2021-06-30", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2021-08-03", "acceptedDate": "2021-08-03 12:04:04", "fiscalYear": "2021", "period": "Q2", "netIncome": 1390200000, "depreciationAndAmortization": 369300000, "deferredIncomeTax": -294700000, "stockBasedCompensation": 91900000, "changeInWorkingCapital": 221200000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": 221200000, "otherNonCashItems": -2400000, "netCashProvidedByOperatingActivities": 1775500000, "investmentsInPropertyPlantAndEquipment": -381300000, "acquisitionsNet": 0, "purchasesOfInvestments": -218800000, "salesMaturitiesOfInvestments": 194400000, "otherInvestingActivities": -77600000, "netCashProvidedByInvestingActivities": -483300000, "netDebtIssuance": 200000000, "longTermNetDebtIssuance": 0, "shortTermNetDebtIssuance": 200000000, "netStockIssuance": -500000000, "netCommonStockIssuance": -500000000, "commonStockIssuance": 0, "commonStockRepurchased": -500000000, "netPreferredStockIssuance": 0, "netDividendsPaid": -768300000, "commonDividendsPaid": -768300000, "preferredDividendsPaid": 0, "otherFinancingActivities": -14900000, "netCashProvidedByFinancingActivities": -1083200000, "effectOfForexChangesOnCash": 8600000, "netChangeInCash": 217600000, "cashAtEndOfPeriod": 3220000000, "cashAtBeginningOfPeriod": 3002400000, "operatingCashFlow": 1775500000, "capitalExpenditure": -531300000, "freeCashFlow": 1244200000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2021-03-31", "symbol": "LLY", "type": "cash_flow_quarter", "result": {"date": "2021-03-31", "symbol": "LLY", "reportedCurrency": "USD", "cik": "0000059478", "filingDate": "2021-04-30", "acceptedDate": "2021-04-30 09:23:35", "fiscalYear": "2021", "period": "Q1", "netIncome": 1355300000, "depreciationAndAmortization": 350300000, "deferredIncomeTax": -119100000, "stockBasedCompensation": 85500000, "changeInWorkingCapital": -102800000, "accountsReceivables": 0, "inventory": 0, "accountsPayables": 0, "otherWorkingCapital": -102800000, "otherNonCashItems": 128200000, "netCashProvidedByOperatingActivities": 1697400000, "investmentsInPropertyPlantAndEquipment": -300300000, "acquisitionsNet": -747400000, "purchasesOfInvestments": -310900000, "salesMaturitiesOfInvestments": 288800000, "otherInvestingActivities": -213700000, "netCashProvidedByInvestingActivities": -1283500000, "netDebtIssuance": -3700000, "longTermNetDebtIssuance": 0, "shortTermNetDebtIssuance": -3700000, "netStockIssuance": 0, "netCommonStockIssuance": 0, "commonStockIssuance": 0, "commonStockRepurchased": 0, "netPreferredStockIssuance": 0, "netDividendsPaid": -774800000, "commonDividendsPaid": -774800000, "preferredDividendsPaid": 0, "otherFinancingActivities": -279900000, "netCashProvidedByFinancingActivities": -1058400000, "effectOfForexChangesOnCash": -10200000, "netChangeInCash": -654700000, "cashAtEndOfPeriod": 3002400000, "cashAtBeginningOfPeriod": 3657100000, "operatingCashFlow": 1697400000, "capitalExpenditure": -492100000, "freeCashFlow": 1205300000, "incomeTaxesPaid": 0, "interestPaid": 0}}
{"date": "2025-09-30", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2025-09-30", "fiscalYear": "2025", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.8290816326530612, "ebitMargin": 0.410913140311804, "ebitdaMargin": 0.4376164719785464, "operatingProfitMargin": 0.4392073087586928, "pretaxProfitMargin": 0.410913140311804, "continuousOperationsProfitMargin": 0.3171730830416799, "netProfitMargin": 0.3171730830416799, "bottomLineProfitMargin": 0.3171730830416799, "receivablesTurnover": 0.9045905885738955, "payablesTurnover": 0.7058092065130683, "inventoryTurnover": 0.2469787527503202, "fixedAssetTurnover": 0.7887076537013802, "assetTurnover": 0.15313645752309557, "currentRatio": 1.546335533084709, "quickRatio": 1.2428944044602885, "solvencyRatio": 0.06644921314909435, "cashRatio": 0.24393822759330258, "priceToEarningsRatio": 30.646426332288403, "priceToEarningsGrowthRatio": -24.134060736676993, "forwardPriceToEarningsGrowthRatio": -24.134060736676993, "priceToBookRatio": 28.76165559212047, "priceToSalesRatio": 38.88088609608654, "priceToFreeCashFlowRatio": 79.46292382721784, "priceToOperatingCashFlowRatio": 77.44934867981756, "debtToAssetsRatio": 0.3698303568787336, "debtToEquityRatio": 1.786494517364132, "debtToCapitalRatio": 0.6411261555447293, "longTermDebtToCapitalRatio": 0.6320636987392314, "financialLeverageRatio": 4.830578356091841, "workingCapitalTurnoverRatio": 1.0743823345389065, "operatingCashFlowRatio": 0.22012211983288865, "operatingCashFlowSalesRatio": 0.5020169537748285, "freeCashFlowOperatingCashFlowRatio": 0.9746601930759742, "debtServiceCoverageRatio": 3.3391261171797417, "interestCoverageRatio": 43.042316258351896, "shortTermOperatingCashFlowCoverageRatio": 5.410838946723821, "operatingCashFlowCoverageRatio": 0.2078712482296867, "capitalExpenditureCoverageRatio": 39.463599821348815, "dividendPaidAndCapexCoverageRatio": 5.6311898540564655, "dividendPayoutRatio": 0.24096730855351545, "dividendYield": 0.0019657047932831696, "dividendYieldPercentage": 0.19657047932831698, "revenuePerShare": 19.624038354331585, "netIncomePerShare": 6.224216746571524, "interestDebtPerShare": 47.593042702642435, "cashPerShare": 11.053071691381424, "bookValuePerShare": 26.59248522689263, "tangibleBookValuePerShare": 12.82874344965994, "shareholdersEquityPerShare": 26.52837551566507, "operatingCashFlowPerShare": 9.851599955401941, "capexPerShare": 0.24963764076262682, "freeCashFlowPerShare": 9.601962314639314, "netIncomePerEBT": 0.7718737901664731, "ebtPerEbit": 0.9355790127289662, "priceToFairValue": 28.76165559212047, "debtToMarketCap": 0.06211375807773594, "effectiveTaxRate": 0.2281262098335269, "enterpriseValueMultiple": 93.09428230162027, "dividendPerShare": 1.4998327572750585}}
{"date": "2025-06-30", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2025-06-30", "fiscalYear": "2025", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.8426631185843666, "ebitMargin": 0.45157060490946604, "ebitdaMargin": 0.4823270791955109, "operatingProfitMargin": 0.4580497117183131, "pretaxProfitMargin": 0.4355656684471355, "continuousOperationsProfitMargin": 0.36383912789165496, "netProfitMargin": 0.36383912789165496, "bottomLineProfitMargin": 0.36383912789165496, "receivablesTurnover": 0.9042230436602037, "payablesTurnover": 0.6005839487695365, "inventoryTurnover": 0.222248451942109, "fixedAssetTurnover": 0.7578142885672952, "assetTurnover": 0.15415476810942247, "currentRatio": 1.2776557602659155, "quickRatio": 0.9953946575977899, "solvencyRatio": 0.07434588578660224, "cashRatio": 0.08651739240746388, "priceToEarningsRatio": 30.91334630333009, "priceToEarningsGrowthRatio": 0.29382035031338505, "forwardPriceToEarningsGrowthRatio": 0.29382035031338505, "priceToBookRatio": 38.30481133262919, "priceToSalesRatio": 44.98993983686535, "priceToFreeCashFlowRatio": 545.5494832424006, "priceToOperatingCashFlowRatio": 226.74527422333082, "debtToAssetsRatio": 0.39539013065458084, "debtToEquityRatio": 2.1837694071548577, "debtToCapitalRatio": 0.6859069008726861, "longTermDebtToCapitalRatio": 0.6516328903971175, "financialLeverageRatio": 5.5230751550109725, "workingCapitalTurnoverRatio": 1.4125898888646764, "operatingCashFlowRatio": 0.07911091519968017, "operatingCashFlowSalesRatio": 0.19841621833561515, "freeCashFlowOperatingCashFlowRatio": 0.4156273283877029, "debtServiceCoverageRatio": 1.0695330420078022, "interestCoverageRatio": 28.619277108433735, "shortTermOperatingCashFlowCoverageRatio": 0.5393189719936404, "operatingCashFlowCoverageRatio": 0.07735854730627158, "capitalExpenditureCoverageRatio": 1.7112367647874052, "dividendPaidAndCapexCoverageRatio": 0.9796883430131074, "dividendPayoutRatio": 0.23796484409504462, "dividendYield": 0.0019244507029429084, "dividendYieldPercentage": 0.19244507029429084, "revenuePerShare": 17.32676244570665, "netIncomePerShare": 6.3041541374317855, "interestDebtPerShare": 44.7185655418198, "cashPerShare": 3.9492148346140996, "bookValuePerShare": 20.435571889965473, "tangibleBookValuePerShare": 7.428778260385344, "shareholdersEquityPerShare": 20.350707205702193, "operatingCashFlowPerShare": 3.437910680476668, "capexPerShare": 2.0090210491146006, "freeCashFlowPerShare": 1.4288896313620671, "netIncomePerEBT": 0.8353255415855027, "ebtPerEbit": 0.9509135303527827, "priceToFairValue": 38.30481133262919, "debtToMarketCap": 0.057010316228725474, "effectiveTaxRate": 0.16467445841449738, "enterpriseValueMultiple": 98.14468303149029, "dividendPerShare": 1.5001670564650853}}
{"date": "2025-03-31", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2025-03-31", "fiscalYear": "2025", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.8252582786659858, "ebitMargin": 0.2906705424834034, "ebitdaMargin": 0.3270298935459795, "operatingProfitMargin": 0.42490474132851475, "pretaxProfitMargin": 0.27152453156302786, "continuousOperationsProfitMargin": 0.2167812389519582, "netProfitMargin": 0.2167812389519582, "bottomLineProfitMargin": 0.2167812389519582, "receivablesTurnover": 0.9089708066727605, "payablesTurnover": 0.6461940732132481, "inventoryTurnover": 0.2388787455697562, "fixedAssetTurnover": 0.6889916152884308, "assetTurnover": 0.1423947966635641, "currentRatio": 1.3722583069764966, "quickRatio": 1.062594576976929, "solvencyRatio": 0.04381305920426423, "cashRatio": 0.10287647041216438, "priceToEarningsRatio": 67.196217789838, "priceToEarningsGrowthRatio": -1.793116463848394, "forwardPriceToEarningsGrowthRatio": -1.793116463848394, "priceToBookRatio": 47.045195307901146, "priceToSalesRatio": 58.26751738146679, "priceToFreeCashFlowRatio": -463.27571677806236, "priceToOperatingCashFlowRatio": 445.279836089097, "debtToAssetsRatio": 0.43088060249158733, "debtToEquityRatio": 2.4431581751750735, "debtToCapitalRatio": 0.7095689628173549, "longTermDebtToCapitalRatio": 0.6863618910439417, "financialLeverageRatio": 5.670151222977773, "workingCapitalTurnoverRatio": 1.6364536326352195, "operatingCashFlowRatio": 0.0553942550410568, "operatingCashFlowSalesRatio": 0.13085595317594376, "freeCashFlowOperatingCashFlowRatio": -0.9611551392891451, "debtServiceCoverageRatio": 0.8135489777235276, "interestCoverageRatio": 22.192860073861304, "shortTermOperatingCashFlowCoverageRatio": 0.4146997311024798, "operatingCashFlowCoverageRatio": 0.043244478254435184, "capitalExpenditureCoverageRatio": 0.5099035665084953, "dividendPaidAndCapexCoverageRatio": 0.3610822060353798, "dividendPayoutRatio": 0.48791360127568584, "dividendYield": 0.0018152569345557439, "dividendYieldPercentage": 0.1815256934555744, "revenuePerShare": 14.174449798382831, "netIncomePerShare": 3.0727547887557645, "interestDebtPerShare": 43.162666803268195, "cashPerShare": 3.586569545952122, "bookValuePerShare": 17.646986767098483, "tangibleBookValuePerShare": 4.525779269011091, "shareholdersEquityPerShare": 17.555671617358342, "operatingCashFlowPerShare": 1.854811139111949, "capexPerShare": 3.6375723978801524, "freeCashFlowPerShare": -1.7827612587682031, "netIncomePerEBT": 0.7983854633835826, "ebtPerEbit": 0.6390244804378374, "priceToFairValue": 47.045195307901146, "debtToMarketCap": 0.051932150758118974, "effectiveTaxRate": 0.20161453661641734, "enterpriseValueMultiple": 186.68156800797578, "dividendPerShare": 1.4992388548189344}}
{"date": "2024-12-31", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2024-12-31", "fiscalYear": "2024", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.8223723102388272, "ebitMargin": 0.3889365098131946, "ebitdaMargin": 0.4247605816978009, "operatingProfitMargin": 0.4284257507685032, "pretaxProfitMargin": 0.3723324071884606, "continuousOperationsProfitMargin": 0.32586013241901157, "netProfitMargin": 0.32586013241901157, "bottomLineProfitMargin": 0.32586013241901157, "receivablesTurnover": 1.019389246275065, "payablesTurnover": 0.7445332342191662, "inventoryTurnover": 0.31673957729404945, "fixedAssetTurnover": 0.7912807559172982, "assetTurnover": 0.171921707326059, "currentRatio": 1.1537569687700429, "quickRatio": 0.8863112564577856, "solvencyRatio": 0.07595203845861401, "cashRatio": 0.11517940838578265, "priceToEarningsRatio": 39.28178919678897, "priceToEarningsGrowthRatio": 0.11076849172984882, "forwardPriceToEarningsGrowthRatio": 0.11076849172984882, "priceToBookRatio": 48.82288991763023, "priceToSalesRatio": 51.20147611728541, "priceToFreeCashFlowRatio": 953.6186842829618, "priceToOperatingCashFlowRatio": 280.09513137682916, "debtToAssetsRatio": 0.4274184430139656, "debtToEquityRatio": 2.3706287300681366, "debtToCapitalRatio": 0.7033194456929153, "longTermDebtToCapitalRatio": 0.6677817000318358, "financialLeverageRatio": 5.546388483733908, "workingCapitalTurnoverRatio": 2.4374420259183545, "operatingCashFlowRatio": 0.08717746312102224, "operatingCashFlowSalesRatio": 0.1828003074012769, "freeCashFlowOperatingCashFlowRatio": 0.2937181663837012, "debtServiceCoverageRatio": 0.9583473735444981, "interestCoverageRatio": 25.802403204272363, "shortTermOperatingCashFlowCoverageRatio": 0.4834378847394032, "operatingCashFlowCoverageRatio": 0.07352827530451014, "capitalExpenditureCoverageRatio": 1.4158653846153846, "dividendPaidAndCapexCoverageRatio": 0.848499399759904, "dividendPayoutRatio": 0.26493265000680305, "dividendYield": 0.001686103506382924, "dividendYieldPercentage": 0.1686103506382924, "revenuePerShare": 15.07769030392028, "netIncomePerShare": 4.913218159008309, "interestDebtPerShare": 37.73533822523392, "cashPerShare": 3.8139889341732607, "bookValuePerShare": 15.900830939748513, "tangibleBookValuePerShare": 2.6015611595275074, "shareholdersEquityPerShare": 15.812255302839546, "operatingCashFlowPerShare": 2.756206422457879, "capexPerShare": 1.94665852587857, "freeCashFlowPerShare": 0.8095478965793091, "netIncomePerEBT": 0.8751860598964019, "ebtPerEbit": 0.8690710269412536, "priceToFairValue": 48.82288991763023, "debtToMarketCap": 0.04855568226435708, "effectiveTaxRate": 0.12481394010359816, "enterpriseValueMultiple": 125.8263692982151, "dividendPerShare": 1.3016719069276175}}
{"date": "2024-09-30", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2024-09-30", "fiscalYear": "2024", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.8102298257730066, "ebitMargin": 0.1557028087874046, "ebitdaMargin": 0.196510214964464, "operatingProfitMargin": 0.39774108102910194, "pretaxProfitMargin": 0.138857077916969, "continuousOperationsProfitMargin": 0.0848231067129407, "netProfitMargin": 0.0848231067129407, "bottomLineProfitMargin": 0.0848231067129407, "receivablesTurnover": 0.949168996905001, "payablesTurnover": 0.7520526589294994, "inventoryTurnover": 0.2909997587066677, "fixedAssetTurnover": 0.7073485944669116, "assetTurnover": 0.1512970377042307, "currentRatio": 1.2732014541563825, "quickRatio": 0.9708682383551984, "solvencyRatio": 0.02344899830630713, "cashRatio": 0.13653993458727978, "priceToEarningsRatio": 205.66627331753068, "priceToEarningsGrowthRatio": -3.0617286842293034, "forwardPriceToEarningsGrowthRatio": -3.0617286842293034, "priceToBookRatio": 56.05561376404495, "priceToSalesRatio": 69.78100899546293, "priceToFreeCashFlowRatio": -1739.4463717585531, "priceToOperatingCashFlowRatio": 215.0467253966971, "debtToAssetsRatio": 0.4115986768403413, "debtToEquityRatio": 2.185372191011236, "debtToCapitalRatio": 0.686064943110294, "longTermDebtToCapitalRatio": 0.6710207136817495, "financialLeverageRatio": 5.309473314606741, "workingCapitalTurnoverRatio": 2.3287832982156127, "operatingCashFlowRatio": 0.15043709800965385, "operatingCashFlowSalesRatio": 0.3244923114580692, "freeCashFlowOperatingCashFlowRatio": -0.12362940811983081, "debtServiceCoverageRatio": 0.7189236876929863, "interestCoverageRatio": 23.610793980280228, "shortTermOperatingCashFlowCoverageRatio": 1.7894711468929276, "operatingCashFlowCoverageRatio": 0.11927814214147309, "capitalExpenditureCoverageRatio": 0.8899731466385346, "dividendPaidAndCapexCoverageRatio": 0.694943178626926, "dividendPayoutRatio": 1.2063279398124291, "dividendYield": 0.0014663657783475813, "dividendYieldPercentage": 0.14663657783475811, "revenuePerShare": 12.696004439511654, "netIncomePerShare": 1.0769145394006658, "interestDebtPerShare": 34.752941176470586, "cashPerShare": 3.904994450610433, "bookValuePerShare": 15.894228634850167, "tangibleBookValuePerShare": 2.2364039955604884, "shareholdersEquityPerShare": 15.804661487236404, "operatingCashFlowPerShare": 4.119755826859046, "capexPerShare": 4.629078801331853, "freeCashFlowPerShare": -0.5093229744728079, "netIncomePerEBT": 0.6108662805338706, "ebtPerEbit": 0.34911424678007824, "priceToFairValue": 56.05561376404495, "debtToMarketCap": 0.03898578651212579, "effectiveTaxRate": 0.38913371946612946, "enterpriseValueMultiple": 367.4463454780017, "dividendPerShare": 1.2991120976692563}}
{"date": "2024-06-30", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2024-06-30", "fiscalYear": "2024", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.8079944792440811, "ebitMargin": 0.3274232933432424, "ebitdaMargin": 0.3640867749584174, "operatingProfitMargin": 0.3909208337757016, "pretaxProfitMargin": 0.3111795307357469, "continuousOperationsProfitMargin": 0.2625013271047882, "netProfitMargin": 0.2625013271047882, "bottomLineProfitMargin": 0.2625013271047882, "receivablesTurnover": 0.8641945102836608, "payablesTurnover": 0.7419994529540481, "inventoryTurnover": 0.3348299004859986, "fixedAssetTurnover": 0.7621886252983937, "assetTurnover": 0.15725678541018548, "currentRatio": 1.113678598292111, "quickRatio": 0.874695809919915, "solvencyRatio": 0.05806045058920695, "cashRatio": 0.11885904753476985, "priceToEarningsRatio": 69.4098359453994, "priceToEarningsGrowthRatio": 2.160381143800556, "forwardPriceToEarningsGrowthRatio": 2.160381143800556, "priceToBookRatio": 60.74000390797818, "priceToSalesRatio": 72.8806961991719, "priceToFreeCashFlowRatio": 12992.995788643533, "priceToOperatingCashFlowRatio": 561.8305367616969, "debtToAssetsRatio": 0.40197677071797067, "debtToEquityRatio": 2.1303642530600206, "debtToCapitalRatio": 0.6805483582230178, "longTermDebtToCapitalRatio": 0.6363334084156558, "financialLeverageRatio": 5.299719805338445, "workingCapitalTurnoverRatio": 2.3367859579482726, "operatingCashFlowRatio": 0.05406102974794626, "operatingCashFlowSalesRatio": 0.1297200693633436, "freeCashFlowOperatingCashFlowRatio": 0.04324103123721184, "debtServiceCoverageRatio": 0.6669535283993115, "interestCoverageRatio": 24.065904139433552, "shortTermOperatingCashFlowCoverageRatio": 0.2840592064476131, "operatingCashFlowCoverageRatio": 0.05074761179565278, "capitalExpenditureCoverageRatio": 1.0451953236384375, "dividendPaidAndCapexCoverageRatio": 0.5693538365952159, "dividendPayoutRatio": 0.39514661274014157, "dividendYield": 0.001423237093698723, "dividendYieldPercentage": 0.1423237093698723, "revenuePerShare": 12.546120546120546, "netIncomePerShare": 3.2933732933732935, "interestDebtPerShare": 32.27394827394827, "cashPerShare": 3.734043734043734, "bookValuePerShare": 15.135420135420135, "tangibleBookValuePerShare": 1.3666333666333665, "shareholdersEquityPerShare": 15.053835053835053, "operatingCashFlowPerShare": 1.6274836274836275, "capexPerShare": 1.557109557109557, "freeCashFlowPerShare": 0.07037407037407037, "netIncomePerEBT": 0.8435687478676219, "ebtPerEbit": 0.7960167477650787, "priceToFairValue": 60.74000390797818, "debtToMarketCap": 0.035073495488863446, "effectiveTaxRate": 0.15643125213237802, "enterpriseValueMultiple": 206.4114339521773, "dividendPerShare": 1.3013653013653013}}
{"date": "2024-03-31", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2024-03-31", "fiscalYear": "2024", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.8091354927007299, "ebitMargin": 0.3097285583941606, "ebitdaMargin": 0.3554174270072993, "operatingProfitMargin": 0.31199817518248174, "pretaxProfitMargin": 0.28924498175182484, "continuousOperationsProfitMargin": 0.255805200729927, "netProfitMargin": 0.255805200729927, "bottomLineProfitMargin": 0.255805200729927, "receivablesTurnover": 0.8756179158136516, "payablesTurnover": 0.6765169584023932, "inventoryTurnover": 0.27426333213150217, "fixedAssetTurnover": 0.6435701702877276, "assetTurnover": 0.13712105217887666, "currentRatio": 1.3543749092649249, "quickRatio": 1.0262876315322533, "solvencyRatio": 0.05178652237879094, "cashRatio": 0.13228232991542146, "priceToEarningsRatio": 76.36357394444691, "priceToEarningsGrowthRatio": 30.92724744750086, "forwardPriceToEarningsGrowthRatio": 30.92724744750086, "priceToBookRatio": 53.472740044644944, "priceToSalesRatio": 78.13679744525547, "priceToFreeCashFlowRatio": 3812.4843628269336, "priceToOperatingCashFlowRatio": 587.5672727272727, "debtToAssetsRatio": 0.4099150030886642, "debtToEquityRatio": 2.045815706904357, "debtToCapitalRatio": 0.6716807265347123, "longTermDebtToCapitalRatio": 0.6571720615111273, "financialLeverageRatio": 4.990829053558327, "workingCapitalTurnoverRatio": 3.4900985172653995, "operatingCashFlowRatio": 0.06269457632768939, "operatingCashFlowSalesRatio": 0.13298357664233576, "freeCashFlowOperatingCashFlowRatio": 0.15411663807890222, "debtServiceCoverageRatio": 1.5417508601387144, "interestCoverageRatio": 15.231625835189309, "shortTermOperatingCashFlowCoverageRatio": 0.706024825915834, "operatingCashFlowCoverageRatio": 0.04448446095973508, "capitalExpenditureCoverageRatio": 1.1821960863834533, "dividendPaidAndCapexCoverageRatio": 0.5409417768499188, "dividendPayoutRatio": 0.5212894021133354, "dividendYield": 0.0017066036042674081, "dividendYieldPercentage": 0.1706603604267408, "revenuePerShare": 9.733570159857905, "netIncomePerShare": 2.489897868561279, "interestDebtPerShare": 29.29729129662522, "cashPerShare": 2.8711145648312613, "bookValuePerShare": 14.317717584369449, "tangibleBookValuePerShare": 1.3272646536412078, "shareholdersEquityPerShare": 14.223134991119005, "operatingCashFlowPerShare": 1.294404973357016, "capexPerShare": 1.0949156305506216, "freeCashFlowPerShare": 0.19948934280639433, "netIncomePerEBT": 0.8843894168211033, "ebtPerEbit": 0.9270726714431935, "priceToFairValue": 53.472740044644944, "debtToMarketCap": 0.0382590401239264, "effectiveTaxRate": 0.11561058317889673, "enterpriseValueMultiple": 227.46675223823124, "dividendPerShare": 1.2979573712255772}}
{"date": "2023-12-31", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2023-12-31", "fiscalYear": "2023", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.8088395663608955, "ebitMargin": 0.2829986956614707, "ebitdaMargin": 0.3244488635148716, "operatingProfitMargin": 0.3413838817969936, "pretaxProfitMargin": 0.2682233198622961, "continuousOperationsProfitMargin": 0.23410738341137982, "netProfitMargin": 0.23410738341137982, "bottomLineProfitMargin": 0.23410738341137982, "receivablesTurnover": 0.8250913004357722, "payablesTurnover": 0.6880098507003233, "inventoryTurnover": 0.30972838137472286, "fixedAssetTurnover": 0.7243061578490894, "assetTurnover": 0.14613249008300747, "currentRatio": 0.9426157431155013, "quickRatio": 0.7311051837087627, "solvencyRatio": 0.048499697041544824, "cashRatio": 0.10327114446089136, "priceToEarningsRatio": 59.85591709823263, "priceToEarningsGrowthRatio": -0.01454038540230104, "forwardPriceToEarningsGrowthRatio": -0.01454038540230104, "priceToBookRatio": 48.66978032473379, "priceToSalesRatio": 56.050848534222844, "priceToFreeCashFlowRatio": -267.0738699337748, "priceToOperatingCashFlowRatio": -1680.878508111574, "debtToAssetsRatio": 0.39410651763966986, "debtToEquityRatio": 2.341768861575024, "debtToCapitalRatio": 0.7007572811218651, "longTermDebtToCapitalRatio": 0.6297387317093291, "financialLeverageRatio": 5.941969383302853, "workingCapitalTurnoverRatio": -33.56081808396125, "operatingCashFlowRatio": -0.011427754898656075, "operatingCashFlowSalesRatio": -0.03334616289263797, "freeCashFlowOperatingCashFlowRatio": 6.29368387303623, "debtServiceCoverageRatio": 0.3855907535462252, "interestCoverageRatio": 23.104920405209842, "shortTermOperatingCashFlowCoverageRatio": -0.045173437613150846, "operatingCashFlowCoverageRatio": -0.012364570490737473, "capitalExpenditureCoverageRatio": -0.18890436678577918, "dividendPaidAndCapexCoverageRatio": -0.1168514910834707, "dividendPayoutRatio": 0.4649495364661826, "dividendYield": 0.0019419531059190435, "dividendYieldPercentage": 0.19419531059190437, "revenuePerShare": 10.39984255803171, "netIncomePerShare": 2.4346799291511143, "interestDebtPerShare": 28.20112544322249, "cashPerShare": 3.2552461198226776, "bookValuePerShare": 12.079112365309841, "tangibleBookValuePerShare": -1.0925316245987509, "shareholdersEquityPerShare": 11.97704193671411, "operatingCashFlowPerShare": -0.3467948439979141, "capexPerShare": 1.8358222729238731, "freeCashFlowPerShare": -2.182617116921787, "netIncomePerEBT": 0.8728077168367347, "ebtPerEbit": 0.7856941530174438, "priceToFairValue": 48.66978032473379, "debtToMarketCap": 0.048115459859286565, "effectiveTaxRate": 0.1271922831632653, "enterpriseValueMultiple": 180.14060918047912, "dividendPerShare": 1.1320033045023288}}
{"date": "2023-09-30", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2023-09-30", "fiscalYear": "2023", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.8041711410102541, "ebitMargin": 0.05809277156633609, "ebitdaMargin": 0.10136230602404565, "operatingProfitMargin": 0.37279177984123973, "pretaxProfitMargin": 0.04497504895458278, "continuousOperationsProfitMargin": -0.006042995809908829, "netProfitMargin": -0.006042995809908829, "bottomLineProfitMargin": -0.006042995809908829, "receivablesTurnover": 0.9165171076246165, "payablesTurnover": 0.7638700669377028, "inventoryTurnover": 0.37950381523646304, "fixedAssetTurnover": 0.800677726077281, "assetTurnover": 0.1640079080729684, "currentRatio": 1.045858297497068, "quickRatio": 0.8230491585675191, "solvencyRatio": 0.007586664120614228, "cashRatio": 0.1082270367575529, "priceToEarningsRatio": -2220.8149842770035, "priceToEarningsGrowthRatio": 21.508543976856167, "forwardPriceToEarningsGrowthRatio": 21.508543976856167, "priceToBookRatio": 45.44393429735125, "priceToSalesRatio": 53.681502578274696, "priceToFreeCashFlowRatio": -281.4478778992107, "priceToOperatingCashFlowRatio": 232.8838184014615, "debtToAssetsRatio": 0.34823665512686586, "debtToEquityRatio": 1.7974671134718905, "debtToCapitalRatio": 0.6425337780793725, "longTermDebtToCapitalRatio": 0.6150013724951963, "financialLeverageRatio": 5.16162525400164, "workingCapitalTurnoverRatio": 5.545980031529164, "operatingCashFlowRatio": 0.09953087070760334, "operatingCashFlowSalesRatio": 0.2305076537595014, "freeCashFlowOperatingCashFlowRatio": -0.8274491893126285, "debtServiceCoverageRatio": 0.20183176465622757, "interestCoverageRatio": 28.418940609951846, "shortTermOperatingCashFlowCoverageRatio": 0.9754087405889429, "operatingCashFlowCoverageRatio": 0.1085614553532028, "capitalExpenditureCoverageRatio": 0.5472108367489753, "dividendPaidAndCapexCoverageRatio": 0.4363813927532188, "dividendPayoutRatio": -17.70383275261324, "dividendYield": 0.0019929432300701995, "dividendYieldPercentage": 0.19929432300701994, "revenuePerShare": 10.00586746275952, "netIncomePerShare": -0.06046541515195886, "interestDebtPerShare": 21.37663106510777, "cashPerShare": 2.6270853457747423, "bookValuePerShare": 11.911265423157833, "tangibleBookValuePerShare": 0.4640246580912522, "shareholdersEquityPerShare": 11.819619236429254, "operatingCashFlowPerShare": 2.3064290326692323, "capexPerShare": 4.214881865958498, "freeCashFlowPerShare": -1.9084528332892658, "netIncomePerEBT": -0.1343632958801498, "ebtPerEbit": 0.12064388590793561, "priceToFairValue": 45.44393429735125, "debtToMarketCap": 0.039553510083669356, "effectiveTaxRate": 1.1343632958801497, "enterpriseValueMultiple": 548.0750107914416, "dividendPerShare": 1.0704695971676061}}
{"date": "2023-06-30", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2023-06-30", "fiscalYear": "2023", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.7825579576761589, "ebitMargin": 0.2657812105244162, "ebitdaMargin": 0.3098494965171256, "operatingProfitMargin": 0.2813248156302258, "pretaxProfitMargin": 0.2513083336340997, "continuousOperationsProfitMargin": 0.21212449320869575, "netProfitMargin": 0.21212449320869575, "bottomLineProfitMargin": 0.21212449320869575, "receivablesTurnover": 0.9063065617026844, "payablesTurnover": 0.7304987470697599, "inventoryTurnover": 0.37664367432846396, "fixedAssetTurnover": 0.7370581871708017, "assetTurnover": 0.15164191629875579, "currentRatio": 1.1277610362146444, "quickRatio": 0.8740629130319852, "solvencyRatio": 0.048769372055688, "cashRatio": 0.14245307956648162, "priceToEarningsRatio": 63.12331957236842, "priceToEarningsGrowthRatio": 2.0371616771082532, "forwardPriceToEarningsGrowthRatio": 2.0371616771082532, "priceToBookRatio": 40.238990968744915, "priceToSalesRatio": 53.560008695756785, "priceToFreeCashFlowRatio": -2178.0633477495107, "priceToOperatingCashFlowRatio": 704.5357624307644, "debtToAssetsRatio": 0.3433429415842668, "debtToEquityRatio": 1.7010430412697264, "debtToCapitalRatio": 0.6297726527416192, "longTermDebtToCapitalRatio": 0.6213905866088111, "financialLeverageRatio": 4.954355646342124, "workingCapitalTurnoverRatio": 2.303158769742311, "operatingCashFlowRatio": 0.033407348665080626, "operatingCashFlowSalesRatio": 0.07602170330000842, "freeCashFlowOperatingCashFlowRatio": -0.32346890330748534, "debtServiceCoverageRatio": 2.8773500447627574, "interestCoverageRatio": 19.4380714879468, "shortTermOperatingCashFlowCoverageRatio": 0.9551088270858524, "operatingCashFlowCoverageRatio": 0.0335759829968119, "capitalExpenditureCoverageRatio": 0.7555900992466819, "dividendPaidAndCapexCoverageRatio": 0.3408122539237366, "dividendPayoutRatio": 0.5772459165154264, "dividendYield": 0.00228618330129817, "dividendYieldPercentage": 0.228618330129817, "revenuePerShare": 8.756159892803645, "netIncomePerShare": 1.8573959797152808, "interestDebtPerShare": 19.95215351327208, "cashPerShare": 2.9802398855560917, "bookValuePerShare": 11.744932507168546, "tangibleBookValuePerShare": 0.17581635039387497, "shareholdersEquityPerShare": 11.654864814186663, "operatingCashFlowPerShare": 0.6656581894181521, "capexPerShare": 0.8809779139268882, "freeCashFlowPerShare": -0.21531972450873604, "netIncomePerEBT": 0.8440806165924649, "ebtPerEbit": 0.8933031132398221, "priceToFairValue": 40.238990968744915, "debtToMarketCap": 0.04227350140541517, "effectiveTaxRate": 0.15591938340753506, "enterpriseValueMultiple": 179.11925772859638, "dividendPerShare": 1.0721742446428157}}
{"date": "2023-03-31", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2023-03-31", "fiscalYear": "2023", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.766278735632184, "ebitMargin": 0.23455459770114942, "ebitdaMargin": 0.28660919540229884, "operatingProfitMargin": 0.24637931034482757, "pretaxProfitMargin": 0.2197844827586207, "continuousOperationsProfitMargin": 0.19323275862068964, "netProfitMargin": 0.19323275862068964, "bottomLineProfitMargin": 0.19323275862068964, "receivablesTurnover": 0.771439021957194, "payablesTurnover": 0.8069348678009822, "inventoryTurnover": 0.357925541277944, "fixedAssetTurnover": 0.6599533481253911, "assetTurnover": 0.1309181197449354, "currentRatio": 1.2999000624609618, "quickRatio": 1.0160274828232354, "solvencyRatio": 0.04077567408122174, "cashRatio": 0.2214803247970019, "priceToEarningsRatio": 60.59879417428805, "priceToEarningsGrowthRatio": -1.9938958083152842, "forwardPriceToEarningsGrowthRatio": -1.9938958083152842, "priceToBookRatio": 29.13186956140978, "priceToSalesRatio": 46.83868866954023, "priceToFreeCashFlowRatio": 394.1449318583001, "priceToOperatingCashFlowRatio": 188.37239867098117, "debtToAssetsRatio": 0.3552019261516468, "debtToEquityRatio": 1.6874821275378895, "debtToCapitalRatio": 0.627904502227838, "longTermDebtToCapitalRatio": 0.6278661430153404, "financialLeverageRatio": 4.750768515870746, "workingCapitalTurnoverRatio": 2.443091071836004, "operatingCashFlowRatio": 0.10809494066208619, "operatingCashFlowSalesRatio": 0.2486494252873563, "freeCashFlowOperatingCashFlowRatio": 0.47792673061366, "debtServiceCoverageRatio": 17.091595845136922, "interestCoverageRatio": 16.68093385214008, "shortTermOperatingCashFlowCoverageRatio": 558.258064516129, "operatingCashFlowCoverageRatio": 0.0916456607850198, "capitalExpenditureCoverageRatio": 1.9154399557277255, "dividendPaidAndCapexCoverageRatio": 0.9010256677253085, "dividendPayoutRatio": 0.7563387612461893, "dividendYield": 0.0031202714985998116, "dividendYieldPercentage": 0.31202714985998115, "revenuePerShare": 7.331972985471948, "netIncomePerShare": 1.4167773661151184, "interestDebtPerShare": 20.001116651058133, "cashPerShare": 3.865403516608078, "bookValuePerShare": 11.898549091035504, "tangibleBookValuePerShare": 0.14189895993434934, "shareholdersEquityPerShare": 11.78846415181398, "operatingCashFlowPerShare": 1.823090869060022, "capexPerShare": 0.9517870103985496, "freeCashFlowPerShare": 0.8713038586614725, "netIncomePerEBT": 0.8791919984310649, "ebtPerEbit": 0.8920573827851644, "priceToFairValue": 29.13186956140978, "debtToMarketCap": 0.057925637899094974, "effectiveTaxRate": 0.12080800156893509, "enterpriseValueMultiple": 171.11237875476237, "dividendPerShare": 1.0715636380491473}}
{"date": "2022-12-31", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2022-12-31", "fiscalYear": "2022", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.7879837848201813, "ebitMargin": 0.2986113013229615, "ebitdaMargin": 0.34996850091758197, "operatingProfitMargin": 0.30232271494699936, "pretaxProfitMargin": 0.28710728861376644, "continuousOperationsProfitMargin": 0.26537292174532306, "netProfitMargin": 0.26537292174532306, "bottomLineProfitMargin": 0.26537292174532306, "receivablesTurnover": 0.853123649067053, "payablesTurnover": 0.8018750647467109, "inventoryTurnover": 0.35921293825556305, "fixedAssetTurnover": 0.7198146687697161, "assetTurnover": 0.14754151360482362, "currentRatio": 1.0522983743917098, "quickRatio": 0.8008308923924333, "solvencyRatio": 0.059737462029632385, "cashRatio": 0.12060776510952143, "priceToEarningsRatio": 44.84886500490271, "priceToEarningsGrowthRatio": 1.6792249455324042, "forwardPriceToEarningsGrowthRatio": 1.6792249455324042, "priceToBookRatio": 32.64047990384796, "priceToSalesRatio": 47.606697373250434, "priceToFreeCashFlowRatio": 339.43421822087686, "priceToOperatingCashFlowRatio": 220.05101150851428, "debtToAssetsRatio": 0.32812013788699895, "debtToEquityRatio": 1.5247798080715131, "debtToCapitalRatio": 0.6039258565031761, "longTermDebtToCapitalRatio": 0.5805067888274846, "financialLeverageRatio": 4.6470168453867675, "workingCapitalTurnoverRatio": 5.064715266699036, "operatingCashFlowRatio": 0.09217420732632366, "operatingCashFlowSalesRatio": 0.21634391519899204, "freeCashFlowOperatingCashFlowRatio": 0.6482876495537128, "debtServiceCoverageRatio": 1.5120181692006813, "interestCoverageRatio": 26.279761904761905, "shortTermOperatingCashFlowCoverageRatio": 1.052361601492239, "operatingCashFlowCoverageRatio": 0.09728055374231769, "capitalExpenditureCoverageRatio": 2.8432325413966884, "dividendPaidAndCapexCoverageRatio": 1.097013888888889, "dividendPayoutRatio": 0.45641740207462456, "dividendYield": 0.0025441970606431773, "dividendYieldPercentage": 0.2544197060643177, "revenuePerShare": 7.684633049247408, "netIncomePerShare": 2.0392935248194557, "interestDebtPerShare": 17.178393192041103, "cashPerShare": 2.327764575628669, "bookValuePerShare": 11.340353742756651, "tangibleBookValuePerShare": -0.5306351835753571, "shareholdersEquityPerShare": 11.208168540342797, "operatingCashFlowPerShare": 1.6625236007417525, "capexPerShare": 0.5847300832893066, "freeCashFlowPerShare": 1.077793517452446, "netIncomePerEBT": 0.9242987979393246, "ebtPerEbit": 0.9496715741789354, "priceToFairValue": 32.64047990384796, "debtToMarketCap": 0.046714380810674236, "effectiveTaxRate": 0.07570120206067545, "enterpriseValueMultiple": 141.57712408233544, "dividendPerShare": 0.9307690526656999}}
{"date": "2022-09-30", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2022-09-30", "fiscalYear": "2022", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.7725164227267489, "ebitMargin": 0.23726518381929237, "ebitdaMargin": 0.2895441973032154, "operatingProfitMargin": 0.293563443586493, "pretaxProfitMargin": 0.2255243747839115, "continuousOperationsProfitMargin": 0.20913045983634898, "netProfitMargin": 0.20913045983634898, "bottomLineProfitMargin": 0.20913045983634898, "receivablesTurnover": 0.8338458581587546, "payablesTurnover": 0.9381535171102662, "inventoryTurnover": 0.41217926966145496, "fixedAssetTurnover": 0.7455027761966643, "assetTurnover": 0.14625749291531032, "currentRatio": 1.1269485331697844, "quickRatio": 0.8821936011448431, "solvencyRatio": 0.048654532974399124, "cashRatio": 0.1672160891342124, "priceToEarningsRatio": 50.15522232554936, "priceToEarningsGrowthRatio": 0.966627921183315, "forwardPriceToEarningsGrowthRatio": 0.966627921183315, "priceToBookRatio": 28.921395517422866, "priceToSalesRatio": 41.95593883254581, "priceToFreeCashFlowRatio": 186.14428288380418, "priceToOperatingCashFlowRatio": 131.38509721658323, "debtToAssetsRatio": 0.3347639665834413, "debtToEquityRatio": 1.5777797638553739, "debtToCapitalRatio": 0.6120692644027967, "longTermDebtToCapitalRatio": 0.584119039064339, "financialLeverageRatio": 4.713111091250335, "workingCapitalTurnoverRatio": 3.9874773817388056, "operatingCashFlowRatio": 0.14161683532658695, "operatingCashFlowSalesRatio": 0.31933559986170335, "freeCashFlowOperatingCashFlowRatio": 0.705823972571841, "debtServiceCoverageRatio": 1.0383330595257654, "interestCoverageRatio": 25.003680981595092, "shortTermOperatingCashFlowCoverageRatio": 1.2706064427375903, "operatingCashFlowCoverageRatio": 0.1395168802396717, "capitalExpenditureCoverageRatio": 3.3993252568624444, "dividendPaidAndCapexCoverageRatio": 1.4447630841426058, "dividendPayoutRatio": 0.6077013156988359, "dividendYield": 0.0030291028905940535, "dividendYieldPercentage": 0.30291028905940537, "revenuePerShare": 7.706894637504163, "netIncomePerShare": 1.6117464194515376, "interestDebtPerShare": 17.73054291106917, "cashPerShare": 3.04440990340846, "bookValuePerShare": 11.28666592650161, "tangibleBookValuePerShare": -0.9434883979127345, "shareholdersEquityPerShare": 11.180304207838349, "operatingCashFlowPerShare": 2.4610858221383367, "capexPerShare": 0.7239924503164206, "freeCashFlowPerShare": 1.7370933718219164, "netIncomePerEBT": 0.9273075694666241, "ebtPerEbit": 0.7682304445971145, "priceToFairValue": 28.921395517422866, "debtToMarketCap": 0.05455406752087345, "effectiveTaxRate": 0.07269243053337592, "enterpriseValueMultiple": 151.50621672720035, "dividendPerShare": 0.9794604196735872}}
{"date": "2022-06-30", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2022-06-30", "fiscalYear": "2022", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.779516029593095, "ebitMargin": 0.1806565967940814, "ebitdaMargin": 0.2344327990135635, "operatingProfitMargin": 0.2689272503082614, "pretaxProfitMargin": 0.16814118372379777, "continuousOperationsProfitMargin": 0.1468094944512947, "netProfitMargin": 0.1468094944512947, "bottomLineProfitMargin": 0.1468094944512947, "receivablesTurnover": 0.8456284865231218, "payablesTurnover": 0.8621105285361297, "inventoryTurnover": 0.36685131045801916, "fixedAssetTurnover": 0.7107644442496878, "assetTurnover": 0.13785600761522707, "currentRatio": 1.0956813438664328, "quickRatio": 0.8460494475244229, "solvencyRatio": 0.03388674214412932, "cashRatio": 0.16791288426820994, "priceToEarningsRatio": 76.61529370078742, "priceToEarningsGrowthRatio": -1.6301126319316472, "forwardPriceToEarningsGrowthRatio": -1.6301126319316472, "priceToBookRatio": 34.16202663639449, "priceToSalesRatio": 44.991410141800245, "priceToFreeCashFlowRatio": 789.5706491750068, "priceToOperatingCashFlowRatio": 246.68661286233416, "debtToAssetsRatio": 0.3572569884156758, "debtToEquityRatio": 1.967746088218428, "debtToCapitalRatio": 0.6630439497604353, "longTermDebtToCapitalRatio": 0.6322756673710123, "financialLeverageRatio": 5.507928891593619, "workingCapitalTurnoverRatio": 2.5577040585023556, "operatingCashFlowRatio": 0.0757525319129867, "operatingCashFlowSalesRatio": 0.18238286066584464, "freeCashFlowOperatingCashFlowRatio": 0.3124313360939745, "debtServiceCoverageRatio": 0.6275987290059011, "interestCoverageRatio": 21.48768472906404, "shortTermOperatingCashFlowCoverageRatio": 0.5576868696389857, "operatingCashFlowCoverageRatio": 0.07037671436558066, "capitalExpenditureCoverageRatio": 1.4544001966568338, "dividendPaidAndCapexCoverageRatio": 0.6971660873151476, "dividendPayoutRatio": 0.9277690288713911, "dividendYield": 0.0030273623713259223, "dividendYieldPercentage": 0.30273623713259223, "revenuePerShare": 7.2064867266466734, "netIncomePerShare": 1.0579806731089636, "interestDebtPerShare": 18.765966899922248, "cashPerShare": 3.0397645229367987, "bookValuePerShare": 9.618127290903033, "tangibleBookValuePerShare": -3.032655781406198, "shareholdersEquityPerShare": 9.490947461957125, "operatingCashFlowPerShare": 1.314339664556259, "capexPerShare": 0.9036987670776407, "freeCashFlowPerShare": 0.41064089747861826, "netIncomePerEBT": 0.8731322761023008, "ebtPerEbit": 0.6252292526364053, "priceToFairValue": 34.16202663639449, "debtToMarketCap": 0.05760039090075795, "effectiveTaxRate": 0.12686772389769915, "enterpriseValueMultiple": 201.24600197238658, "dividendPerShare": 0.9815617016550039}}
{"date": "2022-03-31", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2022-03-31", "fiscalYear": "2022", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.7346862996158771, "ebitMargin": 0.2738156209987196, "ebitdaMargin": 0.3296030729833547, "operatingProfitMargin": 0.3409987195902689, "pretaxProfitMargin": 0.2629449423815621, "continuousOperationsProfitMargin": 0.2436491677336748, "netProfitMargin": 0.2436491677336748, "bottomLineProfitMargin": 0.2436491677336748, "receivablesTurnover": 1.0005508794855043, "payablesTurnover": 1.445684783367055, "inventoryTurnover": 0.5322630362188544, "fixedAssetTurnover": 0.8579871906137739, "assetTurnover": 0.1664560212961404, "currentRatio": 1.267346481398476, "quickRatio": 0.9765202450321231, "solvencyRatio": 0.06243375790566859, "cashRatio": 0.1837143284028089, "priceToEarningsRatio": 35.764458701192915, "priceToEarningsGrowthRatio": 3.4070352762715337, "forwardPriceToEarningsGrowthRatio": 3.4070352762715337, "priceToBookRatio": 29.174856802203458, "priceToSalesRatio": 34.85592238796415, "priceToFreeCashFlowRatio": 165.78852244214372, "priceToOperatingCashFlowRatio": 107.89724686880697, "debtToAssetsRatio": 0.3518552067059824, "debtToEquityRatio": 1.769280233206156, "debtToCapitalRatio": 0.6388953389371352, "longTermDebtToCapitalRatio": 0.6188974705620474, "financialLeverageRatio": 5.02843271745188, "workingCapitalTurnoverRatio": 2.2383354350567464, "operatingCashFlowRatio": 0.18848050201703273, "operatingCashFlowSalesRatio": 0.3230473751600512, "freeCashFlowOperatingCashFlowRatio": 0.6508125247720967, "debtServiceCoverageRatio": 1.6820516379789006, "interestCoverageRatio": 31.36866902237927, "shortTermOperatingCashFlowCoverageRatio": 1.860756692971458, "operatingCashFlowCoverageRatio": 0.1528275828648963, "capitalExpenditureCoverageRatio": 2.8637911464245174, "dividendPaidAndCapexCoverageRatio": 1.428247947919615, "dividendPayoutRatio": 0.465342372168795, "dividendYield": 0.0032528268920317366, "dividendYieldPercentage": 0.32528268920317366, "revenuePerShare": 8.21582045118635, "netIncomePerShare": 2.0017778151808585, "interestDebtPerShare": 17.455935956575022, "cashPerShare": 2.7017530940821897, "bookValuePerShare": 9.953661089516677, "tangibleBookValuePerShare": -2.0117714508129034, "shareholdersEquityPerShare": 9.81564372162991, "operatingCashFlowPerShare": 2.654099231542018, "capexPerShare": 0.9267782096664755, "freeCashFlowPerShare": 1.7273210218755424, "netIncomePerEBT": 0.9266166731593299, "ebtPerEbit": 0.771102433163112, "priceToFairValue": 29.174856802203458, "debtToMarketCap": 0.060644007447965595, "effectiveTaxRate": 0.07338332684067005, "enterpriseValueMultiple": 111.20905673607335, "dividendPerShare": 0.9315120370711284}}
{"date": "2021-12-31", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2021-12-31", "fiscalYear": "2021", "period": "Q4", "reportedCurrency": "USD", "grossProfitMargin": 0.7437217965224565, "ebitMargin": 0.24016550206877585, "ebitdaMargin": 0.29587869848373105, "operatingProfitMargin": 0.30886636082951036, "pretaxProfitMargin": 0.229990374879686, "continuousOperationsProfitMargin": 0.2157651970649633, "netProfitMargin": 0.2157651970649633, "bottomLineProfitMargin": 0.2157651970649633, "receivablesTurnover": 0.9843365488729205, "payablesTurnover": 1.2272237519454088, "inventoryTurnover": 0.5275862068965518, "fixedAssetTurnover": 0.8903518046543722, "assetTurnover": 0.1639122239068967, "currentRatio": 1.2258531691988812, "quickRatio": 0.9676935034910681, "solvencyRatio": 0.05477261722217739, "cashRatio": 0.2536754203564809, "priceToEarningsRatio": 38.15219739007011, "priceToEarningsGrowthRatio": 0.6808699841920202, "forwardPriceToEarningsGrowthRatio": 0.6808699841920202, "priceToBookRatio": 29.336470026282967, "priceToSalesRatio": 32.92766555331942, "priceToFreeCashFlowRatio": 149.47400082846283, "priceToOperatingCashFlowRatio": 122.15072184558313, "debtToAssetsRatio": 0.3459554153177888, "debtToEquityRatio": 1.8804236457590877, "debtToCapitalRatio": 0.6528288463843427, "longTermDebtToCapitalRatio": 0.6308744696944782, "financialLeverageRatio": 5.435450819672131, "workingCapitalTurnoverRatio": 2.1259367525910178, "operatingCashFlowRatio": 0.14326333481700956, "operatingCashFlowSalesRatio": 0.26956586957336964, "freeCashFlowOperatingCashFlowRatio": 0.8172038024576861, "debtServiceCoverageRatio": 1.3911218126813607, "interestCoverageRatio": 30.355036855036854, "shortTermOperatingCashFlowCoverageRatio": 1.4018721965806409, "operatingCashFlowCoverageRatio": 0.12771917771710484, "capitalExpenditureCoverageRatio": 5.470573313039067, "dividendPaidAndCapexCoverageRatio": 1.8471092077087794, "dividendPayoutRatio": 0.448004171253114, "dividendYield": 0.002935638062158618, "dividendYieldPercentage": 0.2935638062158618, "revenuePerShare": 8.388690645339553, "netIncomePerShare": 1.8099874902087028, "interestDebtPerShare": 17.79064292777352, "cashPerShare": 4.098555763993821, "bookValuePerShare": 9.599718136471022, "tangibleBookValuePerShare": -2.5471528952354787, "shareholdersEquityPerShare": 9.415584075130052, "operatingCashFlowPerShare": 2.261304688392948, "capexPerShare": 0.413357898522838, "freeCashFlowPerShare": 1.84794678987011, "netIncomePerEBT": 0.9381488124354584, "ebtPerEbit": 0.7446274636772027, "priceToFairValue": 29.336470026282967, "debtToMarketCap": 0.06409849733367337, "effectiveTaxRate": 0.061851187564541554, "enterpriseValueMultiple": 116.80787142374314, "dividendPerShare": 0.8108819455294536}}
{"date": "2021-09-30", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2021-09-30", "fiscalYear": "2021", "period": "Q3", "reportedCurrency": "USD", "grossProfitMargin": 0.7887432081266241, "ebitMargin": 0.19621131585164187, "ebitdaMargin": 0.25265768958185686, "operatingProfitMargin": 0.3146999763760926, "pretaxProfitMargin": 0.18386782423812897, "continuousOperationsProfitMargin": 0.16390562248995985, "netProfitMargin": 0.16390562248995985, "bottomLineProfitMargin": 0.16390562248995985, "receivablesTurnover": 0.9640996441281139, "payablesTurnover": 0.9131988766913454, "inventoryTurnover": 0.3661769974919384, "fixedAssetTurnover": 0.7592484641944307, "assetTurnover": 0.14055243115363064, "currentRatio": 1.301586025434878, "quickRatio": 1.0159991229352434, "solvencyRatio": 0.037094020068153176, "cashRatio": 0.27687472591726353, "priceToEarningsRatio": 49.774769941897134, "priceToEarningsGrowthRatio": -2.0582540003000704, "forwardPriceToEarningsGrowthRatio": -2.0582540003000704, "priceToBookRatio": 28.492959707361095, "priceToSalesRatio": 32.633458606484766, "priceToFreeCashFlowRatio": 187.99003865782086, "priceToOperatingCashFlowRatio": 135.48696649911116, "debtToAssetsRatio": 0.35456450909996473, "debtToEquityRatio": 2.2025783163594173, "debtToCapitalRatio": 0.6877515859981322, "longTermDebtToCapitalRatio": 0.6667869446807049, "financialLeverageRatio": 6.212066520562073, "workingCapitalTurnoverRatio": 2.1403785987422177, "operatingCashFlowRatio": 0.11922964478877357, "operatingCashFlowSalesRatio": 0.24086050082683677, "freeCashFlowOperatingCashFlowRatio": 0.7207135413473916, "debtServiceCoverageRatio": 0.9571237701931252, "interestCoverageRatio": 25.495215311004785, "shortTermOperatingCashFlowCoverageRatio": 1.043698016634677, "operatingCashFlowCoverageRatio": 0.0954791810551699, "capitalExpenditureCoverageRatio": 3.580553116769096, "dividendPaidAndCapexCoverageRatio": 1.3305872756933115, "dividendPayoutRatio": 0.6939915322943879, "dividendYield": 0.0034856591658007415, "dividendYieldPercentage": 0.34856591658007413, "revenuePerShare": 7.0801566817097, "netIncomePerShare": 1.1604774882420767, "interestDebtPerShare": 17.94814700984435, "cashPerShare": 3.998896077625814, "bookValuePerShare": 8.315065299726424, "tangibleBookValuePerShare": -3.9909511817509924, "shareholdersEquityPerShare": 8.109020697499135, "operatingCashFlowPerShare": 1.7053300842890728, "capexPerShare": 0.47627560007484926, "freeCashFlowPerShare": 1.2290544842142237, "netIncomePerEBT": 0.8914317835059825, "ebtPerEbit": 0.5842638641268649, "priceToFairValue": 28.492959707361095, "debtToMarketCap": 0.07730254557550882, "effectiveTaxRate": 0.1085682164940175, "enterpriseValueMultiple": 136.93144486325386, "dividendPerShare": 0.8053615502582614}}
{"date": "2021-06-30", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2021-06-30", "fiscalYear": "2021", "period": "Q2", "reportedCurrency": "USD", "grossProfitMargin": 0.7102120146585362, "ebitMargin": 0.24937315470096882, "ebitdaMargin": 0.304164626637587, "operatingProfitMargin": 0.22511535437159685, "pretaxProfitMargin": 0.23648017091734544, "continuousOperationsProfitMargin": 0.20625806738772423, "netProfitMargin": 0.20625806738772423, "bottomLineProfitMargin": 0.20625806738772423, "receivablesTurnover": 0.9764298545517761, "payablesTurnover": 1.2224308424083115, "inventoryTurnover": 0.5106538733038772, "fixedAssetTurnover": 0.7611202077804754, "assetTurnover": 0.14097973184965173, "currentRatio": 1.1459133914610553, "quickRatio": 0.8924946333448175, "solvencyRatio": 0.04276287807901229, "cashRatio": 0.21334110725359764, "priceToEarningsRatio": 37.4484779168465, "priceToEarningsGrowthRatio": 4.400196155229457, "forwardPriceToEarningsGrowthRatio": 4.400196155229457, "priceToBookRatio": 32.31386878530197, "priceToSalesRatio": 30.896202726962507, "priceToFreeCashFlowRatio": 167.37140009644753, "priceToOperatingCashFlowRatio": 117.28724077724586, "debtToAssetsRatio": 0.34543914325754566, "debtToEquityRatio": 2.5627056048662404, "debtToCapitalRatio": 0.71931444500098, "longTermDebtToCapitalRatio": 0.6957461876209811, "financialLeverageRatio": 7.418689094407547, "workingCapitalTurnoverRatio": 1.9006006260045682, "operatingCashFlowRatio": 0.11763575649961572, "operatingCashFlowSalesRatio": 0.26342339134434206, "freeCashFlowOperatingCashFlowRatio": 0.7007603491974091, "debtServiceCoverageRatio": 0.9898145169936743, "interestCoverageRatio": 17.46029919447641, "shortTermOperatingCashFlowCoverageRatio": 0.9983131852684847, "operatingCashFlowCoverageRatio": 0.10750767479458193, "capitalExpenditureCoverageRatio": 3.34180312441182, "dividendPaidAndCapexCoverageRatio": 1.366189596799015, "dividendPayoutRatio": 0.5526542943461372, "dividendYield": 0.003689430953464208, "dividendYieldPercentage": 0.3689430953464208, "revenuePerShare": 7.428744626915023, "netIncomePerShare": 1.5322385098644329, "interestDebtPerShare": 18.298247547668907, "cashPerShare": 3.6054226826848894, "bookValuePerShare": 7.344318307064918, "tangibleBookValuePerShare": -5.738013887358095, "shareholdersEquityPerShare": 7.102832580182961, "operatingCashFlowPerShare": 1.9569051030530145, "capexPerShare": 0.5855835996913921, "freeCashFlowPerShare": 1.3713215033616224, "netIncomePerEBT": 0.8722002635046113, "ebtPerEbit": 1.050484413102221, "priceToFairValue": 32.31386878530197, "debtToMarketCap": 0.07930667856248437, "effectiveTaxRate": 0.12779973649538867, "enterpriseValueMultiple": 108.06233647139165, "dividendPerShare": 0.846798192439105}}
{"date": "2021-03-31", "symbol": "LLY", "type": "ratios_quarter", "result": {"symbol": "LLY", "date": "2021-03-31", "fiscalYear": "2021", "period": "Q1", "reportedCurrency": "USD", "grossProfitMargin": 0.7239626190196309, "ebitMargin": 0.22984013165628306, "ebitdaMargin": 0.2813124485717644, "operatingProfitMargin": 0.2574791348301399, "pretaxProfitMargin": 0.21693899141883155, "continuousOperationsProfitMargin": 0.19914482191136712, "netProfitMargin": 0.19914482191136712, "bottomLineProfitMargin": 0.19914482191136712, "receivablesTurnover": 1.0220767128225152, "payablesTurnover": 1.145767260307392, "inventoryTurnover": 0.5131665209790209, "fixedAssetTurnover": 0.7885887764915818, "assetTurnover": 0.1452998934632555, "currentRatio": 1.4174676887879667, "quickRatio": 1.104958085059159, "solvencyRatio": 0.04292005334809633, "cashRatio": 0.25630431442181284, "priceToEarningsRatio": 33.064713945251974, "priceToEarningsGrowthRatio": -0.9134127227375857, "forwardPriceToEarningsGrowthRatio": -0.9134127227375857, "priceToBookRatio": 25.983218177337758, "priceToSalesRatio": 26.338666280710004, "priceToFreeCashFlowRatio": 148.71851592134738, "priceToOperatingCashFlowRatio": 105.6029381642512, "debtToAssetsRatio": 0.34596686899396434, "debtToEquityRatio": 2.3489208111673214, "debtToCapitalRatio": 0.7013963433636898, "longTermDebtToCapitalRatio": 0.7013329985323595, "financialLeverageRatio": 6.789438589879253, "workingCapitalTurnoverRatio": 1.3789358511974714, "operatingCashFlowRatio": 0.14490106025166039, "operatingCashFlowSalesRatio": 0.24941224873633477, "freeCashFlowOperatingCashFlowRatio": 0.7100860139036173, "debtServiceCoverageRatio": 19.346278317152105, "interestCoverageRatio": 19.95785876993166, "shortTermOperatingCashFlowCoverageRatio": 346.40816326530614, "operatingCashFlowCoverageRatio": 0.10474868092196613, "capitalExpenditureCoverageRatio": 3.4492989229831337, "dividendPaidAndCapexCoverageRatio": 1.3398058252427185, "dividendPayoutRatio": 0.5716815465210654, "dividendYield": 0.004322444369756583, "dividendYieldPercentage": 0.43224443697565834, "revenuePerShare": 7.092993927973636, "netIncomePerShare": 1.412533012604718, "interestDebtPerShare": 16.980308124592227, "cashPerShare": 3.1802576807068816, "bookValuePerShare": 7.399096595871522, "tangibleBookValuePerShare": -5.071382266681397, "shareholdersEquityPerShare": 7.190025451233061, "operatingCashFlowPerShare": 1.7690795658490728, "capexPerShare": 0.5128809086569628, "freeCashFlowPerShare": 1.25619865719211, "netIncomePerEBT": 0.9179761582227038, "ebtPerEbit": 0.8425497917023341, "priceToFairValue": 25.983218177337758, "debtToMarketCap": 0.0904014581694896, "effectiveTaxRate": 0.08202384177729613, "enterpriseValueMultiple": 100.52364964220423, "dividendPerShare": 0.8075190571579248}}
{"date": "2024-12-31", "symbol": "LLY", "type": "ratios_annual", "result": {"symbol": "LLY", "date": "2024-12-31", "fiscalYear": "2024", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.8131040101947707, "ebitMargin": 0.29884975811840764, "ebitdaMargin": 0.3380703199408561, "operatingProfitMargin": 0.3885579683278311, "pretaxProfitMargin": 0.2815195359070393, "continuousOperationsProfitMargin": 0.23511023983908602, "netProfitMargin": 0.23511023983908602, "bottomLineProfitMargin": 0.23511023983908602, "receivablesTurnover": 3.392944845353059, "payablesTurnover": 2.607414978628508, "inventoryTurnover": 1.1092473514994994, "fixedAssetTurnover": 2.633706380391056, "assetTurnover": 0.5722258428836218, "currentRatio": 1.1537569687700429, "quickRatio": 0.8863112564577856, "solvencyRatio": 0.19174374993211085, "cashRatio": 0.11517940838578265, "priceToEarningsRatio": 65.65316902738432, "priceToEarningsGrowthRatio": 0.6454603295609622, "forwardPriceToEarningsGrowthRatio": 0.6454603295609622, "priceToBookRatio": 48.98972386045758, "priceToSalesRatio": 15.435732316224383, "priceToFreeCashFlowRatio": 1678.1729664494328, "priceToOperatingCashFlowRatio": 78.84723800451354, "debtToAssetsRatio": 0.4274184430139656, "debtToEquityRatio": 2.3706287300681366, "debtToCapitalRatio": 0.7033194456929153, "longTermDebtToCapitalRatio": 0.6677817000318358, "financialLeverageRatio": 5.546388483733908, "workingCapitalTurnoverRatio": 32.2090171261039, "operatingCashFlowRatio": 0.3107454733829987, "operatingCashFlowSalesRatio": 0.19576757165978062, "freeCashFlowOperatingCashFlowRatio": 0.046983975776545436, "debtServiceCoverageRatio": 2.2275124200959695, "interestCoverageRatio": 22.420830130668715, "shortTermOperatingCashFlowCoverageRatio": 1.7232221375388403, "operatingCashFlowCoverageRatio": 0.26209272326285066, "capitalExpenditureCoverageRatio": 1.0493002998714835, "dividendPaidAndCapexCoverageRatio": 0.6739452766738001, "dividendPayoutRatio": 0.44196411709159583, "dividendYield": 0.006731801733854614, "dividendYieldPercentage": 0.6731801733854613, "revenuePerShare": 50.0138240405061, "netIncomePerShare": 11.758762165433236, "interestDebtPerShare": 38.2240826999628, "cashPerShare": 3.8010004385940563, "bookValuePerShare": 15.84668084232266, "tangibleBookValuePerShare": 2.5927015728315967, "shareholdersEquityPerShare": 15.758406848729464, "operatingCashFlowPerShare": 9.791084881829438, "capexPerShare": 9.331060786915462, "freeCashFlowPerShare": 0.4600240949139745, "netIncomePerEBT": 0.835147156241128, "ebtPerEbit": 0.7245239033922419, "priceToFairValue": 48.98972386045758, "debtToMarketCap": 0.04839032644520797, "effectiveTaxRate": 0.16485284375887196, "enterpriseValueMultiple": 47.653133783393315, "dividendPerShare": 5.196950938535762}}
{"date": "2023-12-31", "symbol": "LLY", "type": "ratios_annual", "result": {"symbol": "LLY", "date": "2023-12-31", "fiscalYear": "2023", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.7924575300154436, "ebitMargin": 0.20632045973373656, "ebitdaMargin": 0.25107768410009346, "operatingProfitMargin": 0.31611969253401556, "pretaxProfitMargin": 0.19208125635547899, "continuousOperationsProfitMargin": 0.15356888533323956, "netProfitMargin": 0.15356888533323956, "bottomLineProfitMargin": 0.15356888533323956, "receivablesTurnover": 3.010188599354281, "payablesTurnover": 2.725180852701247, "inventoryTurnover": 1.2268223392461197, "fixedAssetTurnover": 2.642493185478875, "assetTurnover": 0.5331365818677224, "currentRatio": 0.9426157431155013, "quickRatio": 0.7311051837087627, "solvencyRatio": 0.127349809757144, "cashRatio": 0.10327114446089136, "priceToEarningsRatio": 100.04312775360658, "priceToEarningsGrowthRatio": -8.882207423529666, "forwardPriceToEarningsGrowthRatio": -8.882207423529666, "priceToBookRatio": 48.66978032473379, "priceToSalesRatio": 15.363511614372245, "priceToFreeCashFlowRatio": -166.3280478045685, "priceToOperatingCashFlowRatio": 123.64472693568547, "debtToAssetsRatio": 0.39410651763966986, "debtToEquityRatio": 2.341768861575024, "debtToCapitalRatio": 0.7007572811218651, "longTermDebtToCapitalRatio": 0.6297387317093291, "financialLeverageRatio": 5.941969383302853, "workingCapitalTurnoverRatio": -101.87819077474249, "operatingCashFlowRatio": 0.1553537144783316, "operatingCashFlowSalesRatio": 0.12425529171465328, "freeCashFlowOperatingCashFlowRatio": -0.7433786938987288, "debtServiceCoverageRatio": 0.9814894998917515, "interestCoverageRatio": 22.200658571722578, "shortTermOperatingCashFlowCoverageRatio": 0.6141067419798683, "operatingCashFlowCoverageRatio": 0.16808918030707265, "capitalExpenditureCoverageRatio": 0.5735988420070075, "dividendPaidAndCapexCoverageRatio": 0.3699460798855288, "dividendPayoutRatio": 0.7765246927715441, "dividendYield": 0.007761899394869231, "dividendYieldPercentage": 0.7761899394869232, "revenuePerShare": 37.94184654077981, "netIncomePerShare": 5.826687080752386, "interestDebtPerShare": 28.587725530616126, "cashPerShare": 3.2552461198226776, "bookValuePerShare": 12.079112365309841, "tangibleBookValuePerShare": -1.0925316245987509, "shareholdersEquityPerShare": 11.97704193671411, "operatingCashFlowPerShare": 4.714475210117203, "capexPerShare": 8.219115634232065, "freeCashFlowPerShare": -3.5046404241148617, "netIncomePerEBT": 0.79949958807555, "ebtPerEbit": 0.6076219257830968, "priceToFairValue": 48.66978032473379, "debtToMarketCap": 0.048115459859286565, "effectiveTaxRate": 0.20050041192445, "enterpriseValueMultiple": 63.80549343822217, "dividendPerShare": 4.524566395257172}}
{"date": "2022-12-31", "symbol": "LLY", "type": "ratios_annual", "result": {"symbol": "LLY", "date": "2022-12-31", "fiscalYear": "2022", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.7677128662223998, "ebitMargin": 0.25009284758280953, "ebitdaMargin": 0.30343641166866375, "operatingProfitMargin": 0.30318414653801146, "pretaxProfitMargin": 0.23847463684332232, "continuousOperationsProfitMargin": 0.21879795665244173, "netProfitMargin": 0.21879795665244173, "bottomLineProfitMargin": 0.21879795665244173, "receivablesTurnover": 3.3347042260103517, "payablesTurnover": 3.4340619496529574, "inventoryTurnover": 1.5383437362229389, "fixedAssetTurnover": 2.8136238170347, "assetTurnover": 0.5767127771783277, "currentRatio": 1.0522983743917098, "quickRatio": 0.8008308923924333, "solvencyRatio": 0.20063077304568844, "cashRatio": 0.12060776510952143, "priceToEarningsRatio": 55.66464624647706, "priceToEarningsGrowthRatio": 4.522752507526261, "forwardPriceToEarningsGrowthRatio": 4.522752507526261, "priceToBookRatio": 32.64047990384796, "priceToSalesRatio": 12.179310856510192, "priceToFreeCashFlowRatio": 75.56181698982697, "priceToOperatingCashFlowRatio": 45.82498423085542, "debtToAssetsRatio": 0.32812013788699895, "debtToEquityRatio": 1.5247798080715131, "debtToCapitalRatio": 0.6039258565031761, "longTermDebtToCapitalRatio": 0.5805067888274846, "financialLeverageRatio": 4.6470168453867675, "workingCapitalTurnoverRatio": 13.287430167597766, "operatingCashFlowRatio": 0.44261941160681983, "operatingCashFlowSalesRatio": 0.26577883355406534, "freeCashFlowOperatingCashFlowRatio": 0.6064568859828361, "debtServiceCoverageRatio": 4.419108419272113, "interestCoverageRatio": 26.095597104945718, "shortTermOperatingCashFlowCoverageRatio": 5.053427486509893, "operatingCashFlowCoverageRatio": 0.4671400243863387, "capitalExpenditureCoverageRatio": 2.5410176531671858, "dividendPaidAndCapexCoverageRatio": 1.1632546656238978, "dividendPayoutRatio": 0.5661990776325904, "dividendYield": 0.010171610093873977, "dividendYieldPercentage": 1.0171610093873977, "revenuePerShare": 30.037824332601545, "netIncomePerShare": 6.5722145862582115, "interestDebtPerShare": 17.438974849028924, "cashPerShare": 2.327764575628669, "bookValuePerShare": 11.340353742756651, "tangibleBookValuePerShare": -0.5306351835753571, "shareholdersEquityPerShare": 11.208168540342797, "operatingCashFlowPerShare": 7.983417913620759, "capexPerShare": 3.141819146226723, "freeCashFlowPerShare": 4.841598767394036, "netIncomePerEBT": 0.9174894217207334, "ebtPerEbit": 0.7865669744490541, "priceToFairValue": 32.64047990384796, "debtToMarketCap": 0.046714380810674236, "effectiveTaxRate": 0.08251057827926657, "enterpriseValueMultiple": 41.774283572542004, "dividendPerShare": 3.7211818367428555}}
{"date": "2021-12-31", "symbol": "LLY", "type": "ratios_annual", "result": {"symbol": "LLY", "date": "2021-12-31", "fiscalYear": "2021", "period": "FY", "reportedCurrency": "USD", "grossProfitMargin": 0.7417650714729646, "ebitMargin": 0.22936677213401888, "ebitdaMargin": 0.28401675235889035, "operatingProfitMargin": 0.28013588338324197, "pretaxProfitMargin": 0.21736750663879315, "continuousOperationsProfitMargin": 0.19710506243290582, "netProfitMargin": 0.19710506243290582, "bottomLineProfitMargin": 0.19710506243290582, "receivablesTurnover": 3.4843980706762476, "payablesTurnover": 4.377349455285526, "inventoryTurnover": 1.8818322182192486, "fixedAssetTurnover": 3.1517067144494773, "assetTurnover": 0.5802237429824202, "currentRatio": 1.2258531691988812, "quickRatio": 0.9676935034910681, "solvencyRatio": 0.17980035913162778, "cashRatio": 0.2536754203564809, "priceToEarningsRatio": 47.193154712721935, "priceToEarningsGrowthRatio": -4.924834048246952, "forwardPriceToEarningsGrowthRatio": -4.924834048246952, "priceToBookRatio": 29.336470026282967, "priceToSalesRatio": 9.30200970605684, "priceToFreeCashFlowRatio": 48.894298219953605, "priceToOperatingCashFlowRatio": 35.761825664209404, "debtToAssetsRatio": 0.3459554153177888, "debtToEquityRatio": 1.8804236457590877, "debtToCapitalRatio": 0.6528288463843427, "longTermDebtToCapitalRatio": 0.6308744696944782, "financialLeverageRatio": 5.435450819672131, "workingCapitalTurnoverRatio": 6.758406720603327, "operatingCashFlowRatio": 0.48934078271672193, "operatingCashFlowSalesRatio": 0.260110034465224, "freeCashFlowOperatingCashFlowRatio": 0.7314109613217665, "debtServiceCoverageRatio": 3.976944784622757, "interestCoverageRatio": 23.34608593290171, "shortTermOperatingCashFlowCoverageRatio": 4.788337775466424, "operatingCashFlowCoverageRatio": 0.4362470165297577, "capitalExpenditureCoverageRatio": 3.7231601293974927, "dividendPaidAndCapexCoverageRatio": 1.4542170101871594, "dividendPayoutRatio": 0.5530214809108336, "dividendYield": 0.011718256265706998, "dividendYieldPercentage": 1.1718256265706999, "revenuePerShare": 29.694658329602067, "netIncomePerShare": 5.852967483980022, "interestDebtPerShare": 18.06160102259417, "cashPerShare": 4.098555763993821, "bookValuePerShare": 9.599718136471022, "tangibleBookValuePerShare": -2.5471528952354787, "shareholdersEquityPerShare": 9.415584075130052, "operatingCashFlowPerShare": 7.723878601545845, "capexPerShare": 2.074549128456577, "freeCashFlowPerShare": 5.649329473089268, "netIncomePerEBT": 0.9067825521890992, "ebtPerEbit": 0.7759359636959536, "priceToFairValue": 29.336470026282967, "debtToMarketCap": 0.06409849733367337, "effectiveTaxRate": 0.09321744781090081, "enterpriseValueMultiple": 34.376186656554225, "dividendPerShare": 3.2368167457135875}}
{"date": "2025-09-30", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2025-09-30", "fiscalYear": "2025", "period": "Q3", "reportedCurrency": "USD", "marketCap": 684334700000, "enterpriseValue": 717049400000, "evToSales": 40.7395913822099, "evToOperatingCashFlow": 81.15182380968548, "evToFreeCashFlow": 83.26165815141663, "evToEBITDA": 93.09428230162027, "netDebtToEBITDA": 4.247338491898629, "currentRatio": 1.546335533084709, "incomeQuality": 1.5827854903716974, "grahamNumber": 60.9521376223891, "grahamNetNet": -67.44118630839559, "taxBurden": 0.7718737901664731, "interestBurden": 1, "workingCapital": 21930400000, "investedCapital": 56591100000, "returnOnAssets": 0.048570762358681484, "operatingReturnOnAssets": 0.07162486449425085, "returnOnTangibleAssets": 0.054415263761724994, "returnOnEquity": 0.2346248733887271, "returnOnInvestedCapital": 0.07807259360181745, "returnOnCapitalEmployed": 0.1033551932294487, "earningsYield": 0.00815755799026412, "freeCashFlowYield": 0.012584485340287435, "capexToOperatingCashFlow": 0.02533980692402585, "capexToDepreciation": 0.47638297872340424, "capexToRevenue": 0.012721012681241761, "salesGeneralAndAdministrativeToRevenue": 0.15571451297668287, "researchAndDevelopementToRevenue": 0.23415981091768556, "stockBasedCompensationToRevenue": 0.008584837052861234, "intangiblesToTotalAssets": 0.10740555129229115, "averageReceivables": 18331400000, "averagePayables": 4168950000, "averageInventory": 11597100000, "daysOfSalesOutstanding": 99.4925230671333, "daysOfPayablesOutstanding": 127.51321344280822, "daysOfInventoryOutstanding": 364.40381610876574, "operatingCycle": 463.896339175899, "cashConversionCycle": 336.38312573309076, "freeCashFlowToEquity": -25966500000, "freeCashFlowToFirm": -7131500000, "tangibleAssetValue": 11506100000, "netCurrentAssetValue": -29013300000}}
{"date": "2025-06-30", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2025-06-30", "fiscalYear": "2025", "period": "Q2", "reportedCurrency": "USD", "marketCap": 699939987000, "enterpriseValue": 736467887000, "evToSales": 47.33783830514793, "evToOperatingCashFlow": 238.57847257766693, "evToFreeCashFlow": 574.0201769290725, "evToEBITDA": 98.14468303149029, "netDebtToEBITDA": 4.867855381868095, "currentRatio": 1.2776557602659155, "incomeQuality": 0.5453405176221182, "grahamNumber": 53.727226693605104, "grahamNetNet": -67.50907673460296, "taxBurden": 0.8353255415855027, "interestBurden": 0.9645571782389615, "workingCapital": 10834100000, "investedCapital": 43042600000, "returnOnAssets": 0.05608753638927257, "operatingReturnOnAssets": 0.0748898909891893, "returnOnTangibleAssets": 0.06342737534708294, "returnOnEquity": 0.30977567873736517, "returnOnInvestedCapital": 0.08802327012005087, "returnOnCapitalEmployed": 0.11511937282218708, "earningsYield": 0.008087121903495422, "freeCashFlowYield": 0.0018330142924096147, "capexToOperatingCashFlow": 0.5843726716122971, "capexToDepreciation": 3.7699059561128525, "capexToRevenue": 0.11594901559999228, "salesGeneralAndAdministrativeToRevenue": 0.17017939669745527, "researchAndDevelopementToRevenue": 0.2144340101685982, "stockBasedCompensationToRevenue": 0.011897645538865, "intangiblesToTotalAssets": 0.11572036392245147, "averageReceivables": 15604400000, "averagePayables": 3758850000, "averageInventory": 10162400000, "daysOfSalesOutstanding": 99.53296438419561, "daysOfPayablesOutstanding": 149.8541547512052, "daysOfInventoryOutstanding": 404.95220197728577, "operatingCycle": 504.4851663614814, "cashConversionCycle": 354.63101161027623, "freeCashFlowToEquity": -35138100000, "freeCashFlowToFirm": 5008896059.854791, "tangibleAssetValue": 6670300000, "netCurrentAssetValue": -32719500000}}
{"date": "2025-03-31", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2025-03-31", "fiscalYear": "2025", "period": "Q1", "reportedCurrency": "USD", "marketCap": 741658094990, "enterpriseValue": 777080694990, "evToSales": 61.050453312644855, "evToOperatingCashFlow": 466.54700707853027, "evToFreeCashFlow": -485.4023955212693, "evToEBITDA": 186.68156800797578, "netDebtToEBITDA": 8.509729495988084, "currentRatio": 1.3722583069764966, "incomeQuality": 0.6036313557786395, "grahamNumber": 34.83885999457192, "grahamNetNet": -61.42992842896739, "taxBurden": 0.7983854633835826, "interestBurden": 0.9341315746797124, "workingCapital": 11193100000, "investedCapital": 41449900000, "returnOnAssets": 0.030868520441039594, "operatingReturnOnAssets": 0.0643459959536881, "returnOnTangibleAssets": 0.03555519475917486, "returnOnEquity": 0.17502917893027503, "returnOnInvestedCapital": 0.06817470234923556, "returnOnCapitalEmployed": 0.0911722215010949, "earningsYield": 0.0037204474927725354, "freeCashFlowYield": -0.0021585418008841194, "capexToOperatingCashFlow": 1.961155139289145, "capexToDepreciation": 7.058124459809853, "capexToRevenue": 0.2566288250775818, "salesGeneralAndAdministrativeToRevenue": 0.18558353301645913, "researchAndDevelopementToRevenue": 0.2147700043210119, "stockBasedCompensationToRevenue": 0.012075264170954943, "intangiblesToTotalAssets": 0.13181405276723707, "averageReceivables": 13639300000, "averagePayables": 3335300000, "averageInventory": 8450100000, "daysOfSalesOutstanding": 99.01308088148642, "daysOfPayablesOutstanding": 139.2770434313461, "daysOfInventoryOutstanding": 376.76018343674133, "operatingCycle": 475.77326431822775, "cashConversionCycle": 336.49622088688164, "freeCashFlowToEquity": -35266500000, "freeCashFlowToFirm": -4922833462.5734215, "tangibleAssetValue": 4064100000, "netCurrentAssetValue": -32280800000}}
{"date": "2024-12-31", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2024-12-31", "fiscalYear": "2024", "period": "Q4", "reportedCurrency": "USD", "marketCap": 692899336000, "enterpriseValue": 723275136000, "evToSales": 53.44608181603216, "evToOperatingCashFlow": 292.37413533834587, "evToFreeCashFlow": 995.4240792733278, "evToEBITDA": 125.8263692982151, "netDebtToEBITDA": 5.284402073692634, "currentRatio": 1.1537569687700429, "incomeQuality": 0.5609778221234523, "grahamNumber": 41.80913593340217, "grahamNetNet": -52.665123927900545, "taxBurden": 0.8751860598964019, "interestBurden": 0.9573089637876657, "workingCapital": 4363100000, "investedCapital": 33402100000, "returnOnAssets": 0.05602243031497214, "operatingReturnOnAssets": 0.07513909246781725, "returnOnTangibleAssets": 0.06603642201134201, "returnOnEquity": 0.3107221623297468, "returnOnInvestedCapital": 0.09149972298581129, "returnOnCapitalEmployed": 0.11517671435070315, "earningsYield": 0.006364272226694701, "freeCashFlowYield": 0.0010486371717348564, "capexToOperatingCashFlow": 0.7062818336162988, "capexToDepreciation": 3.603960396039604, "capexToRevenue": 0.12910853629699692, "salesGeneralAndAdministrativeToRevenue": 0.17060031922440294, "researchAndDevelopementToRevenue": 0.22334624024592103, "stockBasedCompensationToRevenue": 0.010485634901868053, "intangiblesToTotalAssets": 0.15164346267352177, "averageReceivables": 12663550000, "averagePayables": 3057550000, "averageInventory": 7524500000, "daysOfSalesOutstanding": 88.28815913927642, "daysOfPayablesOutstanding": 120.88110491721442, "daysOfInventoryOutstanding": 284.14510358598886, "operatingCycle": 372.4332627252653, "cashConversionCycle": 251.55215780805088, "freeCashFlowToEquity": -29398000000, "freeCashFlowToFirm": 5973154307.658722, "tangibleAssetValue": 2335000000, "netCurrentAssetValue": -31703600000}}
{"date": "2024-09-30", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2024-09-30", "fiscalYear": "2024", "period": "Q3", "reportedCurrency": "USD", "marketCap": 798231940000, "enterpriseValue": 825982640000, "evToSales": 72.20696033778881, "evToOperatingCashFlow": 222.52286968937742, "evToFreeCashFlow": -1799.918587927653, "evToEBITDA": 367.4463454780017, "netDebtToEBITDA": 12.34516659993772, "currentRatio": 1.2732014541563825, "incomeQuality": 3.825517881067711, "grahamNumber": 19.569263381205467, "grahamNetNet": -49.94353496115427, "taxBurden": 0.6108662805338706, "interestBurden": 0.8918084329908483, "workingCapital": 6741000000, "investedCapital": 35218500000, "returnOnAssets": 0.012833484774537773, "operatingReturnOnAssets": 0.061699858355307814, "returnOnTangibleAssets": 0.015328303412889488, "returnOnEquity": 0.06813904494382023, "returnOnInvestedCapital": 0.05243296470044587, "returnOnCapitalEmployed": 0.08932946941852794, "earningsYield": 0.0012155614820424248, "freeCashFlowYield": -0.000574895562309872, "capexToOperatingCashFlow": 1.1236294081198308, "capexToDepreciation": 8.934875749785775, "capexToRevenue": 0.36460910386306616, "salesGeneralAndAdministrativeToRevenue": 0.1734751859849114, "researchAndDevelopementToRevenue": 0.23901355875899327, "stockBasedCompensationToRevenue": 0.011644272713762446, "intangiblesToTotalAssets": 0.16275895453986342, "averageReceivables": 12565350000, "averagePayables": 2905650000, "averageInventory": 6970650000, "daysOfSalesOutstanding": 94.81978477327762, "daysOfPayablesOutstanding": 119.67247097844113, "daysOfInventoryOutstanding": 309.2786069651741, "operatingCycle": 404.0983917384517, "cashConversionCycle": 284.42592076001057, "freeCashFlowToEquity": -25211500000, "freeCashFlowToFirm": -3275786067.741123, "tangibleAssetValue": 2015000000, "netCurrentAssetValue": -29871100000}}
{"date": "2024-06-30", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2024-06-30", "fiscalYear": "2024", "period": "Q2", "reportedCurrency": "USD", "marketCap": 823755933000, "enterpriseValue": 849424333000, "evToSales": 75.1516733021906, "evToOperatingCashFlow": 579.3372889101078, "evToFreeCashFlow": 13397.860141955836, "evToEBITDA": 206.4114339521773, "netDebtToEBITDA": 6.237461119751166, "currentRatio": 1.113678598292111, "incomeQuality": 0.49416919447253116, "grahamNumber": 33.39914239027417, "grahamNetNet": -46.42612942612943, "taxBurden": 0.8435687478676219, "interestBurden": 0.9503891050583657, "workingCapital": 3083100000, "investedCapital": 30316800000, "returnOnAssets": 0.041280114866406585, "operatingReturnOnAssets": 0.06506486975613743, "returnOnTangibleAssets": 0.04989028173632305, "returnOnEquity": 0.218773042324141, "returnOnInvestedCapital": 0.07467281534388498, "returnOnCapitalEmployed": 0.09872948768367237, "earningsYield": 0.0036017949991505554, "freeCashFlowYield": 7.696454430271156e-05, "capexToOperatingCashFlow": 0.9567589687627882, "capexToDepreciation": 3.385135135135135, "capexToRevenue": 0.12411083979190997, "salesGeneralAndAdministrativeToRevenue": 0.17720387868492762, "researchAndDevelopementToRevenue": 0.2398697667834519, "stockBasedCompensationToRevenue": 0.01867678805251796, "intangiblesToTotalAssets": 0.17258204544569167, "averageReceivables": 11546250000, "averagePayables": 2699250000, "averageInventory": 6291650000, "daysOfSalesOutstanding": 104.1432211487419, "daysOfPayablesOutstanding": 121.29388996405862, "daysOfInventoryOutstanding": 268.79319878352226, "operatingCycle": 372.93641993226413, "cashConversionCycle": 251.6425299682055, "freeCashFlowToEquity": -25605000000, "freeCashFlowToFirm": 5641079222.108496, "tangibleAssetValue": 1231200000, "netCurrentAssetValue": -28035000000}}
{"date": "2024-03-31", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2024-03-31", "fiscalYear": "2024", "period": "Q1", "reportedCurrency": "USD", "marketCap": 685103440000, "enterpriseValue": 708854640000, "evToSales": 80.84564781021898, "evToOperatingCashFlow": 607.9370840480275, "evToFreeCashFlow": 3944.655759599332, "evToEBITDA": 227.46675223823124, "netDebtToEBITDA": 7.621602541475467, "currentRatio": 1.3543749092649249, "incomeQuality": 0.519862677783227, "grahamNumber": 28.22797289426833, "grahamNetNet": -42.072352353463586, "taxBurden": 0.8843894168211033, "interestBurden": 0.9338660382221895, "workingCapital": 6590700000, "investedCapital": 31916500000, "returnOnAssets": 0.03507627827691634, "operatingReturnOnAssets": 0.042760520141492994, "returnOnTangibleAssets": 0.04293313578999152, "returnOnEquity": 0.17505970871513088, "returnOnInvestedCapital": 0.05147862281673494, "returnOnCapitalEmployed": 0.060328059737040585, "earningsYield": 0.003273812199804456, "freeCashFlowYield": 0.000262296157788961, "capexToOperatingCashFlow": 0.8458833619210978, "capexToDepreciation": 2.4620569146280578, "capexToRevenue": 0.11248859489051095, "salesGeneralAndAdministrativeToRevenue": 0.20940921532846715, "researchAndDevelopementToRevenue": 0.287728102189781, "stockBasedCompensationToRevenue": 0.018179744525547444, "intangiblesToTotalAssets": 0.18300218161345563, "averageReceivables": 10674850000, "averagePayables": 2536250000, "averageInventory": 5937300000, "daysOfSalesOutstanding": 102.78455748175182, "daysOfPayablesOutstanding": 133.03435912757695, "daysOfInventoryOutstanding": 328.1517777113833, "operatingCycle": 430.93633519313516, "cashConversionCycle": 297.9019760655582, "freeCashFlowToEquity": -23571500000, "freeCashFlowToFirm": -6340863660.73893, "tangibleAssetValue": 1195600000, "netCurrentAssetValue": -25857300000}}
{"date": "2023-12-31", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2023-12-31", "fiscalYear": "2023", "period": "Q4", "reportedCurrency": "USD", "marketCap": 524266006679.99994, "enterpriseValue": 546672706679.99994, "evToSales": 58.44641592148309, "evToOperatingCashFlow": -1752.7178797050335, "evToFreeCashFlow": -278.4883885277636, "evToEBITDA": 180.14060918047912, "netDebtToEBITDA": 7.383497545062115, "currentRatio": 0.9426157431155013, "incomeQuality": -0.14244610887833395, "grahamNumber": 25.614564827714297, "grahamNetNet": -43.17017631054316, "taxBurden": 0.8728077168367347, "interestBurden": 0.9477899508877975, "workingCapital": -1566200000, "investedCapital": 23193700000, "returnOnAssets": 0.03421069488472229, "operatingReturnOnAssets": 0.05237947602479622, "returnOnTangibleAssets": 0.04198044478527607, "returnOnEquity": 0.20327890158653533, "returnOnInvestedCapital": 0.06389536151992264, "returnOnCapitalEmployed": 0.086974404231732, "earningsYield": 0.004176696509214154, "freeCashFlowYield": -0.003744282434848328, "capexToOperatingCashFlow": -5.29368387303623, "capexToDepreciation": 4.258705184420944, "capexToRevenue": 0.17652404473239677, "salesGeneralAndAdministrativeToRevenue": 0.1934697543139393, "researchAndDevelopementToRevenue": 0.2739859302499626, "stockBasedCompensationToRevenue": 0.012850941903478949, "intangiblesToTotalAssets": 0.18508021866597507, "averageReceivables": 10850000000, "averagePayables": 2516950000, "averageInventory": 5337100000, "daysOfSalesOutstanding": 109.078837641927, "daysOfPayablesOutstanding": 130.81208053691273, "daysOfInventoryOutstanding": 290.5771812080537, "operatingCycle": 399.6560188499807, "cashConversionCycle": 268.84393831306795, "freeCashFlowToEquity": -23789200000, "freeCashFlowToFirm": 4202422026.466837, "tangibleAssetValue": -982600000, "netCurrentAssetValue": -27415600000}}
{"date": "2023-09-30", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2023-09-30", "fiscalYear": "2023", "period": "Q3", "reportedCurrency": "USD", "marketCap": 509899120390, "enterpriseValue": 527686620390, "evToSales": 55.554146967974226, "evToOperatingCashFlow": 241.00781931491207, "evToFreeCashFlow": -291.266004520616, "evToEBITDA": 548.0750107914416, "netDebtToEBITDA": 18.474761113419195, "currentRatio": 1.045858297497068, "incomeQuality": -38.14459930313589, "grahamNumber": null, "grahamNetNet": -35.70056135922882, "taxBurden": -0.1343632958801498, "interestBurden": 0.7741935483870968, "workingCapital": 1008800000, "investedCapital": 23738900000, "returnOnAssets": -0.0009910991012768602, "operatingReturnOnAssets": 0.06282295228844269, "returnOnTangibleAssets": -0.0012200150482692366, "returnOnEquity": -0.005115682150368971, "returnOnInvestedCapital": -0.012467387210094077, "returnOnCapitalEmployed": 0.09858758871073271, "earningsYield": -0.00011257128656369754, "freeCashFlowYield": -0.003553055746819701, "capexToOperatingCashFlow": 1.8274491893126286, "capexToDepreciation": 9.735279805352798, "capexToRevenue": 0.4212410249931569, "salesGeneralAndAdministrativeToRevenue": 0.1777525108963426, "researchAndDevelopementToRevenue": 0.2536268502726718, "stockBasedCompensationToRevenue": 0.02269808182258438, "intangiblesToTotalAssets": 0.18763370772936433, "averageReceivables": 9767600000, "averagePayables": 2454650000, "averageInventory": 4850050000, "daysOfSalesOutstanding": 98.19783968163729, "daysOfPayablesOutstanding": 117.82108488790927, "daysOfInventoryOutstanding": 237.1517660340842, "operatingCycle": 335.3496057157215, "cashConversionCycle": 217.52852082781226, "freeCashFlowToEquity": -16568300000, "freeCashFlowToFirm": 774358333.3333335, "tangibleAssetValue": 440500000, "netCurrentAssetValue": -23601100000}}
{"date": "2023-06-30", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2023-06-30", "fiscalYear": "2023", "period": "Q2", "reportedCurrency": "USD", "marketCap": 445196148280, "enterpriseValue": 461321648280, "evToSales": 55.50001182372686, "evToOperatingCashFlow": 730.0548319037822, "evToFreeCashFlow": -2256.955226418787, "evToEBITDA": 179.11925772859638, "netDebtToEBITDA": 6.261114346728791, "currentRatio": 1.1277610362146444, "incomeQuality": 0.35838248638838477, "grahamNumber": 22.069735581218374, "grahamNetNet": -33.24361678145469, "taxBurden": 0.8440806165924649, "interestBurden": 0.9455458989679522, "workingCapital": 2416600000, "investedCapital": 24676400000, "returnOnAssets": 0.032166964644069033, "operatingReturnOnAssets": 0.04331292775313261, "returnOnTangibleAssets": 0.04022668577008368, "returnOnEquity": 0.15936658291003092, "returnOnInvestedCapital": 0.05398702739670082, "returnOnCapitalEmployed": 0.06513830468815288, "earningsYield": 0.00396050147067099, "freeCashFlowYield": -0.0004591234690364963, "capexToOperatingCashFlow": 1.3234689033074853, "capexToDepreciation": 2.283101283101283, "capexToRevenue": 0.10061236029402919, "salesGeneralAndAdministrativeToRevenue": 0.21773077802240107, "researchAndDevelopementToRevenue": 0.28350236402353196, "stockBasedCompensationToRevenue": 0.019429506382262002, "intangiblesToTotalAssets": 0.20035757288284015, "averageReceivables": 9096750000, "averagePayables": 2245050000, "averageInventory": 4671750000, "daysOfSalesOutstanding": 99.30414696647057, "daysOfPayablesOutstanding": 123.20349673564235, "daysOfInventoryOutstanding": 238.95263915016042, "operatingCycle": 338.256786116631, "cashConversionCycle": 215.05328938098867, "freeCashFlowToEquity": -16231800000, "freeCashFlowToFirm": 3877642898.176073, "tangibleAssetValue": 166900000, "netCurrentAssetValue": -22333100000}}
{"date": "2023-03-31", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2023-03-31", "fiscalYear": "2023", "period": "Q1", "reportedCurrency": "USD", "marketCap": 325997273140, "enterpriseValue": 341334973140, "evToSales": 49.04238119827586, "evToOperatingCashFlow": 197.23504746330752, "evToFreeCashFlow": 412.6888805948495, "evToEBITDA": 171.11237875476237, "netDebtToEBITDA": 7.6888409865650695, "currentRatio": 1.2999000624609618, "incomeQuality": 1.286787121719087, "grahamNumber": 19.38521748162408, "grahamNetNet": -30.718254189811717, "taxBurden": 0.8791919984310649, "interestBurden": 0.9370290964777948, "workingCapital": 4801400000, "investedCapital": 26507800000, "returnOnAssets": 0.025297669431747643, "operatingReturnOnAssets": 0.03340970728513981, "returnOnTangibleAssets": 0.032019293951831784, "returnOnEquity": 0.1201833714612525, "returnOnInvestedCapital": 0.040575798830059934, "returnOnCapitalEmployed": 0.04615508841816273, "earningsYield": 0.0041254946308168375, "freeCashFlowYield": 0.0025371377865630205, "capexToOperatingCashFlow": 0.52207326938634, "capexToDepreciation": 2.4937896770632073, "capexToRevenue": 0.1298132183908046, "salesGeneralAndAdministrativeToRevenue": 0.23468390804597702, "researchAndDevelopementToRevenue": 0.28521551724137933, "stockBasedCompensationToRevenue": 0.01885057471264368, "intangiblesToTotalAssets": 0.20992419539905574, "averageReceivables": 8790500000, "averagePayables": 1973250000, "averageInventory": 4427250000, "daysOfSalesOutstanding": 116.66508620689656, "daysOfPayablesOutstanding": 111.53316530398968, "daysOfInventoryOutstanding": 251.44894571832546, "operatingCycle": 368.11403192522204, "cashConversionCycle": 256.58086662123236, "freeCashFlowToEquity": -14275600000, "freeCashFlowToFirm": -2776019062.561287, "tangibleAssetValue": 134700000, "netCurrentAssetValue": -21056700000}}
{"date": "2022-12-31", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2022-12-31", "fiscalYear": "2022", "period": "Q4", "reportedCurrency": "USD", "marketCap": 347614582880, "enterpriseValue": 361786182880, "evToSales": 49.54753387931743, "evToOperatingCashFlow": 229.02208196493004, "evToFreeCashFlow": 353.27231996875304, "evToEBITDA": 141.57712408233544, "netDebtToEBITDA": 5.545746262815998, "currentRatio": 1.0522983743917098, "incomeQuality": 0.8152448779480828, "grahamNumber": 22.67767127400076, "grahamNetNet": -29.39286894510736, "taxBurden": 0.9242987979393246, "interestBurden": 0.96147495872317, "workingCapital": 896300000, "investedCapital": 22319900000, "returnOnAssets": 0.03915352254403938, "operatingReturnOnAssets": 0.04553832697447069, "returnOnTangibleAssets": 0.050711590098978805, "returnOnEquity": 0.18194707881838157, "returnOnInvestedCapital": 0.06027258081190153, "returnOnCapitalEmployed": 0.06823464681808628, "earningsYield": 0.005574277074183949, "freeCashFlowYield": 0.002946078934650246, "capexToOperatingCashFlow": 0.3517123504462873, "capexToDepreciation": 1.4816, "capexToRevenue": 0.07609082691938975, "salesGeneralAndAdministrativeToRevenue": 0.2123175107507738, "researchAndDevelopementToRevenue": 0.27334355912240815, "stockBasedCompensationToRevenue": 0.012722890246240653, "intangiblesToTotalAssets": 0.22791767192431572, "averageReceivables": 8441850000, "averagePayables": 1806900000, "averageInventory": 4070400000, "daysOfSalesOutstanding": 105.4946725464954, "daysOfPayablesOutstanding": 112.23693559847554, "daysOfInventoryOutstanding": 250.54776823202636, "operatingCycle": 356.0424407785217, "cashConversionCycle": 243.80550518004617, "freeCashFlowToEquity": -13092600000, "freeCashFlowToFirm": 2980441099.026903, "tangibleAssetValue": -504200000, "netCurrentAssetValue": -20679900000}}
{"date": "2022-09-30", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2022-09-30", "fiscalYear": "2022", "period": "Q3", "reportedCurrency": "USD", "marketCap": 291241345000, "enterpriseValue": 304512345000, "evToSales": 43.86774590872422, "evToOperatingCashFlow": 137.3719244823386, "evToFreeCashFlow": 194.6263230218586, "evToEBITDA": 151.50621672720035, "netDebtToEBITDA": 6.602816060500523, "currentRatio": 1.1269485331697844, "incomeQuality": 1.5269683818970863, "grahamNumber": 20.135685826304858, "grahamNetNet": -29.30426335072721, "taxBurden": 0.9273075694666241, "interestBurden": 0.9505160898603522, "workingCapital": 1987100000, "investedCapital": 22314100000, "returnOnAssets": 0.030586896747890394, "operatingReturnOnAssets": 0.04311659019667792, "returnOnTangibleAssets": 0.039831750160512325, "returnOnEquity": 0.14415944230941102, "returnOnInvestedCapital": 0.056318375988623666, "returnOnCapitalEmployed": 0.06406423399887452, "earningsYield": 0.004984525806251855, "freeCashFlowYield": 0.005372176810953816, "capexToOperatingCashFlow": 0.29417602742815896, "capexToDepreciation": 1.7969137503444474, "capexToRevenue": 0.09394087818370404, "salesGeneralAndAdministrativeToRevenue": 0.21922899619684222, "researchAndDevelopementToRevenue": 0.25972398294341364, "stockBasedCompensationToRevenue": 0.01225942145902962, "intangiblesToTotalAssets": 0.2320975948927025, "averageReceivables": 7998600000, "averagePayables": 1671250000, "averageInventory": 3865250000, "daysOfSalesOutstanding": 107.93361760977295, "daysOfPayablesOutstanding": 95.93312646444177, "daysOfInventoryOutstanding": 218.35159267937433, "operatingCycle": 326.2852102891473, "cashConversionCycle": 230.35208382470552, "freeCashFlowToEquity": -11671500000, "freeCashFlowToFirm": 780475566.9115298, "tangibleAssetValue": -849800000, "netCurrentAssetValue": -19655700000}}
{"date": "2022-06-30", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2022-06-30", "fiscalYear": "2022", "period": "Q2", "reportedCurrency": "USD", "marketCap": 291904269000, "enterpriseValue": 306095169000, "evToSales": 47.17866353267571, "evToOperatingCashFlow": 258.6792605425505, "evToFreeCashFlow": 827.9555558560995, "evToEBITDA": 201.24600197238658, "netDebtToEBITDA": 9.329980276134123, "currentRatio": 1.0956813438664328, "incomeQuality": 1.2423097112860892, "grahamNumber": 15.030897416504185, "grahamNetNet": -31.06042430301011, "taxBurden": 0.8731322761023008, "interestBurden": 0.9307226345874925, "workingCapital": 1494600000, "investedCapital": 22012300000, "returnOnAssets": 0.020238570785065316, "operatingReturnOnAssets": 0.03713015878420436, "returnOnTangibleAssets": 0.026700042888257867, "returnOnEquity": 0.11147260875162382, "returnOnInvestedCapital": 0.04538806116357894, "returnOnCapitalEmployed": 0.055490888274019656, "earningsYield": 0.003263056080896165, "freeCashFlowYield": 0.0012665111108738187, "capexToOperatingCashFlow": 0.6875686639060256, "capexToDepreciation": 2.3319002579535684, "capexToRevenue": 0.12540073982737363, "salesGeneralAndAdministrativeToRevenue": 0.23594327990135636, "researchAndDevelopementToRevenue": 0.2746454993834772, "stockBasedCompensationToRevenue": 0.014195437731196055, "intangiblesToTotalAssets": 0.2420023117653558, "averageReceivables": 7739050000, "averagePayables": 1546300000, "averageInventory": 3896200000, "daysOfSalesOutstanding": 106.42971639950677, "daysOfPayablesOutstanding": 104.39496679482698, "daysOfInventoryOutstanding": 245.33100314575324, "operatingCycle": 351.76071954526003, "cashConversionCycle": 247.36575275043305, "freeCashFlowToEquity": -13378600000, "freeCashFlowToFirm": 3085398340.8195066, "tangibleAssetValue": -2730300000, "netCurrentAssetValue": -21289200000}}
{"date": "2022-03-31", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2022-03-31", "fiscalYear": "2022", "period": "Q1", "reportedCurrency": "USD", "marketCap": 272224753850, "enterpriseValue": 286274353850, "evToSales": 36.65484684379001, "evToOperatingCashFlow": 113.46585566785572, "evToFreeCashFlow": 174.34491708282582, "evToEBITDA": 111.20905673607335, "netDebtToEBITDA": 5.457850982829617, "currentRatio": 1.267346481398476, "incomeQuality": 1.3258710389405644, "grahamNumber": 21.026093348093834, "grahamNetNet": -28.49577374408929, "taxBurden": 0.9266166731593299, "interestBurden": 0.9602992751928923, "workingCapital": 3578700000, "investedCapital": 24055800000, "returnOnAssets": 0.04055687105306345, "operatingReturnOnAssets": 0.05564255217795087, "returnOnTangibleAssets": 0.053535106302169934, "returnOnEquity": 0.20393749732070132, "returnOnInvestedCapital": 0.07073150212552674, "returnOnCapitalEmployed": 0.07941956204727837, "earningsYield": 0.006990179890284801, "freeCashFlowYield": 0.006031780639995608, "capexToOperatingCashFlow": 0.3491874752279033, "capexToDepreciation": 2.0220335092953867, "capexToRevenue": 0.11280409731113956, "salesGeneralAndAdministrativeToRevenue": 0.18752880921895007, "researchAndDevelopementToRevenue": 0.20615877080665812, "stockBasedCompensationToRevenue": 0.01293213828425096, "intangiblesToTotalAssets": 0.24242475910765932, "averageReceivables": 7966450000, "averagePayables": 1551950000, "averageInventory": 3889500000, "daysOfSalesOutstanding": 89.9504481434059, "daysOfPayablesOutstanding": 62.25423483422615, "daysOfInventoryOutstanding": 169.0893296655567, "operatingCycle": 259.0397778089626, "cashConversionCycle": 196.78554297473642, "freeCashFlowToEquity": -11892000000, "freeCashFlowToFirm": 1872869755.551227, "tangibleAssetValue": -1912400000, "netCurrentAssetValue": -20492600000}}
{"date": "2021-12-31", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2021-12-31", "fiscalYear": "2021", "period": "Q4", "reportedCurrency": "USD", "marketCap": 263418031660.00003, "enterpriseValue": 276484231660, "evToSales": 34.56096096951212, "evToOperatingCashFlow": 128.20970631115233, "evToFreeCashFlow": 156.88828897463543, "evToEBITDA": 116.80787142374314, "netDebtToEBITDA": 5.520152091254753, "currentRatio": 1.2258531691988812, "incomeQuality": 1.2493482417009443, "grahamNumber": 19.581803064384996, "grahamNetNet": -29.050608554683937, "taxBurden": 0.9381488124354584, "interestBurden": 0.9576328527559465, "workingCapital": 3399700000, "investedCapital": 23968700000, "returnOnAssets": 0.03536655329262796, "operatingReturnOnAssets": 0.05095006856164878, "returnOnTangibleAssets": 0.04637298809040866, "returnOnEquity": 0.19223316108339272, "returnOnInvestedCapital": 0.06568338926675964, "returnOnCapitalEmployed": 0.0732046940595438, "earningsYield": 0.006552702520486216, "freeCashFlowYield": 0.006690126673919737, "capexToOperatingCashFlow": 0.18279619754231394, "capexToDepreciation": 0.8844514247251515, "capexToRevenue": 0.049275615945199316, "salesGeneralAndAdministrativeToRevenue": 0.18992737409217617, "researchAndDevelopementToRevenue": 0.24492806160077002, "stockBasedCompensationToRevenue": 0.009412617657720721, "intangiblesToTotalAssets": 0.23734581813711428, "averageReceivables": 7576100000, "averagePayables": 1618700000, "averageInventory": 3896700000, "daysOfSalesOutstanding": 91.43214290178628, "daysOfPayablesOutstanding": 73.33625987708517, "daysOfInventoryOutstanding": 170.58823529411765, "operatingCycle": 262.02037819590396, "cashConversionCycle": 188.68411831881878, "freeCashFlowToEquity": -11201100000, "freeCashFlowToFirm": 2683365313.3322463, "tangibleAssetValue": -2429100000, "netCurrentAssetValue": -21198800000}}
{"date": "2021-09-30", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2021-09-30", "fiscalYear": "2021", "period": "Q3", "reportedCurrency": "USD", "marketCap": 221019888450, "enterpriseValue": 234317088450, "evToSales": 34.59678249025514, "evToOperatingCashFlow": 143.63825688101514, "evToFreeCashFlow": 199.30006672620567, "evToEBITDA": 136.93144486325386, "netDebtToEBITDA": 7.770687237026648, "currentRatio": 1.301586025434878, "incomeQuality": 1.4695072515989551, "grahamNumber": 14.551032930709017, "grahamNetNet": -30.509602347507656, "taxBurden": 0.8914317835059825, "interestBurden": 0.9370908269997742, "workingCapital": 4126300000, "investedCapital": 24818500000, "returnOnAssets": 0.023037333720713055, "operatingReturnOnAssets": 0.04440601691737156, "returnOnTangibleAssets": 0.030484522946461916, "returnOnEquity": 0.14310944952945726, "returnOnInvestedCapital": 0.052678210695482175, "returnOnCapitalEmployed": 0.06177075786117954, "earningsYield": 0.005022624922060492, "freeCashFlowYield": 0.005319430790799496, "capexToOperatingCashFlow": 0.27928645865260837, "capexToDepreciation": 1.191734240125556, "capexToRevenue": 0.06726907630522089, "salesGeneralAndAdministrativeToRevenue": 0.2222566737538389, "researchAndDevelopementToRevenue": 0.25178655799669264, "stockBasedCompensationToRevenue": 0.013303212851405623, "intangiblesToTotalAssets": 0.24429410421898023, "averageReceivables": 6963900000, "averagePayables": 1582300000, "averageInventory": 3866150000, "daysOfSalesOutstanding": 93.35134656272147, "daysOfPayablesOutstanding": 98.55465473860777, "daysOfInventoryOutstanding": 245.78277886497065, "operatingCycle": 339.13412542769214, "cashConversionCycle": 240.57947068908436, "freeCashFlowToEquity": -12002700000, "freeCashFlowToFirm": -693876302.8988998, "tangibleAssetValue": -3817700000, "netCurrentAssetValue": -22424600000}}
{"date": "2021-06-30", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2021-06-30", "fiscalYear": "2021", "period": "Q2", "reportedCurrency": "USD", "marketCap": 208243496000, "enterpriseValue": 221538596000, "evToSales": 32.86874022640614, "evToOperatingCashFlow": 124.77532863981978, "evToFreeCashFlow": 178.0570615656647, "evToEBITDA": 108.06233647139165, "netDebtToEBITDA": 6.485098287888396, "currentRatio": 1.1459133914610553, "incomeQuality": 1.2771543662782334, "grahamNumber": 15.648410660214408, "grahamNetNet": -33.930067232447925, "taxBurden": 0.8722002635046113, "interestBurden": 0.9482984293193717, "workingCapital": 2202300000, "investedCapital": 22927400000, "returnOnAssets": 0.029078207032148758, "operatingReturnOnAssets": 0.032062193004977424, "returnOnTangibleAssets": 0.038681780998013324, "returnOnEquity": 0.21572217739432686, "returnOnInvestedCapital": 0.03836545341739205, "returnOnCapitalEmployed": 0.0463782025810159, "earningsYield": 0.006675838749845037, "freeCashFlowYield": 0.005974736421059701, "capexToOperatingCashFlow": 0.2992396508025908, "capexToDepreciation": 1.4386677497969131, "capexToRevenue": 0.07882672363911515, "salesGeneralAndAdministrativeToRevenue": 0.23955134196822006, "researchAndDevelopementToRevenue": 0.2455453183187193, "stockBasedCompensationToRevenue": 0.013634812539873295, "intangiblesToTotalAssets": 0.24827124599970718, "averageReceivables": 6780700000, "averagePayables": 1618700000, "averageInventory": 3742850000, "daysOfSalesOutstanding": 92.17251969555348, "daysOfPayablesOutstanding": 73.6237968462011, "daysOfInventoryOutstanding": 176.24462420643047, "operatingCycle": 268.41714390198393, "cashConversionCycle": 194.79334705578282, "freeCashFlowToEquity": -11900900000, "freeCashFlowToFirm": 4141994202.898551, "tangibleAssetValue": -5206100000, "netCurrentAssetValue": -23850000000}}
{"date": "2021-03-31", "symbol": "LLY", "type": "key_metrics_quarter", "result": {"symbol": "LLY", "date": "2021-03-31", "fiscalYear": "2021", "period": "Q1", "reportedCurrency": "USD", "marketCap": 179250427240, "enterpriseValue": 192452527240, "evToSales": 28.278554020218643, "evToOperatingCashFlow": 113.3807748556616, "evToFreeCashFlow": 159.67188852567824, "evToEBITDA": 100.52364964220423, "netDebtToEBITDA": 6.895847479759729, "currentRatio": 1.4174676887879667, "incomeQuality": 1.2524164391647605, "grahamNumber": 15.116657600310782, "grahamNetNet": -31.124346261837115, "taxBurden": 0.9179761582227038, "interestBurden": 0.9438690704513489, "workingCapital": 4890300000, "investedCapital": 25485600000, "returnOnAssets": 0.02893572140748063, "operatingReturnOnAssets": 0.03749382163956034, "returnOnTangibleAssets": 0.0388637660546381, "returnOnEquity": 0.1964573035499442, "returnOnInvestedCapital": 0.045790361867791396, "returnOnCapitalEmployed": 0.04988882277410667, "earningsYield": 0.007560930374717472, "freeCashFlowYield": 0.00672411228558029, "capexToOperatingCashFlow": 0.2899139860963827, "capexToDepreciation": 1.404795889237796, "capexToRevenue": 0.07230809921241331, "salesGeneralAndAdministrativeToRevenue": 0.22078876219583873, "researchAndDevelopementToRevenue": 0.24569472199365228, "stockBasedCompensationToRevenue": 0.012563183260844012, "intangiblesToTotalAssets": 0.2554576062752064, "averageReceivables": 6793800000, "averagePayables": 1623150000, "averageInventory": 3820550000, "daysOfSalesOutstanding": 88.0560126954273, "daysOfPayablesOutstanding": 78.54998403066114, "daysOfInventoryOutstanding": 175.38166719897796, "operatingCycle": 263.4376798944053, "cashConversionCycle": 184.88769586374414, "freeCashFlowToEquity": -11805000000, "freeCashFlowToFirm": 1576098306.6919534, "tangibleAssetValue": -4865900000, "netCurrentAssetValue": -23134500000}}
{"date": "2024-12-31", "symbol": "LLY", "type": "key_metrics_annual", "result": {"symbol": "LLY", "date": "2024-12-31", "fiscalYear": "2024", "period": "FY", "reportedCurrency": "USD", "marketCap": 695267060000, "enterpriseValue": 725642860000, "evToSales": 16.110110184336197, "evToOperatingCashFlow": 82.29202644620601, "evToFreeCashFlow": 1751.4913347815593, "evToEBITDA": 47.653133783393315, "netDebtToEBITDA": 1.9947857837085292, "currentRatio": 1.1537569687700429, "incomeQuality": 0.8326628895184136, "grahamNumber": 64.5696179360521, "grahamNetNet": -52.4857734522904, "taxBurden": 0.835147156241128, "interestBurden": 0.942010251838645, "workingCapital": 4363100000, "investedCapital": 33402100000, "returnOnAssets": 0.13453615516249148, "operatingReturnOnAssets": 0.24525718673890073, "returnOnTangibleAssets": 0.15858445033790916, "returnOnEquity": 0.7461897816390809, "returnOnInvestedCapital": 0.2635720774601815, "returnOnCapitalEmployed": 0.34768158638650887, "earningsYield": 0.01523155720911041, "freeCashFlowYield": 0.0005958861333082571, "capexToOperatingCashFlow": 0.9530160242234545, "capexToDepreciation": 4.756934223932979, "capexToRevenue": 0.18656963281508435, "salesGeneralAndAdministrativeToRevenue": 0.18054201901751005, "researchAndDevelopementToRevenue": 0.24400402284942954, "stockBasedCompensationToRevenue": 0.014333066179425301, "intangiblesToTotalAssets": 0.15164346267352177, "averageReceivables": 12305800000, "averagePayables": 2913700000, "averageInventory": 6681000000, "daysOfSalesOutstanding": 107.57616661523399, "daysOfPayablesOutstanding": 139.98538897402088, "daysOfInventoryOutstanding": 329.0519463549648, "operatingCycle": 436.6281129701988, "cashConversionCycle": 296.6427239961779, "freeCashFlowToEquity": -26615700000, "freeCashFlowToFirm": 2021415870.1618233, "tangibleAssetValue": 2335000000, "netCurrentAssetValue": -31703600000}}
{"date": "2023-12-31", "symbol": "LLY", "type": "key_metrics_annual", "result": {"symbol": "LLY", "date": "2023-12-31", "fiscalYear": "2023", "period": "FY", "reportedCurrency": "USD", "marketCap": 524266006679.99994, "enterpriseValue": 546672706679.99994, "evToSales": 16.020135525332535, "evToOperatingCashFlow": 128.9292013584585, "evToFreeCashFlow": -173.43677242385786, "evToEBITDA": 63.80549343822217, "netDebtToEBITDA": 2.615222110693527, "currentRatio": 0.9426157431155013, "incomeQuality": 0.8091176246088085, "grahamNumber": 39.62569493600506, "grahamNetNet": -43.17017631054316, "taxBurden": 0.79949958807555, "interestBurden": 0.930985015268802, "workingCapital": -1566200000, "investedCapital": 23193700000, "returnOnAssets": 0.08187319060779955, "operatingReturnOnAssets": 0.1900911132629227, "returnOnTangibleAssets": 0.10046779141104295, "returnOnEquity": 0.4864879919048636, "returnOnInvestedCapital": 0.19772848360403553, "returnOnCapitalEmployed": 0.29382699908207155, "earningsYield": 0.009995689083840641, "freeCashFlowYield": -0.006012215096608217, "capexToOperatingCashFlow": 1.7433786938987288, "capexToDepreciation": 4.83997904799319, "capexToRevenue": 0.21662402817949777, "salesGeneralAndAdministrativeToRevenue": 0.20341049287746782, "researchAndDevelopementToRevenue": 0.27292734460396023, "stockBasedCompensationToRevenue": 0.018418068168830827, "intangiblesToTotalAssets": 0.18508021866597507, "averageReceivables": 9947550000, "averagePayables": 2264700000, "averageInventory": 5041250000, "daysOfSalesOutstanding": 121.25486093406127, "daysOfPayablesOutstanding": 133.93606506452798, "daysOfInventoryOutstanding": 297.5165908898365, "operatingCycle": 418.7714518238978, "cashConversionCycle": 284.83538675936984, "freeCashFlowToEquity": -21614200000, "freeCashFlowToFirm": 6171076849.845909, "tangibleAssetValue": -982600000, "netCurrentAssetValue": -27415600000}}
{"date": "2022-12-31", "symbol": "LLY", "type": "key_metrics_annual", "result": {"symbol": "LLY", "date": "2022-12-31", "fiscalYear": "2022", "period": "FY", "reportedCurrency": "USD", "marketCap": 347614582880, "enterpriseValue": 361786182880, "evToSales": 12.675838707281352, "evToOperatingCashFlow": 47.69318360599549, "evToFreeCashFlow": 78.64233172767585, "evToEBITDA": 41.774283572542004, "netDebtToEBITDA": 1.6363489405923446, "currentRatio": 1.0522983743917098, "incomeQuality": 1.2147226492441712, "grahamNumber": 40.71125148207594, "grahamNetNet": -29.39286894510736, "taxBurden": 0.9174894217207334, "interestBurden": 0.9535444101989353, "workingCapital": 896300000, "investedCapital": 22319900000, "returnOnAssets": 0.12618357722197301, "operatingReturnOnAssets": 0.17606652573151652, "returnOnTangibleAssets": 0.1634328006657908, "returnOnEquity": 0.5863772089616707, "returnOnInvestedCapital": 0.2345251992596166, "returnOnCapitalEmployed": 0.26747672448966975, "earningsYield": 0.01796472388546417, "freeCashFlowYield": 0.01323419737424567, "capexToOperatingCashFlow": 0.39354311401716385, "capexToDepreciation": 1.9607881773399014, "capexToRevenue": 0.10459542979671635, "salesGeneralAndAdministrativeToRevenue": 0.21258592781012844, "researchAndDevelopementToRevenue": 0.25194279187425983, "stockBasedCompensationToRevenue": 0.013002165275704766, "intangiblesToTotalAssets": 0.22791767192431572, "averageReceivables": 8343050000, "averagePayables": 1800600000, "averageInventory": 4097850000, "daysOfSalesOutstanding": 109.45498468890804, "daysOfPayablesOutstanding": 106.2881233219705, "daysOfInventoryOutstanding": 237.26816796886786, "operatingCycle": 346.7231526577759, "cashConversionCycle": 240.43502933580544, "freeCashFlowToEquity": -8440200000, "freeCashFlowToFirm": 8720639492.242596, "tangibleAssetValue": -504200000, "netCurrentAssetValue": -20679900000}}
{"date": "2021-12-31", "symbol": "LLY", "type": "key_metrics_annual", "result": {"symbol": "LLY", "date": "2021-12-31", "fiscalYear": "2021", "period": "FY", "reportedCurrency": "USD", "marketCap": 263418031660.00003, "enterpriseValue": 276484231660, "evToSales": 9.763412892677552, "evToOperatingCashFlow": 37.53570258352679, "evToFreeCashFlow": 51.31957896241299, "evToEBITDA": 34.376186656554225, "netDebtToEBITDA": 1.6245632794141416, "currentRatio": 1.2258531691988812, "incomeQuality": 1.3196517190103374, "grahamNumber": 35.212993585811006, "grahamNetNet": -29.050608554683937, "taxBurden": 0.9067825521890992, "interestBurden": 0.9476852493341339, "workingCapital": 3399700000, "investedCapital": 23968700000, "returnOnAssets": 0.11436503708560423, "operatingReturnOnAssets": 0.16624213765636936, "returnOnTangibleAssets": 0.1499566117978298, "returnOnEquity": 0.6216255345687812, "returnOnInvestedCapital": 0.20383054286334776, "returnOnCapitalEmployed": 0.2350288712511073, "earningsYield": 0.021189513735355953, "freeCashFlowYield": 0.020452282503400435, "capexToOperatingCashFlow": 0.26858903867823347, "capexToDepreciation": 1.2783665029723443, "capexToRevenue": 0.0698627041075767, "salesGeneralAndAdministrativeToRevenue": 0.21688725351714785, "researchAndDevelopementToRevenue": 0.24474193457257473, "stockBasedCompensationToRevenue": 0.012105203683823946, "intangiblesToTotalAssets": 0.23734581813711428, "averageReceivables": 7528100000, "averagePayables": 1638650000, "averageInventory": 3933150000, "daysOfSalesOutstanding": 104.75266964235267, "daysOfPayablesOutstanding": 83.38379280166284, "daysOfInventoryOutstanding": 193.95990591838967, "operatingCycle": 298.7125755607423, "cashConversionCycle": 215.3287827590795, "freeCashFlowToEquity": -7010100000, "freeCashFlowToFirm": 7708424711.233856, "tangibleAssetValue": -2429100000, "netCurrentAssetValue": -21198800000}}
{"date": "2025-12-23", "symbol": "LLY", "type": "ratios_ttm", "result": [{"symbol": "LLY", "grossProfitMarginTTM": 0.8302905765418261, "ebitMarginTTM": 0.3907956607056907, "ebitdaMarginTTM": 0.42270589938034125, "operatingProfitMarginTTM": 0.43862146961113974, "pretaxProfitMarginTTM": 0.37872224410045136, "continuousOperationsProfitMarginTTM": 0.3098647252262714, "netProfitMarginTTM": 0.3098647252262714, "bottomLineProfitMarginTTM": 0.3098647252262714, "receivablesTurnoverTTM": 3.0538720884813846, "payablesTurnoverTTM": 2.3659377786119844, "inventoryTurnoverTTM": 0.82789563561131, "fixedAssetTurnoverTTM": 2.6626545975981357, "assetTurnoverTTM": 0.5169843233677353, "currentRatioTTM": 1.546335533084709, "quickRatioTTM": 1.2428944044602885, "solvencyRatioTTM": 0.22295975389912234, "cashRatioTTM": 0.24393822759330258, "priceToEarningsRatioTTM": 51.851079833370456, "priceToEarningsGrowthRatioTTM": 1.549479739767646, "forwardPriceToEarningsGrowthRatioTTM": 1.4122379066671187, "priceToBookRatioTTM": 40.12420584786474, "priceToSalesRatioTTM": 16.091642848882024, "priceToFreeCashFlowRatioTTM": 105.99645257596417, "priceToOperatingCashFlowRatioTTM": 59.43689326493258, "debtToAssetsRatioTTM": 0.3698303568787336, "debtToEquityRatioTTM": 1.786494517364132, "debtToCapitalRatioTTM": 0.6411261555447293, "longTermDebtToCapitalRatioTTM": 0.6320636987392314, "financialLeverageRatioTTM": 4.830578356091841, "workingCapitalTurnoverRatioTTM": 3.627084191731905, "operatingCashFlowRatioTTM": 0.40014548752021006, "operatingCashFlowSalesRatioTTM": 0.270317301640194, "freeCashFlowOperatingCashFlowRatioTTM": 0.561610489223145, "debtServiceCoverageRatioTTM": 8.310513833992095, "interestCoverageRatioTTM": 29.05551839464883, "shortTermOperatingCashFlowCoverageRatioTTM": 9.836007348438457, "operatingCashFlowCoverageRatioTTM": 0.3778754358146735, "capitalExpenditureCoverageRatioTTM": 2.2810764751828447, "dividendPaidAndCapexCoverageRatioTTM": 1.3113819877044162, "dividendPayoutRatioTTM": 0.2827922941978373, "dividendYieldTTM": 0.00563682, "enterpriseValueTTM": 988876899752, "revenuePerShareTTM": 66.25019511651243, "netIncomePerShareTTM": 20.52859850596499, "interestDebtPerShareTTM": 48.39290890846248, "cashPerShareTTM": 11.053071691381424, "bookValuePerShareTTM": 26.59248522689263, "tangibleBookValuePerShareTTM": 12.82874344965994, "shareholdersEquityPerShareTTM": 26.52837551566507, "operatingCashFlowPerShareTTM": 17.908573977032, "capexPerShareTTM": 7.850930984502174, "freeCashFlowPerShareTTM": 10.057642992529825, "netIncomePerEBTTTM": 0.8181846460121937, "ebtPerEbitTTM": 0.8634375431649708, "priceToFairValueTTM": 40.12420584786474, "debtToMarketCapTTM": 0.04445542818051681, "effectiveTaxRateTTM": 0.1818153539878064, "enterpriseValueMultipleTTM": 39.37066380083688, "dividendPerShareTTM": 6}]}
{"date": "2025-12-23", "symbol": "LLY", "type": "key_metrics_ttm", "result": [{"symbol": "LLY", "marketCap": 956162199752, "enterpriseValueTTM": 988876899752, "evToSalesTTM": 16.642211851133798, "evToOperatingCashFlowTTM": 61.56547046805543, "evToFreeCashFlowTTM": 109.62307800414602, "evToEBITDATTM": 39.37066380083688, "netDebtToEBITDATTM": 1.302487150188517, "currentRatioTTM": 1.546335533084709, "incomeQualityTTM": 0.8723719727787704, "grahamNumberTTM": 110.6945496601915, "grahamNetNetTTM": -67.44118630839559, "taxBurdenTTM": 0.8181846460121937, "interestBurdenTTM": 0.9691055510098617, "workingCapitalTTM": 21930400000, "investedCapitalTTM": 56591100000, "returnOnAssetsTTM": 0.16019520530663311, "operatingReturnOnAssetsTTM": 0.2414809736030168, "returnOnTangibleAssetsTTM": 0.17947143357048934, "returnOnEquityTTM": 1.0225663710670605, "returnOnInvestedCapitalTTM": 0.27901191053071994, "returnOnCapitalEmployedTTM": 0.3484587770491146, "earningsYieldTTM": 0.01928600143359825, "freeCashFlowYieldTTM": 0.009434277994193559, "capexToOperatingCashFlowTTM": 0.43838951077685495, "capexToDepreciationTTM": 3.7136754390591213, "capexToRevenueTTM": 0.11850426962056419, "salesGeneralAndAdministrativeToRevenueTTM": 0.16929037122306032, "researchAndDevelopementToRevenueTTM": 0.2223787357076261, "stockBasedCompensationToRevenueTTM": 0.010632819363242556, "intangiblesToTotalAssetsTTM": 0.10740555129229115, "averageReceivablesTTM": 18331400000, "averagePayablesTTM": 4168950000, "averageInventoryTTM": 11597100000, "daysOfSalesOutstandingTTM": 119.5203955583829, "daysOfPayablesOutstandingTTM": 154.27286520363742, "daysOfInventoryOutstandingTTM": 440.87682589422957, "operatingCycleTTM": 560.3972214526125, "cashConversionCycleTTM": 406.12435624897506, "freeCashFlowToEquityTTM": -23442800000, "freeCashFlowToFirmTTM": 3008565665.0491486, "tangibleAssetValueTTM": 11506100000, "netCurrentAssetValueTTM": -29013300000}]}
{"date": "2025-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2025-09-30", "stockPrice": 763, "numberOfShares": 896900000, "marketCapitalization": 684334700000, "minusCashAndCashEquivalents": 9791900000, "addTotalDebt": 42506600000, "enterpriseValue": 717049400000}}
{"date": "2025-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2025-06-30", "stockPrice": 779.53, "numberOfShares": 897900000, "marketCapitalization": 699939987000, "minusCashAndCashEquivalents": 3375900000, "addTotalDebt": 39903800000, "enterpriseValue": 736467887000}}
{"date": "2025-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2025-03-31", "stockPrice": 825.91, "numberOfShares": 897989000, "marketCapitalization": 741658094990, "minusCashAndCashEquivalents": 3093300000, "addTotalDebt": 38515900000, "enterpriseValue": 777080694990}}
{"date": "2024-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2024-12-31", "stockPrice": 772, "numberOfShares": 897538000, "marketCapitalization": 692899336000, "minusCashAndCashEquivalents": 3268400000, "addTotalDebt": 33644200000, "enterpriseValue": 723275136000}}
{"date": "2024-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2024-09-30", "stockPrice": 885.94, "numberOfShares": 901000000, "marketCapitalization": 798231940000, "minusCashAndCashEquivalents": 3369000000, "addTotalDebt": 31119700000, "enterpriseValue": 825982640000}}
{"date": "2024-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2024-06-30", "stockPrice": 914.37, "numberOfShares": 900900000, "marketCapitalization": 823755933000, "minusCashAndCashEquivalents": 3223600000, "addTotalDebt": 28892000000, "enterpriseValue": 849424333000}}
{"date": "2024-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2024-03-31", "stockPrice": 760.55, "numberOfShares": 900800000, "marketCapitalization": 685103440000, "minusCashAndCashEquivalents": 2460200000, "addTotalDebt": 26211400000, "enterpriseValue": 708854640000}}
{"date": "2023-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2023-12-31", "stockPrice": 582.92, "numberOfShares": 899379000, "marketCapitalization": 524266006679, "minusCashAndCashEquivalents": 2818600000, "addTotalDebt": 25225300000, "enterpriseValue": 546672706679}}
{"date": "2023-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2023-09-30", "stockPrice": 537.13, "numberOfShares": 949303000, "marketCapitalization": 509899120390, "minusCashAndCashEquivalents": 2380800000, "addTotalDebt": 20168300000, "enterpriseValue": 527686620390}}
{"date": "2023-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2023-06-30", "stockPrice": 468.98, "numberOfShares": 949286000, "marketCapitalization": 445196148280, "minusCashAndCashEquivalents": 2694500000, "addTotalDebt": 18820000000, "enterpriseValue": 461321648280}}
{"date": "2023-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2023-03-31", "stockPrice": 343.42, "numberOfShares": 949267000, "marketCapitalization": 325997273140, "minusCashAndCashEquivalents": 3545900000, "addTotalDebt": 18883600000, "enterpriseValue": 341334973140}}
{"date": "2022-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2022-12-31", "stockPrice": 365.84, "numberOfShares": 950182000, "marketCapitalization": 347614582880, "minusCashAndCashEquivalents": 2067000000, "addTotalDebt": 16238600000, "enterpriseValue": 361786182880}}
{"date": "2022-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2022-09-30", "stockPrice": 323.35, "numberOfShares": 900700000, "marketCapitalization": 291241345000, "minusCashAndCashEquivalents": 2617400000, "addTotalDebt": 15888400000, "enterpriseValue": 304512345000}}
{"date": "2022-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2022-06-30", "stockPrice": 324.23, "numberOfShares": 900300000, "marketCapitalization": 291904269000, "minusCashAndCashEquivalents": 2622900000, "addTotalDebt": 16813800000, "enterpriseValue": 306095169000}}
{"date": "2022-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2022-03-31", "stockPrice": 286.37, "numberOfShares": 950605000, "marketCapitalization": 272224753850, "minusCashAndCashEquivalents": 2459200000, "addTotalDebt": 16508800000, "enterpriseValue": 286274353850}}
{"date": "2021-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2021-12-31", "stockPrice": 276.22, "numberOfShares": 953653000, "marketCapitalization": 263418031660, "minusCashAndCashEquivalents": 3818500000, "addTotalDebt": 16884700000, "enterpriseValue": 276484231660}}
{"date": "2021-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2021-09-30", "stockPrice": 231.05, "numberOfShares": 956589000, "marketCapitalization": 221019888450, "minusCashAndCashEquivalents": 3788200000, "addTotalDebt": 17085400000, "enterpriseValue": 234317088450}}
{"date": "2021-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2021-06-30", "stockPrice": 229.52, "numberOfShares": 907300000, "marketCapitalization": 208243496000, "minusCashAndCashEquivalents": 3220000000, "addTotalDebt": 16515100000, "enterpriseValue": 221538596000}}
{"date": "2021-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2021-03-31", "stockPrice": 186.82, "numberOfShares": 959482000, "marketCapitalization": 179250427240, "minusCashAndCashEquivalents": 3002400000, "addTotalDebt": 16204500000, "enterpriseValue": 192452527240}}
{"date": "2020-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2020-12-31", "stockPrice": 168.84, "numberOfShares": 956590000, "marketCapitalization": 161510655600, "minusCashAndCashEquivalents": 3657100000, "addTotalDebt": 16595300000, "enterpriseValue": 174448855600}}
{"date": "2020-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2020-09-30", "stockPrice": 148.02, "numberOfShares": 956491000, "marketCapitalization": 141579797820, "minusCashAndCashEquivalents": 3595300000, "addTotalDebt": 16922100000, "enterpriseValue": 154906597820}}
{"date": "2020-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2020-06-30", "stockPrice": 164.18, "numberOfShares": 956466000, "marketCapitalization": 157032587880, "minusCashAndCashEquivalents": 2365100000, "addTotalDebt": 16328200000, "enterpriseValue": 170995687880}}
{"date": "2020-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2020-03-31", "stockPrice": 138.72, "numberOfShares": 956929000, "marketCapitalization": 132745190880, "minusCashAndCashEquivalents": 1699000000, "addTotalDebt": 17230300000, "enterpriseValue": 148276490880}}
{"date": "2019-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2019-12-31", "stockPrice": 131.43, "numberOfShares": 957526000, "marketCapitalization": 125847642180, "minusCashAndCashEquivalents": 2337500000, "addTotalDebt": 15803900000, "enterpriseValue": 139314042180}}
{"date": "2019-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2019-09-30", "stockPrice": 111.83, "numberOfShares": 960046000, "marketCapitalization": 107361944180, "minusCashAndCashEquivalents": 1563800000, "addTotalDebt": 15710500000, "enterpriseValue": 121508644180}}
{"date": "2019-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2019-06-30", "stockPrice": 112.74, "numberOfShares": 965957000, "marketCapitalization": 108901992180, "minusCashAndCashEquivalents": 2290200000, "addTotalDebt": 16289500000, "enterpriseValue": 122901292180}}
{"date": "2019-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2019-03-31", "stockPrice": 129.05, "numberOfShares": 979584296, "marketCapitalization": 126415353398, "minusCashAndCashEquivalents": 2036400000, "addTotalDebt": 16473300000, "enterpriseValue": 140852253398}}
{"date": "2018-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2018-12-31", "stockPrice": 115.72, "numberOfShares": 1027721000, "marketCapitalization": 118927874120, "minusCashAndCashEquivalents": 7320700000, "addTotalDebt": 10298600000, "enterpriseValue": 121905774120}}
{"date": "2018-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2018-09-30", "stockPrice": 107.6, "numberOfShares": 1020400000, "marketCapitalization": 109795040000, "minusCashAndCashEquivalents": 8960000000, "addTotalDebt": 12676900000, "enterpriseValue": 113511940000}}
{"date": "2018-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2018-06-30", "stockPrice": 85.33, "numberOfShares": 1030210000, "marketCapitalization": 87907819300, "minusCashAndCashEquivalents": 6817300000, "addTotalDebt": 12219600000, "enterpriseValue": 93310119300}}
{"date": "2018-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2018-03-31", "stockPrice": 77.37, "numberOfShares": 1048000000, "marketCapitalization": 81083760000, "minusCashAndCashEquivalents": 3084300000, "addTotalDebt": 11697700000, "enterpriseValue": 89697160000}}
{"date": "2017-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2017-12-31", "stockPrice": 84.46, "numberOfShares": 1052023000, "marketCapitalization": 88853862580, "minusCashAndCashEquivalents": 6536200000, "addTotalDebt": 13647100000, "enterpriseValue": 95964762580}}
{"date": "2017-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2017-09-30", "stockPrice": 85.54, "numberOfShares": 1101094711, "marketCapitalization": 94187641578, "minusCashAndCashEquivalents": 3724300000, "addTotalDebt": 13464700000, "enterpriseValue": 103928041578}}
{"date": "2017-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2017-06-30", "stockPrice": 82.3, "numberOfShares": 1100989000, "marketCapitalization": 90611394700, "minusCashAndCashEquivalents": 3069900000, "addTotalDebt": 12312100000, "enterpriseValue": 99853594700}}
{"date": "2017-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2017-03-31", "stockPrice": 84.11, "numberOfShares": 1103388743, "marketCapitalization": 92806027173, "minusCashAndCashEquivalents": 2616900000, "addTotalDebt": 10246800000, "enterpriseValue": 100435927173}}
{"date": "2016-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2016-12-31", "stockPrice": 73.55, "numberOfShares": 1100875000, "marketCapitalization": 80969356250, "minusCashAndCashEquivalents": 4582100000, "addTotalDebt": 10305200000, "enterpriseValue": 86692456250}}
{"date": "2016-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2016-09-30", "stockPrice": 80.26, "numberOfShares": 1103948230, "marketCapitalization": 88602884939, "minusCashAndCashEquivalents": 3489000000, "addTotalDebt": 9348800000, "enterpriseValue": 94462684939}}
{"date": "2016-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2016-06-30", "stockPrice": 78.75, "numberOfShares": 1103843444, "marketCapitalization": 86927671215, "minusCashAndCashEquivalents": 3238000000, "addTotalDebt": 9331300000, "enterpriseValue": 93020971215}}
{"date": "2016-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2016-03-31", "stockPrice": 72.01, "numberOfShares": 1103837000, "marketCapitalization": 79487302370, "minusCashAndCashEquivalents": 2307600000, "addTotalDebt": 8125900000, "enterpriseValue": 85305602370}}
{"date": "2015-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2015-12-31", "stockPrice": 84.26, "numberOfShares": 1105267000, "marketCapitalization": 93129797420, "minusCashAndCashEquivalents": 3666400000, "addTotalDebt": 7978500000, "enterpriseValue": 97441897420}}
{"date": "2015-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2015-09-30", "stockPrice": 83.69, "numberOfShares": 1108076549, "marketCapitalization": 92734926385, "minusCashAndCashEquivalents": 3238800000, "addTotalDebt": 8078900000, "enterpriseValue": 97575026385}}
{"date": "2015-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2015-06-30", "stockPrice": 83.49, "numberOfShares": 1108540541, "marketCapitalization": 92552049768, "minusCashAndCashEquivalents": 3315500000, "addTotalDebt": 7999400000, "enterpriseValue": 97235949768}}
{"date": "2015-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2015-03-31", "stockPrice": 72.65, "numberOfShares": 1109741140, "marketCapitalization": 80622693821, "minusCashAndCashEquivalents": 3064800000, "addTotalDebt": 8220700000, "enterpriseValue": 85778593821}}
{"date": "2014-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2014-12-31", "stockPrice": 68.99, "numberOfShares": 1110627000, "marketCapitalization": 76622156730, "minusCashAndCashEquivalents": 3871600000, "addTotalDebt": 8021500000, "enterpriseValue": 80772056730}}
{"date": "2014-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2014-09-30", "stockPrice": 64.85, "numberOfShares": 1113429817, "marketCapitalization": 72205923632, "minusCashAndCashEquivalents": 3165800000, "addTotalDebt": 5605600000, "enterpriseValue": 74645723632}}
{"date": "2014-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2014-06-30", "stockPrice": 62.17, "numberOfShares": 1117308330, "marketCapitalization": 69463058876, "minusCashAndCashEquivalents": 3765700000, "addTotalDebt": 5311300000, "enterpriseValue": 71008658876}}
{"date": "2014-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2014-03-31", "stockPrice": 58.86, "numberOfShares": 1119451042, "marketCapitalization": 65890888332, "minusCashAndCashEquivalents": 3888000000, "addTotalDebt": 5264400000, "enterpriseValue": 67267288332}}
{"date": "2013-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2013-12-31", "stockPrice": 51, "numberOfShares": 1116795000, "marketCapitalization": 56956545000, "minusCashAndCashEquivalents": 3830200000, "addTotalDebt": 5212900000, "enterpriseValue": 58339245000}}
{"date": "2013-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2013-09-30", "stockPrice": 50.33, "numberOfShares": 1126650000, "marketCapitalization": 56704294500, "minusCashAndCashEquivalents": 4368900000, "addTotalDebt": 5282900000, "enterpriseValue": 57618294500}}
{"date": "2013-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2013-06-30", "stockPrice": 50.16, "numberOfShares": 1126638000, "marketCapitalization": 56512162079, "minusCashAndCashEquivalents": 3786500000, "addTotalDebt": 5314000000, "enterpriseValue": 58039662079}}
{"date": "2013-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2013-03-31", "stockPrice": 56.61, "numberOfShares": 1126561000, "marketCapitalization": 63774618210, "minusCashAndCashEquivalents": 3936600000, "addTotalDebt": 5459600000, "enterpriseValue": 65297618210}}
{"date": "2012-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2012-12-31", "stockPrice": 49.32, "numberOfShares": 1146493000, "marketCapitalization": 56545034760, "minusCashAndCashEquivalents": 4018800000, "addTotalDebt": 5531300000, "enterpriseValue": 58057534760}}
{"date": "2012-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2012-09-30", "stockPrice": 47.57, "numberOfShares": 1119617000, "marketCapitalization": 53260180690, "minusCashAndCashEquivalents": 5319200000, "addTotalDebt": 5520000000, "enterpriseValue": 53460980690}}
{"date": "2012-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2012-06-30", "stockPrice": 42.91, "numberOfShares": 1118686000, "marketCapitalization": 48002816259, "minusCashAndCashEquivalents": 4345800000, "addTotalDebt": 5509300000, "enterpriseValue": 49166316259}}
{"date": "2012-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2012-03-31", "stockPrice": 40.27, "numberOfShares": 1116962000, "marketCapitalization": 44980059740, "minusCashAndCashEquivalents": 4122200000, "addTotalDebt": 5413800000, "enterpriseValue": 46271659740}}
{"date": "2011-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2011-12-31", "stockPrice": 41.56, "numberOfShares": 1115846000, "marketCapitalization": 46374559760, "minusCashAndCashEquivalents": 5922500000, "addTotalDebt": 6987000000, "enterpriseValue": 47439059760}}
{"date": "2011-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2011-09-30", "stockPrice": 36.97, "numberOfShares": 1113820000, "marketCapitalization": 41177925400, "minusCashAndCashEquivalents": 6597700000, "addTotalDebt": 7080000000, "enterpriseValue": 41660225400}}
{"date": "2011-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2011-06-30", "stockPrice": 37.53, "numberOfShares": 1113933000, "marketCapitalization": 41805905490, "minusCashAndCashEquivalents": 6113500000, "addTotalDebt": 6728600000, "enterpriseValue": 42421005490}}
{"date": "2011-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2011-03-31", "stockPrice": 35.17, "numberOfShares": 1112003000, "marketCapitalization": 39109145510, "minusCashAndCashEquivalents": 6506400000, "addTotalDebt": 6672300000, "enterpriseValue": 39275045510}}
{"date": "2010-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2010-12-31", "stockPrice": 35.04, "numberOfShares": 1108895500, "marketCapitalization": 38855698320, "minusCashAndCashEquivalents": 5993200000, "addTotalDebt": 6926500000, "enterpriseValue": 39788998320}}
{"date": "2010-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2010-09-30", "stockPrice": 36.53, "numberOfShares": 1099000000, "marketCapitalization": 40146470000, "minusCashAndCashEquivalents": 5909000000, "addTotalDebt": 7137000000, "enterpriseValue": 41374470000}}
{"date": "2010-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2010-06-30", "stockPrice": 33.5, "numberOfShares": 1099200000, "marketCapitalization": 36823200000, "minusCashAndCashEquivalents": 5163500000, "addTotalDebt": 6888900000, "enterpriseValue": 38548600000}}
{"date": "2010-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2010-03-31", "stockPrice": 36.22, "numberOfShares": 1103400000, "marketCapitalization": 39965148000, "minusCashAndCashEquivalents": 4725200000, "addTotalDebt": 6681400000, "enterpriseValue": 41921348000}}
{"date": "2009-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2009-12-31", "stockPrice": 35.71, "numberOfShares": 1098019000, "marketCapitalization": 39210258490, "minusCashAndCashEquivalents": 4462900000, "addTotalDebt": 6662100000, "enterpriseValue": 41409458490}}
{"date": "2009-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2009-09-30", "stockPrice": 33.03, "numberOfShares": 1097700000, "marketCapitalization": 36257031000, "minusCashAndCashEquivalents": 3848200000, "addTotalDebt": 7392200000, "enterpriseValue": 39801031000}}
{"date": "2009-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2009-06-30", "stockPrice": 34.64, "numberOfShares": 1097184000, "marketCapitalization": 38006453760, "minusCashAndCashEquivalents": 3322300000, "addTotalDebt": 7722900000, "enterpriseValue": 42407053760}}
{"date": "2009-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2009-03-31", "stockPrice": 33.41, "numberOfShares": 1097200000, "marketCapitalization": 36657452000, "minusCashAndCashEquivalents": 3313100000, "addTotalDebt": 8473600000, "enterpriseValue": 41817952000}}
{"date": "2008-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2008-12-31", "stockPrice": 40.27, "numberOfShares": 1094499000, "marketCapitalization": 44075474730, "minusCashAndCashEquivalents": 5496700000, "addTotalDebt": 10462000000, "enterpriseValue": 49040774730}}
{"date": "2008-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2008-09-30", "stockPrice": 44.03, "numberOfShares": 1094000000, "marketCapitalization": 48168820000, "minusCashAndCashEquivalents": 4353600000, "addTotalDebt": 4612100000, "enterpriseValue": 48427320000}}
{"date": "2008-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2008-06-30", "stockPrice": 46.16, "numberOfShares": 1093800000, "marketCapitalization": 50489808000, "minusCashAndCashEquivalents": 2868300000, "addTotalDebt": 4613800000, "enterpriseValue": 52235308000}}
{"date": "2008-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2008-03-31", "stockPrice": 51.59, "numberOfShares": 1093900000, "marketCapitalization": 56434301000, "minusCashAndCashEquivalents": 3145400000, "addTotalDebt": 4721300000, "enterpriseValue": 58010201000}}
{"date": "2007-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2007-12-31", "stockPrice": 53.39, "numberOfShares": 1090097353, "marketCapitalization": 58200297676, "minusCashAndCashEquivalents": 3220500000, "addTotalDebt": 5007200000, "enterpriseValue": 59986997676}}
{"date": "2007-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2007-09-30", "stockPrice": 58.29, "numberOfShares": 1089764706, "marketCapitalization": 63522384712, "minusCashAndCashEquivalents": 2495500000, "addTotalDebt": 4974300000, "enterpriseValue": 66001184712}}
{"date": "2007-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2007-06-30", "stockPrice": 55.88, "numberOfShares": 1087868852, "marketCapitalization": 60790111449, "minusCashAndCashEquivalents": 2220500000, "addTotalDebt": 5038200000, "enterpriseValue": 63607811449}}
{"date": "2007-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2007-03-31", "stockPrice": 53.71, "numberOfShares": 1082340426, "marketCapitalization": 58132504280, "minusCashAndCashEquivalents": 2491400000, "addTotalDebt": 5358200000, "enterpriseValue": 60999304280}}
{"date": "2006-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2006-12-31", "stockPrice": 52.1, "numberOfShares": 1084578213, "marketCapitalization": 56506524897, "minusCashAndCashEquivalents": 3109300000, "addTotalDebt": 3713800000, "enterpriseValue": 57111024897}}
{"date": "2006-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2006-09-30", "stockPrice": 57, "numberOfShares": 1092000000, "marketCapitalization": 62244000000, "minusCashAndCashEquivalents": 2169900000, "addTotalDebt": 4887500000, "enterpriseValue": 64961600000}}
{"date": "2006-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2006-06-30", "stockPrice": 55.27, "numberOfShares": 1081578947, "marketCapitalization": 59778868400, "minusCashAndCashEquivalents": 2669700000, "addTotalDebt": 6316600000, "enterpriseValue": 63425768400}}
{"date": "2006-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2006-03-31", "stockPrice": 55.3, "numberOfShares": 1084155844, "marketCapitalization": 59953818173, "minusCashAndCashEquivalents": 2458300000, "addTotalDebt": 6348500000, "enterpriseValue": 63844018173}}
{"date": "2005-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2005-12-31", "stockPrice": 56.59, "numberOfShares": 1085923922, "marketCapitalization": 61452434745, "minusCashAndCashEquivalents": 3006700000, "addTotalDebt": 6498200000, "enterpriseValue": 64943934745}}
{"date": "2005-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2005-09-30", "stockPrice": 53.52, "numberOfShares": 1088219178, "marketCapitalization": 58241490406, "minusCashAndCashEquivalents": 4969700000, "addTotalDebt": 6510200000, "enterpriseValue": 59781990406}}
{"date": "2005-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2005-06-30", "stockPrice": 55.71, "numberOfShares": 1095652174, "marketCapitalization": 61038782613, "minusCashAndCashEquivalents": 4642400000, "addTotalDebt": 4676100000, "enterpriseValue": 61072482613}}
{"date": "2005-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2005-03-31", "stockPrice": 52.1, "numberOfShares": 1083235294, "marketCapitalization": 56436558817, "minusCashAndCashEquivalents": 5607700000, "addTotalDebt": 4590100000, "enterpriseValue": 55418958817}}
{"date": "2004-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2004-12-31", "stockPrice": 56.75, "numberOfShares": 1081374572, "marketCapitalization": 61368006961, "minusCashAndCashEquivalents": 5365300000, "addTotalDebt": 6512500000, "enterpriseValue": 62515206961}}
{"date": "2004-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2004-09-30", "stockPrice": 60.05, "numberOfShares": 1078857143, "marketCapitalization": 64785371437, "minusCashAndCashEquivalents": 2577400000, "addTotalDebt": 6179100000, "enterpriseValue": 68387071437}}
{"date": "2004-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2004-06-30", "stockPrice": 69.91, "numberOfShares": 1076885246, "marketCapitalization": 75285047547, "minusCashAndCashEquivalents": 2396700000, "addTotalDebt": 5129700000, "enterpriseValue": 78018047547}}
{"date": "2004-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2004-03-31", "stockPrice": 66.9, "numberOfShares": 1082162162, "marketCapitalization": 72396648637, "minusCashAndCashEquivalents": 2410400000, "addTotalDebt": 5310700000, "enterpriseValue": 75296948637}}
{"date": "2003-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2003-12-31", "stockPrice": 70.33, "numberOfShares": 1079064081, "marketCapitalization": 75890576816, "minusCashAndCashEquivalents": 2756300000, "addTotalDebt": 4884300000, "enterpriseValue": 78018576816}}
{"date": "2003-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2003-09-30", "stockPrice": 59.4, "numberOfShares": 1082424242, "marketCapitalization": 64295999974, "minusCashAndCashEquivalents": 2916100000, "addTotalDebt": 5200500000, "enterpriseValue": 66580399974}}
{"date": "2003-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2003-06-30", "stockPrice": 68.97, "numberOfShares": 1081562500, "marketCapitalization": 74595365625, "minusCashAndCashEquivalents": 2037300000, "addTotalDebt": 5022000000, "enterpriseValue": 77580065625}}
{"date": "2003-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2003-03-31", "stockPrice": 57.15, "numberOfShares": 1071052632, "marketCapitalization": 61210657918, "minusCashAndCashEquivalents": 2204100000, "addTotalDebt": 4954800000, "enterpriseValue": 63961357918}}
{"date": "2002-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2002-12-31", "stockPrice": 63.5, "numberOfShares": 1074948816, "marketCapitalization": 68259249816, "minusCashAndCashEquivalents": 1945900000, "addTotalDebt": 4903600000, "enterpriseValue": 71216949816}}
{"date": "2002-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2002-09-30", "stockPrice": 55.34, "numberOfShares": 1068593750, "marketCapitalization": 59135978125, "minusCashAndCashEquivalents": 2786200000, "addTotalDebt": 5247400000, "enterpriseValue": 61597178125}}
{"date": "2002-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2002-06-30", "stockPrice": 53.76, "numberOfShares": 1079508197, "marketCapitalization": 58034360670, "minusCashAndCashEquivalents": 3051200000, "addTotalDebt": 3978500000, "enterpriseValue": 58961660670}}
{"date": "2002-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2002-03-31", "stockPrice": 77.72, "numberOfShares": 1084827586, "marketCapitalization": 84312799983, "minusCashAndCashEquivalents": 2880900000, "addTotalDebt": 3855500000, "enterpriseValue": 85287399983}}
{"date": "2001-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2001-12-31", "stockPrice": 78.54, "numberOfShares": 1076589689, "marketCapitalization": 84555354174, "minusCashAndCashEquivalents": 2702300000, "addTotalDebt": 3418400000, "enterpriseValue": 85271454174}}
{"date": "2001-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2001-09-30", "stockPrice": 81.66, "numberOfShares": 1075660377, "marketCapitalization": 87838426385, "minusCashAndCashEquivalents": 2646300000, "addTotalDebt": 3592300000, "enterpriseValue": 88784426385}}
{"date": "2001-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2001-06-30", "stockPrice": 74, "numberOfShares": 1074935065, "marketCapitalization": 79545194810, "minusCashAndCashEquivalents": 2971800000, "addTotalDebt": 3328400000, "enterpriseValue": 79901794810}}
{"date": "2001-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2001-03-31", "stockPrice": 76.66, "numberOfShares": 1075733333, "marketCapitalization": 82465717307, "minusCashAndCashEquivalents": 3231300000, "addTotalDebt": 3089000000, "enterpriseValue": 82323417307}}
{"date": "2000-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2000-12-31", "stockPrice": 93.06, "numberOfShares": 1078114167, "marketCapitalization": 100329304381, "minusCashAndCashEquivalents": 4114900000, "addTotalDebt": 2818000000, "enterpriseValue": 99032404381}}
{"date": "2000-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2000-09-30", "stockPrice": 81.13, "numberOfShares": 1081666667, "marketCapitalization": 87755616693, "minusCashAndCashEquivalents": 3116200000, "addTotalDebt": 2830400000, "enterpriseValue": 87469816693}}
{"date": "2000-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2000-06-30", "stockPrice": 99.88, "numberOfShares": 1074516129, "marketCapitalization": 107322670964, "minusCashAndCashEquivalents": 3370500000, "addTotalDebt": 2847500000, "enterpriseValue": 106799670964}}
{"date": "2000-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "2000-03-31", "stockPrice": 62.63, "numberOfShares": 1083974359, "marketCapitalization": 67889314104, "minusCashAndCashEquivalents": 3797800000, "addTotalDebt": 2834900000, "enterpriseValue": 66926414104}}
{"date": "1999-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1999-12-31", "stockPrice": 66.5, "numberOfShares": 1086167180, "marketCapitalization": 72230117470, "minusCashAndCashEquivalents": 3700400000, "addTotalDebt": 3053400000, "enterpriseValue": 71583117470}}
{"date": "1999-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1999-09-30", "stockPrice": 64.19, "numberOfShares": 1077352941, "marketCapitalization": 69155285282, "minusCashAndCashEquivalents": 3291900000, "addTotalDebt": 3161900000, "enterpriseValue": 69025285282}}
{"date": "1999-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1999-06-30", "stockPrice": 71.63, "numberOfShares": 1087547170, "marketCapitalization": 77901003787, "minusCashAndCashEquivalents": 2031700000, "addTotalDebt": 2337800000, "enterpriseValue": 78207103787}}
{"date": "1999-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1999-03-31", "stockPrice": 84.88, "numberOfShares": 1092100000, "marketCapitalization": 92697448000, "minusCashAndCashEquivalents": 2404400000, "addTotalDebt": 2338900000, "enterpriseValue": 92631948000}}
{"date": "1998-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1998-12-31", "stockPrice": 88.88, "numberOfShares": 1094505498, "marketCapitalization": 97279648662, "minusCashAndCashEquivalents": 1495700000, "addTotalDebt": 2366900000, "enterpriseValue": 98150848662}}
{"date": "1998-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1998-09-30", "stockPrice": 78.31, "numberOfShares": 1102127660, "marketCapitalization": 86307617054, "minusCashAndCashEquivalents": 1543500000, "addTotalDebt": 2666300000, "enterpriseValue": 87430417054}}
{"date": "1998-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1998-06-30", "stockPrice": 66.25, "numberOfShares": 1090222222, "marketCapitalization": 72227222207, "minusCashAndCashEquivalents": 1315200000, "addTotalDebt": 2502600000, "enterpriseValue": 73414622207}}
{"date": "1998-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1998-03-31", "stockPrice": 59.63, "numberOfShares": 1101100000, "marketCapitalization": 65658593000, "minusCashAndCashEquivalents": 1264700000, "addTotalDebt": 2557200000, "enterpriseValue": 66951093000}}
{"date": "1997-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1997-12-31", "stockPrice": 69.63, "numberOfShares": 1101099500, "marketCapitalization": 76669558185, "minusCashAndCashEquivalents": 1947500000, "addTotalDebt": 2553700000, "enterpriseValue": 77275758185}}
{"date": "1997-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1997-09-30", "stockPrice": 60.5, "numberOfShares": 1101800000, "marketCapitalization": 66658900000, "minusCashAndCashEquivalents": 1504100000, "addTotalDebt": 2767200000, "enterpriseValue": 67922000000}}
{"date": "1997-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1997-06-30", "stockPrice": 54.66, "numberOfShares": 1102500000, "marketCapitalization": 60262650000, "minusCashAndCashEquivalents": 1853000000, "addTotalDebt": 3079800000, "enterpriseValue": 61489450000}}
{"date": "1997-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1997-03-31", "stockPrice": 41.13, "numberOfShares": 1100600000, "marketCapitalization": 45267678000, "minusCashAndCashEquivalents": 1042100000, "addTotalDebt": 3843200000, "enterpriseValue": 48068778000}}
{"date": "1996-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1996-12-31", "stockPrice": 36.5, "numberOfShares": 1097127000, "marketCapitalization": 40045135500, "minusCashAndCashEquivalents": 813700000, "addTotalDebt": 3729400000, "enterpriseValue": 42960835500}}
{"date": "1996-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1996-09-30", "stockPrice": 32.25, "numberOfShares": 1092932000, "marketCapitalization": 35247057000, "minusCashAndCashEquivalents": 738100000, "addTotalDebt": 4081700000, "enterpriseValue": 38590657000}}
{"date": "1996-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1996-06-30", "stockPrice": 32.44, "numberOfShares": 1094554000, "marketCapitalization": 35507331760, "minusCashAndCashEquivalents": 1125000000, "addTotalDebt": 4538100000, "enterpriseValue": 38920431760}}
{"date": "1996-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1996-03-31", "stockPrice": 32.69, "numberOfShares": 1092628000, "marketCapitalization": 35718009320, "minusCashAndCashEquivalents": 898400000, "addTotalDebt": 4603800000, "enterpriseValue": 39423409320}}
{"date": "1995-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1995-12-31", "stockPrice": 28.13, "numberOfShares": 1114775500, "marketCapitalization": 31358634815, "minusCashAndCashEquivalents": 999500000, "addTotalDebt": 4501700000, "enterpriseValue": 34860834815}}
{"date": "1995-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1995-09-30", "stockPrice": 22.47, "numberOfShares": 1146148000, "marketCapitalization": 25753945560, "minusCashAndCashEquivalents": 976200000, "addTotalDebt": 4699000000, "enterpriseValue": 29476745560}}
{"date": "1995-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1995-06-30", "stockPrice": 19.63, "numberOfShares": 1157136000, "marketCapitalization": 22714579680, "minusCashAndCashEquivalents": 989700000, "addTotalDebt": 5271300000, "enterpriseValue": 26996179680}}
{"date": "1995-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1995-03-31", "stockPrice": 18.28, "numberOfShares": 1156248000, "marketCapitalization": 21136213440, "minusCashAndCashEquivalents": 978800000, "addTotalDebt": 5258700000, "enterpriseValue": 25416113440}}
{"date": "1994-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1994-12-31", "stockPrice": 16.41, "numberOfShares": 1156162500, "marketCapitalization": 18972626625, "minusCashAndCashEquivalents": 536900000, "addTotalDebt": 4850200000, "enterpriseValue": 23285926625}}
{"date": "1994-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1994-09-30", "stockPrice": 14.47, "numberOfShares": 1156280000, "marketCapitalization": 16731371600, "minusCashAndCashEquivalents": 999600000, "addTotalDebt": 1912900000, "enterpriseValue": 17644671600}}
{"date": "1994-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1994-06-30", "stockPrice": 14.22, "numberOfShares": 1157036000, "marketCapitalization": 16453051920, "minusCashAndCashEquivalents": 706800000, "addTotalDebt": 1849600000, "enterpriseValue": 17595851920}}
{"date": "1994-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1994-03-31", "stockPrice": 12.47, "numberOfShares": 1157652000, "marketCapitalization": 14435920440, "minusCashAndCashEquivalents": 604900000, "addTotalDebt": 1626700000, "enterpriseValue": 15457720440}}
{"date": "1993-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1993-12-31", "stockPrice": 14.84, "numberOfShares": 1179076000, "marketCapitalization": 17497487840, "minusCashAndCashEquivalents": 539600000, "addTotalDebt": 1360000000, "enterpriseValue": 18317887840}}
{"date": "1993-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1993-09-30", "stockPrice": 12.5, "numberOfShares": 1177600000, "marketCapitalization": 14720000000, "minusCashAndCashEquivalents": 636100000, "addTotalDebt": 1403500000, "enterpriseValue": 15487400000}}
{"date": "1993-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1993-06-30", "stockPrice": 12.31, "numberOfShares": 1156000000, "marketCapitalization": 14230360000, "minusCashAndCashEquivalents": 447700000, "addTotalDebt": 1495800000, "enterpriseValue": 15278460000}}
{"date": "1993-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1993-03-31", "stockPrice": 12.19, "numberOfShares": 1169677419, "marketCapitalization": 14258367737, "minusCashAndCashEquivalents": 594600000, "addTotalDebt": 1560500000, "enterpriseValue": 15224267737}}
{"date": "1992-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1992-12-31", "stockPrice": 15.19, "numberOfShares": 1164597292, "marketCapitalization": 17690232865, "minusCashAndCashEquivalents": 432400000, "addTotalDebt": 1173500000, "enterpriseValue": 18431332865}}
{"date": "1992-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1992-09-30", "stockPrice": 15.66, "numberOfShares": 1167391304, "marketCapitalization": 18281347820, "minusCashAndCashEquivalents": 355200000, "addTotalDebt": 1496600000, "enterpriseValue": 19422747820}}
{"date": "1992-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1992-06-30", "stockPrice": 16.28, "numberOfShares": 1166206897, "marketCapitalization": 18985848283, "minusCashAndCashEquivalents": 425400000, "addTotalDebt": 1331700000, "enterpriseValue": 19892148283}}
{"date": "1992-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1992-03-31", "stockPrice": 17.75, "numberOfShares": 1164736842, "marketCapitalization": 20674078945, "minusCashAndCashEquivalents": 351300000, "addTotalDebt": 1236100000, "enterpriseValue": 21558878945}}
{"date": "1991-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1991-12-31", "stockPrice": 20.88, "numberOfShares": 1164093921, "marketCapitalization": 24306281070, "minusCashAndCashEquivalents": 479200000, "addTotalDebt": 1085700000, "enterpriseValue": 24912781070}}
{"date": "1991-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1991-09-30", "stockPrice": 19.94, "numberOfShares": 1144230769, "marketCapitalization": 22815961533, "minusCashAndCashEquivalents": 293500000, "addTotalDebt": 1151800000, "enterpriseValue": 23674261533}}
{"date": "1991-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1991-06-30", "stockPrice": 18.47, "numberOfShares": 1175925926, "marketCapitalization": 21719351853, "minusCashAndCashEquivalents": 230400000, "addTotalDebt": 983800000, "enterpriseValue": 22472751853}}
{"date": "1991-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1991-03-31", "stockPrice": 19.81, "numberOfShares": 1142941176, "marketCapitalization": 22641664696, "minusCashAndCashEquivalents": 302800000, "addTotalDebt": 791600000, "enterpriseValue": 23130464696}}
{"date": "1990-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1990-12-31", "stockPrice": 18.31, "numberOfShares": 1133413870, "marketCapitalization": 20752807959, "minusCashAndCashEquivalents": 350200000, "addTotalDebt": 1516500000, "enterpriseValue": 21919107959}}
{"date": "1990-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1990-09-30", "stockPrice": 18.69, "numberOfShares": 1116521739, "marketCapitalization": 20867791301, "minusCashAndCashEquivalents": 494000000, "addTotalDebt": 1528000000, "enterpriseValue": 21901791301}}
{"date": "1990-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1990-06-30", "stockPrice": 20.78, "numberOfShares": 1143333333, "marketCapitalization": 23758466659, "minusCashAndCashEquivalents": 459100000, "addTotalDebt": 920400000, "enterpriseValue": 24219766659}}
{"date": "1990-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1990-03-31", "stockPrice": 16.16, "numberOfShares": 1175172414, "marketCapitalization": 18990786210, "minusCashAndCashEquivalents": 419300000, "addTotalDebt": 490000000, "enterpriseValue": 19061486210}}
{"date": "1989-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1989-12-31", "stockPrice": 17.19, "numberOfShares": 1146134869, "marketCapitalization": 19702058398, "minusCashAndCashEquivalents": 323000000, "addTotalDebt": 403500000, "enterpriseValue": 19782558398}}
{"date": "1989-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1989-09-30", "stockPrice": 15.59, "numberOfShares": 1117894737, "marketCapitalization": 17427978949, "minusCashAndCashEquivalents": 587400000, "addTotalDebt": 551500000, "enterpriseValue": 17392078949}}
{"date": "1989-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1989-06-30", "stockPrice": 13.63, "numberOfShares": 1142631579, "marketCapitalization": 15574068421, "minusCashAndCashEquivalents": 572400000, "addTotalDebt": 544900000, "enterpriseValue": 15546568421}}
{"date": "1989-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1989-03-31", "stockPrice": 12.86, "numberOfShares": 1101640000, "marketCapitalization": 14167090400, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 14167090400}}
{"date": "1988-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1988-12-31", "stockPrice": 10.69, "numberOfShares": 1117394448, "marketCapitalization": 11944946649, "minusCashAndCashEquivalents": 761500000, "addTotalDebt": 514700000, "enterpriseValue": 11698146649}}
{"date": "1988-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1988-09-30", "stockPrice": 11, "numberOfShares": 1098968000, "marketCapitalization": 12088648000, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 12088648000}}
{"date": "1988-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1988-06-30", "stockPrice": 10.47, "numberOfShares": 1104688000, "marketCapitalization": 11566083360, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 11566083360}}
{"date": "1988-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1988-03-31", "stockPrice": 10.5, "numberOfShares": 1114952000, "marketCapitalization": 11706996000, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 11706996000}}
{"date": "1987-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1987-12-31", "stockPrice": 9.75, "numberOfShares": 1132208143, "marketCapitalization": 11039029394, "minusCashAndCashEquivalents": 1030900000, "addTotalDebt": 603900000, "enterpriseValue": 10612029394}}
{"date": "1987-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1987-09-30", "stockPrice": 12.03, "numberOfShares": 1114952000, "marketCapitalization": 13412872560, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 13412872560}}
{"date": "1987-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1987-06-30", "stockPrice": 11.73, "numberOfShares": 1112448000, "marketCapitalization": 13049015040, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 13049015040}}
{"date": "1987-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1987-03-31", "stockPrice": 11.44, "numberOfShares": 1112448000, "marketCapitalization": 12726405120, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 12726405120}}
{"date": "1986-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1986-12-31", "stockPrice": 9.28, "numberOfShares": 1094509804, "marketCapitalization": 10157050981, "minusCashAndCashEquivalents": 486000000, "addTotalDebt": 626200000, "enterpriseValue": 10297250981}}
{"date": "1986-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1986-09-30", "stockPrice": 8.17, "numberOfShares": 1115992000, "marketCapitalization": 9117654640, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 9117654640}}
{"date": "1986-06-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1986-06-30", "stockPrice": 10.11, "numberOfShares": 1115992000, "marketCapitalization": 11282679120, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 11282679120}}
{"date": "1986-03-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1986-03-31", "stockPrice": 9.31, "numberOfShares": 1115992000, "marketCapitalization": 10389885520, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 10389885520}}
{"date": "1985-12-31", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1985-12-31", "stockPrice": 6.97, "numberOfShares": 1108634298, "marketCapitalization": 7727181057, "minusCashAndCashEquivalents": 406100000, "addTotalDebt": 238600000, "enterpriseValue": 7559681057}}
{"date": "1985-09-30", "symbol": "LLY", "type": "enterprise_values", "result": {"symbol": "LLY", "date": "1985-09-30", "stockPrice": 5.41, "numberOfShares": 1118048000, "marketCapitalization": 6048639680, "minusCashAndCashEquivalents": 0, "addTotalDebt": 0, "enterpriseValue": 6048639680}}
{"date": "2029-12-31", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2029-12-31", "revenueLow": 101868981947, "revenueHigh": 114519502523, "revenueAvg": 108657660534, "ebitdaLow": 31372047657, "ebitdaHigh": 35267961082, "ebitdaAvg": 33462720834, "ebitLow": 26361714981, "ebitHigh": 29635424126, "ebitAvg": 28118493213, "netIncomeLow": 43904811730, "netIncomeHigh": 51137383184, "netIncomeAvg": 47786045508, "sgaExpenseLow": 21445549693, "sgaExpenseHigh": 24108748661, "sgaExpenseAvg": 22874708414, "epsAvg": 52.85722, "epsHigh": 56.56421, "epsLow": 48.5641, "numAnalystsRevenue": 12, "numAnalystsEps": 4}}
{"date": "2028-12-31", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2028-12-31", "revenueLow": 93031795743, "revenueHigh": 104584877199, "revenueAvg": 99231552996, "ebitdaLow": 28650506502, "ebitdaHigh": 32208447449, "ebitdaAvg": 30559812714, "ebitLow": 24074822745, "ebitHigh": 27064535950, "ebitAvg": 25679199568, "netIncomeLow": 38893802540, "netIncomeHigh": 45300895802, "netIncomeAvg": 42332056448, "sgaExpenseLow": 19585137305, "sgaExpenseHigh": 22017302403, "sgaExpenseAvg": 20890315778, "epsAvg": 46.82444, "epsHigh": 50.10834, "epsLow": 43.02131, "numAnalystsRevenue": 11, "numAnalystsEps": 5}}
{"date": "2027-12-31", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2027-12-31", "revenueLow": 89258600594, "revenueHigh": 89391741691, "revenueAvg": 89325171143, "ebitdaLow": 27488495694, "ebitdaHigh": 27529498449, "ebitdaAvg": 27508997072, "ebitLow": 23098393088, "ebitHigh": 23132847419, "ebitAvg": 23115620254, "netIncomeLow": 31367393829, "netIncomeHigh": 42678699791, "netIncomeAvg": 34933269470, "sgaExpenseLow": 18790800869, "sgaExpenseHigh": 18818829853, "sgaExpenseAvg": 18804815361, "epsAvg": 40.02769, "epsHigh": 47.20787, "epsLow": 34.69618, "numAnalystsRevenue": 25, "numAnalystsEps": 11}}
{"date": "2026-12-31", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2026-12-31", "revenueLow": 72612353299, "revenueHigh": 80961645646, "revenueAvg": 76782093896, "ebitdaLow": 22362039599, "ebitdaHigh": 24933326681, "ebitdaAvg": 23646172396, "ebitLow": 18790667436, "ebitHigh": 20951302213, "ebitAvg": 19869715356, "netIncomeLow": 26228505493, "netIncomeHigh": 34245682633, "netIncomeAvg": 28194720260, "sgaExpenseLow": 15286417918, "sgaExpenseHigh": 17044118452, "sgaExpenseAvg": 16164235459, "epsAvg": 32.50304, "epsHigh": 37.87992, "epsLow": 29.01194, "numAnalystsRevenue": 22, "numAnalystsEps": 16}}
{"date": "2025-12-31", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2025-12-31", "revenueLow": 63175292648, "revenueHigh": 64859568474, "revenueAvg": 63753328139, "ebitdaLow": 19455758306, "ebitdaHigh": 19974455759, "ebitdaAvg": 19633772817, "ebitLow": 16348539337, "ebitHigh": 16784397225, "ebitAvg": 16498123701, "netIncomeLow": 20146566091, "netIncomeHigh": 22939430360, "netIncomeAvg": 20398823430, "sgaExpenseLow": 13299719423, "sgaExpenseHigh": 13654294685, "sgaExpenseAvg": 13421407974, "epsAvg": 23.77421, "epsHigh": 25.37382, "epsLow": 22.28457, "numAnalystsRevenue": 19, "numAnalystsEps": 16}}
{"date": "2024-12-31", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2024-12-31", "revenueLow": 45021954756, "revenueHigh": 45402478395, "revenueAvg": 45102064996, "ebitdaLow": 13865171549, "ebitdaHigh": 13982359387, "ebitdaAvg": 13889842673, "ebitLow": 11650807895, "ebitHigh": 11749280026, "ebitAvg": 11671538870, "netIncomeLow": 11246557256, "netIncomeHigh": 12101878436, "netIncomeAvg": 11674217846, "sgaExpenseLow": 9478062404, "sgaExpenseHigh": 9558170583, "sgaExpenseAvg": 9494927284, "epsAvg": 12.8326, "epsHigh": 13.38616, "epsLow": 12.44007, "numAnalystsRevenue": 14, "numAnalystsEps": 17}}
{"date": "2023-12-31", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2023-12-31", "revenueLow": 32921325388, "revenueHigh": 34420450494, "revenueAvg": 33652618170, "ebitdaLow": 7063913952, "ebitdaHigh": 10595870930, "ebitdaAvg": 8829892441, "ebitLow": 7363788095, "ebitHigh": 11045682144, "ebitAvg": 9204735120, "netIncomeLow": 5873760001, "netIncomeHigh": 8810639997, "netIncomeAvg": 7342200000, "sgaExpenseLow": 6076618869, "sgaExpenseHigh": 9114928306, "sgaExpenseAvg": 7595773588, "epsAvg": 6.22792, "epsHigh": 6.6647, "epsLow": 5.72208, "numAnalystsRevenue": 24, "numAnalystsEps": 11}}
{"date": "2022-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2022-12-30", "revenueLow": 26812070001, "revenueHigh": 30141706135, "revenueAvg": 28590039679, "ebitdaLow": 6421739958, "ebitdaHigh": 9632609938, "ebitdaAvg": 8027174948, "ebitLow": 6694352815, "ebitHigh": 10041529223, "ebitAvg": 8367941019, "netIncomeLow": 4782925918, "netIncomeHigh": 7174388875, "netIncomeAvg": 5978657397, "sgaExpenseLow": 5524198973, "sgaExpenseHigh": 8286298461, "sgaExpenseAvg": 6905248717, "epsAvg": 7.63638, "epsHigh": 8.17516, "epsLow": 7.01902, "numAnalystsRevenue": 6, "numAnalystsEps": 5}}
{"date": "2021-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2021-12-30", "revenueLow": 26297423370, "revenueHigh": 29563148511, "revenueAvg": 28041265653, "ebitdaLow": 6643114285, "ebitdaHigh": 9964671428, "ebitdaAvg": 8303892857, "ebitLow": 5242289144, "ebitHigh": 7863433716, "ebitAvg": 6552861430, "netIncomeLow": 4610578442, "netIncomeHigh": 6915867663, "netIncomeAvg": 5763223053, "sgaExpenseLow": 5323420651, "sgaExpenseHigh": 7985130978, "sgaExpenseAvg": 6654275815, "epsAvg": 8.13166, "epsHigh": 8.70539, "epsLow": 7.47426, "numAnalystsRevenue": 7, "numAnalystsEps": 4}}
{"date": "2020-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2020-12-30", "revenueLow": 22859512284, "revenueHigh": 25698303101, "revenueAvg": 24375378821, "ebitdaLow": 6235635666, "ebitdaHigh": 9353453499, "ebitdaAvg": 7794544583, "ebitLow": 4242095087, "ebitHigh": 6363142630, "ebitAvg": 5302618859, "netIncomeLow": 4311297441, "netIncomeHigh": 6466946163, "netIncomeAvg": 5389121802, "sgaExpenseLow": 5252585801, "sgaExpenseHigh": 7878878702, "sgaExpenseAvg": 6565732252, "epsAvg": 7.36953, "epsHigh": 7.88949, "epsLow": 6.77374, "numAnalystsRevenue": 11, "numAnalystsEps": 4}}
{"date": "2019-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2019-12-30", "revenueLow": 20766771450, "revenueHigh": 23345676869, "revenueAvg": 22143863557, "ebitdaLow": 8050535288, "ebitdaHigh": 12075802935, "ebitdaAvg": 10063169112, "ebitLow": 3718647426, "ebitHigh": 5577971139, "ebitAvg": 4648309283, "netIncomeLow": 6351187289, "netIncomeHigh": 9526780934, "netIncomeAvg": 7938984112, "sgaExpenseLow": 4664974449, "sgaExpenseHigh": 6997461673, "sgaExpenseAvg": 5831218061, "epsAvg": 5.81405, "epsHigh": 6.22426, "epsLow": 5.34401, "numAnalystsRevenue": 6, "numAnalystsEps": 5}}
{"date": "2018-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2018-12-30", "revenueLow": 22899107794, "revenueHigh": 25742815749, "revenueAvg": 24417600000, "ebitdaLow": 4157726535, "ebitdaHigh": 6236589804, "ebitdaAvg": 5197158170, "ebitLow": 2876206522, "ebitHigh": 4342402091, "ebitAvg": 3609304307, "netIncomeLow": 2328096565, "netIncomeHigh": 3712060233, "netIncomeAvg": 3020078399, "sgaExpenseLow": 4851692866, "sgaExpenseHigh": 7277539300, "sgaExpenseAvg": 6064616083, "epsAvg": 5.57264, "epsHigh": 5.96582, "epsLow": 5.12212, "numAnalystsRevenue": 7, "numAnalystsEps": 6}}
{"date": "2017-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2017-12-30", "revenueLow": 21236489796, "revenueHigh": 23873726823, "revenueAvg": 22644730000, "ebitdaLow": 3049695076, "ebitdaHigh": 4574542614, "ebitdaAvg": 3812118845, "ebitLow": 1636039650, "ebitHigh": 2454059475, "ebitAvg": 2045049563, "netIncomeLow": -792226286, "netIncomeHigh": 468656909, "netIncomeAvg": -161784689, "sgaExpenseLow": 5433409040, "sgaExpenseHigh": 8150113560, "sgaExpenseAvg": 6791761300, "epsAvg": 4.21622, "epsHigh": 4.51369, "epsLow": 3.87536, "numAnalystsRevenue": 7, "numAnalystsEps": 6}}
{"date": "2016-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2016-12-30", "revenueLow": 19638229116, "revenueHigh": 22076987380, "revenueAvg": 20940485000, "ebitdaLow": 4188972111, "ebitdaHigh": 6283458166, "ebitdaAvg": 5236215139, "ebitLow": 2864871841, "ebitHigh": 4297307760, "ebitAvg": 3581089801, "netIncomeLow": 2269132125, "netIncomeHigh": 3403698187, "netIncomeAvg": 2836415156, "sgaExpenseLow": 5337543182, "sgaExpenseHigh": 8006314774, "sgaExpenseAvg": 6671928978, "epsAvg": 3.54178, "epsHigh": 3.79167, "epsLow": 3.25544, "numAnalystsRevenue": 6, "numAnalystsEps": 7}}
{"date": "2015-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2015-12-30", "revenueLow": 18666917190, "revenueHigh": 20985053834, "revenueAvg": 19904763158, "ebitdaLow": 3012063134, "ebitdaHigh": 4518094701, "ebitdaAvg": 3765078918, "ebitLow": 1826510152, "ebitHigh": 2739765229, "ebitAvg": 2283137691, "netIncomeLow": 1658352217, "netIncomeHigh": 2487528327, "netIncomeAvg": 2072940272, "sgaExpenseLow": 4569612179, "sgaExpenseHigh": 6854418270, "sgaExpenseAvg": 5712015225, "epsAvg": 3.43666, "epsHigh": 3.67913, "epsLow": 3.15882, "numAnalystsRevenue": 7, "numAnalystsEps": 6}}
{"date": "2014-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2014-12-30", "revenueLow": 15522753333, "revenueHigh": 23284130001, "revenueAvg": 19403441667, "ebitdaLow": 3576326972, "ebitdaHigh": 5364490457, "ebitdaAvg": 4470408715, "ebitLow": 2097745257, "ebitHigh": 3146617887, "ebitAvg": 2622181572, "netIncomeLow": 1886661803, "netIncomeHigh": 2829992705, "netIncomeAvg": 2358327254, "sgaExpenseLow": 5235710686, "sgaExpenseHigh": 7853566029, "sgaExpenseAvg": 6544638358, "epsAvg": 2.73, "epsHigh": 3.28, "epsLow": 2.18, "numAnalystsRevenue": 8, "numAnalystsEps": 8}}
{"date": "2013-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2013-12-30", "revenueLow": 17191127477, "revenueHigh": 25786691217, "revenueAvg": 21488909347, "ebitdaLow": 5485215903, "ebitdaHigh": 8227823854, "ebitdaAvg": 6856519879, "ebitLow": 3923258131, "ebitHigh": 5884887197, "ebitAvg": 4904072664, "netIncomeLow": 3422515520, "netIncomeHigh": 5133773280, "netIncomeAvg": 4278144400, "sgaExpenseLow": 5259171815, "sgaExpenseHigh": 7888757722, "sgaExpenseAvg": 6573964769, "epsAvg": 3.51, "epsHigh": 4.21, "epsLow": 2.81, "numAnalystsRevenue": 15, "numAnalystsEps": 15}}
{"date": "2012-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2012-12-30", "revenueLow": 16904842058, "revenueHigh": 25357263086, "revenueAvg": 21131052572, "ebitdaLow": 5273607226, "ebitdaHigh": 7910410840, "ebitdaAvg": 6592009033, "ebitLow": 3479456277, "ebitHigh": 5219184415, "ebitAvg": 4349320346, "netIncomeLow": 3059871471, "netIncomeHigh": 4589807206, "netIncomeAvg": 3824839339, "sgaExpenseLow": 5550918509, "sgaExpenseHigh": 8326377765, "sgaExpenseAvg": 6938648137, "epsAvg": 2.93, "epsHigh": 3.51, "epsLow": 2.35, "numAnalystsRevenue": 10, "numAnalystsEps": 10}}
{"date": "2011-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2011-12-30", "revenueLow": 18831888675, "revenueHigh": 28247833014, "revenueAvg": 23539860845, "ebitdaLow": 5364195327, "ebitdaHigh": 8046292989, "ebitdaAvg": 6705244159, "ebitLow": 4297966495, "ebitHigh": 6446949743, "ebitAvg": 5372458119, "netIncomeLow": 3376764899, "netIncomeHigh": 5065147349, "netIncomeAvg": 4220956124, "sgaExpenseLow": 6092026894, "sgaExpenseHigh": 9138040341, "sgaExpenseAvg": 7615033618, "epsAvg": 4.16, "epsHigh": 5, "epsLow": 3.32, "numAnalystsRevenue": 19, "numAnalystsEps": 19}}
{"date": "2010-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2010-12-30", "revenueLow": 17375130299, "revenueHigh": 26062695449, "revenueAvg": 21718912874, "ebitdaLow": 5995592189, "ebitdaHigh": 8993388284, "ebitdaAvg": 7494490237, "ebitLow": 5052577262, "ebitHigh": 7578865895, "ebitAvg": 6315721579, "netIncomeLow": 3782752630, "netIncomeHigh": 5674128947, "netIncomeAvg": 4728440789, "sgaExpenseLow": 5284852709, "sgaExpenseHigh": 7927279064, "sgaExpenseAvg": 6606065887, "epsAvg": 4.16, "epsHigh": 4.99, "epsLow": 3.33, "numAnalystsRevenue": 12, "numAnalystsEps": 12}}
{"date": "2009-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2009-12-30", "revenueLow": 15768891648, "revenueHigh": 23653337471, "revenueAvg": 19711114560, "ebitdaLow": 4847376428, "ebitdaHigh": 7271064644, "ebitdaAvg": 6059220536, "ebitLow": 4370869292, "ebitHigh": 6556303938, "ebitAvg": 5463586616, "netIncomeLow": 3024348163, "netIncomeHigh": 4536522245, "netIncomeAvg": 3780435204, "sgaExpenseLow": 4897254021, "sgaExpenseHigh": 7345881033, "sgaExpenseAvg": 6121567527, "epsAvg": 3.47, "epsHigh": 4.17, "epsLow": 2.77, "numAnalystsRevenue": 14, "numAnalystsEps": 14}}
{"date": "2008-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2008-12-30", "revenueLow": 16348391304, "revenueHigh": 24522586957, "revenueAvg": 20435489131, "ebitdaLow": -1245393186, "ebitdaHigh": 1130779744, "ebitdaAvg": -57306721, "ebitLow": 4429217825, "ebitHigh": 6643826739, "ebitAvg": 5536522282, "netIncomeLow": -3158459924, "netIncomeHigh": -720950727, "netIncomeAvg": -1939705326, "sgaExpenseLow": 5314224233, "sgaExpenseHigh": 7971336350, "sgaExpenseAvg": 6642780292, "epsAvg": 4.04, "epsHigh": 4.85, "epsLow": 3.23, "numAnalystsRevenue": 13, "numAnalystsEps": 13}}
{"date": "2007-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2007-12-30", "revenueLow": 14168817742, "revenueHigh": 21253226614, "revenueAvg": 17711022178, "ebitdaLow": 3733070991, "ebitdaHigh": 5599606487, "ebitdaAvg": 4666338739, "ebitLow": 3631822939, "ebitHigh": 5447734408, "ebitAvg": 4539778674, "netIncomeLow": 2243099061, "netIncomeHigh": 3364648592, "netIncomeAvg": 2803873827, "sgaExpenseLow": 4619254613, "sgaExpenseHigh": 6928881920, "sgaExpenseAvg": 5774068267, "epsAvg": 3.19, "epsHigh": 3.84, "epsLow": 2.54, "numAnalystsRevenue": 12, "numAnalystsEps": 12}}
{"date": "2006-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2006-12-30", "revenueLow": 12276398922, "revenueHigh": 18414598384, "revenueAvg": 15345498653, "ebitdaLow": 3310856051, "ebitdaHigh": 4966284078, "ebitdaAvg": 4138570065, "ebitLow": 3226283493, "ebitHigh": 4839425239, "ebitAvg": 4032854366, "netIncomeLow": 2090864154, "netIncomeHigh": 3136296232, "netIncomeAvg": 2613580193, "sgaExpenseLow": 3823755316, "sgaExpenseHigh": 5735632974, "sgaExpenseAvg": 4779694145, "epsAvg": 3.04, "epsHigh": 3.66, "epsLow": 2.42, "numAnalystsRevenue": 15, "numAnalystsEps": 15}}
{"date": "2005-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2005-12-30", "revenueLow": 11475448732, "revenueHigh": 17213173099, "revenueAvg": 14344310916, "ebitdaLow": 2661162867, "ebitdaHigh": 3991744302, "ebitdaAvg": 3326453585, "ebitLow": 2857207854, "ebitHigh": 4285811782, "ebitAvg": 3571509818, "netIncomeLow": 1432749774, "netIncomeHigh": 2401124663, "netIncomeAvg": 1916937219, "sgaExpenseLow": 3522631050, "sgaExpenseHigh": 5283946576, "sgaExpenseAvg": 4403288813, "epsAvg": 2.76, "epsHigh": 3.31, "epsLow": 2.21, "numAnalystsRevenue": 9, "numAnalystsEps": 9}}
{"date": "2004-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2004-12-30", "revenueLow": 10854515965, "revenueHigh": 16281773949, "revenueAvg": 13568144957, "ebitdaLow": 2774111163, "ebitdaHigh": 4161166744, "ebitdaAvg": 3467638954, "ebitLow": 2861911449, "ebitHigh": 4292867173, "ebitAvg": 3577389311, "netIncomeLow": 1418860879, "netIncomeHigh": 2130658887, "netIncomeAvg": 1774759883, "sgaExpenseLow": 3352705712, "sgaExpenseHigh": 5029058569, "sgaExpenseAvg": 4190882141, "epsAvg": 2.7, "epsHigh": 3.24, "epsLow": 2.16, "numAnalystsRevenue": 13, "numAnalystsEps": 13}}
{"date": "2003-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2003-12-30", "revenueLow": 9797908688, "revenueHigh": 14696863032, "revenueAvg": 12247385860, "ebitdaLow": 2966704643, "ebitdaHigh": 4450056965, "ebitdaAvg": 3708380804, "ebitLow": 2721508781, "ebitHigh": 4082263170, "ebitAvg": 3401885976, "netIncomeLow": 1994881286, "netIncomeHigh": 2992321930, "netIncomeAvg": 2493601608, "sgaExpenseLow": 3150835953, "sgaExpenseHigh": 4726253930, "sgaExpenseAvg": 3938544942, "epsAvg": 2.44, "epsHigh": 2.92, "epsLow": 1.96, "numAnalystsRevenue": 19, "numAnalystsEps": 19}}
{"date": "2002-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2002-12-30", "revenueLow": 8862000000, "revenueHigh": 13293000000, "revenueAvg": 11077500000, "ebitdaLow": 3160560000, "ebitdaHigh": 4740840000, "ebitdaAvg": 3950700000, "ebitLow": 2662160000, "ebitHigh": 3993240000, "ebitAvg": 3327700000, "netIncomeLow": 2166320000, "netIncomeHigh": 3249480000, "netIncomeAvg": 2707900000, "sgaExpenseLow": 2739200000, "sgaExpenseHigh": 4108800000, "sgaExpenseAvg": 3424000000, "epsAvg": 2.55, "epsHigh": 3.07, "epsLow": 2.03, "numAnalystsRevenue": 16, "numAnalystsEps": 16}}
{"date": "2001-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2001-12-30", "revenueLow": 9139804950, "revenueHigh": 13709707425, "revenueAvg": 11424756188, "ebitdaLow": 3143727359, "ebitdaHigh": 4715591040, "ebitdaAvg": 3929659200, "ebitLow": 2950239081, "ebitHigh": 4425358622, "ebitAvg": 3687798852, "netIncomeLow": 2197262139, "netIncomeHigh": 3295893209, "netIncomeAvg": 2746577674, "sgaExpenseLow": 2706036400, "sgaExpenseHigh": 4059054600, "sgaExpenseAvg": 3382545501, "epsAvg": 2.7, "epsHigh": 3.23, "epsLow": 2.17, "numAnalystsRevenue": 15, "numAnalystsEps": 15}}
{"date": "2000-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "2000-12-30", "revenueLow": 8593129513, "revenueHigh": 12889694269, "revenueAvg": 10741411891, "ebitdaLow": 3392728459, "ebitdaHigh": 5089092688, "ebitdaAvg": 4240910574, "ebitLow": 2815883803, "ebitHigh": 4223825704, "ebitAvg": 3519854754, "netIncomeLow": 2415180283, "netIncomeHigh": 3622770425, "netIncomeAvg": 3018975354, "sgaExpenseLow": 2553980895, "sgaExpenseHigh": 3830971343, "sgaExpenseAvg": 3192476119, "epsAvg": 2.59, "epsHigh": 3.11, "epsLow": 2.07, "numAnalystsRevenue": 12, "numAnalystsEps": 12}}
{"date": "1999-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "1999-12-30", "revenueLow": 7966295384, "revenueHigh": 11949443076, "revenueAvg": 9957869230, "ebitdaLow": 3074170980, "ebitdaHigh": 4611256470, "ebitdaAvg": 3842713725, "ebitLow": 2679345882, "ebitHigh": 4019018822, "ebitAvg": 3349182353, "netIncomeLow": 2167758431, "netIncomeHigh": 3251637647, "netIncomeAvg": 2709698039, "sgaExpenseLow": 2195890196, "sgaExpenseHigh": 3293835294, "sgaExpenseAvg": 2744862745, "epsAvg": 2.26, "epsHigh": 2.71, "epsLow": 1.81, "numAnalystsRevenue": 18, "numAnalystsEps": 18}}
{"date": "1998-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "1998-12-30", "revenueLow": 6773003672, "revenueHigh": 10159505509, "revenueAvg": 8466254591, "ebitdaLow": 2472545777, "ebitdaHigh": 3708818666, "ebitdaAvg": 3090682222, "ebitLow": 2208717772, "ebitHigh": 3313076659, "ebitAvg": 2760897216, "netIncomeLow": 1643618028, "netIncomeHigh": 2465427042, "netIncomeAvg": 2054522535, "sgaExpenseLow": 2082994386, "sgaExpenseHigh": 3124491580, "sgaExpenseAvg": 2603742983, "epsAvg": 1.87, "epsHigh": 2.24, "epsLow": 1.5, "numAnalystsRevenue": 9, "numAnalystsEps": 9}}
{"date": "1997-12-30", "symbol": "LLY", "type": "analyst_estimates_annual", "result": {"symbol": "LLY", "date": "1997-12-30", "revenueLow": 6779839626, "revenueHigh": 10169759440, "revenueAvg": 8474799533, "ebitdaLow": 339496285, "ebitdaHigh": 1662144428, "ebitdaAvg": 1000820357, "ebitLow": 1953247142, "ebitHigh": 2929870714, "ebitAvg": 2441558928, "netIncomeLow": -1009995715, "netIncomeHigh": 217106428, "netIncomeAvg": -396444644, "sgaExpenseLow": 1843347714, "sgaExpenseHigh": 2765021571, "sgaExpenseAvg": 2304184643, "epsAvg": 1.59, "epsHigh": 1.92, "epsLow": 1.26, "numAnalystsRevenue": 11, "numAnalystsEps": 11}}
{"date": "2025-12-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-12-16 00:00:00", "acceptedDate": "2025-12-16 16:46:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000126238825000010/0001262388-25-000010-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000126238825000010/xslF345X05/wk-form4_1765921596.xml"}}
{"date": "2025-12-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-12-16 00:00:00", "acceptedDate": "2025-12-16 16:45:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000275/0000059478-25-000275-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000275/xslF345X05/wk-form4_1765921510.xml"}}
{"date": "2025-12-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-12-16 00:00:00", "acceptedDate": "2025-12-16 16:43:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000134082325000012/0001340823-25-000012-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000134082325000012/xslF345X05/wk-form4_1765921413.xml"}}
{"date": "2025-12-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-12-16 00:00:00", "acceptedDate": "2025-12-16 16:42:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000273/0000059478-25-000273-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000273/xslF345X05/wk-form4_1765921326.xml"}}
{"date": "2025-12-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-12-16 00:00:00", "acceptedDate": "2025-12-16 16:41:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000131021525000012/0001310215-25-000012-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000131021525000012/xslF345X05/wk-form4_1765921259.xml"}}
{"date": "2025-12-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-12-09 00:00:00", "acceptedDate": "2025-12-09 08:46:33", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525311997/0001193125-25-311997-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525311997/d14417dsctota.htm"}}
{"date": "2025-12-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-12-08 00:00:00", "acceptedDate": "2025-12-08 16:10:25", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000169876625000008/0001698766-25-000008-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000169876625000008/xslF345X02/wk-form3_1765228221.xml"}}
{"date": "2025-11-26", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-26 00:00:00", "acceptedDate": "2025-11-26 16:00:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000093/0000316011-25-000093-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000093/xslF345X05/form4-11262025_041104.xml"}}
{"date": "2025-11-26", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-26 00:00:00", "acceptedDate": "2025-11-26 16:00:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000092/0000316011-25-000092-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000092/xslF345X05/form4-11262025_041101.xml"}}
{"date": "2025-11-25", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-25 00:00:00", "acceptedDate": "2025-11-25 16:00:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000089/0000316011-25-000089-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000089/xslF345X05/form4-11252025_041101.xml"}}
{"date": "2025-11-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-24 00:00:00", "acceptedDate": "2025-11-24 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000087/0000316011-25-000087-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000087/xslF345X05/form4-11242025_041101.xml"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-21 00:00:00", "acceptedDate": "2025-11-21 16:19:05", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000271/0000059478-25-000271-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000271/lly-20251118.htm"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-21 00:00:00", "acceptedDate": "2025-11-21 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000083/0000316011-25-000083-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000083/xslF345X05/form4-11212025_041101.xml"}}
{"date": "2025-11-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-20 00:00:00", "acceptedDate": "2025-11-20 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000081/0000316011-25-000081-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000081/xslF345X05/form4-11202025_041101.xml"}}
{"date": "2025-11-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-19 00:00:00", "acceptedDate": "2025-11-19 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000079/0000316011-25-000079-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000079/xslF345X05/form4-11192025_041102.xml"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-18 00:00:00", "acceptedDate": "2025-11-18 16:39:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000269/0000059478-25-000269-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000269/xslF345X05/wk-form4_1763501994.xml"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-18 00:00:00", "acceptedDate": "2025-11-18 16:26:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000126238825000008/0001262388-25-000008-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000126238825000008/xslF345X05/wk-form4_1763501198.xml"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-18 00:00:00", "acceptedDate": "2025-11-18 16:25:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000266/0000059478-25-000266-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000266/xslF345X05/wk-form4_1763501099.xml"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-18 00:00:00", "acceptedDate": "2025-11-18 16:23:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000264/0000059478-25-000264-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000264/xslF345X05/wk-form4_1763501018.xml"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-18 00:00:00", "acceptedDate": "2025-11-18 16:21:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000155171525000006/0001551715-25-000006-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000155171525000006/xslF345X05/wk-form4_1763500905.xml"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-18 00:00:00", "acceptedDate": "2025-11-18 16:19:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000260/0000059478-25-000260-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000260/xslF345X05/wk-form4_1763500742.xml"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-18 00:00:00", "acceptedDate": "2025-11-18 16:17:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000134082325000010/0001340823-25-000010-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000134082325000010/xslF345X05/wk-form4_1763500655.xml"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-18 00:00:00", "acceptedDate": "2025-11-18 16:16:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000258/0000059478-25-000258-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000258/xslF345X05/wk-form4_1763500557.xml"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-18 00:00:00", "acceptedDate": "2025-11-18 16:13:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000153706725000006/0001537067-25-000006-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000153706725000006/xslF345X05/wk-form4_1763500433.xml"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-18 00:00:00", "acceptedDate": "2025-11-18 16:12:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000131021525000010/0001310215-25-000010-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000131021525000010/xslF345X05/wk-form4_1763500326.xml"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-18 00:00:00", "acceptedDate": "2025-11-18 16:00:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000075/0000316011-25-000075-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000075/xslF345X05/form4-11182025_041101.xml"}}
{"date": "2025-11-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-17 00:00:00", "acceptedDate": "2025-11-17 16:00:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000073/0000316011-25-000073-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000073/xslF345X05/form4-11172025_041103.xml"}}
{"date": "2025-11-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-14 00:00:00", "acceptedDate": "2025-11-14 16:11:50", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000256/0000059478-25-000256-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000256/xslF345X02/wk-form3_1763154706.xml"}}
{"date": "2025-11-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-14 00:00:00", "acceptedDate": "2025-11-14 16:00:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000071/0000316011-25-000071-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000071/xslF345X05/form4-11142025_041101.xml"}}
{"date": "2025-11-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-13 00:00:00", "acceptedDate": "2025-11-13 16:14:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000156153925000006/0001561539-25-000006-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000156153925000006/xslF345X05/wk-form4_1763068481.xml"}}
{"date": "2025-11-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-13 00:00:00", "acceptedDate": "2025-11-13 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000069/0000316011-25-000069-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000069/xslF345X05/form4-11132025_041101.xml"}}
{"date": "2025-11-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-12 00:00:00", "acceptedDate": "2025-11-12 16:00:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000065/0000316011-25-000065-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000065/xslF345X05/form4-11122025_041107.xml"}}
{"date": "2025-11-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-12 00:00:00", "acceptedDate": "2025-11-12 16:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000064/0000316011-25-000064-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000064/xslF345X05/form4-11122025_041105.xml"}}
{"date": "2025-11-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-10 00:00:00", "acceptedDate": "2025-11-10 18:01:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000153860425000006/0001538604-25-000006-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000153860425000006/xslF345X05/wk-form4_1762815690.xml"}}
{"date": "2025-11-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-10 00:00:00", "acceptedDate": "2025-11-10 18:00:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000174147425000006/0001741474-25-000006-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000174147425000006/xslF345X05/wk-form4_1762815639.xml"}}
{"date": "2025-11-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-07 00:00:00", "acceptedDate": "2025-11-07 16:07:48", "formType": "SC TO-T", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525272330/0001193125-25-272330-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525272330/d67752dsctot.htm"}}
{"date": "2025-11-06", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-06 00:00:00", "acceptedDate": "2025-11-06 16:00:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000055/0000316011-25-000055-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000055/xslF345X05/form4-11062025_041104.xml"}}
{"date": "2025-11-06", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-06 00:00:00", "acceptedDate": "2025-11-06 16:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000054/0000316011-25-000054-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000054/xslF345X05/form4-11062025_041102.xml"}}
{"date": "2025-11-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-05 00:00:00", "acceptedDate": "2025-11-05 16:00:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000051/0000316011-25-000051-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000051/xslF345X05/form4-11052025_041101.xml"}}
{"date": "2025-11-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-04 00:00:00", "acceptedDate": "2025-11-04 16:00:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000049/0000316011-25-000049-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000049/xslF345X05/form4-11042025_041101.xml"}}
{"date": "2025-11-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-11-03 00:00:00", "acceptedDate": "2025-11-03 16:00:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000045/0000316011-25-000045-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000045/xslF345X05/form4-11032025_041101.xml"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-30 00:00:00", "acceptedDate": "2025-10-30 17:34:25", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000041/0000316011-25-000041-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000041/xslSCHEDULE_13G_X01/primary_doc.xml"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-30 00:00:00", "acceptedDate": "2025-10-30 14:54:59", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000010290925000087/0000102909-25-000087-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000010290925000087/xslSCHEDULE_13G_X01/primary_doc.xml"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-30 00:00:00", "acceptedDate": "2025-10-30 11:15:28", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000254/0000059478-25-000254-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000254/lly-20250930.htm"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-30 00:00:00", "acceptedDate": "2025-10-30 07:03:41", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000251/0000059478-25-000251-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000251/lly-20251030.htm"}}
{"date": "2025-10-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-24 00:00:00", "acceptedDate": "2025-10-24 16:30:08", "formType": "SC TO-C", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525250031/0001193125-25-250031-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525250031/d234815dsctoc.htm"}}
{"date": "2025-10-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-22 00:00:00", "acceptedDate": "2025-10-22 16:24:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000126238825000006/0001262388-25-000006-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000126238825000006/xslF345X05/wk-form4_1761164695.xml"}}
{"date": "2025-10-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-22 00:00:00", "acceptedDate": "2025-10-22 16:24:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000247/0000059478-25-000247-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000247/xslF345X05/wk-form4_1761164643.xml"}}
{"date": "2025-10-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-22 00:00:00", "acceptedDate": "2025-10-22 16:22:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000134082325000008/0001340823-25-000008-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000134082325000008/xslF345X05/wk-form4_1761164553.xml"}}
{"date": "2025-10-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-22 00:00:00", "acceptedDate": "2025-10-22 16:19:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000245/0000059478-25-000245-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000245/xslF345X05/wk-form4_1761164359.xml"}}
{"date": "2025-10-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-22 00:00:00", "acceptedDate": "2025-10-22 16:17:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000131021525000008/0001310215-25-000008-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000131021525000008/xslF345X05/wk-form4_1761164262.xml"}}
{"date": "2025-10-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-14 00:00:00", "acceptedDate": "2025-10-14 16:00:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000037/0000316011-25-000037-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000037/xslF345X05/form4-10142025_041001.xml"}}
{"date": "2025-10-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-10 00:00:00", "acceptedDate": "2025-10-10 16:00:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000035/0000316011-25-000035-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000035/xslF345X05/form4-10102025_041001.xml"}}
{"date": "2025-10-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-09 00:00:00", "acceptedDate": "2025-10-09 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000031/0000316011-25-000031-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000031/xslF345X05/form4-10092025_041002.xml"}}
{"date": "2025-10-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-08 00:00:00", "acceptedDate": "2025-10-08 16:00:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000029/0000316011-25-000029-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000029/xslF345X05/form4-10082025_041001.xml"}}
{"date": "2025-10-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-07 00:00:00", "acceptedDate": "2025-10-07 16:00:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000027/0000316011-25-000027-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000027/xslF345X05/form4-10072025_041001.xml"}}
{"date": "2025-10-06", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-06 00:00:00", "acceptedDate": "2025-10-06 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000025/0000316011-25-000025-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000025/xslF345X05/form4-10062025_041001.xml"}}
{"date": "2025-10-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-03 00:00:00", "acceptedDate": "2025-10-03 16:16:39", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000243/0000059478-25-000243-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000243/xslSCHEDULE_13G_X01/primary_doc.xml"}}
{"date": "2025-10-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-03 00:00:00", "acceptedDate": "2025-10-03 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000021/0000316011-25-000021-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000021/xslF345X05/form4-10032025_041001.xml"}}
{"date": "2025-10-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-02 00:00:00", "acceptedDate": "2025-10-02 16:56:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000019/0000316011-25-000019-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000019/xslF345X05/form4-10022025_081019.xml"}}
{"date": "2025-10-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-02 00:00:00", "acceptedDate": "2025-10-02 16:55:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000018/0000316011-25-000018-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000018/xslF345X05/form4-10022025_081016.xml"}}
{"date": "2025-10-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-10-01 00:00:00", "acceptedDate": "2025-10-01 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000011/0000316011-25-000011-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000011/xslF345X05/form4-10012025_041001.xml"}}
{"date": "2025-09-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-09-22 00:00:00", "acceptedDate": "2025-09-22 16:00:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000009/0000316011-25-000009-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000009/xslF345X05/form4-09222025_040901.xml"}}
{"date": "2025-09-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-09-19 00:00:00", "acceptedDate": "2025-09-19 16:00:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000007/0000316011-25-000007-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000007/xslF345X05/form4-09192025_040901.xml"}}
{"date": "2025-09-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-09-17 00:00:00", "acceptedDate": "2025-09-17 16:49:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000126238825000004/0001262388-25-000004-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000126238825000004/xslF345X05/wk-form4_1758142191.xml"}}
{"date": "2025-09-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-09-17 00:00:00", "acceptedDate": "2025-09-17 16:49:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000242/0000059478-25-000242-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000242/xslF345X05/wk-form4_1758142140.xml"}}
{"date": "2025-09-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-09-17 00:00:00", "acceptedDate": "2025-09-17 16:48:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000134082325000006/0001340823-25-000006-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000134082325000006/xslF345X05/wk-form4_1758142082.xml"}}
{"date": "2025-09-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-09-17 00:00:00", "acceptedDate": "2025-09-17 16:47:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000240/0000059478-25-000240-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000240/xslF345X05/wk-form4_1758142037.xml"}}
{"date": "2025-09-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-09-17 00:00:00", "acceptedDate": "2025-09-17 16:45:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000131021525000005/0001310215-25-000005-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000131021525000005/xslF345X05/wk-form4_1758141956.xml"}}
{"date": "2025-09-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-09-08 00:00:00", "acceptedDate": "2025-09-08 16:19:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000238/0000059478-25-000238-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000238/xslF345X05/wk-form4_1757362781.xml"}}
{"date": "2025-08-28", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-28 00:00:00", "acceptedDate": "2025-08-28 16:15:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000236/0000059478-25-000236-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000236/xslF345X05/wk-form4_1756412129.xml"}}
{"date": "2025-08-28", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-28 00:00:00", "acceptedDate": "2025-08-28 16:14:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000234/0000059478-25-000234-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000234/xslF345X05/wk-form4_1756412046.xml"}}
{"date": "2025-08-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-20 00:00:00", "acceptedDate": "2025-08-20 16:16:08", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525184093/0001193125-25-184093-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525184093/d929636d8k.htm"}}
{"date": "2025-08-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-19 00:00:00", "acceptedDate": "2025-08-19 17:17:32", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525183493/0001193125-25-183493-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525183493/d70052d424b2.htm"}}
{"date": "2025-08-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-19 00:00:00", "acceptedDate": "2025-08-19 16:23:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000232/0000059478-25-000232-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000232/xslF345X05/wk-form4_1755634987.xml"}}
{"date": "2025-08-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-19 00:00:00", "acceptedDate": "2025-08-19 16:22:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000230/0000059478-25-000230-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000230/xslF345X05/wk-form4_1755634943.xml"}}
{"date": "2025-08-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-19 00:00:00", "acceptedDate": "2025-08-19 16:21:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000228/0000059478-25-000228-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000228/xslF345X05/wk-form4_1755634883.xml"}}
{"date": "2025-08-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-19 00:00:00", "acceptedDate": "2025-08-19 16:20:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000226/0000059478-25-000226-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000226/xslF345X05/wk-form4_1755634822.xml"}}
{"date": "2025-08-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-19 00:00:00", "acceptedDate": "2025-08-19 16:19:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000224/0000059478-25-000224-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000224/xslF345X05/wk-form4_1755634774.xml"}}
{"date": "2025-08-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-18 00:00:00", "acceptedDate": "2025-08-18 17:28:50", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525182780/0001193125-25-182780-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525182780/d70052dfwp.htm"}}
{"date": "2025-08-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-18 00:00:00", "acceptedDate": "2025-08-18 08:34:59", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525182271/0001193125-25-182271-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525182271/d70052d424b2.htm"}}
{"date": "2025-08-15", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-15 00:00:00", "acceptedDate": "2025-08-15 16:13:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000222/0000059478-25-000222-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000222/xslF345X05/wk-form4_1755288778.xml"}}
{"date": "2025-08-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-14 00:00:00", "acceptedDate": "2025-08-14 16:12:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000220/0000059478-25-000220-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000220/xslF345X05/wk-form4_1755202367.xml"}}
{"date": "2025-08-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-13 00:00:00", "acceptedDate": "2025-08-13 16:15:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000218/0000059478-25-000218-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000218/xslF345X05/wk-form4_1755116139.xml"}}
{"date": "2025-08-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-12 00:00:00", "acceptedDate": "2025-08-12 16:23:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000216/0000059478-25-000216-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000216/xslF345X05/wk-form4_1755030182.xml"}}
{"date": "2025-08-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-12 00:00:00", "acceptedDate": "2025-08-12 16:20:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000214/0000059478-25-000214-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000214/xslF345X05/wk-form4_1755030049.xml"}}
{"date": "2025-08-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-12 00:00:00", "acceptedDate": "2025-08-12 16:19:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000212/0000059478-25-000212-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000212/xslF345X05/wk-form4_1755029946.xml"}}
{"date": "2025-08-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-12 00:00:00", "acceptedDate": "2025-08-12 16:17:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000210/0000059478-25-000210-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000210/xslF345X05/wk-form4_1755029865.xml"}}
{"date": "2025-08-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-12 00:00:00", "acceptedDate": "2025-08-12 16:16:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000208/0000059478-25-000208-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000208/xslF345X05/wk-form4_1755029810.xml"}}
{"date": "2025-08-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-08 00:00:00", "acceptedDate": "2025-08-08 16:20:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000206/0000059478-25-000206-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000206/xslF345X05/wk-form4_1754684451.xml"}}
{"date": "2025-08-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-07 00:00:00", "acceptedDate": "2025-08-07 09:59:55", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000204/0000059478-25-000204-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000204/lly-20250630.htm"}}
{"date": "2025-08-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-07 00:00:00", "acceptedDate": "2025-08-07 07:05:40", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000202/0000059478-25-000202-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000202/lly-20250807.htm"}}
{"date": "2025-08-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-08-04 00:00:00", "acceptedDate": "2025-08-04 16:16:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000198/0000059478-25-000198-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000198/xslF345X05/wk-form4_1754338601.xml"}}
{"date": "2025-07-25", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-07-25 00:00:00", "acceptedDate": "2025-07-25 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588925020284/0001415889-25-020284-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588925020284/xslF345X05/form4-07252025_040701.xml"}}
{"date": "2025-07-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-07-24 00:00:00", "acceptedDate": "2025-07-24 08:12:05", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525163856/0001193125-25-163856-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525163856/d948476dsctota.htm"}}
{"date": "2025-07-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-07-22 00:00:00", "acceptedDate": "2025-07-22 17:27:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000196/0000059478-25-000196-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000196/xslF345X05/wk-form4_1753219662.xml"}}
{"date": "2025-07-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-07-22 00:00:00", "acceptedDate": "2025-07-22 17:16:02", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525162670/0001193125-25-162670-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525162670/d98536dsctota.htm"}}
{"date": "2025-07-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-07-22 00:00:00", "acceptedDate": "2025-07-22 16:34:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000188/0000059478-25-000188-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000188/xslF345X05/wk-form4_1753216439.xml"}}
{"date": "2025-07-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-07-22 00:00:00", "acceptedDate": "2025-07-22 16:22:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000184/0000059478-25-000184-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000184/xslF345X05/wk-form4_1753215735.xml"}}
{"date": "2025-07-15", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-07-15 00:00:00", "acceptedDate": "2025-07-15 06:04:14", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525158992/0001193125-25-158992-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525158992/d96326dsctota.htm"}}
{"date": "2025-06-25", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-06-25 00:00:00", "acceptedDate": "2025-06-25 06:10:08", "formType": "SC TO-T", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525146107/0001193125-25-146107-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525146107/d948389dsctot.htm"}}
{"date": "2025-06-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-06-20 00:00:00", "acceptedDate": "2025-06-20 16:23:15", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000180/0000059478-25-000180-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000180/a2025form11-k.htm"}}
{"date": "2025-06-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-06-17 00:00:00", "acceptedDate": "2025-06-17 18:28:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000176/0000059478-25-000176-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000176/xslF345X05/wk-form4_1750199300.xml"}}
{"date": "2025-06-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-06-17 00:00:00", "acceptedDate": "2025-06-17 18:26:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000174/0000059478-25-000174-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000174/xslF345X05/wk-form4_1750199159.xml"}}
{"date": "2025-06-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-06-17 00:00:00", "acceptedDate": "2025-06-17 18:23:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000172/0000059478-25-000172-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000172/xslF345X05/wk-form4_1750198988.xml"}}
{"date": "2025-06-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-06-17 00:00:00", "acceptedDate": "2025-06-17 18:18:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000170/0000059478-25-000170-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000170/xslF345X05/wk-form4_1750198711.xml"}}
{"date": "2025-06-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-06-17 00:00:00", "acceptedDate": "2025-06-17 18:15:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000168/0000059478-25-000168-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000168/xslF345X05/wk-form4_1750198504.xml"}}
{"date": "2025-06-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-06-17 00:00:00", "acceptedDate": "2025-06-17 16:04:51", "formType": "SC TO-C", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525142044/0001193125-25-142044-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525142044/d152816dsctoc.htm"}}
{"date": "2025-06-06", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-06-06 00:00:00", "acceptedDate": "2025-06-06 16:11:11", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000161/0000059478-25-000161-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000161/xslF345X02/wk-form3_1749240662.xml"}}
{"date": "2025-06-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-06-02 00:00:00", "acceptedDate": "2025-06-02 09:35:24", "formType": "25-NSE", "link": "https://www.sec.gov/Archives/edgar/data/59478/000087666125000413/0000876661-25-000413-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000087666125000413/xslF25X02/primary_doc.xml"}}
{"date": "2025-05-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-05-27 00:00:00", "acceptedDate": "2025-05-27 16:13:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000156/0000059478-25-000156-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000156/xslF345X05/wk-form4_1748376794.xml"}}
{"date": "2025-05-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-05-20 00:00:00", "acceptedDate": "2025-05-20 16:25:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000154/0000059478-25-000154-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000154/xslF345X05/wk-form4_1747772733.xml"}}
{"date": "2025-05-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-05-20 00:00:00", "acceptedDate": "2025-05-20 16:24:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000152/0000059478-25-000152-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000152/xslF345X05/wk-form4_1747772668.xml"}}
{"date": "2025-05-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-05-20 00:00:00", "acceptedDate": "2025-05-20 16:23:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000150/0000059478-25-000150-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000150/xslF345X05/wk-form4_1747772589.xml"}}
{"date": "2025-05-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-05-20 00:00:00", "acceptedDate": "2025-05-20 16:22:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000148/0000059478-25-000148-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000148/xslF345X05/wk-form4_1747772518.xml"}}
{"date": "2025-05-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-05-20 00:00:00", "acceptedDate": "2025-05-20 16:20:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000146/0000059478-25-000146-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000146/xslF345X05/wk-form4_1747772448.xml"}}
{"date": "2025-05-15", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-05-15 00:00:00", "acceptedDate": "2025-05-15 16:17:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000144/0000059478-25-000144-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000144/xslF345X05/wk-form4_1747340244.xml"}}
{"date": "2025-05-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-05-09 00:00:00", "acceptedDate": "2025-05-09 16:12:45", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000142/0000059478-25-000142-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000142/formsd2025.htm"}}
{"date": "2025-05-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-05-08 00:00:00", "acceptedDate": "2025-05-08 16:34:55", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000138/0000059478-25-000138-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000138/lly-20250505.htm"}}
{"date": "2025-05-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-05-05 00:00:00", "acceptedDate": "2025-05-05 16:17:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000134/0000059478-25-000134-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000134/xslF345X05/wk-form4_1746476222.xml"}}
{"date": "2025-05-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-05-01 00:00:00", "acceptedDate": "2025-05-01 11:30:18", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000132/0000059478-25-000132-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000132/lly-20250331.htm"}}
{"date": "2025-05-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-05-01 00:00:00", "acceptedDate": "2025-05-01 07:03:11", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000129/0000059478-25-000129-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000129/q125lillysalesandearningsp.htm"}}
{"date": "2025-04-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-04-22 00:00:00", "acceptedDate": "2025-04-22 16:22:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000124/0000059478-25-000124-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000124/xslF345X05/wk-form4_1745353361.xml"}}
{"date": "2025-04-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-04-22 00:00:00", "acceptedDate": "2025-04-22 16:21:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000122/0000059478-25-000122-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000122/xslF345X05/wk-form4_1745353273.xml"}}
{"date": "2025-04-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-04-22 00:00:00", "acceptedDate": "2025-04-22 16:19:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000120/0000059478-25-000120-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000120/xslF345X05/wk-form4_1745353160.xml"}}
{"date": "2025-04-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-04-22 00:00:00", "acceptedDate": "2025-04-22 16:16:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000118/0000059478-25-000118-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000118/xslF345X05/wk-form4_1745352964.xml"}}
{"date": "2025-04-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-04-22 00:00:00", "acceptedDate": "2025-04-22 16:14:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000116/0000059478-25-000116-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000116/xslF345X05/wk-form4_1745352850.xml"}}
{"date": "2025-04-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-04-16 00:00:00", "acceptedDate": "2025-04-16 11:20:25", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588925010779/0001415889-25-010779-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588925010779/xslSCHEDULE_13G_X01/primary_doc.xml"}}
{"date": "2025-03-31", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-03-31 00:00:00", "acceptedDate": "2025-03-28 21:08:39", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465925005003/0001214659-25-005003-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465925005003/x328250px14a6g.htm"}}
{"date": "2025-03-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-03-21 00:00:00", "acceptedDate": "2025-03-21 16:14:03", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000109/0000059478-25-000109-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000109/llydefa14a2025_additionalm.htm"}}
{"date": "2025-03-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-03-21 00:00:00", "acceptedDate": "2025-03-21 16:10:52", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000107/0000059478-25-000107-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000107/lly-20250321.htm"}}
{"date": "2025-03-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-03-19 00:00:00", "acceptedDate": "2025-03-19 16:27:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000103/0000059478-25-000103-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000103/xslF345X05/wk-form4_1742416067.xml"}}
{"date": "2025-03-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-03-19 00:00:00", "acceptedDate": "2025-03-19 16:25:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000101/0000059478-25-000101-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000101/xslF345X05/wk-form4_1742415936.xml"}}
{"date": "2025-03-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-03-19 00:00:00", "acceptedDate": "2025-03-19 16:24:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000099/0000059478-25-000099-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000099/xslF345X05/wk-form4_1742415842.xml"}}
{"date": "2025-03-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-03-19 00:00:00", "acceptedDate": "2025-03-19 16:21:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000097/0000059478-25-000097-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000097/xslF345X05/wk-form4_1742415665.xml"}}
{"date": "2025-03-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-03-19 00:00:00", "acceptedDate": "2025-03-19 16:17:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000095/0000059478-25-000095-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000095/xslF345X05/wk-form4_1742415462.xml"}}
{"date": "2025-03-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-03-13 00:00:00", "acceptedDate": "2025-03-13 16:17:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000091/0000059478-25-000091-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000091/xslF345X05/wk-form4_1741897046.xml"}}
{"date": "2025-03-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-03-07 00:00:00", "acceptedDate": "2025-03-07 16:07:04", "formType": "PRE 14A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000089/0000059478-25-000089-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000089/lly-20250307.htm"}}
{"date": "2025-03-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-03-04 00:00:00", "acceptedDate": "2025-03-04 16:00:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588925006450/0001415889-25-006450-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588925006450/xslF345X05/form4-03042025_040301.xml"}}
{"date": "2025-03-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-03-03 00:00:00", "acceptedDate": "2025-03-03 16:53:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000083/0000059478-25-000083-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000083/xslF345X05/wk-form4_1741038785.xml"}}
{"date": "2025-03-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-03-03 00:00:00", "acceptedDate": "2025-03-03 16:51:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000081/0000059478-25-000081-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000081/xslF345X05/wk-form4_1741038712.xml"}}
{"date": "2025-02-26", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-26 00:00:00", "acceptedDate": "2025-02-26 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588925005670/0001415889-25-005670-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588925005670/xslF345X05/form4-02262025_040201.xml"}}
{"date": "2025-02-25", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-25 00:00:00", "acceptedDate": "2025-02-25 16:00:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588925005456/0001415889-25-005456-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588925005456/xslF345X05/form4-02252025_040201.xml"}}
{"date": "2025-02-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-24 00:00:00", "acceptedDate": "2025-02-24 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588925005240/0001415889-25-005240-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588925005240/xslF345X05/form4-02242025_040201.xml"}}
{"date": "2025-02-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-21 00:00:00", "acceptedDate": "2025-02-21 16:04:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000079/0000059478-25-000079-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000079/xslF345X05/wk-form4_1740171853.xml"}}
{"date": "2025-02-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-21 00:00:00", "acceptedDate": "2025-02-21 16:00:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588925005034/0001415889-25-005034-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588925005034/xslF345X05/form4-02212025_040201.xml"}}
{"date": "2025-02-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-20 00:00:00", "acceptedDate": "2025-02-20 16:00:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588925004833/0001415889-25-004833-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588925004833/xslF345X05/form4-02202025_040201.xml"}}
{"date": "2025-02-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 16:23:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000077/0000059478-25-000077-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000077/xslF345X05/wk-form4_1740000210.xml"}}
{"date": "2025-02-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 16:22:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000075/0000059478-25-000075-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000075/xslF345X05/wk-form4_1740000166.xml"}}
{"date": "2025-02-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 16:22:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000073/0000059478-25-000073-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000073/xslF345X05/wk-form4_1740000116.xml"}}
{"date": "2025-02-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 16:18:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000071/0000059478-25-000071-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000071/xslF345X05/wk-form4_1739999917.xml"}}
{"date": "2025-02-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 16:17:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000069/0000059478-25-000069-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000069/xslF345X05/wk-form4_1739999835.xml"}}
{"date": "2025-02-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 16:15:46", "formType": "S-3ASR", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525029608/0001193125-25-029608-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525029608/d933321ds3asr.htm"}}
{"date": "2025-02-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-19 00:00:00", "acceptedDate": "2025-02-19 10:10:59", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000067/0000059478-25-000067-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000067/lly-20241231.htm"}}
{"date": "2025-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-14 00:00:00", "acceptedDate": "2025-02-14 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588925004090/0001415889-25-004090-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588925004090/xslF345X05/form4-02142025_040201.xml"}}
{"date": "2025-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 16:30:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000061/0000059478-25-000061-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000061/xslF345X05/wk-form4_1739395815.xml"}}
{"date": "2025-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 16:29:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000059/0000059478-25-000059-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000059/xslF345X05/wk-form4_1739395756.xml"}}
{"date": "2025-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 16:28:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000057/0000059478-25-000057-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000057/xslF345X05/wk-form4_1739395681.xml"}}
{"date": "2025-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 16:27:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000055/0000059478-25-000055-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000055/xslF345X05/wk-form4_1739395622.xml"}}
{"date": "2025-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 16:26:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000053/0000059478-25-000053-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000053/xslF345X05/wk-form4_1739395561.xml"}}
{"date": "2025-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 16:24:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000051/0000059478-25-000051-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000051/xslF345X05/wk-form4_1739395443.xml"}}
{"date": "2025-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 16:22:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000049/0000059478-25-000049-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000049/xslF345X05/wk-form4_1739395357.xml"}}
{"date": "2025-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 16:21:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000047/0000059478-25-000047-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000047/xslF345X05/wk-form4_1739395274.xml"}}
{"date": "2025-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 16:20:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000045/0000059478-25-000045-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000045/xslF345X05/wk-form4_1739395216.xml"}}
{"date": "2025-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 16:19:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000043/0000059478-25-000043-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000043/xslF345X05/wk-form4_1739395137.xml"}}
{"date": "2025-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 16:16:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000041/0000059478-25-000041-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000041/xslF345X05/wk-form4_1739395004.xml"}}
{"date": "2025-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 16:15:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000039/0000059478-25-000039-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000039/xslF345X05/wk-form4_1739394922.xml"}}
{"date": "2025-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-12 00:00:00", "acceptedDate": "2025-02-12 15:28:48", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525025057/0001193125-25-025057-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525025057/d868986dex11.htm"}}
{"date": "2025-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-11 00:00:00", "acceptedDate": "2025-02-11 16:49:40", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525024361/0001193125-25-024361-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525024361/d863266d424b2.htm"}}
{"date": "2025-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-10 00:00:00", "acceptedDate": "2025-02-10 17:21:57", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525023658/0001193125-25-023658-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525023658/d863266dfwp.htm"}}
{"date": "2025-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-10 00:00:00", "acceptedDate": "2025-02-10 08:15:56", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312525023205/0001193125-25-023205-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312525023205/d863266d424b2.htm"}}
{"date": "2025-02-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-07 00:00:00", "acceptedDate": "2025-02-07 16:00:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588925003338/0001415889-25-003338-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588925003338/xslF345X05/form4-02072025_040211.xml"}}
{"date": "2025-02-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-07 00:00:00", "acceptedDate": "2025-02-07 08:52:47", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000095017025015899/0000950170-25-015899-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000095017025015899/xslSCHEDULE_13G_X01/primary_doc.xml"}}
{"date": "2025-02-06", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-06 00:00:00", "acceptedDate": "2025-02-06 07:05:12", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000037/0000059478-25-000037-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000037/q424lillysalesandearningsp.htm"}}
{"date": "2025-02-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-04 00:00:00", "acceptedDate": "2025-02-04 16:28:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000034/0000059478-25-000034-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000034/xslF345X05/wk-form4_1738704486.xml"}}
{"date": "2025-02-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-04 00:00:00", "acceptedDate": "2025-02-04 16:27:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000032/0000059478-25-000032-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000032/xslF345X05/wk-form4_1738704436.xml"}}
{"date": "2025-02-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-04 00:00:00", "acceptedDate": "2025-02-04 16:26:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000030/0000059478-25-000030-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000030/xslF345X05/wk-form4_1738704376.xml"}}
{"date": "2025-02-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-04 00:00:00", "acceptedDate": "2025-02-04 16:25:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000028/0000059478-25-000028-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000028/xslF345X05/wk-form4_1738704326.xml"}}
{"date": "2025-02-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-04 00:00:00", "acceptedDate": "2025-02-04 16:24:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000026/0000059478-25-000026-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000026/xslF345X05/wk-form4_1738704275.xml"}}
{"date": "2025-02-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-04 00:00:00", "acceptedDate": "2025-02-04 16:23:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000024/0000059478-25-000024-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000024/xslF345X05/wk-form4_1738704227.xml"}}
{"date": "2025-02-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-04 00:00:00", "acceptedDate": "2025-02-04 16:23:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000022/0000059478-25-000022-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000022/xslF345X05/wk-form4_1738704180.xml"}}
{"date": "2025-02-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-04 00:00:00", "acceptedDate": "2025-02-04 16:21:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000020/0000059478-25-000020-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000020/xslF345X05/wk-form4_1738704064.xml"}}
{"date": "2025-02-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-02-04 00:00:00", "acceptedDate": "2025-02-04 16:19:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000018/0000059478-25-000018-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000018/xslF345X05/wk-form4_1738703991.xml"}}
{"date": "2025-01-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-01-27 00:00:00", "acceptedDate": "2025-01-27 15:54:31", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588925002113/0001415889-25-002113-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588925002113/xslSCHEDULE_13G_X01/primary_doc.xml"}}
{"date": "2025-01-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-01-23 00:00:00", "acceptedDate": "2025-01-23 16:24:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000016/0000059478-25-000016-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000016/xslF345X05/wk-form4_1737667469.xml"}}
{"date": "2025-01-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-01-23 00:00:00", "acceptedDate": "2025-01-23 16:23:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000014/0000059478-25-000014-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000014/xslF345X05/wk-form4_1737667411.xml"}}
{"date": "2025-01-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-01-23 00:00:00", "acceptedDate": "2025-01-23 16:22:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000012/0000059478-25-000012-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000012/xslF345X05/wk-form4_1737667361.xml"}}
{"date": "2025-01-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-01-23 00:00:00", "acceptedDate": "2025-01-23 16:21:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000010/0000059478-25-000010-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000010/xslF345X05/wk-form4_1737667303.xml"}}
{"date": "2025-01-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-01-23 00:00:00", "acceptedDate": "2025-01-23 16:20:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000008/0000059478-25-000008-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000008/xslF345X05/wk-form4_1737667237.xml"}}
{"date": "2025-01-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2025-01-14 00:00:00", "acceptedDate": "2025-01-14 09:05:19", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000005/0000059478-25-000005-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000005/jpm_2025guidancexpressrele.htm"}}
{"date": "2024-12-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-12-17 00:00:00", "acceptedDate": "2024-12-17 16:23:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000291/0000059478-24-000291-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000291/xslF345X05/wk-form4_1734470584.xml"}}
{"date": "2024-12-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-12-17 00:00:00", "acceptedDate": "2024-12-17 16:21:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000289/0000059478-24-000289-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000289/xslF345X05/wk-form4_1734470498.xml"}}
{"date": "2024-12-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-12-17 00:00:00", "acceptedDate": "2024-12-17 16:19:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000287/0000059478-24-000287-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000287/xslF345X05/wk-form4_1734470366.xml"}}
{"date": "2024-12-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-12-17 00:00:00", "acceptedDate": "2024-12-17 16:17:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000285/0000059478-24-000285-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000285/xslF345X05/wk-form4_1734470270.xml"}}
{"date": "2024-12-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-12-17 00:00:00", "acceptedDate": "2024-12-17 16:16:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000283/0000059478-24-000283-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000283/xslF345X05/wk-form4_1734470180.xml"}}
{"date": "2024-12-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-12-04 00:00:00", "acceptedDate": "2024-12-04 16:20:01", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000281/0000059478-24-000281-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000281/xslF345X02/wk-form3_1733347191.xml"}}
{"date": "2024-11-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-20 00:00:00", "acceptedDate": "2024-11-20 16:29:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000278/0000059478-24-000278-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000278/xslF345X05/wk-form4_1732138184.xml"}}
{"date": "2024-11-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-20 00:00:00", "acceptedDate": "2024-11-20 16:28:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000276/0000059478-24-000276-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000276/xslF345X05/wk-form4_1732138122.xml"}}
{"date": "2024-11-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-20 00:00:00", "acceptedDate": "2024-11-20 16:27:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000274/0000059478-24-000274-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000274/xslF345X05/wk-form4_1732138066.xml"}}
{"date": "2024-11-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-20 00:00:00", "acceptedDate": "2024-11-20 16:26:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000272/0000059478-24-000272-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000272/xslF345X05/wk-form4_1732138010.xml"}}
{"date": "2024-11-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-20 00:00:00", "acceptedDate": "2024-11-20 16:26:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000270/0000059478-24-000270-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000270/xslF345X05/wk-form4_1732137954.xml"}}
{"date": "2024-11-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-20 00:00:00", "acceptedDate": "2024-11-20 16:24:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000268/0000059478-24-000268-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000268/xslF345X05/wk-form4_1732137888.xml"}}
{"date": "2024-11-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-20 00:00:00", "acceptedDate": "2024-11-20 16:23:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000266/0000059478-24-000266-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000266/xslF345X05/wk-form4_1732137825.xml"}}
{"date": "2024-11-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-20 00:00:00", "acceptedDate": "2024-11-20 16:22:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000264/0000059478-24-000264-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000264/xslF345X05/wk-form4_1732137757.xml"}}
{"date": "2024-11-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-20 00:00:00", "acceptedDate": "2024-11-20 16:21:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000262/0000059478-24-000262-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000262/xslF345X05/wk-form4_1732137654.xml"}}
{"date": "2024-11-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-20 00:00:00", "acceptedDate": "2024-11-20 16:19:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000260/0000059478-24-000260-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000260/xslF345X05/wk-form4_1732137575.xml"}}
{"date": "2024-11-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-19 00:00:00", "acceptedDate": "2024-11-19 16:49:17", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000258/0000059478-24-000258-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000258/pr_november2024.htm"}}
{"date": "2024-11-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-14 00:00:00", "acceptedDate": "2024-11-14 19:00:58", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312524258945/0001193125-24-258945-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312524258945/d884825dsc13ga.htm"}}
{"date": "2024-11-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-08 00:00:00", "acceptedDate": "2024-11-08 16:18:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000255/0000059478-24-000255-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000255/xslF345X05/wk-form4_1731100686.xml"}}
{"date": "2024-11-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-05 00:00:00", "acceptedDate": "2024-11-05 16:15:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000253/0000059478-24-000253-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000253/xslF345X05/wk-form4_1730841326.xml"}}
{"date": "2024-11-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-05 00:00:00", "acceptedDate": "2024-11-05 16:14:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000251/0000059478-24-000251-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000251/xslF345X05/wk-form4_1730841247.xml"}}
{"date": "2024-11-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-05 00:00:00", "acceptedDate": "2024-11-05 16:13:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000249/0000059478-24-000249-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000249/xslF345X05/wk-form4_1730841188.xml"}}
{"date": "2024-11-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-11-01 00:00:00", "acceptedDate": "2024-11-01 16:17:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000247/0000059478-24-000247-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000247/xslF345X05/wk-form4_1730492255.xml"}}
{"date": "2024-10-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-10-30 00:00:00", "acceptedDate": "2024-10-30 11:54:10", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000245/0000059478-24-000245-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000245/lly-20240930.htm"}}
{"date": "2024-10-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-10-30 00:00:00", "acceptedDate": "2024-10-30 07:05:55", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000242/0000059478-24-000242-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000242/q324lillysalesandearningsp.htm"}}
{"date": "2024-10-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-10-23 00:00:00", "acceptedDate": "2024-10-23 17:17:34", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000089710124000546/0000897101-24-000546-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000089710124000546/lilly241106_sc13ga.htm"}}
{"date": "2024-10-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-10-22 00:00:00", "acceptedDate": "2024-10-22 16:23:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000238/0000059478-24-000238-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000238/xslF345X05/wk-form4_1729628600.xml"}}
{"date": "2024-10-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-10-22 00:00:00", "acceptedDate": "2024-10-22 16:22:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000236/0000059478-24-000236-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000236/xslF345X05/wk-form4_1729628526.xml"}}
{"date": "2024-10-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-10-22 00:00:00", "acceptedDate": "2024-10-22 16:20:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000234/0000059478-24-000234-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000234/xslF345X05/wk-form4_1729628404.xml"}}
{"date": "2024-10-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-10-22 00:00:00", "acceptedDate": "2024-10-22 16:18:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000232/0000059478-24-000232-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000232/xslF345X05/wk-form4_1729628298.xml"}}
{"date": "2024-10-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-10-22 00:00:00", "acceptedDate": "2024-10-22 16:16:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000230/0000059478-24-000230-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000230/xslF345X05/wk-form4_1729628166.xml"}}
{"date": "2024-09-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-09-18 00:00:00", "acceptedDate": "2024-09-18 16:19:42", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000228/0000059478-24-000228-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000228/xslF345X02/wk-form3_1726690776.xml"}}
{"date": "2024-09-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-09-17 00:00:00", "acceptedDate": "2024-09-17 17:19:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000225/0000059478-24-000225-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000225/xslF345X05/wk-form4_1726607955.xml"}}
{"date": "2024-09-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-09-17 00:00:00", "acceptedDate": "2024-09-17 17:17:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000223/0000059478-24-000223-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000223/xslF345X05/wk-form4_1726607834.xml"}}
{"date": "2024-09-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-09-17 00:00:00", "acceptedDate": "2024-09-17 17:15:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000221/0000059478-24-000221-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000221/xslF345X05/wk-form4_1726607719.xml"}}
{"date": "2024-09-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-09-17 00:00:00", "acceptedDate": "2024-09-17 17:11:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000219/0000059478-24-000219-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000219/xslF345X05/wk-form4_1726607497.xml"}}
{"date": "2024-09-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-09-17 00:00:00", "acceptedDate": "2024-09-17 17:08:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000217/0000059478-24-000217-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000217/xslF345X05/wk-form4_1726607318.xml"}}
{"date": "2024-09-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-09-12 00:00:00", "acceptedDate": "2024-09-12 16:16:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000215/0000059478-24-000215-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000215/xslF345X05/wk-form4_1726172178.xml"}}
{"date": "2024-09-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-09-09 00:00:00", "acceptedDate": "2024-09-09 07:03:46", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000213/0000059478-24-000213-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000213/ecannouncement_pressreleas.htm"}}
{"date": "2024-09-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-09-04 00:00:00", "acceptedDate": "2024-09-04 16:05:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924022759/0001415889-24-022759-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924022759/xslF345X05/form4-09042024_040904.xml"}}
{"date": "2024-08-28", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-28 00:00:00", "acceptedDate": "2024-08-28 16:05:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924022413/0001415889-24-022413-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924022413/xslF345X05/form4-08282024_040801.xml"}}
{"date": "2024-08-26", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-26 00:00:00", "acceptedDate": "2024-08-26 16:21:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000210/0000059478-24-000210-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000210/xslF345X05/wk-form4_1724703707.xml"}}
{"date": "2024-08-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-23 00:00:00", "acceptedDate": "2024-08-23 16:05:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924022123/0001415889-24-022123-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924022123/xslF345X05/form4-08232024_040804.xml"}}
{"date": "2024-08-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-21 00:00:00", "acceptedDate": "2024-08-21 16:15:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000208/0000059478-24-000208-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000208/xslF345X05/wk-form4_1724271305.xml"}}
{"date": "2024-08-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-20 00:00:00", "acceptedDate": "2024-08-20 16:18:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000206/0000059478-24-000206-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000206/xslF345X05/wk-form4_1724185087.xml"}}
{"date": "2024-08-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-20 00:00:00", "acceptedDate": "2024-08-20 16:17:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000204/0000059478-24-000204-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000204/xslF345X05/wk-form4_1724185018.xml"}}
{"date": "2024-08-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-20 00:00:00", "acceptedDate": "2024-08-20 16:15:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000202/0000059478-24-000202-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000202/xslF345X05/wk-form4_1724184929.xml"}}
{"date": "2024-08-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-20 00:00:00", "acceptedDate": "2024-08-20 16:14:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000200/0000059478-24-000200-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000200/xslF345X05/wk-form4_1724184842.xml"}}
{"date": "2024-08-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-20 00:00:00", "acceptedDate": "2024-08-20 16:12:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000198/0000059478-24-000198-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000198/xslF345X05/wk-form4_1724184769.xml"}}
{"date": "2024-08-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-16 00:00:00", "acceptedDate": "2024-08-16 16:16:48", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000196/0000059478-24-000196-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000196/praugust2024.htm"}}
{"date": "2024-08-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-16 00:00:00", "acceptedDate": "2024-08-16 08:51:59", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312524201684/0001193125-24-201684-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312524201684/d873721dsctota.htm"}}
{"date": "2024-08-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-14 00:00:00", "acceptedDate": "2024-08-14 12:27:03", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312524200435/0001193125-24-200435-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312524200435/d876011dex11.htm"}}
{"date": "2024-08-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-13 00:00:00", "acceptedDate": "2024-08-13 16:31:25", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312524199813/0001193125-24-199813-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312524199813/d863403d424b2.htm"}}
{"date": "2024-08-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-13 00:00:00", "acceptedDate": "2024-08-13 16:19:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000189/0000059478-24-000189-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000189/xslF345X05/wk-form4_1723580342.xml"}}
{"date": "2024-08-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-12 00:00:00", "acceptedDate": "2024-08-12 16:51:27", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312524198946/0001193125-24-198946-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312524198946/d863403dfwp.htm"}}
{"date": "2024-08-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-12 00:00:00", "acceptedDate": "2024-08-12 08:12:41", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312524198398/0001193125-24-198398-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312524198398/d863403d424b2.htm"}}
{"date": "2024-08-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-08 00:00:00", "acceptedDate": "2024-08-08 11:28:54", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000187/0000059478-24-000187-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000187/lly-20240630.htm"}}
{"date": "2024-08-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-08 00:00:00", "acceptedDate": "2024-08-08 07:04:30", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000185/0000059478-24-000185-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000185/q224lillysalesandearningsp.htm"}}
{"date": "2024-08-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-05 00:00:00", "acceptedDate": "2024-08-05 17:04:37", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312524194015/0001193125-24-194015-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312524194015/d881604dsctota.htm"}}
{"date": "2024-08-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-02 00:00:00", "acceptedDate": "2024-08-02 16:03:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000180/0000059478-24-000180-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000180/xslF345X05/wk-form4_1722628999.xml"}}
{"date": "2024-08-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-08-01 00:00:00", "acceptedDate": "2024-08-01 06:07:09", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312524190515/0001193125-24-190515-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312524190515/d880504dsctota.htm"}}
{"date": "2024-07-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-30 00:00:00", "acceptedDate": "2024-07-30 16:16:36", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000178/0000059478-24-000178-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000178/xslF345X02/wk-form3_1722370587.xml"}}
{"date": "2024-07-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-19 00:00:00", "acceptedDate": "2024-07-19 16:16:12", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000176/0000059478-24-000176-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000176/xslF345X02/wk-form3_1721420164.xml"}}
{"date": "2024-07-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-19 00:00:00", "acceptedDate": "2024-07-19 06:09:07", "formType": "SC TO-T", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312524181268/0001193125-24-181268-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312524181268/d843899dsctot.htm"}}
{"date": "2024-07-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-16 00:00:00", "acceptedDate": "2024-07-16 16:22:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000174/0000059478-24-000174-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000174/xslF345X05/wk-form4_1721161365.xml"}}
{"date": "2024-07-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-16 00:00:00", "acceptedDate": "2024-07-16 16:21:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000172/0000059478-24-000172-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000172/xslF345X05/wk-form4_1721161273.xml"}}
{"date": "2024-07-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-16 00:00:00", "acceptedDate": "2024-07-16 16:20:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000170/0000059478-24-000170-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000170/xslF345X05/wk-form4_1721161209.xml"}}
{"date": "2024-07-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-16 00:00:00", "acceptedDate": "2024-07-16 16:18:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000168/0000059478-24-000168-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000168/xslF345X05/wk-form4_1721161124.xml"}}
{"date": "2024-07-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-16 00:00:00", "acceptedDate": "2024-07-16 16:17:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000166/0000059478-24-000166-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000166/xslF345X05/wk-form4_1721161041.xml"}}
{"date": "2024-07-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-11 00:00:00", "acceptedDate": "2024-07-11 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924019484/0001415889-24-019484-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924019484/xslF345X05/form4-07112024_040702.xml"}}
{"date": "2024-07-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-10 00:00:00", "acceptedDate": "2024-07-10 08:40:20", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000164/0000059478-24-000164-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000164/0000059478-24-000164.txt"}}
{"date": "2024-07-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-09 00:00:00", "acceptedDate": "2024-07-09 16:00:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924019420/0001415889-24-019420-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924019420/xslF345X05/form4-07092024_040702.xml"}}
{"date": "2024-07-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-08 00:00:00", "acceptedDate": "2024-07-08 16:00:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924019328/0001415889-24-019328-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924019328/xslF345X05/form4-07082024_040701.xml"}}
{"date": "2024-07-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-08 00:00:00", "acceptedDate": "2024-07-08 07:14:54", "formType": "SC TO-C", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312524175904/0001193125-24-175904-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312524175904/d574860dsctoc.htm"}}
{"date": "2024-07-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-03 00:00:00", "acceptedDate": "2024-07-03 16:00:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924019154/0001415889-24-019154-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924019154/xslF345X05/form4-07032024_040704.xml"}}
{"date": "2024-07-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-02 00:00:00", "acceptedDate": "2024-07-02 16:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924018842/0001415889-24-018842-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924018842/xslF345X05/form4-07022024_040702.xml"}}
{"date": "2024-07-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-07-01 00:00:00", "acceptedDate": "2024-07-01 16:00:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924018572/0001415889-24-018572-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924018572/xslF345X05/form4-07012024_040701.xml"}}
{"date": "2024-06-26", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-26 00:00:00", "acceptedDate": "2024-06-26 16:00:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924018204/0001415889-24-018204-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924018204/xslF345X05/form4-06262024_040602.xml"}}
{"date": "2024-06-25", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-25 00:00:00", "acceptedDate": "2024-06-25 16:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924018119/0001415889-24-018119-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924018119/xslF345X05/form4-06252024_040604.xml"}}
{"date": "2024-06-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-24 00:00:00", "acceptedDate": "2024-06-24 16:11:10", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000160/0000059478-24-000160-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000160/a2024form11-k.htm"}}
{"date": "2024-06-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-21 00:00:00", "acceptedDate": "2024-06-21 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924017805/0001415889-24-017805-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924017805/xslF345X05/form4-06212024_040602.xml"}}
{"date": "2024-06-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-18 00:00:00", "acceptedDate": "2024-06-18 16:23:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000156/0000059478-24-000156-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000156/xslF345X05/wk-form4_1718742175.xml"}}
{"date": "2024-06-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-18 00:00:00", "acceptedDate": "2024-06-18 16:22:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000154/0000059478-24-000154-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000154/xslF345X05/wk-form4_1718742118.xml"}}
{"date": "2024-06-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-18 00:00:00", "acceptedDate": "2024-06-18 16:20:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000152/0000059478-24-000152-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000152/xslF345X05/wk-form4_1718742030.xml"}}
{"date": "2024-06-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-18 00:00:00", "acceptedDate": "2024-06-18 16:19:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000150/0000059478-24-000150-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000150/xslF345X05/wk-form4_1718741947.xml"}}
{"date": "2024-06-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-18 00:00:00", "acceptedDate": "2024-06-18 16:17:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000148/0000059478-24-000148-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000148/xslF345X05/wk-form4_1718741854.xml"}}
{"date": "2024-06-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-18 00:00:00", "acceptedDate": "2024-06-18 16:00:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924017361/0001415889-24-017361-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924017361/xslF345X05/form4-06182024_040602.xml"}}
{"date": "2024-06-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-17 00:00:00", "acceptedDate": "2024-06-17 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924017134/0001415889-24-017134-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924017134/xslF345X05/form4-06172024_040602.xml"}}
{"date": "2024-06-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-11 00:00:00", "acceptedDate": "2024-06-11 16:00:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924016341/0001415889-24-016341-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924016341/xslF345X05/form4-06112024_040603.xml"}}
{"date": "2024-06-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-10 00:00:00", "acceptedDate": "2024-06-10 16:00:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924016176/0001415889-24-016176-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924016176/xslF345X05/form4-06102024_040602.xml"}}
{"date": "2024-06-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-07 00:00:00", "acceptedDate": "2024-06-07 16:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924015944/0001415889-24-015944-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924015944/xslF345X05/form4-06072024_040605.xml"}}
{"date": "2024-06-06", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-06 00:00:00", "acceptedDate": "2024-06-06 16:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924015735/0001415889-24-015735-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924015735/xslF345X05/form4-06062024_040605.xml"}}
{"date": "2024-06-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-05 00:00:00", "acceptedDate": "2024-06-05 07:48:12", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000146/0000059478-24-000146-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000146/ashkenazi_060524.htm"}}
{"date": "2024-06-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-04 00:00:00", "acceptedDate": "2024-06-04 16:14:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000143/0000059478-24-000143-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000143/xslF345X05/wk-form4_1717532059.xml"}}
{"date": "2024-06-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-04 00:00:00", "acceptedDate": "2024-06-04 16:00:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924015316/0001415889-24-015316-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924015316/xslF345X05/form4-06042024_040604.xml"}}
{"date": "2024-06-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-03 00:00:00", "acceptedDate": "2024-06-03 16:15:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000141/0000059478-24-000141-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000141/xslF345X05/wk-form4_1717445746.xml"}}
{"date": "2024-06-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-03 00:00:00", "acceptedDate": "2024-06-03 16:14:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000139/0000059478-24-000139-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000139/xslF345X05/wk-form4_1717445655.xml"}}
{"date": "2024-06-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-06-03 00:00:00", "acceptedDate": "2024-06-03 16:00:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924015136/0001415889-24-015136-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924015136/xslF345X05/form4-06032024_040602.xml"}}
{"date": "2024-05-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-05-30 00:00:00", "acceptedDate": "2024-05-30 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924014861/0001415889-24-014861-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924014861/xslF345X05/form4-05302024_040503.xml"}}
{"date": "2024-05-29", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-05-29 00:00:00", "acceptedDate": "2024-05-29 16:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924014752/0001415889-24-014752-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924014752/xslF345X05/form4-05292024_040501.xml"}}
{"date": "2024-05-28", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-05-28 00:00:00", "acceptedDate": "2024-05-28 16:00:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924014643/0001415889-24-014643-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924014643/xslF345X05/form4-05282024_040503.xml"}}
{"date": "2024-05-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-05-24 00:00:00", "acceptedDate": "2024-05-24 16:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924014447/0001415889-24-014447-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924014447/xslF345X05/form4-05242024_040502.xml"}}
{"date": "2024-05-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-05-23 00:00:00", "acceptedDate": "2024-05-23 16:00:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924014234/0001415889-24-014234-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924014234/xslF345X05/form4-05232024_040503.xml"}}
{"date": "2024-05-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-05-22 00:00:00", "acceptedDate": "2024-05-22 16:00:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924014071/0001415889-24-014071-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924014071/xslF345X05/form4-05222024_040506.xml"}}
{"date": "2024-05-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-05-21 00:00:00", "acceptedDate": "2024-05-21 16:24:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000137/0000059478-24-000137-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000137/xslF345X05/wk-form4_1716323062.xml"}}
{"date": "2024-05-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-05-21 00:00:00", "acceptedDate": "2024-05-21 16:23:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000135/0000059478-24-000135-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000135/xslF345X05/wk-form4_1716322972.xml"}}
{"date": "2024-05-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-05-21 00:00:00", "acceptedDate": "2024-05-21 16:21:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000133/0000059478-24-000133-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000133/xslF345X05/wk-form4_1716322881.xml"}}
{"date": "2024-05-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-05-21 00:00:00", "acceptedDate": "2024-05-21 16:19:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000131/0000059478-24-000131-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000131/xslF345X05/wk-form4_1716322774.xml"}}
{"date": "2024-05-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-05-21 00:00:00", "acceptedDate": "2024-05-21 16:18:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000129/0000059478-24-000129-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000129/xslF345X05/wk-form4_1716322694.xml"}}
{"date": "2024-05-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-05-09 00:00:00", "acceptedDate": "2024-05-09 16:34:08", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000127/0000059478-24-000127-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000127/0000059478-24-000127.txt"}}
{"date": "2024-05-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-05-03 00:00:00", "acceptedDate": "2024-05-03 17:20:05", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000124/0000059478-24-000124-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000124/formsd2024.htm"}}
{"date": "2024-04-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-04-30 00:00:00", "acceptedDate": "2024-04-30 12:04:51", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000118/0000059478-24-000118-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000118/lly-20240331.htm"}}
{"date": "2024-04-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-04-30 00:00:00", "acceptedDate": "2024-04-30 07:04:14", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000116/0000059478-24-000116-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000116/q124lillysalesandearningsp.htm"}}
{"date": "2024-04-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-04-16 00:00:00", "acceptedDate": "2024-04-16 16:14:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000111/0000059478-24-000111-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000111/xslF345X05/wk-form4_1713298480.xml"}}
{"date": "2024-04-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-04-16 00:00:00", "acceptedDate": "2024-04-16 16:13:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000109/0000059478-24-000109-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000109/xslF345X05/wk-form4_1713298423.xml"}}
{"date": "2024-04-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-04-16 00:00:00", "acceptedDate": "2024-04-16 16:12:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000107/0000059478-24-000107-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000107/xslF345X05/wk-form4_1713298359.xml"}}
{"date": "2024-04-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-04-16 00:00:00", "acceptedDate": "2024-04-16 16:11:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000105/0000059478-24-000105-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000105/xslF345X05/wk-form4_1713298290.xml"}}
{"date": "2024-04-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-04-16 00:00:00", "acceptedDate": "2024-04-16 16:10:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000103/0000059478-24-000103-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000103/xslF345X05/wk-form4_1713298233.xml"}}
{"date": "2024-04-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-04-11 00:00:00", "acceptedDate": "2024-04-11 12:59:00", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465924006578/0001214659-24-006578-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465924006578/r410246px14a6g.htm"}}
{"date": "2024-04-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-04-04 00:00:00", "acceptedDate": "2024-04-03 17:38:18", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465924006045/0001214659-24-006045-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465924006045/b43242px14a6g.htm"}}
{"date": "2024-03-28", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-03-28 00:00:00", "acceptedDate": "2024-03-28 13:10:11", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465924005398/0001214659-24-005398-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465924005398/e32824px14a6g.htm"}}
{"date": "2024-03-28", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-03-28 00:00:00", "acceptedDate": "2024-03-28 12:20:34", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465924005391/0001214659-24-005391-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465924005391/o328240px14a6g.htm"}}
{"date": "2024-03-28", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-03-28 00:00:00", "acceptedDate": "2024-03-27 18:06:58", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465924005350/0001214659-24-005350-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465924005350/p327240px14a6g.htm"}}
{"date": "2024-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-03-22 00:00:00", "acceptedDate": "2024-03-22 16:26:00", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000101/0000059478-24-000101-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000101/llydefa14a2024_additionalm.htm"}}
{"date": "2024-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-03-22 00:00:00", "acceptedDate": "2024-03-22 16:23:05", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000099/0000059478-24-000099-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000099/lly-20240322.htm"}}
{"date": "2024-03-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-03-19 00:00:00", "acceptedDate": "2024-03-19 16:23:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000092/0000059478-24-000092-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000092/xslF345X05/wk-form4_1710879793.xml"}}
{"date": "2024-03-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-03-19 00:00:00", "acceptedDate": "2024-03-19 16:21:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000090/0000059478-24-000090-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000090/xslF345X05/wk-form4_1710879670.xml"}}
{"date": "2024-03-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-03-19 00:00:00", "acceptedDate": "2024-03-19 16:19:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000088/0000059478-24-000088-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000088/xslF345X05/wk-form4_1710879543.xml"}}
{"date": "2024-03-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-03-19 00:00:00", "acceptedDate": "2024-03-19 16:17:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000086/0000059478-24-000086-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000086/xslF345X05/wk-form4_1710879436.xml"}}
{"date": "2024-03-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-03-19 00:00:00", "acceptedDate": "2024-03-19 16:15:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000084/0000059478-24-000084-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000084/xslF345X05/wk-form4_1710879320.xml"}}
{"date": "2024-03-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-03-11 00:00:00", "acceptedDate": "2024-03-11 16:27:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000082/0000059478-24-000082-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000082/xslF345X05/wk-form4_1710188730.xml"}}
{"date": "2024-03-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-03-08 00:00:00", "acceptedDate": "2024-03-08 16:31:06", "formType": "PRE 14A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000080/0000059478-24-000080-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000080/lly-20240308.htm"}}
{"date": "2024-02-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-21 00:00:00", "acceptedDate": "2024-02-21 16:26:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000075/0000059478-24-000075-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000075/xslF345X05/wk-form4_1708550776.xml"}}
{"date": "2024-02-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-21 00:00:00", "acceptedDate": "2024-02-21 16:24:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000073/0000059478-24-000073-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000073/xslF345X05/wk-form4_1708550604.xml"}}
{"date": "2024-02-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-21 00:00:00", "acceptedDate": "2024-02-21 16:21:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000071/0000059478-24-000071-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000071/xslF345X05/wk-form4_1708550444.xml"}}
{"date": "2024-02-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-21 00:00:00", "acceptedDate": "2024-02-21 16:18:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000069/0000059478-24-000069-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000069/xslF345X05/wk-form4_1708550301.xml"}}
{"date": "2024-02-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-21 00:00:00", "acceptedDate": "2024-02-21 16:16:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000067/0000059478-24-000067-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000067/xslF345X05/wk-form4_1708550179.xml"}}
{"date": "2024-02-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-21 00:00:00", "acceptedDate": "2024-02-21 11:44:37", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000065/0000059478-24-000065-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000065/lly-20231231.htm"}}
{"date": "2024-02-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-20 00:00:00", "acceptedDate": "2024-02-20 16:05:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924004339/0001415889-24-004339-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924004339/xslF345X05/form4-02202024_040226.xml"}}
{"date": "2024-02-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-16 00:00:00", "acceptedDate": "2024-02-16 16:05:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924004090/0001415889-24-004090-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924004090/xslF345X05/form4-02162024_040201.xml"}}
{"date": "2024-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 16:44:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000062/0000059478-24-000062-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000062/xslF345X05/wk-form4_1707947068.xml"}}
{"date": "2024-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 16:43:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000060/0000059478-24-000060-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000060/xslF345X05/wk-form4_1707946973.xml"}}
{"date": "2024-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 16:41:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000058/0000059478-24-000058-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000058/xslF345X05/wk-form4_1707946860.xml"}}
{"date": "2024-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 16:39:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000056/0000059478-24-000056-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000056/xslF345X05/wk-form4_1707946769.xml"}}
{"date": "2024-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 16:38:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000054/0000059478-24-000054-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000054/xslF345X05/wk-form4_1707946682.xml"}}
{"date": "2024-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 16:36:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000052/0000059478-24-000052-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000052/xslF345X05/wk-form4_1707946554.xml"}}
{"date": "2024-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 16:34:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000050/0000059478-24-000050-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000050/xslF345X05/wk-form4_1707946408.xml"}}
{"date": "2024-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 16:31:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000048/0000059478-24-000048-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000048/xslF345X05/wk-form4_1707946275.xml"}}
{"date": "2024-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 16:29:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000046/0000059478-24-000046-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000046/xslF345X05/wk-form4_1707946126.xml"}}
{"date": "2024-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 16:27:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000044/0000059478-24-000044-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000044/xslF345X05/wk-form4_1707946006.xml"}}
{"date": "2024-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 16:25:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000042/0000059478-24-000042-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000042/xslF345X05/wk-form4_1707945907.xml"}}
{"date": "2024-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 16:23:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000040/0000059478-24-000040-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000040/xslF345X05/wk-form4_1707945812.xml"}}
{"date": "2024-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 16:21:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000038/0000059478-24-000038-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000038/xslF345X05/wk-form4_1707945676.xml"}}
{"date": "2024-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-14 00:00:00", "acceptedDate": "2024-02-14 16:19:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000036/0000059478-24-000036-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000036/xslF345X05/wk-form4_1707945531.xml"}}
{"date": "2024-02-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-13 00:00:00", "acceptedDate": "2024-02-13 17:04:42", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000110465924020827/0001104659-24-020827-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000110465924020827/tv0827-elilillyco.htm"}}
{"date": "2024-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 16:16:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000034/0000059478-24-000034-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000034/xslF345X05/wk-form4_1707772578.xml"}}
{"date": "2024-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-12 00:00:00", "acceptedDate": "2024-02-12 16:05:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924003359/0001415889-24-003359-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924003359/xslF345X05/form4-02122024_040201.xml"}}
{"date": "2024-02-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-09 00:00:00", "acceptedDate": "2024-02-09 16:05:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924003164/0001415889-24-003164-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924003164/xslF345X05/form4-02092024_040201.xml"}}
{"date": "2024-02-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-09 00:00:00", "acceptedDate": "2024-02-09 11:56:35", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312524029551/0001193125-24-029551-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312524029551/d728700dex11.htm"}}
{"date": "2024-02-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-09 00:00:00", "acceptedDate": "2024-02-09 09:26:26", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312524029364/0001193125-24-029364-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312524029364/d727532dsc13ga.htm"}}
{"date": "2024-02-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-08 00:00:00", "acceptedDate": "2024-02-08 16:51:28", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312524028438/0001193125-24-028438-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312524028438/d728516d424b2.htm"}}
{"date": "2024-02-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-07 00:00:00", "acceptedDate": "2024-02-07 17:08:56", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312524026801/0001193125-24-026801-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312524026801/d728516dfwp.htm"}}
{"date": "2024-02-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-07 00:00:00", "acceptedDate": "2024-02-07 08:12:38", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312524025953/0001193125-24-025953-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312524025953/d728516d424b2.htm"}}
{"date": "2024-02-06", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-06 00:00:00", "acceptedDate": "2024-02-06 07:04:24", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000032/0000059478-24-000032-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000032/q423lillysalesandearningsp.htm"}}
{"date": "2024-02-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 16:32:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000027/0000059478-24-000027-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000027/xslF345X05/wk-form4_1706909506.xml"}}
{"date": "2024-02-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 16:29:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000025/0000059478-24-000025-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000025/xslF345X05/wk-form4_1706909331.xml"}}
{"date": "2024-02-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 16:28:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000023/0000059478-24-000023-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000023/xslF345X05/wk-form4_1706909271.xml"}}
{"date": "2024-02-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 16:26:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000021/0000059478-24-000021-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000021/xslF345X05/wk-form4_1706909191.xml"}}
{"date": "2024-02-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 16:25:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000019/0000059478-24-000019-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000019/xslF345X05/wk-form4_1706909126.xml"}}
{"date": "2024-02-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 16:24:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000017/0000059478-24-000017-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000017/xslF345X05/wk-form4_1706909035.xml"}}
{"date": "2024-02-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 16:22:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000015/0000059478-24-000015-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000015/xslF345X05/wk-form4_1706908964.xml"}}
{"date": "2024-02-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-02 00:00:00", "acceptedDate": "2024-02-02 16:20:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000013/0000059478-24-000013-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000013/xslF345X05/wk-form4_1706908818.xml"}}
{"date": "2024-02-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-02-01 00:00:00", "acceptedDate": "2024-02-01 16:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924002161/0001415889-24-002161-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924002161/xslF345X05/form4-02012024_040201.xml"}}
{"date": "2024-01-31", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-01-31 00:00:00", "acceptedDate": "2024-01-31 16:05:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924002047/0001415889-24-002047-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924002047/xslF345X05/form4-01312024_040101.xml"}}
{"date": "2024-01-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-01-30 00:00:00", "acceptedDate": "2024-01-30 16:05:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924001974/0001415889-24-001974-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924001974/xslF345X05/form4-01302024_040117.xml"}}
{"date": "2024-01-29", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-01-29 00:00:00", "acceptedDate": "2024-01-29 15:26:28", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000108636424005150/0001086364-24-005150-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000108636424005150/us5324571083_012924.txt"}}
{"date": "2024-01-26", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-01-26 00:00:00", "acceptedDate": "2024-01-26 16:25:45", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000089710124000026/0000897101-24-000026-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000089710124000026/lilly240086_sc13ga.htm"}}
{"date": "2024-01-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-01-17 00:00:00", "acceptedDate": "2024-01-17 16:19:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000010/0000059478-24-000010-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000010/xslF345X05/wk-form4_1705526334.xml"}}
{"date": "2024-01-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-01-17 00:00:00", "acceptedDate": "2024-01-17 16:17:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000008/0000059478-24-000008-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000008/xslF345X05/wk-form4_1705526206.xml"}}
{"date": "2024-01-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-01-17 00:00:00", "acceptedDate": "2024-01-17 16:15:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000006/0000059478-24-000006-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000006/xslF345X05/wk-form4_1705526116.xml"}}
{"date": "2024-01-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-01-17 00:00:00", "acceptedDate": "2024-01-17 16:14:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000004/0000059478-24-000004-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000004/xslF345X05/wk-form4_1705526038.xml"}}
{"date": "2024-01-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-01-17 00:00:00", "acceptedDate": "2024-01-17 16:12:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000002/0000059478-24-000002-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947824000002/xslF345X05/wk-form4_1705525943.xml"}}
{"date": "2024-01-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-01-17 00:00:00", "acceptedDate": "2024-01-17 16:05:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924001274/0001415889-24-001274-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924001274/xslF345X05/form4-01172024_040101.xml"}}
{"date": "2024-01-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-01-12 00:00:00", "acceptedDate": "2024-01-12 16:05:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924001028/0001415889-24-001028-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924001028/xslF345X05/form4-01122024_040107.xml"}}
{"date": "2024-01-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-01-11 00:00:00", "acceptedDate": "2024-01-11 16:05:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924000980/0001415889-24-000980-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924000980/xslF345X05/form4-01112024_040101.xml"}}
{"date": "2024-01-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-01-10 00:00:00", "acceptedDate": "2024-01-10 16:00:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924000904/0001415889-24-000904-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924000904/xslF345X05/form4-01102024_040102.xml"}}
{"date": "2024-01-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2024-01-05 00:00:00", "acceptedDate": "2024-01-05 14:15:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588924000758/0001415889-24-000758-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588924000758/xslF345X05/form4-01052024_070143.xml"}}
{"date": "2023-12-26", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-12-26 00:00:00", "acceptedDate": "2023-12-22 18:40:31", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523302265/0001193125-23-302265-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523302265/d676385dsctota.htm"}}
{"date": "2023-12-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-12-19 00:00:00", "acceptedDate": "2023-12-19 16:16:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000328/0000059478-23-000328-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000328/xslF345X05/wk-form4_1703020592.xml"}}
{"date": "2023-12-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-12-19 00:00:00", "acceptedDate": "2023-12-19 16:15:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000326/0000059478-23-000326-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000326/xslF345X05/wk-form4_1703020494.xml"}}
{"date": "2023-12-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-12-19 00:00:00", "acceptedDate": "2023-12-19 16:13:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000324/0000059478-23-000324-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000324/xslF345X05/wk-form4_1703020406.xml"}}
{"date": "2023-12-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-12-19 00:00:00", "acceptedDate": "2023-12-19 16:12:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000322/0000059478-23-000322-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000322/xslF345X05/wk-form4_1703020305.xml"}}
{"date": "2023-12-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-12-19 00:00:00", "acceptedDate": "2023-12-19 16:10:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000320/0000059478-23-000320-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000320/xslF345X05/wk-form4_1703020205.xml"}}
{"date": "2023-12-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-12-19 00:00:00", "acceptedDate": "2023-12-19 16:08:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000318/0000059478-23-000318-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000318/xslF345X05/wk-form4_1703020095.xml"}}
{"date": "2023-12-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-12-18 00:00:00", "acceptedDate": "2023-12-18 06:59:01", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523297093/0001193125-23-297093-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523297093/d16808dsctota.htm"}}
{"date": "2023-12-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-12-04 00:00:00", "acceptedDate": "2023-12-04 16:17:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000316/0000059478-23-000316-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000316/xslF345X05/wk-form4_1701724633.xml"}}
{"date": "2023-12-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-12-04 00:00:00", "acceptedDate": "2023-12-04 07:04:00", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523287939/0001193125-23-287939-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523287939/d555801dsctota.htm"}}
{"date": "2023-11-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-21 00:00:00", "acceptedDate": "2023-11-21 16:31:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000314/0000059478-23-000314-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000314/xslF345X05/wk-form4_1700602310.xml"}}
{"date": "2023-11-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-21 00:00:00", "acceptedDate": "2023-11-21 16:30:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000312/0000059478-23-000312-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000312/xslF345X05/wk-form4_1700602226.xml"}}
{"date": "2023-11-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-21 00:00:00", "acceptedDate": "2023-11-21 16:29:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000310/0000059478-23-000310-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000310/xslF345X05/wk-form4_1700602131.xml"}}
{"date": "2023-11-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-21 00:00:00", "acceptedDate": "2023-11-21 16:27:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000308/0000059478-23-000308-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000308/xslF345X05/wk-form4_1700602048.xml"}}
{"date": "2023-11-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-21 00:00:00", "acceptedDate": "2023-11-21 16:26:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000306/0000059478-23-000306-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000306/xslF345X05/wk-form4_1700601953.xml"}}
{"date": "2023-11-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-21 00:00:00", "acceptedDate": "2023-11-21 16:24:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000304/0000059478-23-000304-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000304/xslF345X05/wk-form4_1700601853.xml"}}
{"date": "2023-11-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-21 00:00:00", "acceptedDate": "2023-11-21 16:22:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000302/0000059478-23-000302-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000302/xslF345X05/wk-form4_1700601755.xml"}}
{"date": "2023-11-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-21 00:00:00", "acceptedDate": "2023-11-21 16:20:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000300/0000059478-23-000300-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000300/xslF345X05/wk-form4_1700601640.xml"}}
{"date": "2023-11-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-21 00:00:00", "acceptedDate": "2023-11-21 16:18:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000298/0000059478-23-000298-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000298/xslF345X05/wk-form4_1700601516.xml"}}
{"date": "2023-11-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-21 00:00:00", "acceptedDate": "2023-11-21 16:15:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000296/0000059478-23-000296-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000296/xslF345X05/wk-form4_1700601310.xml"}}
{"date": "2023-11-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-17 00:00:00", "acceptedDate": "2023-11-17 06:53:29", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523279299/0001193125-23-279299-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523279299/d328817dsctota.htm"}}
{"date": "2023-11-15", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-15 00:00:00", "acceptedDate": "2023-11-15 16:16:27", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000292/0000059478-23-000292-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000292/xslF345X05/wk-form4_1700082977.xml"}}
{"date": "2023-11-15", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-15 00:00:00", "acceptedDate": "2023-11-15 06:51:05", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523277516/0001193125-23-277516-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523277516/d426292dsctota.htm"}}
{"date": "2023-11-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-13 00:00:00", "acceptedDate": "2023-11-13 16:19:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000290/0000059478-23-000290-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000290/xslF345X05/wk-form4_1699910380.xml"}}
{"date": "2023-11-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-08 00:00:00", "acceptedDate": "2023-11-08 17:06:28", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523273624/0001193125-23-273624-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523273624/d589444dsctota.htm"}}
{"date": "2023-11-06", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-06 00:00:00", "acceptedDate": "2023-11-06 16:25:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000286/0000059478-23-000286-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000286/xslF345X05/wk-form4_1699305940.xml"}}
{"date": "2023-11-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-02 00:00:00", "acceptedDate": "2023-11-02 11:21:53", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000284/0000059478-23-000284-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000284/lly-20230930.htm"}}
{"date": "2023-11-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-11-02 00:00:00", "acceptedDate": "2023-11-02 07:02:01", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000282/0000059478-23-000282-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000282/q323lillysalesandearningsp.htm"}}
{"date": "2023-10-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-10-27 00:00:00", "acceptedDate": "2023-10-27 16:15:59", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523265133/0001193125-23-265133-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523265133/d560699dsctota.htm"}}
{"date": "2023-10-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-10-17 00:00:00", "acceptedDate": "2023-10-17 16:24:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000276/0000059478-23-000276-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000276/xslF345X05/wk-form4_1697574262.xml"}}
{"date": "2023-10-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-10-17 00:00:00", "acceptedDate": "2023-10-17 16:22:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000274/0000059478-23-000274-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000274/xslF345X05/wk-form4_1697574169.xml"}}
{"date": "2023-10-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-10-17 00:00:00", "acceptedDate": "2023-10-17 16:21:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000272/0000059478-23-000272-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000272/xslF345X05/wk-form4_1697574065.xml"}}
{"date": "2023-10-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-10-17 00:00:00", "acceptedDate": "2023-10-17 16:19:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000270/0000059478-23-000270-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000270/xslF345X05/wk-form4_1697573978.xml"}}
{"date": "2023-10-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-10-17 00:00:00", "acceptedDate": "2023-10-17 16:18:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000268/0000059478-23-000268-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000268/xslF345X05/wk-form4_1697573880.xml"}}
{"date": "2023-10-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-10-17 00:00:00", "acceptedDate": "2023-10-17 16:15:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000266/0000059478-23-000266-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000266/xslF345X05/wk-form4_1697573710.xml"}}
{"date": "2023-10-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-10-13 00:00:00", "acceptedDate": "2023-10-13 06:52:37", "formType": "SC TO-T", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523255631/0001193125-23-255631-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523255631/d564373dsctot.htm"}}
{"date": "2023-10-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-10-12 00:00:00", "acceptedDate": "2023-10-12 16:00:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923014136/0001415889-23-014136-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923014136/xslF345X05/form4-10122023_041001.xml"}}
{"date": "2023-10-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-10-03 00:00:00", "acceptedDate": "2023-10-03 16:30:51", "formType": "SC TO-C", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523249957/0001193125-23-249957-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523249957/d457617dsctoc.htm"}}
{"date": "2023-09-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-09-20 00:00:00", "acceptedDate": "2023-09-20 16:29:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000261/0000059478-23-000261-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000261/xslF345X05/wk-form4_1695241761.xml"}}
{"date": "2023-09-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-09-20 00:00:00", "acceptedDate": "2023-09-20 16:28:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000259/0000059478-23-000259-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000259/xslF345X05/wk-form4_1695241687.xml"}}
{"date": "2023-09-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-09-20 00:00:00", "acceptedDate": "2023-09-20 16:27:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000257/0000059478-23-000257-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000257/xslF345X05/wk-form4_1695241617.xml"}}
{"date": "2023-09-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-09-20 00:00:00", "acceptedDate": "2023-09-20 16:25:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000255/0000059478-23-000255-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000255/xslF345X05/wk-form4_1695241528.xml"}}
{"date": "2023-09-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-09-20 00:00:00", "acceptedDate": "2023-09-20 16:24:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000253/0000059478-23-000253-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000253/xslF345X05/wk-form4_1695241452.xml"}}
{"date": "2023-09-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-09-20 00:00:00", "acceptedDate": "2023-09-20 16:22:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000251/0000059478-23-000251-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000251/xslF345X05/wk-form4_1695241367.xml"}}
{"date": "2023-09-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-09-13 00:00:00", "acceptedDate": "2023-09-13 16:14:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000243/0000059478-23-000243-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000243/xslF345X05/wk-form4_1694636046.xml"}}
{"date": "2023-09-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-09-08 00:00:00", "acceptedDate": "2023-09-08 16:00:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923013115/0001415889-23-013115-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923013115/xslF345X05/form4-09082023_040901.xml"}}
{"date": "2023-09-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-09-01 00:00:00", "acceptedDate": "2023-09-01 16:05:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000241/0000059478-23-000241-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000241/xslF345X05/wk-form4_1693598730.xml"}}
{"date": "2023-09-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-09-01 00:00:00", "acceptedDate": "2023-09-01 16:00:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012859/0001415889-23-012859-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012859/xslF345X05/form4-09012023_040902.xml"}}
{"date": "2023-08-31", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-31 00:00:00", "acceptedDate": "2023-08-31 16:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012835/0001415889-23-012835-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012835/xslF345X05/form4-08312023_040801.xml"}}
{"date": "2023-08-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-30 00:00:00", "acceptedDate": "2023-08-30 16:00:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012799/0001415889-23-012799-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012799/xslF345X05/form4-08302023_040804.xml"}}
{"date": "2023-08-29", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-29 00:00:00", "acceptedDate": "2023-08-29 16:00:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012748/0001415889-23-012748-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012748/xslF345X05/form4-08292023_040801.xml"}}
{"date": "2023-08-28", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-28 00:00:00", "acceptedDate": "2023-08-28 16:00:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012716/0001415889-23-012716-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012716/xslF345X05/form4-08282023_040801.xml"}}
{"date": "2023-08-25", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-25 00:00:00", "acceptedDate": "2023-08-25 16:00:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012661/0001415889-23-012661-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012661/xslF345X05/form4-08252023_040801.xml"}}
{"date": "2023-08-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-24 00:00:00", "acceptedDate": "2023-08-24 16:00:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012600/0001415889-23-012600-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012600/xslF345X05/form4-08242023_040801.xml"}}
{"date": "2023-08-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-22 00:00:00", "acceptedDate": "2023-08-22 16:34:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000239/0000059478-23-000239-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000239/xslF345X05/wk-form4_1692736474.xml"}}
{"date": "2023-08-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-22 00:00:00", "acceptedDate": "2023-08-22 16:33:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000237/0000059478-23-000237-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000237/xslF345X05/wk-form4_1692736404.xml"}}
{"date": "2023-08-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-22 00:00:00", "acceptedDate": "2023-08-22 16:31:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000235/0000059478-23-000235-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000235/xslF345X05/wk-form4_1692736300.xml"}}
{"date": "2023-08-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-22 00:00:00", "acceptedDate": "2023-08-22 16:29:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000233/0000059478-23-000233-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000233/xslF345X05/wk-form4_1692736167.xml"}}
{"date": "2023-08-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-22 00:00:00", "acceptedDate": "2023-08-22 16:28:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000231/0000059478-23-000231-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000231/xslF345X05/wk-form4_1692736074.xml"}}
{"date": "2023-08-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-22 00:00:00", "acceptedDate": "2023-08-22 16:26:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000229/0000059478-23-000229-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000229/xslF345X05/wk-form4_1692735987.xml"}}
{"date": "2023-08-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-22 00:00:00", "acceptedDate": "2023-08-22 16:24:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000227/0000059478-23-000227-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000227/xslF345X05/wk-form4_1692735851.xml"}}
{"date": "2023-08-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-16 00:00:00", "acceptedDate": "2023-08-16 16:00:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012311/0001415889-23-012311-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012311/xslF345X05/form4-08162023_040802.xml"}}
{"date": "2023-08-15", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-15 00:00:00", "acceptedDate": "2023-08-15 16:00:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012256/0001415889-23-012256-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012256/xslF345X05/form4-08152023_040801.xml"}}
{"date": "2023-08-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-14 00:00:00", "acceptedDate": "2023-08-14 16:30:34", "formType": "SC 13D/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523212400/0001193125-23-212400-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523212400/d401100dsc13da.htm"}}
{"date": "2023-08-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-14 00:00:00", "acceptedDate": "2023-08-14 16:30:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000089924323018115/0000899243-23-018115-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000089924323018115/xslF345X05/doc4.xml"}}
{"date": "2023-08-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-14 00:00:00", "acceptedDate": "2023-08-14 16:00:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012196/0001415889-23-012196-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012196/xslF345X05/form4-08142023_040801.xml"}}
{"date": "2023-08-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-11 00:00:00", "acceptedDate": "2023-08-11 16:31:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000225/0000059478-23-000225-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000225/xslF345X05/wk-form4_1691785909.xml"}}
{"date": "2023-08-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-11 00:00:00", "acceptedDate": "2023-08-11 15:50:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012124/0001415889-23-012124-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012124/xslF345X05/form4-08112023_030801.xml"}}
{"date": "2023-08-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-10 00:00:00", "acceptedDate": "2023-08-10 16:51:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000223/0000059478-23-000223-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000223/xslF345X05/wk-form4_1691700658.xml"}}
{"date": "2023-08-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-10 00:00:00", "acceptedDate": "2023-08-10 16:00:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012027/0001415889-23-012027-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923012027/xslF345X05/form4-08102023_040801.xml"}}
{"date": "2023-08-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-10 00:00:00", "acceptedDate": "2023-08-10 08:34:18", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523208193/0001193125-23-208193-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523208193/d540522dsctota.htm"}}
{"date": "2023-08-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-09 00:00:00", "acceptedDate": "2023-08-09 17:10:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923011979/0001415889-23-011979-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923011979/xslF345X05/form4-08092023_090809.xml"}}
{"date": "2023-08-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-09 00:00:00", "acceptedDate": "2023-08-09 09:14:59", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523206881/0001193125-23-206881-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523206881/d533148dsctota.htm"}}
{"date": "2023-08-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-08 00:00:00", "acceptedDate": "2023-08-08 13:23:19", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000221/0000059478-23-000221-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000221/lly-20230630.htm"}}
{"date": "2023-08-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-08 00:00:00", "acceptedDate": "2023-08-08 07:01:37", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000219/0000059478-23-000219-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000219/q223lillysalesandearningsp.htm"}}
{"date": "2023-08-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-08-01 00:00:00", "acceptedDate": "2023-08-01 16:46:26", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523200603/0001193125-23-200603-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523200603/d510191dsctota.htm"}}
{"date": "2023-07-25", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-07-25 00:00:00", "acceptedDate": "2023-07-25 07:04:31", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523192733/0001193125-23-192733-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523192733/d465121dsctota.htm"}}
{"date": "2023-07-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-07-24 00:00:00", "acceptedDate": "2023-07-24 15:55:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000141588923011406/0001415889-23-011406-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000141588923011406/xslF345X05/form4-07242023_030701.xml"}}
{"date": "2023-07-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-07-18 00:00:00", "acceptedDate": "2023-07-18 16:43:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000215/0000059478-23-000215-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000215/xslF345X05/wk-form4_1689713028.xml"}}
{"date": "2023-07-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-07-18 00:00:00", "acceptedDate": "2023-07-18 16:40:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000213/0000059478-23-000213-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000213/xslF345X05/wk-form4_1689712822.xml"}}
{"date": "2023-07-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-07-18 00:00:00", "acceptedDate": "2023-07-18 16:36:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000211/0000059478-23-000211-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000211/xslF345X05/wk-form4_1689712598.xml"}}
{"date": "2023-07-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-07-18 00:00:00", "acceptedDate": "2023-07-18 16:33:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000209/0000059478-23-000209-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000209/xslF345X05/wk-form4_1689712393.xml"}}
{"date": "2023-07-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-07-18 00:00:00", "acceptedDate": "2023-07-18 16:31:06", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523188884/0001193125-23-188884-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523188884/d396049dsctota.htm"}}
{"date": "2023-07-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-07-18 00:00:00", "acceptedDate": "2023-07-18 16:29:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000207/0000059478-23-000207-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000207/xslF345X05/wk-form4_1689712142.xml"}}
{"date": "2023-07-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-07-18 00:00:00", "acceptedDate": "2023-07-18 16:25:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000205/0000059478-23-000205-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000205/xslF345X05/wk-form4_1689711941.xml"}}
{"date": "2023-07-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-07-17 00:00:00", "acceptedDate": "2023-07-17 17:14:34", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523188200/0001193125-23-188200-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523188200/d538003dsctota.htm"}}
{"date": "2023-07-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-07-13 00:00:00", "acceptedDate": "2023-07-13 08:01:30", "formType": "SC TO-T", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523186293/0001193125-23-186293-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523186293/d497638dsctot.htm"}}
{"date": "2023-07-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-07-07 00:00:00", "acceptedDate": "2023-07-07 16:33:26", "formType": "SC 13D", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523183831/0001193125-23-183831-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523183831/d266530dsc13d.htm"}}
{"date": "2023-07-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-07-07 00:00:00", "acceptedDate": "2023-07-07 16:30:13", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000089924323017270/0000899243-23-017270-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000089924323017270/xslF345X02/doc3.xml"}}
{"date": "2023-07-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-07-03 00:00:00", "acceptedDate": "2023-07-03 12:00:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123040451/0001209191-23-040451-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123040451/xslF345X04/doc4.xml"}}
{"date": "2023-06-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-30 00:00:00", "acceptedDate": "2023-06-30 16:06:48", "formType": "SC TO-T", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523180387/0001193125-23-180387-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523180387/d459740dsctot.htm"}}
{"date": "2023-06-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-30 00:00:00", "acceptedDate": "2023-06-30 15:00:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123040274/0001209191-23-040274-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123040274/xslF345X04/doc4.xml"}}
{"date": "2023-06-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-30 00:00:00", "acceptedDate": "2023-06-30 09:06:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123040236/0001209191-23-040236-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123040236/xslF345X04/doc4.xml"}}
{"date": "2023-06-29", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-29 00:00:00", "acceptedDate": "2023-06-29 06:56:54", "formType": "SC TO-C", "link": "https://www.sec.gov/Archives/edgar/data/59478/000092963823001859/0000929638-23-001859-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000092963823001859/sctoc.htm"}}
{"date": "2023-06-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-23 00:00:00", "acceptedDate": "2023-06-23 11:27:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123039261/0001209191-23-039261-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123039261/xslF345X04/doc4.xml"}}
{"date": "2023-06-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-22 00:00:00", "acceptedDate": "2023-06-22 15:14:50", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000203/0000059478-23-000203-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000203/a2023form11-k.htm"}}
{"date": "2023-06-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-22 00:00:00", "acceptedDate": "2023-06-22 13:06:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123039009/0001209191-23-039009-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123039009/xslF345X04/doc4.xml"}}
{"date": "2023-06-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-21 00:00:00", "acceptedDate": "2023-06-21 16:28:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000200/0000059478-23-000200-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000200/xslF345X04/wk-form4_1687379325.xml"}}
{"date": "2023-06-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-21 00:00:00", "acceptedDate": "2023-06-21 16:27:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000198/0000059478-23-000198-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000198/xslF345X04/wk-form4_1687379226.xml"}}
{"date": "2023-06-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-21 00:00:00", "acceptedDate": "2023-06-21 16:25:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000196/0000059478-23-000196-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000196/xslF345X04/wk-form4_1687379094.xml"}}
{"date": "2023-06-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-21 00:00:00", "acceptedDate": "2023-06-21 16:22:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000194/0000059478-23-000194-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000194/xslF345X04/wk-form4_1687378943.xml"}}
{"date": "2023-06-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-21 00:00:00", "acceptedDate": "2023-06-21 16:19:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000192/0000059478-23-000192-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000192/xslF345X04/wk-form4_1687378775.xml"}}
{"date": "2023-06-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-21 00:00:00", "acceptedDate": "2023-06-21 16:17:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000190/0000059478-23-000190-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000190/xslF345X04/wk-form4_1687378634.xml"}}
{"date": "2023-06-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-21 00:00:00", "acceptedDate": "2023-06-21 15:13:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123038733/0001209191-23-038733-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123038733/xslF345X04/doc4.xml"}}
{"date": "2023-06-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-20 00:00:00", "acceptedDate": "2023-06-20 13:26:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123038288/0001209191-23-038288-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123038288/xslF345X04/doc4.xml"}}
{"date": "2023-06-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-20 00:00:00", "acceptedDate": "2023-06-20 08:20:26", "formType": "SC TO-C", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523169657/0001193125-23-169657-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523169657/d511803dsctoc.htm"}}
{"date": "2023-06-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-16 00:00:00", "acceptedDate": "2023-06-16 15:58:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123037789/0001209191-23-037789-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123037789/xslF345X04/doc4.xml"}}
{"date": "2023-06-15", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-15 00:00:00", "acceptedDate": "2023-06-15 16:21:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000188/0000059478-23-000188-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000188/xslF345X04/wk-form4_1686860461.xml"}}
{"date": "2023-06-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-02 00:00:00", "acceptedDate": "2023-06-02 16:44:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000186/0000059478-23-000186-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000186/xslF345X04/wk-form4_1685738624.xml"}}
{"date": "2023-06-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-06-02 00:00:00", "acceptedDate": "2023-06-02 16:29:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000184/0000059478-23-000184-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000184/xslF345X04/wk-form4_1685737755.xml"}}
{"date": "2023-05-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-05-22 00:00:00", "acceptedDate": "2023-05-22 12:01:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123031356/0001209191-23-031356-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123031356/xslF345X04/doc4.xml"}}
{"date": "2023-05-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-05-16 00:00:00", "acceptedDate": "2023-05-16 16:31:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000182/0000059478-23-000182-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000182/xslF345X04/wf-form4_168426907790371.xml"}}
{"date": "2023-05-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-05-16 00:00:00", "acceptedDate": "2023-05-16 16:29:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000180/0000059478-23-000180-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000180/xslF345X04/wf-form4_168426897503157.xml"}}
{"date": "2023-05-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-05-16 00:00:00", "acceptedDate": "2023-05-16 16:28:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000178/0000059478-23-000178-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000178/xslF345X04/wf-form4_168426886823912.xml"}}
{"date": "2023-05-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-05-16 00:00:00", "acceptedDate": "2023-05-16 16:26:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000176/0000059478-23-000176-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000176/xslF345X04/wf-form4_168426878118857.xml"}}
{"date": "2023-05-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-05-16 00:00:00", "acceptedDate": "2023-05-16 16:24:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000174/0000059478-23-000174-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000174/xslF345X04/wf-form4_168426865232884.xml"}}
{"date": "2023-05-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-05-16 00:00:00", "acceptedDate": "2023-05-16 16:23:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000172/0000059478-23-000172-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000172/xslF345X04/wf-form4_168426856870058.xml"}}
{"date": "2023-05-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-05-16 00:00:00", "acceptedDate": "2023-05-16 16:21:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000170/0000059478-23-000170-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000170/xslF345X04/wf-form4_168426847189268.xml"}}
{"date": "2023-05-15", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-05-15 00:00:00", "acceptedDate": "2023-05-15 13:01:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123029303/0001209191-23-029303-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123029303/xslF345X04/doc4.xml"}}
{"date": "2023-05-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-05-05 00:00:00", "acceptedDate": "2023-05-05 16:32:33", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000168/0000059478-23-000168-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000168/formsd2023.htm"}}
{"date": "2023-05-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 16:33:56", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000165/0000059478-23-000165-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000165/0000059478-23-000165.txt"}}
{"date": "2023-05-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-05-04 00:00:00", "acceptedDate": "2023-05-04 14:30:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123027283/0001209191-23-027283-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123027283/xslF345X04/doc4.xml"}}
{"date": "2023-05-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-05-03 00:00:00", "acceptedDate": "2023-05-03 15:13:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123026907/0001209191-23-026907-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123026907/xslF345X04/doc4.xml"}}
{"date": "2023-05-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-05-01 00:00:00", "acceptedDate": "2023-05-01 14:32:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123026230/0001209191-23-026230-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123026230/xslF345X04/doc4.xml"}}
{"date": "2023-04-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-27 00:00:00", "acceptedDate": "2023-04-27 11:56:56", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000162/0000059478-23-000162-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000162/lly-20230331.htm"}}
{"date": "2023-04-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-27 00:00:00", "acceptedDate": "2023-04-27 07:02:50", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000160/0000059478-23-000160-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000160/q123lillysalesandearningsp.htm"}}
{"date": "2023-04-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-21 00:00:00", "acceptedDate": "2023-04-21 14:02:16", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465923005739/0001214659-23-005739-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465923005739/x421231px14a6g.htm"}}
{"date": "2023-04-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-19 00:00:00", "acceptedDate": "2023-04-19 16:34:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000156/0000059478-23-000156-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000156/xslF345X04/wf-form4_168193646715773.xml"}}
{"date": "2023-04-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-19 00:00:00", "acceptedDate": "2023-04-19 16:33:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000154/0000059478-23-000154-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000154/xslF345X04/wf-form4_168193637640401.xml"}}
{"date": "2023-04-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-19 00:00:00", "acceptedDate": "2023-04-19 16:31:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000152/0000059478-23-000152-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000152/xslF345X04/wf-form4_168193630076058.xml"}}
{"date": "2023-04-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-19 00:00:00", "acceptedDate": "2023-04-19 16:30:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000150/0000059478-23-000150-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000150/xslF345X04/wf-form4_168193620979651.xml"}}
{"date": "2023-04-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-19 00:00:00", "acceptedDate": "2023-04-19 16:29:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000148/0000059478-23-000148-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000148/xslF345X04/wf-form4_168193613806276.xml"}}
{"date": "2023-04-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-19 00:00:00", "acceptedDate": "2023-04-19 16:28:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000146/0000059478-23-000146-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000146/xslF345X04/wf-form4_168193607349396.xml"}}
{"date": "2023-04-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-19 00:00:00", "acceptedDate": "2023-04-19 16:26:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000144/0000059478-23-000144-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000144/xslF345X04/wf-form4_168193599784567.xml"}}
{"date": "2023-04-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-10 00:00:00", "acceptedDate": "2023-04-10 16:51:30", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465923005160/0001214659-23-005160-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465923005160/o410233px14a6g.htm"}}
{"date": "2023-04-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-07 00:00:00", "acceptedDate": "2023-04-07 11:38:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123023712/0001209191-23-023712-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123023712/xslF345X04/doc4.xml"}}
{"date": "2023-04-06", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-06 00:00:00", "acceptedDate": "2023-04-06 13:21:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123023555/0001209191-23-023555-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123023555/xslF345X04/doc4.xml"}}
{"date": "2023-04-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-04 00:00:00", "acceptedDate": "2023-04-04 15:57:29", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465923004831/0001214659-23-004831-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465923004831/x44233px14a6g.htm"}}
{"date": "2023-04-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-04 00:00:00", "acceptedDate": "2023-04-04 11:53:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123022522/0001209191-23-022522-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123022522/xslF345X04/doc4.xml"}}
{"date": "2023-04-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-03 00:00:00", "acceptedDate": "2023-04-03 20:54:28", "formType": "3/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000139/0000059478-23-000139-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000139/xslF345X02/wf-form3a_168056965515938.xml"}}
{"date": "2023-04-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-04-03 00:00:00", "acceptedDate": "2023-04-03 10:25:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123021975/0001209191-23-021975-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123021975/xslF345X04/doc4.xml"}}
{"date": "2023-03-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-27 00:00:00", "acceptedDate": "2023-03-27 10:31:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919123021155/0001209191-23-021155-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919123021155/xslF345X04/doc4.xml"}}
{"date": "2023-03-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-24 00:00:00", "acceptedDate": "2023-03-24 16:30:18", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465923004176/0001214659-23-004176-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465923004176/o324232px14a6g.htm"}}
{"date": "2023-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-22 00:00:00", "acceptedDate": "2023-03-22 16:32:14", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465923004104/0001214659-23-004104-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465923004104/b322232px14a6g.htm"}}
{"date": "2023-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-22 00:00:00", "acceptedDate": "2023-03-22 16:18:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000137/0000059478-23-000137-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000137/xslF345X04/wf-form4_167951630549329.xml"}}
{"date": "2023-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-22 00:00:00", "acceptedDate": "2023-03-22 16:16:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000135/0000059478-23-000135-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000135/xslF345X04/wf-form4_167951619779073.xml"}}
{"date": "2023-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-22 00:00:00", "acceptedDate": "2023-03-22 16:14:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000133/0000059478-23-000133-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000133/xslF345X04/wf-form4_167951608764026.xml"}}
{"date": "2023-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-22 00:00:00", "acceptedDate": "2023-03-22 16:13:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000131/0000059478-23-000131-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000131/xslF345X04/wf-form4_167951598095181.xml"}}
{"date": "2023-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-22 00:00:00", "acceptedDate": "2023-03-22 16:10:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000129/0000059478-23-000129-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000129/xslF345X04/wf-form4_167951581609755.xml"}}
{"date": "2023-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-22 00:00:00", "acceptedDate": "2023-03-22 16:08:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000127/0000059478-23-000127-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000127/xslF345X04/wf-form4_167951570693841.xml"}}
{"date": "2023-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-22 00:00:00", "acceptedDate": "2023-03-22 16:04:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000125/0000059478-23-000125-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000125/xslF345X04/wf-form4_167951545125988.xml"}}
{"date": "2023-03-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-17 00:00:00", "acceptedDate": "2023-03-17 16:26:21", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000122/0000059478-23-000122-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000122/llydefa14a2023_additionalm.htm"}}
{"date": "2023-03-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-17 00:00:00", "acceptedDate": "2023-03-17 16:21:45", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000120/0000059478-23-000120-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000120/lly-20230317.htm"}}
{"date": "2023-03-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-17 00:00:00", "acceptedDate": "2023-03-17 16:05:58", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000118/0000059478-23-000118-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000118/0000059478-23-000118.txt"}}
{"date": "2023-03-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-13 00:00:00", "acceptedDate": "2023-03-13 16:31:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000113/0000059478-23-000113-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000113/xslF345X03/wf-form4_167873947197922.xml"}}
{"date": "2023-03-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-02 00:00:00", "acceptedDate": "2023-03-02 16:39:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000111/0000059478-23-000111-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000111/xslF345X03/wf-form4_167779311613673.xml"}}
{"date": "2023-03-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-02 00:00:00", "acceptedDate": "2023-03-02 16:36:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000109/0000059478-23-000109-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000109/xslF345X03/wf-form4_167779298259738.xml"}}
{"date": "2023-03-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-02 00:00:00", "acceptedDate": "2023-03-02 16:34:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000107/0000059478-23-000107-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000107/xslF345X03/wf-form4_167779282954589.xml"}}
{"date": "2023-03-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-02 00:00:00", "acceptedDate": "2023-03-02 16:31:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000105/0000059478-23-000105-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000105/xslF345X03/wf-form4_167779268700027.xml"}}
{"date": "2023-03-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-03-01 00:00:00", "acceptedDate": "2023-03-01 16:31:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000103/0000059478-23-000103-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000103/xslF345X03/wf-form4_167770626037162.xml"}}
{"date": "2023-02-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-24 00:00:00", "acceptedDate": "2023-02-24 17:00:06", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523048910/0001193125-23-048910-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523048910/d575646dex11.htm"}}
{"date": "2023-02-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-24 00:00:00", "acceptedDate": "2023-02-24 16:56:36", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523048895/0001193125-23-048895-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523048895/d378781d424b2.htm"}}
{"date": "2023-02-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-23 00:00:00", "acceptedDate": "2023-02-23 17:15:00", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523046795/0001193125-23-046795-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523046795/d378781dfwp.htm"}}
{"date": "2023-02-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-23 00:00:00", "acceptedDate": "2023-02-23 08:53:18", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523045724/0001193125-23-045724-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523045724/d378781d424b2.htm"}}
{"date": "2023-02-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-22 00:00:00", "acceptedDate": "2023-02-22 16:59:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000096/0000059478-23-000096-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000096/xslF345X03/wf-form4_167710312267960.xml"}}
{"date": "2023-02-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-22 00:00:00", "acceptedDate": "2023-02-22 16:57:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000094/0000059478-23-000094-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000094/xslF345X03/wf-form4_167710301616620.xml"}}
{"date": "2023-02-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-22 00:00:00", "acceptedDate": "2023-02-22 16:55:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000092/0000059478-23-000092-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000092/xslF345X03/wf-form4_167710292072728.xml"}}
{"date": "2023-02-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-22 00:00:00", "acceptedDate": "2023-02-22 16:53:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000090/0000059478-23-000090-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000090/xslF345X03/wf-form4_167710278960618.xml"}}
{"date": "2023-02-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-22 00:00:00", "acceptedDate": "2023-02-22 16:51:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000088/0000059478-23-000088-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000088/xslF345X03/wf-form4_167710265738457.xml"}}
{"date": "2023-02-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-22 00:00:00", "acceptedDate": "2023-02-22 16:49:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000086/0000059478-23-000086-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000086/xslF345X03/wf-form4_167710254348899.xml"}}
{"date": "2023-02-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-22 00:00:00", "acceptedDate": "2023-02-22 16:47:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000084/0000059478-23-000084-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000084/xslF345X03/wf-form4_167710238309810.xml"}}
{"date": "2023-02-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-22 00:00:00", "acceptedDate": "2023-02-22 10:26:53", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000082/0000059478-23-000082-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000082/lly-20221231.htm"}}
{"date": "2023-02-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-21 00:00:00", "acceptedDate": "2023-02-21 16:35:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000079/0000059478-23-000079-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000079/xslF345X03/wf-form4_167701530938901.xml"}}
{"date": "2023-02-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-21 00:00:00", "acceptedDate": "2023-02-21 16:32:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000077/0000059478-23-000077-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000077/xslF345X03/wf-form4_167701512962950.xml"}}
{"date": "2023-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 17:23:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000073/0000059478-23-000073-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000073/xslF345X03/wf-form4_167641337639907.xml"}}
{"date": "2023-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 17:19:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000071/0000059478-23-000071-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000071/xslF345X03/wf-form4_167641314104117.xml"}}
{"date": "2023-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 17:12:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000069/0000059478-23-000069-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000069/xslF345X03/wf-form4_167641273108663.xml"}}
{"date": "2023-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 17:10:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000067/0000059478-23-000067-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000067/xslF345X03/wf-form4_167641257731994.xml"}}
{"date": "2023-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 17:07:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000065/0000059478-23-000065-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000065/xslF345X03/wf-form4_167641243711205.xml"}}
{"date": "2023-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 17:04:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000063/0000059478-23-000063-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000063/xslF345X03/wf-form4_167641225388328.xml"}}
{"date": "2023-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 17:01:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000061/0000059478-23-000061-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000061/xslF345X03/wf-form4_167641201578324.xml"}}
{"date": "2023-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:55:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000059/0000059478-23-000059-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000059/xslF345X03/wf-form4_167641169507148.xml"}}
{"date": "2023-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:52:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000057/0000059478-23-000057-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000057/xslF345X03/wf-form4_167641155807782.xml"}}
{"date": "2023-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:49:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000055/0000059478-23-000055-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000055/xslF345X03/wf-form4_167641129919422.xml"}}
{"date": "2023-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:46:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000053/0000059478-23-000053-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000053/xslF345X03/wf-form4_167641114634089.xml"}}
{"date": "2023-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:43:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000051/0000059478-23-000051-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000051/xslF345X03/wf-form4_167641096188829.xml"}}
{"date": "2023-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:40:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000049/0000059478-23-000049-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000049/xslF345X03/wf-form4_167641078384260.xml"}}
{"date": "2023-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:37:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000047/0000059478-23-000047-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000047/xslF345X03/wf-form4_167641058187302.xml"}}
{"date": "2023-02-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-14 00:00:00", "acceptedDate": "2023-02-14 16:34:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000045/0000059478-23-000045-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000045/xslF345X03/wf-form4_167641043020681.xml"}}
{"date": "2023-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-10 00:00:00", "acceptedDate": "2023-02-10 10:42:29", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312523031815/0001193125-23-031815-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312523031815/d248716dsc13ga.htm"}}
{"date": "2023-02-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-09 00:00:00", "acceptedDate": "2023-02-09 11:19:19", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000110465923015851/0001104659-23-015851-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000110465923015851/tv0802-elilillyco.htm"}}
{"date": "2023-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-03 00:00:00", "acceptedDate": "2023-02-03 17:04:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000043/0000059478-23-000043-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000043/xslF345X03/wf-form4_167546185628642.xml"}}
{"date": "2023-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-03 00:00:00", "acceptedDate": "2023-02-03 17:01:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000041/0000059478-23-000041-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000041/xslF345X03/wf-form4_167546169517695.xml"}}
{"date": "2023-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-03 00:00:00", "acceptedDate": "2023-02-03 16:57:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000039/0000059478-23-000039-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000039/xslF345X03/wf-form4_167546142093711.xml"}}
{"date": "2023-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-03 00:00:00", "acceptedDate": "2023-02-03 16:54:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000037/0000059478-23-000037-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000037/xslF345X03/wf-form4_167546127265548.xml"}}
{"date": "2023-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-03 00:00:00", "acceptedDate": "2023-02-03 16:51:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000035/0000059478-23-000035-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000035/xslF345X03/wf-form4_167546109073306.xml"}}
{"date": "2023-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-03 00:00:00", "acceptedDate": "2023-02-03 16:48:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000033/0000059478-23-000033-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000033/xslF345X03/wf-form4_167546086780975.xml"}}
{"date": "2023-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-03 00:00:00", "acceptedDate": "2023-02-03 16:45:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000031/0000059478-23-000031-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000031/xslF345X03/wf-form4_167546071347318.xml"}}
{"date": "2023-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-03 00:00:00", "acceptedDate": "2023-02-03 16:41:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000029/0000059478-23-000029-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000029/xslF345X03/wf-form4_167546046254164.xml"}}
{"date": "2023-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-03 00:00:00", "acceptedDate": "2023-02-03 16:35:09", "formType": "5", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000027/0000059478-23-000027-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000027/xslF345X03/wf-form5_167546009467637.xml"}}
{"date": "2023-02-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-02-02 00:00:00", "acceptedDate": "2023-02-02 07:13:44", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000025/0000059478-23-000025-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000025/q422lillysalesandearningsp.htm"}}
{"date": "2023-01-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-01-27 00:00:00", "acceptedDate": "2023-01-27 16:57:49", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000022/0000059478-23-000022-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000022/sc13ga_precisionbiosciences.htm"}}
{"date": "2023-01-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-01-27 00:00:00", "acceptedDate": "2023-01-27 16:41:51", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000018/0000059478-23-000018-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000018/sc13ga_acimmunesa.htm"}}
{"date": "2023-01-25", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-01-25 00:00:00", "acceptedDate": "2023-01-25 16:14:05", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000156761923001272/0001567619-23-001272-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000156761923001272/doc1.htm"}}
{"date": "2023-01-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-01-19 00:00:00", "acceptedDate": "2023-01-19 16:49:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000016/0000059478-23-000016-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000016/xslF345X03/wf-form4_167416492681747.xml"}}
{"date": "2023-01-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-01-19 00:00:00", "acceptedDate": "2023-01-19 16:46:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000014/0000059478-23-000014-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000014/xslF345X03/wf-form4_167416476756500.xml"}}
{"date": "2023-01-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-01-19 00:00:00", "acceptedDate": "2023-01-19 16:44:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000012/0000059478-23-000012-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000012/xslF345X03/wf-form4_167416463446584.xml"}}
{"date": "2023-01-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-01-19 00:00:00", "acceptedDate": "2023-01-19 16:42:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000010/0000059478-23-000010-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000010/xslF345X03/wf-form4_167416451683264.xml"}}
{"date": "2023-01-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-01-19 00:00:00", "acceptedDate": "2023-01-19 16:39:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000008/0000059478-23-000008-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000008/xslF345X03/wf-form4_167416436661581.xml"}}
{"date": "2023-01-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-01-19 00:00:00", "acceptedDate": "2023-01-19 16:37:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000006/0000059478-23-000006-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000006/xslF345X03/wf-form4_167416422047828.xml"}}
{"date": "2023-01-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-01-19 00:00:00", "acceptedDate": "2023-01-19 16:34:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000004/0000059478-23-000004-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000004/xslF345X03/wf-form4_167416403421081.xml"}}
{"date": "2023-01-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2023-01-03 00:00:00", "acceptedDate": "2023-01-03 16:40:20", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000002/0000059478-23-000002-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947823000002/xslF345X02/wf-form3_167278200022116.xml"}}
{"date": "2022-12-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-12-23 00:00:00", "acceptedDate": "2022-12-23 16:39:00", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522311817/0001193125-22-311817-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522311817/d419860dsc13ga.htm"}}
{"date": "2022-12-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-12-20 00:00:00", "acceptedDate": "2022-12-20 17:15:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000289/0000059478-22-000289-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000289/xslF345X03/wf-form4_167157454149342.xml"}}
{"date": "2022-12-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-12-20 00:00:00", "acceptedDate": "2022-12-20 17:14:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000287/0000059478-22-000287-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000287/xslF345X03/wf-form4_167157444176418.xml"}}
{"date": "2022-12-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-12-20 00:00:00", "acceptedDate": "2022-12-20 17:12:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000285/0000059478-22-000285-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000285/xslF345X03/wf-form4_167157436015758.xml"}}
{"date": "2022-12-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-12-20 00:00:00", "acceptedDate": "2022-12-20 17:11:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000283/0000059478-22-000283-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000283/xslF345X03/wf-form4_167157425145374.xml"}}
{"date": "2022-12-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-12-20 00:00:00", "acceptedDate": "2022-12-20 17:09:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000281/0000059478-22-000281-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000281/xslF345X03/wf-form4_167157415592391.xml"}}
{"date": "2022-12-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-12-20 00:00:00", "acceptedDate": "2022-12-20 17:07:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000279/0000059478-22-000279-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000279/xslF345X03/wf-form4_167157403107262.xml"}}
{"date": "2022-12-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-12-13 00:00:00", "acceptedDate": "2022-12-13 07:03:51", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000277/0000059478-22-000277-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000277/lly-2023financialguidancep.htm"}}
{"date": "2022-12-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-12-05 00:00:00", "acceptedDate": "2022-12-05 12:15:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122059567/0001209191-22-059567-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122059567/xslF345X03/doc4.xml"}}
{"date": "2022-12-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-12-02 00:00:00", "acceptedDate": "2022-12-02 11:29:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122059288/0001209191-22-059288-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122059288/xslF345X03/doc4.xml"}}
{"date": "2022-12-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-12-01 00:00:00", "acceptedDate": "2022-12-01 16:11:00", "formType": "SC 13D/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522296525/0001193125-22-296525-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522296525/d379936dsc13da.htm"}}
{"date": "2022-12-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-12-01 00:00:00", "acceptedDate": "2022-12-01 16:10:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000089924322037279/0000899243-22-037279-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000089924322037279/xslF345X03/doc4.xml"}}
{"date": "2022-11-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-30 00:00:00", "acceptedDate": "2022-11-30 06:58:20", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522294887/0001193125-22-294887-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522294887/d424354dsctota.htm"}}
{"date": "2022-11-28", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-28 00:00:00", "acceptedDate": "2022-11-28 06:53:50", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522292865/0001193125-22-292865-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522292865/d277023dsctota.htm"}}
{"date": "2022-11-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-22 00:00:00", "acceptedDate": "2022-11-22 17:40:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000274/0000059478-22-000274-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000274/xslF345X03/wf-form4_166915683557821.xml"}}
{"date": "2022-11-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-22 00:00:00", "acceptedDate": "2022-11-22 17:38:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000272/0000059478-22-000272-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000272/xslF345X03/wf-form4_166915669731679.xml"}}
{"date": "2022-11-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-22 00:00:00", "acceptedDate": "2022-11-22 17:36:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000270/0000059478-22-000270-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000270/xslF345X03/wf-form4_166915656781582.xml"}}
{"date": "2022-11-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-22 00:00:00", "acceptedDate": "2022-11-22 17:34:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000268/0000059478-22-000268-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000268/xslF345X03/wf-form4_166915646583226.xml"}}
{"date": "2022-11-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-22 00:00:00", "acceptedDate": "2022-11-22 17:33:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000267/0000059478-22-000267-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000267/xslF345X03/wf-form4_166915637324950.xml"}}
{"date": "2022-11-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-22 00:00:00", "acceptedDate": "2022-11-22 17:31:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000265/0000059478-22-000265-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000265/xslF345X03/wf-form4_166915626670966.xml"}}
{"date": "2022-11-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-22 00:00:00", "acceptedDate": "2022-11-22 17:29:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000263/0000059478-22-000263-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000263/xslF345X03/wf-form4_166915614214464.xml"}}
{"date": "2022-11-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-22 00:00:00", "acceptedDate": "2022-11-22 17:27:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000261/0000059478-22-000261-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000261/xslF345X03/wf-form4_166915605731417.xml"}}
{"date": "2022-11-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-22 00:00:00", "acceptedDate": "2022-11-22 17:20:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000258/0000059478-22-000258-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000258/xslF345X03/wf-form4_166915558907692.xml"}}
{"date": "2022-11-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-22 00:00:00", "acceptedDate": "2022-11-22 17:15:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000256/0000059478-22-000256-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000256/xslF345X03/wf-form4_166915531957681.xml"}}
{"date": "2022-11-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-22 00:00:00", "acceptedDate": "2022-11-22 17:11:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000254/0000059478-22-000254-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000254/xslF345X03/wf-form4_166915509571116.xml"}}
{"date": "2022-11-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-22 00:00:00", "acceptedDate": "2022-11-22 17:08:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000252/0000059478-22-000252-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000252/xslF345X03/wf-form4_166915488271701.xml"}}
{"date": "2022-11-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-14 00:00:00", "acceptedDate": "2022-11-14 06:51:24", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522283606/0001193125-22-283606-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522283606/d384728dsctota.htm"}}
{"date": "2022-11-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-08 00:00:00", "acceptedDate": "2022-11-08 13:45:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122056062/0001209191-22-056062-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122056062/xslF345X03/doc4.xml"}}
{"date": "2022-11-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-07 00:00:00", "acceptedDate": "2022-11-07 14:34:43", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122055915/0001209191-22-055915-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122055915/xslF345X03/doc4.xml"}}
{"date": "2022-11-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-04 00:00:00", "acceptedDate": "2022-11-04 12:21:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122055740/0001209191-22-055740-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122055740/xslF345X03/doc4.xml"}}
{"date": "2022-11-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-03 00:00:00", "acceptedDate": "2022-11-03 12:16:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122055450/0001209191-22-055450-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122055450/xslF345X03/doc4.xml"}}
{"date": "2022-11-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-01 00:00:00", "acceptedDate": "2022-11-01 11:16:21", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000250/0000059478-22-000250-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000250/lly-20220930.htm"}}
{"date": "2022-11-01", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-11-01 00:00:00", "acceptedDate": "2022-11-01 07:03:47", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000248/0000059478-22-000248-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000248/lly-20221101.htm"}}
{"date": "2022-10-31", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-31 00:00:00", "acceptedDate": "2022-10-31 06:51:15", "formType": "SC TO-T", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522273104/0001193125-22-273104-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522273104/d391968dsctot.htm"}}
{"date": "2022-10-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-27 00:00:00", "acceptedDate": "2022-10-27 16:31:30", "formType": "SC 13D", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522271007/0001193125-22-271007-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522271007/d365874dsc13d.htm"}}
{"date": "2022-10-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-27 00:00:00", "acceptedDate": "2022-10-27 16:30:15", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000089924322034315/0000899243-22-034315-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000089924322034315/xslF345X02/doc3.xml"}}
{"date": "2022-10-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-24 00:00:00", "acceptedDate": "2022-10-24 16:10:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122054393/0001209191-22-054393-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122054393/xslF345X03/doc4.xml"}}
{"date": "2022-10-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-20 00:00:00", "acceptedDate": "2022-10-20 14:17:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122054178/0001209191-22-054178-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122054178/xslF345X03/doc4.xml"}}
{"date": "2022-10-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-19 00:00:00", "acceptedDate": "2022-10-19 16:24:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000245/0000059478-22-000245-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000245/xslF345X03/wf-form4_166621102231184.xml"}}
{"date": "2022-10-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-19 00:00:00", "acceptedDate": "2022-10-19 16:21:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000243/0000059478-22-000243-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000243/xslF345X03/wf-form4_166621086561869.xml"}}
{"date": "2022-10-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-19 00:00:00", "acceptedDate": "2022-10-19 16:17:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000241/0000059478-22-000241-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000241/xslF345X03/wf-form4_166621062349451.xml"}}
{"date": "2022-10-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-19 00:00:00", "acceptedDate": "2022-10-19 16:14:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000239/0000059478-22-000239-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000239/xslF345X03/wf-form4_166621045570353.xml"}}
{"date": "2022-10-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-19 00:00:00", "acceptedDate": "2022-10-19 16:10:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000237/0000059478-22-000237-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000237/xslF345X03/wf-form4_166621020715548.xml"}}
{"date": "2022-10-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-19 00:00:00", "acceptedDate": "2022-10-19 16:05:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000235/0000059478-22-000235-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000235/xslF345X03/wf-form4_166620990049110.xml"}}
{"date": "2022-10-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-19 00:00:00", "acceptedDate": "2022-10-19 14:56:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122054056/0001209191-22-054056-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122054056/xslF345X03/doc4.xml"}}
{"date": "2022-10-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-18 00:00:00", "acceptedDate": "2022-10-18 15:45:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122053950/0001209191-22-053950-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122053950/xslF345X03/doc4.xml"}}
{"date": "2022-10-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-18 00:00:00", "acceptedDate": "2022-10-18 07:02:59", "formType": "SC TO-C", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522264106/0001193125-22-264106-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522264106/d411396dsctoc.htm"}}
{"date": "2022-10-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-17 00:00:00", "acceptedDate": "2022-10-17 13:02:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122053758/0001209191-22-053758-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122053758/xslF345X03/doc4.xml"}}
{"date": "2022-10-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-13 00:00:00", "acceptedDate": "2022-10-13 17:36:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122053587/0001209191-22-053587-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122053587/xslF345X03/doc4.xml"}}
{"date": "2022-10-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-12 00:00:00", "acceptedDate": "2022-10-12 16:08:43", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000233/0000059478-22-000233-index.htm", "finalLink": ""}}
{"date": "2022-10-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-11 00:00:00", "acceptedDate": "2022-10-11 16:09:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000231/0000059478-22-000231-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000231/xslF345X03/wf-form4_166551895597171.xml"}}
{"date": "2022-10-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-10-07 00:00:00", "acceptedDate": "2022-10-07 15:08:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122053073/0001209191-22-053073-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122053073/xslF345X03/doc4.xml"}}
{"date": "2022-09-06", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-09-06 00:00:00", "acceptedDate": "2022-09-06 16:22:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000215/0000059478-22-000215-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000215/xslF345X03/wf-form4_166249570552100.xml"}}
{"date": "2022-08-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-08-16 00:00:00", "acceptedDate": "2022-08-16 16:27:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000213/0000059478-22-000213-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000213/xslF345X03/wf-form4_166068164395088.xml"}}
{"date": "2022-08-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-08-16 00:00:00", "acceptedDate": "2022-08-16 16:24:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000211/0000059478-22-000211-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000211/xslF345X03/wf-form4_166068143998173.xml"}}
{"date": "2022-08-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-08-16 00:00:00", "acceptedDate": "2022-08-16 16:20:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000209/0000059478-22-000209-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000209/xslF345X03/wf-form4_166068122882659.xml"}}
{"date": "2022-08-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-08-16 00:00:00", "acceptedDate": "2022-08-16 16:17:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000207/0000059478-22-000207-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000207/xslF345X03/wf-form4_166068106178799.xml"}}
{"date": "2022-08-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-08-16 00:00:00", "acceptedDate": "2022-08-16 16:14:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000205/0000059478-22-000205-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000205/xslF345X03/wf-form4_166068088472506.xml"}}
{"date": "2022-08-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-08-16 00:00:00", "acceptedDate": "2022-08-16 16:11:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000203/0000059478-22-000203-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000203/xslF345X03/wf-form4_166068065533414.xml"}}
{"date": "2022-08-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-08-16 00:00:00", "acceptedDate": "2022-08-16 16:06:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000201/0000059478-22-000201-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000201/xslF345X03/wf-form4_166068036193577.xml"}}
{"date": "2022-08-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-08-12 00:00:00", "acceptedDate": "2022-08-12 16:34:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000198/0000059478-22-000198-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000198/xslF345X03/wf-form4_166033643803458.xml"}}
{"date": "2022-08-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-08-04 00:00:00", "acceptedDate": "2022-08-04 11:31:24", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000196/0000059478-22-000196-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000196/lly-20220630.htm"}}
{"date": "2022-08-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-08-04 00:00:00", "acceptedDate": "2022-08-04 07:05:33", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000194/0000059478-22-000194-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000194/lly-20220804.htm"}}
{"date": "2022-07-29", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-07-29 00:00:00", "acceptedDate": "2022-07-29 11:43:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122043434/0001209191-22-043434-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122043434/xslF345X03/doc4.xml"}}
{"date": "2022-07-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-07-27 00:00:00", "acceptedDate": "2022-07-27 10:26:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122043241/0001209191-22-043241-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122043241/xslF345X03/doc4.xml"}}
{"date": "2022-07-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-07-19 00:00:00", "acceptedDate": "2022-07-19 20:10:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000190/0000059478-22-000190-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000190/xslF345X03/wf-form4_165827583473559.xml"}}
{"date": "2022-07-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-07-19 00:00:00", "acceptedDate": "2022-07-19 20:09:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000188/0000059478-22-000188-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000188/xslF345X03/wf-form4_165827573308731.xml"}}
{"date": "2022-07-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-07-19 00:00:00", "acceptedDate": "2022-07-19 20:07:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000186/0000059478-22-000186-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000186/xslF345X03/wf-form4_165827561551263.xml"}}
{"date": "2022-07-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-07-19 00:00:00", "acceptedDate": "2022-07-19 20:05:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000184/0000059478-22-000184-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000184/xslF345X03/wf-form4_165827552636440.xml"}}
{"date": "2022-07-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-07-19 00:00:00", "acceptedDate": "2022-07-19 20:04:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000182/0000059478-22-000182-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000182/xslF345X03/wf-form4_165827544709751.xml"}}
{"date": "2022-07-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-07-19 00:00:00", "acceptedDate": "2022-07-19 20:02:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000180/0000059478-22-000180-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000180/xslF345X03/wf-form4_165827536063973.xml"}}
{"date": "2022-07-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-07-18 00:00:00", "acceptedDate": "2022-07-18 13:50:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122042380/0001209191-22-042380-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122042380/xslF345X03/doc4.xml"}}
{"date": "2022-07-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-07-07 00:00:00", "acceptedDate": "2022-07-07 12:03:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122041425/0001209191-22-041425-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122041425/xslF345X03/doc4.xml"}}
{"date": "2022-06-29", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-06-29 00:00:00", "acceptedDate": "2022-06-29 11:31:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122039724/0001209191-22-039724-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122039724/xslF345X03/doc4.xml"}}
{"date": "2022-06-28", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-06-28 00:00:00", "acceptedDate": "2022-06-28 13:54:45", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122039569/0001209191-22-039569-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122039569/xslF345X03/doc4.xml"}}
{"date": "2022-06-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-06-27 00:00:00", "acceptedDate": "2022-06-27 16:36:44", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000178/0000059478-22-000178-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000178/a2022form11-k.htm"}}
{"date": "2022-06-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-06-27 00:00:00", "acceptedDate": "2022-06-27 13:45:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122039382/0001209191-22-039382-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122039382/xslF345X03/doc4.xml"}}
{"date": "2022-06-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-06-24 00:00:00", "acceptedDate": "2022-06-24 13:36:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122039153/0001209191-22-039153-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122039153/xslF345X03/doc4.xml"}}
{"date": "2022-06-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-06-23 00:00:00", "acceptedDate": "2022-06-23 14:50:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122038833/0001209191-22-038833-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122038833/xslF345X03/doc4.xml"}}
{"date": "2022-06-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-06-22 00:00:00", "acceptedDate": "2022-06-22 17:44:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000175/0000059478-22-000175-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000175/xslF345X03/wf-form4_165593425122037.xml"}}
{"date": "2022-06-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-06-22 00:00:00", "acceptedDate": "2022-06-22 17:41:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000173/0000059478-22-000173-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000173/xslF345X03/wf-form4_165593410349832.xml"}}
{"date": "2022-06-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-06-22 00:00:00", "acceptedDate": "2022-06-22 17:39:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000171/0000059478-22-000171-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000171/xslF345X03/wf-form4_165593397653017.xml"}}
{"date": "2022-06-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-06-22 00:00:00", "acceptedDate": "2022-06-22 17:37:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000169/0000059478-22-000169-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000169/xslF345X03/wf-form4_165593384044074.xml"}}
{"date": "2022-06-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-06-22 00:00:00", "acceptedDate": "2022-06-22 17:34:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000167/0000059478-22-000167-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000167/xslF345X03/wf-form4_165593366397520.xml"}}
{"date": "2022-06-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-06-22 00:00:00", "acceptedDate": "2022-06-22 17:31:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000165/0000059478-22-000165-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000165/xslF345X03/wf-form4_165593349399331.xml"}}
{"date": "2022-06-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-06-02 00:00:00", "acceptedDate": "2022-06-02 18:43:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000163/0000059478-22-000163-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000163/xslF345X03/wf-form4_165420977657079.xml"}}
{"date": "2022-06-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-06-02 00:00:00", "acceptedDate": "2022-06-02 18:41:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000161/0000059478-22-000161-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000161/xslF345X03/wf-form4_165420964136601.xml"}}
{"date": "2022-05-31", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-31 00:00:00", "acceptedDate": "2022-05-31 14:44:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122032783/0001209191-22-032783-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122032783/xslF345X03/doc4.xml"}}
{"date": "2022-05-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-27 00:00:00", "acceptedDate": "2022-05-27 10:58:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122032406/0001209191-22-032406-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122032406/xslF345X03/doc4.xml"}}
{"date": "2022-05-26", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-26 00:00:00", "acceptedDate": "2022-05-26 11:40:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122032080/0001209191-22-032080-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122032080/xslF345X03/doc4.xml"}}
{"date": "2022-05-25", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-25 00:00:00", "acceptedDate": "2022-05-25 11:37:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122031796/0001209191-22-031796-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122031796/xslF345X03/doc4.xml"}}
{"date": "2022-05-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-24 00:00:00", "acceptedDate": "2022-05-24 12:51:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122031552/0001209191-22-031552-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122031552/xslF345X03/doc4.xml"}}
{"date": "2022-05-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-19 00:00:00", "acceptedDate": "2022-05-19 10:08:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122030328/0001209191-22-030328-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122030328/xslF345X03/doc4.xml"}}
{"date": "2022-05-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-18 00:00:00", "acceptedDate": "2022-05-18 17:04:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000159/0000059478-22-000159-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000159/xslF345X03/wf-form4_165290743133946.xml"}}
{"date": "2022-05-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-18 00:00:00", "acceptedDate": "2022-05-18 16:48:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000157/0000059478-22-000157-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000157/xslF345X03/wf-form4_165290682953920.xml"}}
{"date": "2022-05-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-18 00:00:00", "acceptedDate": "2022-05-18 16:45:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000155/0000059478-22-000155-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000155/xslF345X03/wf-form4_165290668573559.xml"}}
{"date": "2022-05-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-18 00:00:00", "acceptedDate": "2022-05-18 16:42:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000153/0000059478-22-000153-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000153/xslF345X03/wf-form4_165290650982068.xml"}}
{"date": "2022-05-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-18 00:00:00", "acceptedDate": "2022-05-18 16:40:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000151/0000059478-22-000151-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000151/xslF345X03/wf-form4_165290636559500.xml"}}
{"date": "2022-05-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-18 00:00:00", "acceptedDate": "2022-05-18 16:34:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000149/0000059478-22-000149-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000149/xslF345X03/wf-form4_165290583163311.xml"}}
{"date": "2022-05-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-18 00:00:00", "acceptedDate": "2022-05-18 13:11:29", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122029969/0001209191-22-029969-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122029969/xslF345X03/doc4.xml"}}
{"date": "2022-05-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-17 00:00:00", "acceptedDate": "2022-05-17 11:03:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122029498/0001209191-22-029498-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122029498/xslF345X03/doc4.xml"}}
{"date": "2022-05-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-16 00:00:00", "acceptedDate": "2022-05-16 16:51:51", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000147/0000059478-22-000147-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000147/xslF345X02/wf-form3_165273423572825.xml"}}
{"date": "2022-05-06", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-06 00:00:00", "acceptedDate": "2022-05-06 16:23:10", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000143/0000059478-22-000143-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000143/lly-20220502.htm"}}
{"date": "2022-05-06", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-06 00:00:00", "acceptedDate": "2022-05-06 07:04:42", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000141/0000059478-22-000141-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000141/formsd2022.htm"}}
{"date": "2022-05-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-05-04 00:00:00", "acceptedDate": "2022-05-04 15:04:13", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000138/0000059478-22-000138-index.htm", "finalLink": ""}}
{"date": "2022-04-29", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-29 00:00:00", "acceptedDate": "2022-04-29 11:57:54", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000133/0000059478-22-000133-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000133/lly-20220331.htm"}}
{"date": "2022-04-28", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-28 00:00:00", "acceptedDate": "2022-04-28 07:05:27", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000130/0000059478-22-000130-index.htm", "finalLink": ""}}
{"date": "2022-04-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-19 00:00:00", "acceptedDate": "2022-04-19 16:29:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000127/0000059478-22-000127-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000127/xslF345X03/wf-form4_165040013132753.xml"}}
{"date": "2022-04-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-19 00:00:00", "acceptedDate": "2022-04-19 16:27:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000125/0000059478-22-000125-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000125/xslF345X03/wf-form4_165040001395736.xml"}}
{"date": "2022-04-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-19 00:00:00", "acceptedDate": "2022-04-19 16:25:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000123/0000059478-22-000123-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000123/xslF345X03/wf-form4_165039989320375.xml"}}
{"date": "2022-04-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-19 00:00:00", "acceptedDate": "2022-04-19 16:23:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000121/0000059478-22-000121-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000121/xslF345X03/wf-form4_165039979278907.xml"}}
{"date": "2022-04-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-19 00:00:00", "acceptedDate": "2022-04-19 16:20:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000119/0000059478-22-000119-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000119/xslF345X03/wf-form4_165039964093794.xml"}}
{"date": "2022-04-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-14 00:00:00", "acceptedDate": "2022-04-14 16:57:23", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000117/0000059478-22-000117-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000117/lly-20220414.htm"}}
{"date": "2022-04-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-12 00:00:00", "acceptedDate": "2022-04-12 10:01:28", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465922005111/0001214659-22-005111-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465922005111/o411225px14a6g.htm"}}
{"date": "2022-04-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-11 00:00:00", "acceptedDate": "2022-04-11 14:26:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122023969/0001209191-22-023969-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122023969/xslF345X03/doc4.xml"}}
{"date": "2022-04-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-08 00:00:00", "acceptedDate": "2022-04-08 15:30:03", "formType": "UPLOAD", "link": "https://www.sec.gov/Archives/edgar/data/59478/000000000022003792/0000000000-22-003792-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000000000022003792/filename1.pdf"}}
{"date": "2022-04-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-08 00:00:00", "acceptedDate": "2022-04-08 15:20:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122023822/0001209191-22-023822-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122023822/xslF345X03/doc4.xml"}}
{"date": "2022-04-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-07 00:00:00", "acceptedDate": "2022-04-07 16:48:53", "formType": "CORRESP", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000113/0000059478-22-000113-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000113/filename1.htm"}}
{"date": "2022-04-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-07 00:00:00", "acceptedDate": "2022-04-07 12:44:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122023608/0001209191-22-023608-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122023608/xslF345X03/doc4.xml"}}
{"date": "2022-04-06", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-06 00:00:00", "acceptedDate": "2022-04-06 14:35:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122023450/0001209191-22-023450-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122023450/xslF345X03/doc4.xml"}}
{"date": "2022-04-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-05 00:00:00", "acceptedDate": "2022-04-05 14:31:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122022913/0001209191-22-022913-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122022913/xslF345X03/doc4.xml"}}
{"date": "2022-04-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-04-04 00:00:00", "acceptedDate": "2022-04-04 14:34:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122022249/0001209191-22-022249-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122022249/xslF345X03/doc4.xml"}}
{"date": "2022-03-31", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-31 00:00:00", "acceptedDate": "2022-03-31 12:51:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122021707/0001209191-22-021707-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122021707/xslF345X03/doc4.xml"}}
{"date": "2022-03-31", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-31 00:00:00", "acceptedDate": "2022-03-31 09:10:26", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465922004543/0001214659-22-004543-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465922004543/s325220px14a6g.htm"}}
{"date": "2022-03-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-30 00:00:00", "acceptedDate": "2022-03-30 16:37:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122021598/0001209191-22-021598-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122021598/xslF345X03/doc4.xml"}}
{"date": "2022-03-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-30 00:00:00", "acceptedDate": "2022-03-30 13:37:41", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465922004492/0001214659-22-004492-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465922004492/b330223px14a6g.htm"}}
{"date": "2022-03-29", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-29 00:00:00", "acceptedDate": "2022-03-29 14:14:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122021429/0001209191-22-021429-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122021429/xslF345X03/doc4.xml"}}
{"date": "2022-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-22 00:00:00", "acceptedDate": "2022-03-22 16:58:38", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000110/0000059478-22-000110-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000110/xslF345X03/wf-form4_164798270471935.xml"}}
{"date": "2022-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-22 00:00:00", "acceptedDate": "2022-03-22 16:56:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000108/0000059478-22-000108-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000108/xslF345X03/wf-form4_164798257682756.xml"}}
{"date": "2022-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-22 00:00:00", "acceptedDate": "2022-03-22 16:54:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000106/0000059478-22-000106-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000106/xslF345X03/wf-form4_164798246074827.xml"}}
{"date": "2022-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-22 00:00:00", "acceptedDate": "2022-03-22 16:52:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000104/0000059478-22-000104-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000104/xslF345X03/wf-form4_164798234545441.xml"}}
{"date": "2022-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-22 00:00:00", "acceptedDate": "2022-03-22 16:49:35", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000102/0000059478-22-000102-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000102/xslF345X03/wf-form4_164798215545894.xml"}}
{"date": "2022-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-22 00:00:00", "acceptedDate": "2022-03-22 16:43:04", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465922004220/0001214659-22-004220-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465922004220/d322221px14a6g.htm"}}
{"date": "2022-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-22 00:00:00", "acceptedDate": "2022-03-22 15:41:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122020505/0001209191-22-020505-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122020505/xslF345X03/doc4.xml"}}
{"date": "2022-03-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-22 00:00:00", "acceptedDate": "2022-03-22 15:19:46", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465922004204/0001214659-22-004204-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465922004204/g322220px14a6g.htm"}}
{"date": "2022-03-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-21 00:00:00", "acceptedDate": "2022-03-21 13:12:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122020199/0001209191-22-020199-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122020199/xslF345X03/doc4.xml"}}
{"date": "2022-03-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-18 00:00:00", "acceptedDate": "2022-03-18 16:16:19", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000100/0000059478-22-000100-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000100/llydef14a2022_additionalxm.htm"}}
{"date": "2022-03-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-18 00:00:00", "acceptedDate": "2022-03-18 16:14:07", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000099/0000059478-22-000099-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000099/llydef14a2022.htm"}}
{"date": "2022-03-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-18 00:00:00", "acceptedDate": "2022-03-18 11:48:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122019973/0001209191-22-019973-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122019973/xslF345X03/doc4.xml"}}
{"date": "2022-03-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-17 00:00:00", "acceptedDate": "2022-03-17 16:12:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000098/0000059478-22-000098-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000098/xslF345X03/wf-form4_164754794178841.xml"}}
{"date": "2022-03-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-16 00:00:00", "acceptedDate": "2022-03-16 11:44:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122019093/0001209191-22-019093-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122019093/xslF345X03/doc4.xml"}}
{"date": "2022-03-15", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-15 00:00:00", "acceptedDate": "2022-03-15 14:13:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122018748/0001209191-22-018748-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122018748/xslF345X03/doc4.xml"}}
{"date": "2022-03-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-14 00:00:00", "acceptedDate": "2022-03-14 15:02:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122018419/0001209191-22-018419-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122018419/xslF345X03/doc4.xml"}}
{"date": "2022-03-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-11 00:00:00", "acceptedDate": "2022-03-11 12:04:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122018106/0001209191-22-018106-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122018106/xslF345X03/doc4.xml"}}
{"date": "2022-03-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-10 00:00:00", "acceptedDate": "2022-03-10 12:39:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122017793/0001209191-22-017793-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122017793/xslF345X03/doc4.xml"}}
{"date": "2022-03-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-07 00:00:00", "acceptedDate": "2022-03-07 17:06:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000092/0000059478-22-000092-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000092/xslF345X03/wf-form4_164669076634205.xml"}}
{"date": "2022-03-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-07 00:00:00", "acceptedDate": "2022-03-07 13:27:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122016578/0001209191-22-016578-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122016578/xslF345X03/doc4.xml"}}
{"date": "2022-03-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-03 00:00:00", "acceptedDate": "2022-03-03 18:36:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000090/0000059478-22-000090-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000090/xslF345X03/wf-form4_164635055799971.xml"}}
{"date": "2022-03-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-03 00:00:00", "acceptedDate": "2022-03-03 18:30:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000088/0000059478-22-000088-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000088/xslF345X03/wf-form4_164635021144333.xml"}}
{"date": "2022-03-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-03-02 00:00:00", "acceptedDate": "2022-03-02 09:47:11", "formType": "25-NSE", "link": "https://www.sec.gov/Archives/edgar/data/59478/000087666122000220/0000876661-22-000220-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000087666122000220/xslF25X02/primary_doc.xml"}}
{"date": "2022-02-28", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-28 00:00:00", "acceptedDate": "2022-02-28 16:38:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000086/0000059478-22-000086-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000086/xslF345X03/wf-form4_164608421046516.xml"}}
{"date": "2022-02-25", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-25 00:00:00", "acceptedDate": "2022-02-25 16:36:07", "formType": "PRE 14A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000084/0000059478-22-000084-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000084/llypre14a2022.htm"}}
{"date": "2022-02-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-24 00:00:00", "acceptedDate": "2022-02-24 17:11:48", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000081/0000059478-22-000081-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000081/xslF345X03/wf-form4_164574069068616.xml"}}
{"date": "2022-02-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-24 00:00:00", "acceptedDate": "2022-02-24 17:09:37", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000079/0000059478-22-000079-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000079/xslF345X03/wf-form4_164574055973722.xml"}}
{"date": "2022-02-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-24 00:00:00", "acceptedDate": "2022-02-24 17:06:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000077/0000059478-22-000077-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000077/xslF345X03/wf-form4_164574038793543.xml"}}
{"date": "2022-02-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-24 00:00:00", "acceptedDate": "2022-02-24 17:04:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000075/0000059478-22-000075-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000075/xslF345X03/wf-form4_164574023518687.xml"}}
{"date": "2022-02-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-24 00:00:00", "acceptedDate": "2022-02-24 17:01:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000073/0000059478-22-000073-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000073/xslF345X03/wf-form4_164574009335560.xml"}}
{"date": "2022-02-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-24 00:00:00", "acceptedDate": "2022-02-24 06:31:00", "formType": "S-3ASR", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522050962/0001193125-22-050962-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522050962/d259474ds3asr.htm"}}
{"date": "2022-02-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-23 00:00:00", "acceptedDate": "2022-02-23 11:00:57", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000068/0000059478-22-000068-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000068/lly-20211231.htm"}}
{"date": "2022-02-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:44:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000065/0000059478-22-000065-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000065/xslF345X03/wf-form4_164513426243246.xml"}}
{"date": "2022-02-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-17 00:00:00", "acceptedDate": "2022-02-17 16:40:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000063/0000059478-22-000063-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000063/xslF345X03/wf-form4_164513402373017.xml"}}
{"date": "2022-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 18:45:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000060/0000059478-22-000060-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000060/xslF345X03/wf-form4_164462312066313.xml"}}
{"date": "2022-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 18:42:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000058/0000059478-22-000058-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000058/xslF345X03/wf-form4_164462288785243.xml"}}
{"date": "2022-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 18:38:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000056/0000059478-22-000056-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000056/xslF345X03/wf-form4_164462270168794.xml"}}
{"date": "2022-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 18:35:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000054/0000059478-22-000054-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000054/xslF345X03/wf-form4_164462253456266.xml"}}
{"date": "2022-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 18:31:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000052/0000059478-22-000052-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000052/xslF345X03/wf-form4_164462229151272.xml"}}
{"date": "2022-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 18:28:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000050/0000059478-22-000050-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000050/xslF345X03/wf-form4_164462211639564.xml"}}
{"date": "2022-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 18:25:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000048/0000059478-22-000048-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000048/xslF345X03/wf-form4_164462189343178.xml"}}
{"date": "2022-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 18:22:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000046/0000059478-22-000046-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000046/xslF345X03/wf-form4_164462174983605.xml"}}
{"date": "2022-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 18:19:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000044/0000059478-22-000044-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000044/xslF345X03/wf-form4_164462154515553.xml"}}
{"date": "2022-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 18:16:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000042/0000059478-22-000042-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000042/xslF345X03/wf-form4_164462137367209.xml"}}
{"date": "2022-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 18:12:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000040/0000059478-22-000040-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000040/xslF345X03/wf-form4_164462114168110.xml"}}
{"date": "2022-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 18:09:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000038/0000059478-22-000038-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000038/xslF345X03/wf-form4_164462096325305.xml"}}
{"date": "2022-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 18:06:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000036/0000059478-22-000036-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000036/xslF345X03/wf-form4_164462075615820.xml"}}
{"date": "2022-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 18:03:16", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000034/0000059478-22-000034-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000034/xslF345X03/wf-form4_164462057536904.xml"}}
{"date": "2022-02-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-11 00:00:00", "acceptedDate": "2022-02-11 07:46:53", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522035767/0001193125-22-035767-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522035767/d191612dsc13ga.htm"}}
{"date": "2022-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-10 00:00:00", "acceptedDate": "2022-02-10 16:29:56", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522034514/0001193125-22-034514-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522034514/d309389dsc13ga.htm"}}
{"date": "2022-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-10 00:00:00", "acceptedDate": "2022-02-10 16:26:01", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522034501/0001193125-22-034501-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522034501/d117476dsc13ga.htm"}}
{"date": "2022-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-10 00:00:00", "acceptedDate": "2022-02-10 16:21:00", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522034478/0001193125-22-034478-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522034478/d424344dsc13ga.htm"}}
{"date": "2022-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-10 00:00:00", "acceptedDate": "2022-02-10 16:16:53", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522034465/0001193125-22-034465-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522034465/d290844dsc13ga.htm"}}
{"date": "2022-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-10 00:00:00", "acceptedDate": "2022-02-10 16:13:03", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522034445/0001193125-22-034445-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522034445/d258548dsc13ga.htm"}}
{"date": "2022-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-10 00:00:00", "acceptedDate": "2022-02-10 16:05:54", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522034420/0001193125-22-034420-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522034420/d299755dsc13g.htm"}}
{"date": "2022-02-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-09 00:00:00", "acceptedDate": "2022-02-09 15:43:39", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000110465922017038/0001104659-22-017038-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000110465922017038/tv0798-elilillyco.htm"}}
{"date": "2022-02-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-08 00:00:00", "acceptedDate": "2022-02-08 17:12:16", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000083423722008435/0000834237-22-008435-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000083423722008435/us5324571083_020822.txt"}}
{"date": "2022-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-03 00:00:00", "acceptedDate": "2022-02-03 17:09:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000032/0000059478-22-000032-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000032/xslF345X03/wf-form4_164392615619605.xml"}}
{"date": "2022-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-03 00:00:00", "acceptedDate": "2022-02-03 17:04:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000030/0000059478-22-000030-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000030/xslF345X03/wf-form4_164392587950558.xml"}}
{"date": "2022-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-03 00:00:00", "acceptedDate": "2022-02-03 16:59:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000028/0000059478-22-000028-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000028/xslF345X03/wf-form4_164392557628191.xml"}}
{"date": "2022-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-03 00:00:00", "acceptedDate": "2022-02-03 16:55:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000026/0000059478-22-000026-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000026/xslF345X03/wf-form4_164392526851459.xml"}}
{"date": "2022-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-03 00:00:00", "acceptedDate": "2022-02-03 16:50:34", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000024/0000059478-22-000024-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000024/xslF345X03/wf-form4_164392500589775.xml"}}
{"date": "2022-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-03 00:00:00", "acceptedDate": "2022-02-03 16:46:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000022/0000059478-22-000022-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000022/xslF345X03/wf-form4_164392474521378.xml"}}
{"date": "2022-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-03 00:00:00", "acceptedDate": "2022-02-03 16:38:07", "formType": "5", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000020/0000059478-22-000020-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000020/xslF345X03/wf-form5_164392427358598.xml"}}
{"date": "2022-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-03 00:00:00", "acceptedDate": "2022-02-03 16:33:06", "formType": "5", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000018/0000059478-22-000018-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000018/xslF345X03/wf-form5_164392396285190.xml"}}
{"date": "2022-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-02-03 00:00:00", "acceptedDate": "2022-02-03 07:08:37", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000016/0000059478-22-000016-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000016/lly-20220203.htm"}}
{"date": "2022-01-31", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-01-31 00:00:00", "acceptedDate": "2022-01-31 08:27:07", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312522022446/0001193125-22-022446-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312522022446/d275834d8k.htm"}}
{"date": "2022-01-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-01-27 00:00:00", "acceptedDate": "2022-01-27 16:56:18", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000156761922001876/0001567619-22-001876-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000156761922001876/doc1.htm"}}
{"date": "2022-01-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-01-20 00:00:00", "acceptedDate": "2022-01-20 17:30:33", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000013/0000059478-22-000013-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000013/xslF345X03/wf-form4_164271781581623.xml"}}
{"date": "2022-01-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-01-20 00:00:00", "acceptedDate": "2022-01-20 17:27:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000011/0000059478-22-000011-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000011/xslF345X03/wf-form4_164271765095001.xml"}}
{"date": "2022-01-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-01-20 00:00:00", "acceptedDate": "2022-01-20 17:25:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000009/0000059478-22-000009-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000009/xslF345X03/wf-form4_164271748550939.xml"}}
{"date": "2022-01-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-01-20 00:00:00", "acceptedDate": "2022-01-20 17:23:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000007/0000059478-22-000007-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000007/xslF345X03/wf-form4_164271737120147.xml"}}
{"date": "2022-01-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-01-20 00:00:00", "acceptedDate": "2022-01-20 17:21:00", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000005/0000059478-22-000005-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000005/xslF345X03/wf-form4_164271724684357.xml"}}
{"date": "2022-01-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-01-10 00:00:00", "acceptedDate": "2022-01-10 16:17:27", "formType": "CORRESP", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000003/0000059478-22-000003-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947822000003/filename1.htm"}}
{"date": "2022-01-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2022-01-03 00:00:00", "acceptedDate": "2022-01-03 10:01:05", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919122000027/0001209191-22-000027-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919122000027/xslF345X03/doc4.xml"}}
{"date": "2021-12-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-12-30 00:00:00", "acceptedDate": "2021-12-30 16:09:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000248/0000059478-21-000248-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000248/xslF345X03/wf-form4_164089857090230.xml"}}
{"date": "2021-12-28", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-12-28 00:00:00", "acceptedDate": "2021-12-28 11:25:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121071351/0001209191-21-071351-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121071351/xslF345X03/doc4.xml"}}
{"date": "2021-12-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-12-22 00:00:00", "acceptedDate": "2021-12-22 16:34:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000246/0000059478-21-000246-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000246/xslF345X03/wf-form4_164020884062460.xml"}}
{"date": "2021-12-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-12-22 00:00:00", "acceptedDate": "2021-12-22 16:29:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000244/0000059478-21-000244-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000244/xslF345X03/wf-form4_164020853697362.xml"}}
{"date": "2021-12-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-12-22 00:00:00", "acceptedDate": "2021-12-22 16:26:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000242/0000059478-21-000242-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000242/xslF345X03/wf-form4_164020836805321.xml"}}
{"date": "2021-12-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-12-17 00:00:00", "acceptedDate": "2021-12-17 16:19:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121070263/0001209191-21-070263-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121070263/xslF345X03/doc4.xml"}}
{"date": "2021-12-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-12-16 00:00:00", "acceptedDate": "2021-12-16 16:59:30", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121069987/0001209191-21-069987-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121069987/xslF345X03/doc4.xml"}}
{"date": "2021-12-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-12-16 00:00:00", "acceptedDate": "2021-12-16 16:04:34", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521359144/0001193125-21-359144-index.htm", "finalLink": ""}}
{"date": "2021-12-16", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-12-16 00:00:00", "acceptedDate": "2021-12-16 13:54:13", "formType": "CT ORDER", "link": "https://www.sec.gov/Archives/edgar/data/59478/999999999721005991/9999999997-21-005991-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/999999999721005991/filename1.pdf"}}
{"date": "2021-12-15", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-12-15 00:00:00", "acceptedDate": "2021-12-15 07:05:57", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521357380/0001193125-21-357380-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521357380/d212746d8k.htm"}}
{"date": "2021-12-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-12-13 00:00:00", "acceptedDate": "2021-12-13 08:16:52", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521354688/0001193125-21-354688-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521354688/d264922dsc13g.htm"}}
{"date": "2021-12-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-12-09 00:00:00", "acceptedDate": "2021-12-09 13:30:03", "formType": "UPLOAD", "link": "https://www.sec.gov/Archives/edgar/data/59478/000000000021014789/0000000000-21-014789-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000000000021014789/filename1.pdf"}}
{"date": "2021-11-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-11-17 00:00:00", "acceptedDate": "2021-11-17 17:25:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000240/0000059478-21-000240-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000240/xslF345X03/wf-form4_163718789062421.xml"}}
{"date": "2021-11-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-11-17 00:00:00", "acceptedDate": "2021-11-17 17:23:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000239/0000059478-21-000239-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000239/xslF345X03/wf-form4_163718780965014.xml"}}
{"date": "2021-11-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-11-17 00:00:00", "acceptedDate": "2021-11-17 17:22:24", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000238/0000059478-21-000238-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000238/xslF345X03/wf-form4_163718772026884.xml"}}
{"date": "2021-11-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-11-17 00:00:00", "acceptedDate": "2021-11-17 17:20:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000237/0000059478-21-000237-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000237/xslF345X03/wf-form4_163718763368528.xml"}}
{"date": "2021-11-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-11-17 00:00:00", "acceptedDate": "2021-11-17 17:19:31", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000236/0000059478-21-000236-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000236/xslF345X03/wf-form4_163718755214286.xml"}}
{"date": "2021-11-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-11-17 00:00:00", "acceptedDate": "2021-11-17 17:17:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000235/0000059478-21-000235-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000235/xslF345X03/wf-form4_163718742946790.xml"}}
{"date": "2021-11-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-11-17 00:00:00", "acceptedDate": "2021-11-17 17:16:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000234/0000059478-21-000234-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000234/xslF345X03/wf-form4_163718735403894.xml"}}
{"date": "2021-11-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-11-17 00:00:00", "acceptedDate": "2021-11-17 17:14:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000233/0000059478-21-000233-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000233/xslF345X03/wf-form4_163718722060858.xml"}}
{"date": "2021-11-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-11-17 00:00:00", "acceptedDate": "2021-11-17 16:51:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000224/0000059478-21-000224-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000224/xslF345X03/wf-form4_163718589785740.xml"}}
{"date": "2021-11-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-11-17 00:00:00", "acceptedDate": "2021-11-17 16:46:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000222/0000059478-21-000222-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000222/xslF345X03/wf-form4_163718559717387.xml"}}
{"date": "2021-11-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-11-17 00:00:00", "acceptedDate": "2021-11-17 16:44:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000220/0000059478-21-000220-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000220/xslF345X03/wf-form4_163718546940197.xml"}}
{"date": "2021-11-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-11-17 00:00:00", "acceptedDate": "2021-11-17 16:42:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000218/0000059478-21-000218-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000218/xslF345X03/wf-form4_163718534875121.xml"}}
{"date": "2021-11-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-11-05 00:00:00", "acceptedDate": "2021-11-05 11:19:53", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121063054/0001209191-21-063054-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121063054/xslF345X03/doc4.xml"}}
{"date": "2021-10-29", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-10-29 00:00:00", "acceptedDate": "2021-10-29 14:27:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121062041/0001209191-21-062041-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121062041/xslF345X03/doc4.xml"}}
{"date": "2021-10-28", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-10-28 00:00:00", "acceptedDate": "2021-10-28 13:13:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121061867/0001209191-21-061867-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121061867/xslF345X03/doc4.xml"}}
{"date": "2021-10-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-10-27 00:00:00", "acceptedDate": "2021-10-27 09:06:59", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000216/0000059478-21-000216-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000216/lly-20210930.htm"}}
{"date": "2021-10-26", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-10-26 00:00:00", "acceptedDate": "2021-10-26 07:06:35", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000213/0000059478-21-000213-index.htm", "finalLink": ""}}
{"date": "2021-10-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-10-20 00:00:00", "acceptedDate": "2021-10-20 16:13:40", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000209/0000059478-21-000209-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000209/xslF345X03/wf-form4_163476080396694.xml"}}
{"date": "2021-10-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-10-20 00:00:00", "acceptedDate": "2021-10-20 16:09:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000207/0000059478-21-000207-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000207/xslF345X03/wf-form4_163476055198409.xml"}}
{"date": "2021-10-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-10-20 00:00:00", "acceptedDate": "2021-10-20 16:06:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000205/0000059478-21-000205-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000205/xslF345X03/wf-form4_163476039522394.xml"}}
{"date": "2021-09-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-09-22 00:00:00", "acceptedDate": "2021-09-22 18:07:22", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000202/0000059478-21-000202-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000202/xslF345X03/wf-form4_163234842761955.xml"}}
{"date": "2021-09-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-09-22 00:00:00", "acceptedDate": "2021-09-22 18:04:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000201/0000059478-21-000201-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000201/xslF345X03/wf-form4_163234827123675.xml"}}
{"date": "2021-09-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-09-22 00:00:00", "acceptedDate": "2021-09-22 18:03:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000200/0000059478-21-000200-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000200/xslF345X03/wf-form4_163234816959897.xml"}}
{"date": "2021-09-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-09-14 00:00:00", "acceptedDate": "2021-09-14 13:18:54", "formType": "CERT", "link": "https://www.sec.gov/Archives/edgar/data/59478/000087666121001319/0000876661-21-001319-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000087666121001319/LLYbonds091421.pdf"}}
{"date": "2021-09-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-09-14 00:00:00", "acceptedDate": "2021-09-14 13:02:31", "formType": "8-A12B", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521272656/0001193125-21-272656-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521272656/d130773d8a12b.htm"}}
{"date": "2021-09-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-09-10 00:00:00", "acceptedDate": "2021-09-10 16:54:59", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521270093/0001193125-21-270093-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521270093/d129207d8k.htm"}}
{"date": "2021-09-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-09-10 00:00:00", "acceptedDate": "2021-09-10 13:03:30", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521269733/0001193125-21-269733-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521269733/d181708dsc13g.htm"}}
{"date": "2021-09-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-09-10 00:00:00", "acceptedDate": "2021-09-10 06:07:28", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521269327/0001193125-21-269327-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521269327/d140810d424b2.htm"}}
{"date": "2021-09-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-09-08 00:00:00", "acceptedDate": "2021-09-08 16:44:53", "formType": "FWP", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521267900/0001193125-21-267900-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521267900/d214939dfwp.htm"}}
{"date": "2021-09-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-09-07 00:00:00", "acceptedDate": "2021-09-07 16:56:25", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000196/0000059478-21-000196-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000196/xslF345X02/wf-form3_163104817167136.xml"}}
{"date": "2021-09-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-09-07 00:00:00", "acceptedDate": "2021-09-07 06:02:50", "formType": "424B2", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521265733/0001193125-21-265733-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521265733/d140810d424b2.htm"}}
{"date": "2021-08-25", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-25 00:00:00", "acceptedDate": "2021-08-25 06:54:08", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000190/0000059478-21-000190-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000190/lly-20210823.htm"}}
{"date": "2021-08-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-19 00:00:00", "acceptedDate": "2021-08-19 11:35:47", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121052465/0001209191-21-052465-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121052465/xslF345X03/doc4.xml"}}
{"date": "2021-08-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-18 00:00:00", "acceptedDate": "2021-08-18 13:20:42", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121052155/0001209191-21-052155-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121052155/xslF345X03/doc4.xml"}}
{"date": "2021-08-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-17 00:00:00", "acceptedDate": "2021-08-17 17:11:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000187/0000059478-21-000187-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000187/xslF345X03/wf-form4_162923463359691.xml"}}
{"date": "2021-08-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-17 00:00:00", "acceptedDate": "2021-08-17 17:08:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000186/0000059478-21-000186-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000186/xslF345X03/wf-form4_162923448789367.xml"}}
{"date": "2021-08-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-17 00:00:00", "acceptedDate": "2021-08-17 17:06:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000185/0000059478-21-000185-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000185/xslF345X03/wf-form4_162923434330772.xml"}}
{"date": "2021-08-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-17 00:00:00", "acceptedDate": "2021-08-17 06:50:37", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000175/0000059478-21-000175-index.htm", "finalLink": ""}}
{"date": "2021-08-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-13 00:00:00", "acceptedDate": "2021-08-13 16:12:57", "formType": "S-8", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521246070/0001193125-21-246070-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521246070/d182377ds8.htm"}}
{"date": "2021-08-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-13 00:00:00", "acceptedDate": "2021-08-13 16:07:27", "formType": "S-8", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521246035/0001193125-21-246035-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521246035/d182375ds8.htm"}}
{"date": "2021-08-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-10 00:00:00", "acceptedDate": "2021-08-10 15:48:02", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121050573/0001209191-21-050573-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121050573/xslF345X03/doc4.xml"}}
{"date": "2021-08-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-09 00:00:00", "acceptedDate": "2021-08-09 12:58:17", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121050316/0001209191-21-050316-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121050316/xslF345X03/doc4.xml"}}
{"date": "2021-08-06", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-06 00:00:00", "acceptedDate": "2021-08-06 12:57:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121050110/0001209191-21-050110-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121050110/xslF345X03/doc4.xml"}}
{"date": "2021-08-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-05 00:00:00", "acceptedDate": "2021-08-05 15:52:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121049909/0001209191-21-049909-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121049909/xslF345X03/doc4.xml"}}
{"date": "2021-08-04", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-04 00:00:00", "acceptedDate": "2021-08-04 15:15:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121049587/0001209191-21-049587-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121049587/xslF345X03/doc4.xml"}}
{"date": "2021-08-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-03 00:00:00", "acceptedDate": "2021-08-03 12:04:04", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000171/0000059478-21-000171-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000171/lly-20210630.htm"}}
{"date": "2021-08-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-08-03 00:00:00", "acceptedDate": "2021-08-03 07:37:21", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000168/0000059478-21-000168-index.htm", "finalLink": ""}}
{"date": "2021-07-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-07-22 00:00:00", "acceptedDate": "2021-07-22 10:47:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121047671/0001209191-21-047671-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121047671/xslF345X03/doc4.xml"}}
{"date": "2021-07-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-07-21 00:00:00", "acceptedDate": "2021-07-21 16:23:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000161/0000059478-21-000161-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000161/xslF345X03/wf-form4_162689898615045.xml"}}
{"date": "2021-07-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-07-21 00:00:00", "acceptedDate": "2021-07-21 16:18:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000159/0000059478-21-000159-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000159/xslF345X03/wf-form4_162689867189510.xml"}}
{"date": "2021-07-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-07-21 00:00:00", "acceptedDate": "2021-07-21 16:10:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000157/0000059478-21-000157-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000157/xslF345X03/wf-form4_162689819259778.xml"}}
{"date": "2021-07-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-07-21 00:00:00", "acceptedDate": "2021-07-21 11:12:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121047547/0001209191-21-047547-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121047547/xslF345X03/doc4.xml"}}
{"date": "2021-07-15", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-07-15 00:00:00", "acceptedDate": "2021-07-15 14:03:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121046740/0001209191-21-046740-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121046740/xslF345X03/doc4.xml"}}
{"date": "2021-07-13", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-07-13 00:00:00", "acceptedDate": "2021-07-13 15:08:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121046471/0001209191-21-046471-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121046471/xslF345X03/doc4.xml"}}
{"date": "2021-07-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-07-12 00:00:00", "acceptedDate": "2021-07-12 12:58:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121046268/0001209191-21-046268-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121046268/xslF345X03/doc4.xml"}}
{"date": "2021-07-07", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-07-07 00:00:00", "acceptedDate": "2021-07-07 09:17:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121045737/0001209191-21-045737-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121045737/xslF345X03/doc4.xml"}}
{"date": "2021-07-06", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-07-06 00:00:00", "acceptedDate": "2021-07-06 13:05:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121045315/0001209191-21-045315-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121045315/xslF345X03/doc4.xml"}}
{"date": "2021-06-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-06-30 00:00:00", "acceptedDate": "2021-06-30 17:03:04", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000155/0000059478-21-000155-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000155/xslF345X02/wf-form3_162508696898656.xml"}}
{"date": "2021-06-25", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-06-25 00:00:00", "acceptedDate": "2021-06-25 13:16:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121043246/0001209191-21-043246-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121043246/xslF345X03/doc4.xml"}}
{"date": "2021-06-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-06-24 00:00:00", "acceptedDate": "2021-06-24 15:52:31", "formType": "11-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000153/0000059478-21-000153-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000153/a2021form11-k.htm"}}
{"date": "2021-06-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-06-23 00:00:00", "acceptedDate": "2021-06-23 16:40:01", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000151/0000059478-21-000151-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000151/xslF345X03/wf-form4_162448078769770.xml"}}
{"date": "2021-06-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-06-23 00:00:00", "acceptedDate": "2021-06-23 16:37:13", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000149/0000059478-21-000149-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000149/xslF345X03/wf-form4_162448060883036.xml"}}
{"date": "2021-06-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-06-23 00:00:00", "acceptedDate": "2021-06-23 16:34:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000147/0000059478-21-000147-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000147/xslF345X03/wf-form4_162448043600293.xml"}}
{"date": "2021-06-11", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-06-11 00:00:00", "acceptedDate": "2021-06-11 10:35:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121039767/0001209191-21-039767-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121039767/xslF345X03/doc4.xml"}}
{"date": "2021-06-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-06-10 00:00:00", "acceptedDate": "2021-06-10 15:35:08", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121039422/0001209191-21-039422-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121039422/xslF345X03/doc4.xml"}}
{"date": "2021-06-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-06-08 00:00:00", "acceptedDate": "2021-06-08 15:16:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121038854/0001209191-21-038854-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121038854/xslF345X03/doc4.xml"}}
{"date": "2021-06-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-06-03 00:00:00", "acceptedDate": "2021-06-03 17:41:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000141/0000059478-21-000141-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000141/xslF345X03/wf-form4_162275644126655.xml"}}
{"date": "2021-05-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-05-27 00:00:00", "acceptedDate": "2021-05-27 06:52:07", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521174261/0001193125-21-174261-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521174261/0001193125-21-174261.txt"}}
{"date": "2021-05-25", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-05-25 00:00:00", "acceptedDate": "2021-05-25 10:39:20", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121035631/0001209191-21-035631-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121035631/xslF345X03/doc4.xml"}}
{"date": "2021-05-24", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-05-24 00:00:00", "acceptedDate": "2021-05-24 11:15:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121035188/0001209191-21-035188-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121035188/xslF345X03/doc4.xml"}}
{"date": "2021-05-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-05-21 00:00:00", "acceptedDate": "2021-05-21 12:57:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121034809/0001209191-21-034809-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121034809/xslF345X03/doc4.xml"}}
{"date": "2021-05-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-05-19 00:00:00", "acceptedDate": "2021-05-19 16:41:12", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000139/0000059478-21-000139-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000139/xslF345X02/wf-form3_162145685840231.xml"}}
{"date": "2021-05-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-05-19 00:00:00", "acceptedDate": "2021-05-19 16:35:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000137/0000059478-21-000137-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000137/xslF345X03/wf-form4_162145650331377.xml"}}
{"date": "2021-05-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-05-19 00:00:00", "acceptedDate": "2021-05-19 16:30:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000135/0000059478-21-000135-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000135/xslF345X03/wf-form4_162145623122121.xml"}}
{"date": "2021-05-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-05-19 00:00:00", "acceptedDate": "2021-05-19 16:27:36", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000133/0000059478-21-000133-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000133/xslF345X03/wf-form4_162145604425259.xml"}}
{"date": "2021-05-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-05-10 00:00:00", "acceptedDate": "2021-05-10 16:33:31", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000130/0000059478-21-000130-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000130/xslF345X02/wf-form3_162067879802322.xml"}}
{"date": "2021-05-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-05-05 00:00:00", "acceptedDate": "2021-05-05 07:37:25", "formType": "SD", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000128/0000059478-21-000128-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000128/formsd2021.htm"}}
{"date": "2021-05-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-05-05 00:00:00", "acceptedDate": "2021-05-05 06:57:27", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000126/0000059478-21-000126-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000126/lly-20210503.htm"}}
{"date": "2021-05-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-05-03 00:00:00", "acceptedDate": "2021-05-03 19:01:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000124/0000059478-21-000124-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000124/xslF345X03/wf-form4_162008288985438.xml"}}
{"date": "2021-04-30", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-04-30 00:00:00", "acceptedDate": "2021-04-30 09:23:35", "formType": "10-Q", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000122/0000059478-21-000122-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000122/lly-20210331.htm"}}
{"date": "2021-04-29", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-04-29 00:00:00", "acceptedDate": "2021-04-29 20:31:19", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000120/0000059478-21-000120-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000120/xslF345X03/wf-form4_161974266436017.xml"}}
{"date": "2021-04-27", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-04-27 00:00:00", "acceptedDate": "2021-04-27 06:48:39", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000117/0000059478-21-000117-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000117/lly-20210427.htm"}}
{"date": "2021-04-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-04-21 00:00:00", "acceptedDate": "2021-04-21 16:32:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000115/0000059478-21-000115-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000115/xslF345X03/wf-form4_161903711512243.xml"}}
{"date": "2021-04-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-04-21 00:00:00", "acceptedDate": "2021-04-21 16:27:54", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000113/0000059478-21-000113-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000113/xslF345X03/wf-form4_161903686122680.xml"}}
{"date": "2021-04-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-04-21 00:00:00", "acceptedDate": "2021-04-21 16:23:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000111/0000059478-21-000111-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000111/xslF345X03/wf-form4_161903661718601.xml"}}
{"date": "2021-04-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-04-20 00:00:00", "acceptedDate": "2021-04-20 08:53:27", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000109/0000059478-21-000109-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000109/llydefa14a2021_supportltr.htm"}}
{"date": "2021-03-29", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-03-29 00:00:00", "acceptedDate": "2021-03-29 17:14:10", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465921003555/0001214659-21-003555-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465921003555/p329213px14a6g.htm"}}
{"date": "2021-03-29", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-03-29 00:00:00", "acceptedDate": "2021-03-29 13:36:01", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465921003531/0001214659-21-003531-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465921003531/p329215px14a6g.htm"}}
{"date": "2021-03-25", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-03-25 00:00:00", "acceptedDate": "2021-03-25 16:02:28", "formType": "PX14A6G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000121465921003437/0001214659-21-003437-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000121465921003437/p325212px14a6g.htm"}}
{"date": "2021-03-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-03-19 00:00:00", "acceptedDate": "2021-03-19 16:49:39", "formType": "DEFA14A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000106/0000059478-21-000106-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000106/llydefa14a2021.htm"}}
{"date": "2021-03-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-03-19 00:00:00", "acceptedDate": "2021-03-19 16:38:20", "formType": "DEF 14A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000104/0000059478-21-000104-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000104/llydef14a2021.htm"}}
{"date": "2021-03-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-03-17 00:00:00", "acceptedDate": "2021-03-17 16:41:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000100/0000059478-21-000100-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000100/xslF345X03/wf-form4_161601369690417.xml"}}
{"date": "2021-03-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-03-17 00:00:00", "acceptedDate": "2021-03-17 16:38:21", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000098/0000059478-21-000098-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000098/xslF345X03/wf-form4_161601346433205.xml"}}
{"date": "2021-03-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-03-17 00:00:00", "acceptedDate": "2021-03-17 16:36:11", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000096/0000059478-21-000096-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000096/xslF345X03/wf-form4_161601335903604.xml"}}
{"date": "2021-03-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-03-10 00:00:00", "acceptedDate": "2021-03-10 14:59:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121019413/0001209191-21-019413-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121019413/xslF345X03/doc4.xml"}}
{"date": "2021-03-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-03-09 00:00:00", "acceptedDate": "2021-03-09 12:26:10", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121018870/0001209191-21-018870-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121018870/xslF345X03/doc4.xml"}}
{"date": "2021-03-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-03-03 00:00:00", "acceptedDate": "2021-03-03 17:19:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000094/0000059478-21-000094-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000094/xslF345X03/wf-form4_161480994384681.xml"}}
{"date": "2021-02-23", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-23 00:00:00", "acceptedDate": "2021-02-23 15:57:12", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000092/0000059478-21-000092-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000092/xslF345X02/wf-form3_161411380781596.xml"}}
{"date": "2021-02-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-18 00:00:00", "acceptedDate": "2021-02-18 17:07:02", "formType": "PRE 14A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000090/0000059478-21-000090-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000090/llypre14a2021.htm"}}
{"date": "2021-02-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-18 00:00:00", "acceptedDate": "2021-02-18 16:29:58", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000088/0000059478-21-000088-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000088/xslF345X03/wf-form4_161368376930201.xml"}}
{"date": "2021-02-18", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-18 00:00:00", "acceptedDate": "2021-02-18 16:26:51", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000086/0000059478-21-000086-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000086/xslF345X03/wf-form4_161368359149440.xml"}}
{"date": "2021-02-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-17 00:00:00", "acceptedDate": "2021-02-17 10:59:12", "formType": "10-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000083/0000059478-21-000083-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000083/lly-20201231.htm"}}
{"date": "2021-02-17", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-17 00:00:00", "acceptedDate": "2021-02-17 07:04:03", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000081/0000059478-21-000081-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000081/lly-20210216.htm"}}
{"date": "2021-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-12 00:00:00", "acceptedDate": "2021-02-12 16:50:37", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000078/0000059478-21-000078-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000078/schedule13g_acimmunesa.htm"}}
{"date": "2021-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-12 00:00:00", "acceptedDate": "2021-02-12 16:43:11", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000076/0000059478-21-000076-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000076/schedule13g_aviditybioscie.htm"}}
{"date": "2021-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-12 00:00:00", "acceptedDate": "2021-02-12 16:31:44", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000074/0000059478-21-000074-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000074/schedule13g_sigilontherape.htm"}}
{"date": "2021-02-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-12 00:00:00", "acceptedDate": "2021-02-12 08:44:51", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521040171/0001193125-21-040171-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521040171/d883909dsc13ga.htm"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:53:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000072/0000059478-21-000072-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000072/xslF345X03/wf-form4_161300839694269.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:51:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000070/0000059478-21-000070-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000070/xslF345X03/wf-form4_161300828293741.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:50:12", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000068/0000059478-21-000068-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000068/xslF345X03/wf-form4_161300819720563.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:48:41", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000066/0000059478-21-000066-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000066/xslF345X03/wf-form4_161300810149825.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:46:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000064/0000059478-21-000064-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000064/xslF345X03/wf-form4_161300799296197.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:44:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000062/0000059478-21-000062-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000062/xslF345X03/wf-form4_161300786939313.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:43:07", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000060/0000059478-21-000060-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000060/xslF345X03/wf-form4_161300776263267.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:41:03", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000058/0000059478-21-000058-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000058/xslF345X03/wf-form4_161300764206200.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:39:15", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000056/0000059478-21-000056-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000056/xslF345X03/wf-form4_161300753846399.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:37:39", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000054/0000059478-21-000054-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000054/xslF345X03/wf-form4_161300744414496.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:36:09", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000052/0000059478-21-000052-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000052/xslF345X03/wf-form4_161300734811911.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:34:32", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000050/0000059478-21-000050-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000050/xslF345X03/wf-form4_161300725044581.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:32:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000048/0000059478-21-000048-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000048/xslF345X03/wf-form4_161300715740126.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:31:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000046/0000059478-21-000046-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000046/xslF345X03/wf-form4_161300706667100.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:29:50", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000044/0000059478-21-000044-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000044/xslF345X03/wf-form4_161300696896190.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 20:27:25", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000042/0000059478-21-000042-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000042/xslF345X03/wf-form4_161300682800162.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 12:13:23", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000040/0000059478-21-000040-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000040/xslF345X02/wf-form3_161297718822063.xml"}}
{"date": "2021-02-10", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-10 00:00:00", "acceptedDate": "2021-02-10 10:52:41", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000110465921017977/0001104659-21-017977-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000110465921017977/tv0761-elilillyandco.htm"}}
{"date": "2021-02-09", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-09 00:00:00", "acceptedDate": "2021-02-09 07:14:04", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521033302/0001193125-21-033302-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521033302/d111779dex991.htm"}}
{"date": "2021-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-03 00:00:00", "acceptedDate": "2021-02-03 20:22:56", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000038/0000059478-21-000038-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000038/xslF345X03/wf-form4_161240176096650.xml"}}
{"date": "2021-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-03 00:00:00", "acceptedDate": "2021-02-03 19:26:23", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000036/0000059478-21-000036-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000036/xslF345X03/wf-form4_161239834705746.xml"}}
{"date": "2021-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-03 00:00:00", "acceptedDate": "2021-02-03 19:02:06", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000032/0000059478-21-000032-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000032/xslF345X03/wf-form4_161239691232704.xml"}}
{"date": "2021-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-03 00:00:00", "acceptedDate": "2021-02-03 18:57:57", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000030/0000059478-21-000030-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000030/xslF345X03/wf-form4_161239665929320.xml"}}
{"date": "2021-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-03 00:00:00", "acceptedDate": "2021-02-03 18:51:26", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000028/0000059478-21-000028-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000028/xslF345X03/wf-form4_161239627141009.xml"}}
{"date": "2021-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-03 00:00:00", "acceptedDate": "2021-02-03 18:43:14", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000026/0000059478-21-000026-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000026/xslF345X03/wf-form4_161239577477766.xml"}}
{"date": "2021-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-03 00:00:00", "acceptedDate": "2021-02-03 18:38:28", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000024/0000059478-21-000024-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000024/xslF345X03/wf-form4_161239548901874.xml"}}
{"date": "2021-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-03 00:00:00", "acceptedDate": "2021-02-03 18:33:59", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000022/0000059478-21-000022-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000022/xslF345X03/wf-form4_161239521546685.xml"}}
{"date": "2021-02-03", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-03 00:00:00", "acceptedDate": "2021-02-03 18:29:46", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000020/0000059478-21-000020-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000020/xslF345X03/wf-form4_161239497033708.xml"}}
{"date": "2021-02-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-02 00:00:00", "acceptedDate": "2021-02-02 17:20:40", "formType": "3", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000018/0000059478-21-000018-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000018/xslF345X02/wf-form3_161230442543252.xml"}}
{"date": "2021-02-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-02 00:00:00", "acceptedDate": "2021-02-02 17:16:16", "formType": "5", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000016/0000059478-21-000016-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000016/xslF345X03/wf-form5_161230415317974.xml"}}
{"date": "2021-02-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-02 00:00:00", "acceptedDate": "2021-02-02 17:12:57", "formType": "5", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000014/0000059478-21-000014-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000014/xslF345X03/wf-form5_161230396101811.xml"}}
{"date": "2021-02-02", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-02-02 00:00:00", "acceptedDate": "2021-02-02 17:09:11", "formType": "5", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000012/0000059478-21-000012-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000012/xslF345X03/wf-form5_161230372271295.xml"}}
{"date": "2021-01-29", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-29 00:00:00", "acceptedDate": "2021-01-29 09:57:06", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000083423721003899/0000834237-21-003899-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000083423721003899/us5324571083_012921.txt"}}
{"date": "2021-01-29", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-29 00:00:00", "acceptedDate": "2021-01-29 06:32:40", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000010/0000059478-21-000010-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000010/lly-20210129.htm"}}
{"date": "2021-01-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-22 00:00:00", "acceptedDate": "2021-01-22 16:26:04", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000089924321002923/0000899243-21-002923-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000089924321002923/xslF345X03/doc4.xml"}}
{"date": "2021-01-22", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-22 00:00:00", "acceptedDate": "2021-01-22 09:02:23", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521014250/0001193125-21-014250-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521014250/d111806dsctota.htm"}}
{"date": "2021-01-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-21 00:00:00", "acceptedDate": "2021-01-21 21:49:44", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000008/0000059478-21-000008-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000008/xslF345X03/wf-form4_161128377092505.xml"}}
{"date": "2021-01-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-21 00:00:00", "acceptedDate": "2021-01-21 21:43:52", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000006/0000059478-21-000006-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000006/xslF345X03/wf-form4_161128341846245.xml"}}
{"date": "2021-01-21", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-21 00:00:00", "acceptedDate": "2021-01-21 14:30:03", "formType": "SC 13G/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000156761921001320/0001567619-21-001320-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000156761921001320/doc1.htm"}}
{"date": "2021-01-20", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-20 00:00:00", "acceptedDate": "2021-01-20 06:43:27", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521011883/0001193125-21-011883-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521011883/d113040dsctota.htm"}}
{"date": "2021-01-19", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-19 00:00:00", "acceptedDate": "2021-01-19 13:04:49", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121003958/0001209191-21-003958-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121003958/xslF345X03/doc4.xml"}}
{"date": "2021-01-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-14 00:00:00", "acceptedDate": "2021-01-14 16:47:26", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521009104/0001193125-21-009104-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521009104/d104744dsctota.htm"}}
{"date": "2021-01-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-14 00:00:00", "acceptedDate": "2021-01-14 11:23:55", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121003538/0001209191-21-003538-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121003538/xslF345X03/doc4.xml"}}
{"date": "2021-01-14", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-14 00:00:00", "acceptedDate": "2021-01-14 07:30:31", "formType": "8-K", "link": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000004/0000059478-21-000004-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000005947821000004/lly-20210113.htm"}}
{"date": "2021-01-12", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-12 00:00:00", "acceptedDate": "2021-01-12 11:27:18", "formType": "4", "link": "https://www.sec.gov/Archives/edgar/data/59478/000120919121003183/0001209191-21-003183-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000120919121003183/xslF345X03/doc4.xml"}}
{"date": "2021-01-08", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-08 00:00:00", "acceptedDate": "2021-01-08 06:04:58", "formType": "SC 13G", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521004622/0001193125-21-004622-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521004622/d39619dsc13g.htm"}}
{"date": "2021-01-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-05 00:00:00", "acceptedDate": "2021-01-05 06:45:21", "formType": "SC TO-T/A", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521001455/0001193125-21-001455-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521001455/d32226dsctota.htm"}}
{"date": "2021-01-05", "symbol": "LLY", "type": "sec_filings", "result": {"symbol": "LLY", "cik": "0000059478", "filingDate": "2021-01-05 00:00:00", "acceptedDate": "2021-01-05 06:40:59", "formType": "CORRESP", "link": "https://www.sec.gov/Archives/edgar/data/59478/000119312521001454/0001193125-21-001454-index.htm", "finalLink": "https://www.sec.gov/Archives/edgar/data/59478/000119312521001454/filename1.htm"}}
{"date": "2025-12-22", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-22 10:01:05", "publisher": "Zacks Investment Research", "title": "Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-is-attracting-investor-attention-20251222.jpg", "site": "zacks.com", "text": "Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.", "url": "https://www.zacks.com/stock/news/2807217/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2807217"}}
{"date": "2025-12-22", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-22 05:40:53", "publisher": "Defense World", "title": "Red Door Wealth Management LLC Purchases 866 Shares of Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/red-door-wealth-management-llc-purchases-866-shares-of-20251222.jpg", "site": "defenseworld.net", "text": "Red Door Wealth Management LLC grew its position in shares of Eli Lilly and Company (NYSE: LLY) by 35.5% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,303 shares of the company's stock after buying an additional 866 shares during", "url": "https://www.defenseworld.net/2025/12/22/red-door-wealth-management-llc-purchases-866-shares-of-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-22", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-22 05:40:53", "publisher": "Defense World", "title": "Eli Lilly and Company $LLY Holdings Decreased by Trust Point Inc.", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-holdings-decreased-by-trust-20251222.jpg", "site": "defenseworld.net", "text": "Trust Point Inc. reduced its position in shares of Eli Lilly and Company (NYSE: LLY) by 23.5% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,658 shares of the company's stock after selling 818 shares during the period.", "url": "https://www.defenseworld.net/2025/12/22/eli-lilly-and-company-lly-holdings-decreased-by-trust-point-inc.html"}}
{"date": "2025-12-22", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-22 05:40:52", "publisher": "Defense World", "title": "Clarity Financial LLC Grows Position in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/clarity-financial-llc-grows-position-in-eli-lilly-and-20251222.jpg", "site": "defenseworld.net", "text": "Clarity Financial LLC increased its holdings in Eli Lilly and Company (NYSE: LLY) by 2.6% in the undefined quarter, according to its most recent filing with the SEC. The institutional investor owned 37,674 shares of the company's stock after buying an additional 969 shares during the quarter. Eli Lilly and Company comprises approximately", "url": "https://www.defenseworld.net/2025/12/22/clarity-financial-llc-grows-position-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-22", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-22 05:40:48", "publisher": "Defense World", "title": "Perpetual Ltd Acquires 1,236 Shares of Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/perpetual-ltd-acquires-1236-shares-of-eli-lilly-and-20251222.jpg", "site": "defenseworld.net", "text": "Perpetual Ltd raised its stake in shares of Eli Lilly and Company (NYSE: LLY) by 82.4% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 2,736 shares of the company's stock after acquiring an additional 1,236 shares during the period. Perpetual Ltd's holdings in Eli Lilly", "url": "https://www.defenseworld.net/2025/12/22/perpetual-ltd-acquires-1236-shares-of-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-21 03:22:53", "publisher": "Defense World", "title": "BDF Gestion Sells 4,149 Shares of Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/bdf-gestion-sells-4149-shares-of-eli-lilly-and-20251221.jpg", "site": "defenseworld.net", "text": "BDF Gestion decreased its holdings in Eli Lilly and Company (NYSE: LLY) by 17.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 19,949 shares of the company's stock after selling 4,149 shares during the period. Eli Lilly and Company", "url": "https://www.defenseworld.net/2025/12/21/bdf-gestion-sells-4149-shares-of-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-20", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-20 08:31:05", "publisher": "Benzinga", "title": "Benzinga Bulls And Bears: Carnival, Caterpillar, Meta  And Markets Make Modest Gains", "image": "https://images.financialmodelingprep.com/news/benzinga-bulls-and-bears-carnival-caterpillar-meta-and-markets-20251220.jpeg", "site": "feeds.benzinga.com", "text": "Benzinga examined the prospects for many investors' favorite stocks over the last week - here's a look at some of our top stories.", "url": "https://www.benzinga.com/markets/market-summary/25/12/49525820/benzinga-bulls-and-bears-carnival-caterpillar-meta-and-markets-make-modest-gains"}}
{"date": "2025-12-20", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-20 08:00:00", "publisher": "Seeking Alpha", "title": "Our Top 10 High-Growth Dividend Stocks - December 2025", "image": "https://images.financialmodelingprep.com/news/our-top-10-highgrowth-dividend-stocks-december-2025-20251220.jpg", "site": "seekingalpha.com", "text": "The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rate both quantitatively and qualitatively and select the top 10 names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and positive momentum, and is suitable for investors in the accumulation phase.", "url": "https://seekingalpha.com/article/4853813-our-top-10-high-growth-dividend-stocks-december-2025"}}
{"date": "2025-12-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-19 16:01:00", "publisher": "GuruFocus", "title": "Vanguard Health Care Fund's Strategic Moves: Spotlight on AbbVie Inc", "image": "https://images.financialmodelingprep.com/news/vanguard-health-care-funds-strategic-moves-spotlight-on-abbvie-20251219.png", "site": "gurufocus.com", "text": "Exploring the Fund's Recent Portfolio Adjustments Vanguard Health Care Fund (Trades, Portfolio) recently submitted its N-PORT filing for the third quarter of 2", "url": "https://www.gurufocus.com/news/4078525/vanguard-health-care-funds-strategic-moves-spotlight-on-abbvie-inc"}}
{"date": "2025-12-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-19 15:00:52", "publisher": "Schwab Network", "title": "Graham: A.I. & Fed Top 2026 Themes, Top Picks in ANET, COHR & LLY", "image": "https://images.financialmodelingprep.com/news/graham-ai-fed-top-2026-themes-top-picks-in-20251219.jpg", "site": "youtube.com", "text": "Andrew Graham says the next couple weeks will be hard to \"separate the signal from the noise\" in the A.I.-centric rebound due to low volume trading.", "url": "https://www.youtube.com/watch?v=mCDxvCKGyBc"}}
{"date": "2025-12-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-19 10:45:00", "publisher": "Market Watch", "title": "Trump to announce new drug-pricing deals later today", "image": "https://images.financialmodelingprep.com/news/trump-to-announce-new-drugpricing-deals-later-today-20251219.jpg", "site": "marketwatch.com", "text": "The White House is getting ready to announce more deals with drugmakers aimed at lowering drug prices.", "url": "https://www.marketwatch.com/story/trump-to-announce-new-drug-pricing-deals-later-today-8261bdfe"}}
{"date": "2025-12-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-19 07:37:00", "publisher": "GuruFocus", "title": "First Look: Oracle leads TikTok JV, CPI cools, Nike drops", "image": "https://images.financialmodelingprep.com/news/first-look-oracle-leads-tiktok-jv-cpi-cools-nike-20251219.png", "site": "gurufocus.com", "text": "Stock News TikTok inks U.S. spinoff deal: Oracle (ORCL) and partners Silver Lake and MGX will take major stakes in a new TikTok U.S. venture, with U.S. data hos", "url": "https://www.gurufocus.com/news/4077544/first-look-oracle-leads-tiktok-jv-cpi-cools-nike-drops"}}
{"date": "2025-12-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-19 07:23:21", "publisher": "Benzinga", "title": "Mounjaro Maker Eli Lilly Improves In Quality As BofA Sees 'Room For Stock Upside' With $3 Billion In Sales By 2026", "image": "https://images.financialmodelingprep.com/news/mounjaro-maker-eli-lilly-improves-in-quality-as-bofa-20251219.jpg", "site": "benzinga.com", "text": "Weight loss drug Mounjaro's manufacturer, Eli Lilly and Co. (NYSE: LLY) has crossed a significant threshold in Benzinga Edge's Stock Rankings, moving into the top decile for quality this week. This improvement in fundamental strength coincides with a bullish note from Bank of America, which argues the market is still underestimating the pharmaceutical giant's dominance in the obesity sector.", "url": "https://www.benzinga.com/markets/equities/25/12/49503246/mounjaro-maker-eli-lilly-improves-in-quality-as-bofa-sees-room-for-stock-upside-with-3-billion-in-sales-by-2026"}}
{"date": "2025-12-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-19 06:06:34", "publisher": "Defense World", "title": "Bennett Selby Investments LP Raises Holdings in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/bennett-selby-investments-lp-raises-holdings-in-eli-lilly-20251219.jpg", "site": "defenseworld.net", "text": "Bennett Selby Investments LP increased its stake in shares of Eli Lilly and Company (NYSE: LLY) by 44.5% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,344 shares of the company's stock after purchasing an additional 722 shares during the", "url": "https://www.defenseworld.net/2025/12/19/bennett-selby-investments-lp-raises-holdings-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-19 05:28:54", "publisher": "Defense World", "title": "Czech National Bank Has $154.06 Million Stock Position in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/czech-national-bank-has-15406-million-stock-position-in-20251219.jpg", "site": "defenseworld.net", "text": "Czech National Bank boosted its stake in shares of Eli Lilly and Company (NYSE: LLY) by 5.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 201,919 shares of the company's stock after acquiring an additional 9,641 shares during the", "url": "https://www.defenseworld.net/2025/12/19/czech-national-bank-has-154-06-million-stock-position-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-19 04:48:43", "publisher": "Defense World", "title": "Chesley Taft & Associates LLC Decreases Stock Holdings in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/chesley-taft-associates-llc-decreases-stock-holdings-in-eli-20251219.jpg", "site": "defenseworld.net", "text": "Chesley Taft and Associates LLC trimmed its position in shares of Eli Lilly and Company (NYSE: LLY) by 8.2% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 20,923 shares of the company's stock after selling 1,879 shares", "url": "https://www.defenseworld.net/2025/12/19/chesley-taft-associates-llc-decreases-stock-holdings-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-19 03:24:56", "publisher": "Defense World", "title": "Armstrong Advisory Group Inc. Grows Stock Holdings in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/armstrong-advisory-group-inc-grows-stock-holdings-in-eli-20251219.jpg", "site": "defenseworld.net", "text": "Armstrong Advisory Group Inc. increased its position in shares of Eli Lilly and Company (NYSE: LLY) by 53.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,770 shares of the company's stock after purchasing an additional", "url": "https://www.defenseworld.net/2025/12/19/armstrong-advisory-group-inc-grows-stock-holdings-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 18:19:00", "publisher": "The Motley Fool", "title": "Better Buy in 2026: UnitedHealth Group or Eli Lilly?", "image": "https://images.financialmodelingprep.com/news/better-buy-in-2026-unitedhealth-group-or-eli-lilly-20251218.jpg", "site": "fool.com", "text": "UnitedHealth Group has had a tumultuous year, marred by poor performance and controversy. Eli Lilly has thrived as it's taken control of the obesity drug market.", "url": "https://www.fool.com/investing/2025/12/18/better-buy-in-2026-unitedhealth-group-or-eli-lilly/"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 17:35:00", "publisher": "GuruFocus", "title": "Market Today: CPI Cools; Micron Lifts AI Stocks (MU)", "image": "https://images.financialmodelingprep.com/news/market-today-cpi-cools-micron-lifts-ai-stocks-mu-20251218.png", "site": "gurufocus.com", "text": "Guru Stock PicksCI Select Canadian Equity Fund has made the following transactions:Reduce in TSX: ABX by 9.95%Sold out in TSX:DOLAdd in TSX: KEY by 27.62%New posi", "url": "https://www.gurufocus.com/news/4077010/market-today-cpi-cools-micron-lifts-ai-stocks-mu"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 17:00:13", "publisher": "CNBC Television", "title": "Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound", "image": "https://images.financialmodelingprep.com/news/eli-lilly-says-obesity-pill-helps-maintain-weight-loss-after-20251218.jpg", "site": "youtube.com", "text": "Eli Lilly on Thursday said its closely watched obesity pill helped patients maintain the majority of their weight loss after they switched directly from taking the company's injection Zepbound and Novo Nordisk's rival shot Wegovy in a late-stage trial. CNBC's Annika Kim Constantino has the details.", "url": "https://www.youtube.com/shorts/Dco1T4-Nyqw"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 13:45:00", "publisher": "The Motley Fool", "title": "Worried About the Stock Market in 2026? These 3 Stocks Did Well During the Last Bear Market.", "image": "https://images.financialmodelingprep.com/news/worried-about-the-stock-market-in-2026-these-3-20251218.jpg", "site": "fool.com", "text": "Invest in stocks with good fundamentals, solid growth prospects, and steady dividends. These blue chip stocks have strong businesses that generate consistently strong results.", "url": "https://www.fool.com/investing/2025/12/18/worried-about-the-market-in-2026-these-3-stocks/"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 12:00:24", "publisher": "Investopedia", "title": "Dow Jones Today: Stock Indexes Jump After Inflation Data Comes in Cooler Than Expected; Dow, S&P 500 Poised to Snap 4-Session Skids; Gold Sets Record", "image": "https://images.financialmodelingprep.com/news/dow-jones-today-stock-indexes-jump-after-inflation-data-20251218.jpg", "site": "investopedia.com", "text": "Major stock indexes surged Thursday after delayed Consumer Price Index data came in better than expected, with the blue-chip Dow Jones Industrial Average and benchmark S&P 500 poised to end four-session losing streaks.", "url": "https://www.investopedia.com/dow-jones-today-12182025-11871902"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 11:54:00", "publisher": "Barrons", "title": "Lose Weight on Zepbound, Keep It Off With Eli Lilly's New Pill? Data Say That Works.", "image": "https://images.financialmodelingprep.com/news/lose-weight-on-zepbound-keep-it-off-with-eli-20251218.jpg", "site": "barrons.com", "text": "Eli Lilly has a new pill, called orforglipron, it plans to launch next year.", "url": "https://www.barrons.com/articles/eli-lilly-novo-nordisk-stock-wegovy-zepbound-weight-loss-82026738"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 11:31:05", "publisher": "Zacks Investment Research", "title": "3 Momentum Stocks That Could Continue Their Strong Run in 2026", "image": "https://images.financialmodelingprep.com/news/3-momentum-stocks-that-could-continue-their-strong-run-20251218.jpg", "site": "zacks.com", "text": "AI and healthcare momentum remain strong heading into 2026. NVDA, AVGO and LLY stand out as high-growth leaders with earnings power still driving their rallies.", "url": "https://www.zacks.com/stock/news/2806261/3-momentum-stocks-that-could-continue-their-strong-run-in-2026?cid=CS-STOCKNEWSAPI-FT-analyst_blog|investment_ideas-2806261"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 11:29:06", "publisher": "Benzinga", "title": "After Wegovy, Zepbound Shots, This Eli Lilly Oral Pill Can Help Maintain Weight Loss", "image": "https://images.financialmodelingprep.com/news/after-wegovy-zepbound-shots-this-eli-lilly-oral-pill-20251218.jpg", "site": "benzinga.com", "text": "The global obesity epidemic has spurred pharmaceutical companies to invest heavily in developing effective weight management solutions, leading to a surge in clinical trials for anti-obesity medications.", "url": "https://www.benzinga.com/news/health-care/25/12/49484725/after-wegovy-zepbound-shots-this-eli-lilly-oral-pill-can-help-maintain-weight-loss"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 09:49:34", "publisher": "Investors Business Daily", "title": "Eli Lilly's Weight-Loss Pill Succeeds In A First-Of-Its-Kind Study", "image": "https://images.financialmodelingprep.com/news/eli-lillys-weightloss-pill-succeeds-in-a-firstofitskind-study-20251218.jpg", "site": "investors.com", "text": "Eli Lilly proved the worth of its obesity pill Thursday. A study showed patients who switched to orforglipron mostly kept the weight off.", "url": "https://www.investors.com/news/technology/eli-lilly-weight-loss-pill-novo-nordisk-cagrisema/"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 07:38:00", "publisher": "GuruFocus", "title": "First Look: Micron beats, Oracle drags AI, Medline pops", "image": "https://images.financialmodelingprep.com/news/first-look-micron-beats-oracle-drags-ai-medline-pops-20251218.png", "site": "gurufocus.com", "text": "Stock News Powerball jackpot nears record: Disney (DIS) network reports the Powerball jackpot has risen to an estimated $1.5 billion for Saturday after no winne", "url": "https://www.gurufocus.com/news/4075479/first-look-micron-beats-oracle-drags-ai-medline-pops"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 06:53:00", "publisher": "The Motley Fool", "title": "Eli Lilly Scores Another Major Win: Time to Buy?", "image": "https://images.financialmodelingprep.com/news/eli-lilly-scores-another-major-win-time-to-buy-20251218.jpg", "site": "fool.com", "text": "Eli Lilly's next-gen anti-obesity candidate hit it out of the park in a phase 3 study. This should help solidify the company's lead in this niche of the industry.", "url": "https://www.fool.com/investing/2025/12/18/eli-lilly-scores-another-major-win-time-to-buy/"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 06:45:00", "publisher": "PRNewsWire", "title": "Lilly's orforglipron helped people maintain weight loss after switching from injectable incretins to oral GLP-1 therapy in first-of-its-kind Phase 3 trial", "image": "https://images.financialmodelingprep.com/news/lillys-orforglipron-helped-people-maintain-weight-loss-after-switching-20251218.jpg", "site": "prnewswire.com", "text": "In ATTAIN-MAINTAIN, orforglipron achieved the primary and all key secondary endpoints for weight maintenance vs. placebo at 52 weeks following weight loss on Wegovy or Zepbound Participants who switched to orforglipron from Wegovy maintained all but 0.9 kg of their previously achieved weight loss on average Lilly has submitted orforglipron to the U.S. Food and Drug Administration for the treatment of obesity INDIANAPOLIS , Dec. 18, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the ATTAIN-MAINTAIN trial.", "url": "https://www.prnewswire.com/news-releases/lillys-orforglipron-helped-people-maintain-weight-loss-after-switching-from-injectable-incretins-to-oral-glp-1-therapy-in-first-of-its-kind-phase-3-trial-302645471.html"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 05:26:42", "publisher": "Defense World", "title": "Eli Lilly and Company $LLY Shares Acquired by Grant Private Wealth Management Inc", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-shares-acquired-by-grant-20251218.jpg", "site": "defenseworld.net", "text": "Grant Private Wealth Management Inc lifted its position in shares of Eli Lilly and Company (NYSE: LLY) by 118.8% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 954 shares of the company's stock after acquiring an additional", "url": "https://www.defenseworld.net/2025/12/18/eli-lilly-and-company-lly-shares-acquired-by-grant-private-wealth-management-inc.html"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 04:54:54", "publisher": "Defense World", "title": "Canandaigua National Bank & Trust Co. Raises Holdings in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/canandaigua-national-bank-trust-co-raises-holdings-in-eli-20251218.jpg", "site": "defenseworld.net", "text": "Canandaigua National Bank and Trust Co. boosted its stake in shares of Eli Lilly and Company (NYSE: LLY) by 10.2% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,992 shares of the company's stock after acquiring an additional", "url": "https://www.defenseworld.net/2025/12/18/canandaigua-national-bank-trust-co-raises-holdings-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 04:54:54", "publisher": "Defense World", "title": "Eli Lilly and Company $LLY Shares Sold by Canandaigua National Trust Co of Florida", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-shares-sold-by-canandaigua-20251218.jpg", "site": "defenseworld.net", "text": "Canandaigua National Trust Co of Florida lowered its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 14.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,688 shares of the company's stock after selling 3,048 shares", "url": "https://www.defenseworld.net/2025/12/18/eli-lilly-and-company-lly-shares-sold-by-canandaigua-national-trust-co-of-florida.html"}}
{"date": "2025-12-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-18 03:50:41", "publisher": "Defense World", "title": "Assenagon Asset Management S.A. Sells 908,085 Shares of Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/assenagon-asset-management-sa-sells-908085-shares-of-eli-20251218.jpg", "site": "defenseworld.net", "text": "Assenagon Asset Management S.A. lessened its stake in Eli Lilly and Company (NYSE: LLY) by 61.3% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 572,946 shares of the company's stock after selling 908,085 shares during the quarter. Eli Lilly and Company comprises", "url": "https://www.defenseworld.net/2025/12/18/assenagon-asset-management-s-a-sells-908085-shares-of-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-17", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-17 23:56:14", "publisher": "Reuters", "title": "Eli Lilly cuts price of diabetes, weight-loss drugs in Canada, Globe and Mail reports", "image": "https://images.financialmodelingprep.com/news/eli-lilly-cuts-price-of-diabetes-weightloss-drugs-in-20251217.jpg", "site": "reuters.com", "text": "Eli Lilly is slashing the prices of its popular diabetes and weight-loss drugs Mounjaro and Zepbound by 20% or more in Canada, the Globe and Mail reported on Wednesday, citing a note to pharmacies issued by the U.S.-based drugmaker.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-cuts-price-diabetes-weight-loss-drugs-canada-globe-mail-reports-2025-12-18/"}}
{"date": "2025-12-17", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-17 17:35:00", "publisher": "GuruFocus", "title": "Market Today: Medline IPO Pops, Micron Beats, WBD-NFLX Deal", "image": "https://images.financialmodelingprep.com/news/market-today-medline-ipo-pops-micron-beats-wbdnflx-deal-20251217.png", "site": "gurufocus.com", "text": "Stock News Dalio, Dell back Trump accounts: Ray Dalio (Trades, Portfolio) and Barbara Dalio pledged $75 million to seed child Trump accounts, joinin", "url": "https://www.gurufocus.com/news/4074734/market-today-medline-ipo-pops-micron-beats-wbdnflx-deal"}}
{"date": "2025-12-17", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-17 14:28:00", "publisher": "Market Watch", "title": "Eli Lilly's stock has crushed Nvidia's in recent weeks. What history has to say about that.", "image": "https://images.financialmodelingprep.com/news/eli-lillys-stock-has-crushed-nvidias-in-recent-weeks-20251217.jpg", "site": "marketwatch.com", "text": "History suggests Nvidia should modestly beat Eli Lilly over the next roughly two months, notes a DataTrek analyst  but there are some caveats", "url": "https://www.marketwatch.com/story/eli-lillys-stock-has-crushed-nvidias-in-recent-weeks-what-history-has-to-say-about-that-b24a8a37"}}
{"date": "2025-12-17", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-17 10:05:18", "publisher": "24/7 Wall Street", "title": "Billionaire With 30 Years of 30% CAGR Gains Dumped Nvidia, Palantir, and Eli Lilly", "image": "https://images.financialmodelingprep.com/news/billionaire-with-30-years-of-30-cagr-gains-dumped-20251217.jpg", "site": "247wallst.com", "text": "Very few investors can match Stanley Druckenmiller.", "url": "https://247wallst.com/investing/2025/12/17/billionaire-with-30-years-of-30-cagr-gains-dumped-nvidia-palantir-and-eli-lilly/"}}
{"date": "2025-12-16", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-16 14:29:09", "publisher": "CNBC", "title": "Healthy Returns: 2026 will be the year of obesity pillsfrom Novo Nordisk, Eli Lilly", "image": "https://images.financialmodelingprep.com/news/healthy-returns-2026-will-be-the-year-of-obesity-20251216.jpg", "site": "cnbc.com", "text": "2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.", "url": "https://www.cnbc.com/2025/12/16/healthy-returns-obesity-pills-from-novo-nordisk-eli-lilly-are-coming.html"}}
{"date": "2025-12-16", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-16 11:30:00", "publisher": "The Motley Fool", "title": "Is Eli Lilly a Buy Before 2026?", "image": "https://images.financialmodelingprep.com/news/is-eli-lilly-a-buy-before-2026-20251216.jpg", "site": "fool.com", "text": "Eli Lilly's next-generation obesity treatment may prove highly effective for patients who have high BMI or suffer from obesity-related complications. The company has a diversified portfolio across weight management, neuroscience, and oncology, setting it up for sustained growth through 2026.", "url": "https://www.fool.com/investing/2025/12/16/is-eli-lilly-a-buy-before-2026/"}}
{"date": "2025-12-16", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-16 10:00:00", "publisher": "PRNewsWire", "title": "Lilly to participate in J.P. Morgan Healthcare Conference", "image": "https://images.financialmodelingprep.com/news/lilly-to-participate-in-jp-morgan-healthcare-conference-20251216.jpg", "site": "prnewswire.com", "text": "INDIANAPOLIS , Dec. 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the 44th Annual J.P. Morgan Healthcare Conference, Jan. 12-15, 2025.", "url": "https://www.prnewswire.com/news-releases/lilly-to-participate-in-jp-morgan-healthcare-conference-302640506.html"}}
{"date": "2025-12-16", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-16 09:17:44", "publisher": "MarketBeat", "title": "3 Healthcare Giants Just Raised DividendsHere's Who Pays the Most", "image": "https://images.financialmodelingprep.com/news/3-healthcare-giants-just-raised-dividendsheres-who-pays-the-20251216.jpg", "site": "marketbeat.com", "text": "Major players in healthcare are increasing their commitments to return capital to shareholders, resulting in significantly higherdividends. Recent dividend announcements from major companies in the sector highlight evolving capital return strategies.", "url": "https://www.marketbeat.com/stock-ideas/3-healthcare-giants-just-raised-dividendsheres-who-pays-the-most/"}}
{"date": "2025-12-16", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-16 08:56:42", "publisher": "Defense World", "title": "Central Pacific Bank Trust Division Increases Stock Holdings in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/central-pacific-bank-trust-division-increases-stock-holdings-in-20251216.jpg", "site": "defenseworld.net", "text": "Central Pacific Bank Trust Division boosted its position in shares of Eli Lilly and Company (NYSE: LLY) by 25.8% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,990 shares of the company's stock after acquiring an", "url": "https://www.defenseworld.net/2025/12/16/central-pacific-bank-trust-division-increases-stock-holdings-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-16", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-16 08:09:50", "publisher": "247 Wallst", "title": "Here Are Tuesdays Top Wall Street Analyst Research Calls: Allstate, Chubb Ltd., Eli Lilly, KLA Corp., Lockheed Martin, MongoDB, Roku, and More", "image": "https://images.financialmodelingprep.com/news/here-are-tuesdays-top-wall-street-analyst-research-calls-20251216.jpg", "site": "247wallst.com", "text": "Pre-Market Stock Futures: The futures are trading lower after what started as a bounce-back Monday turned into a reversal Monday, as the AI/Datacenter rotation trade continues to gather steam during the last whole trading week of 2025. Stocks rallied Monday on the open as traders tried to inject some holiday spirit, but by 12 noon... Here Are Tuesday's Top Wall Street Analyst Research Calls: Allstate, Chubb Ltd., Eli Lilly, KLA Corp., Lockheed Martin, MongoDB, Roku, and More.", "url": "https://247wallst.com/investing/2025/12/16/here-are-tuesdays-top-wall-street-analyst-research-calls-allstate-chubb-ltd-eli-lilly-kla-corp-lockheed-martin-mongodb-roku-and-more/"}}
{"date": "2025-12-16", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-16 07:50:42", "publisher": "Defense World", "title": "Eli Lilly and Company $LLY Shares Sold by GAMMA Investing LLC", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-shares-sold-by-gamma-20251216.jpg", "site": "defenseworld.net", "text": "GAMMA Investing LLC reduced its position in Eli Lilly and Company (NYSE: LLY) by 4.5% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,180 shares of the company's stock after selling 804 shares during the quarter.", "url": "https://www.defenseworld.net/2025/12/16/eli-lilly-and-company-lly-shares-sold-by-gamma-investing-llc.html"}}
{"date": "2025-12-16", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-16 06:48:31", "publisher": "Benzinga", "title": "Novo Nordisk Loses Momentum As Eli Lilly Pulls Ahead In Weight-Loss Wars", "image": "https://images.financialmodelingprep.com/news/novo-nordisk-loses-momentum-as-eli-lilly-pulls-ahead-20251216.jpg", "site": "benzinga.com", "text": "Novo Nordisk A/S (NYSE: NVO) stock has plunged around 41% year to date, as per data from Benzinga Pro.", "url": "https://www.benzinga.com/news/health-care/25/12/49415457/novo-nordisk-loses-momentum-as-eli-lilly-pulls-ahead-in-weight-loss-wars"}}
{"date": "2025-12-16", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-16 06:02:48", "publisher": "Defense World", "title": "Eli Lilly and Company $LLY Shares Purchased by Corient Private Wealth LLC", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-shares-purchased-by-corient-20251216.jpg", "site": "defenseworld.net", "text": "Corient Private Wealth LLC increased its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 3.5% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 620,126 shares of the company's stock after buying an additional 20,698 shares during the", "url": "https://www.defenseworld.net/2025/12/16/eli-lilly-and-company-lly-shares-purchased-by-corient-private-wealth-llc.html"}}
{"date": "2025-12-15", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-15 15:30:00", "publisher": "The Motley Fool", "title": "2 Predictions for Eli Lilly in 2026", "image": "https://images.financialmodelingprep.com/news/2-predictions-for-eli-lilly-in-2026-20251215.jpg", "site": "fool.com", "text": "Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also looks ripe to announce a stock split.", "url": "https://www.fool.com/investing/2025/12/15/2-predictions-for-eli-lilly-in-2026/"}}
{"date": "2025-12-15", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-15 12:05:40", "publisher": "Benzinga", "title": "Eli Lilly's Obesity Drug Dominance Still Underpriced By Market, Bank of America Says", "image": "https://images.financialmodelingprep.com/news/eli-lillys-obesity-drug-dominance-still-underpriced-by-market-20251215.jpg", "site": "benzinga.com", "text": "Eli Lilly & Co. (NYSE: LLY)'s dominance in obesity therapeutics looks increasingly difficult to challenge, and Bank of America believes the market is still underestimating just how much growth lies ahead.", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/12/49399288/eli-lilly-obesity-growth-orfoglipron-glp-1-pill-weight-loss-bank-america"}}
{"date": "2025-12-15", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-15 04:31:59", "publisher": "Seeking Alpha", "title": "Eli Lilly: Short-Term Upside Exhausted (Rating Downgrade)", "image": "https://images.financialmodelingprep.com/news/eli-lilly-shortterm-upside-exhausted-rating-downgrade-20251215.jpg", "site": "seekingalpha.com", "text": "Eli Lilly's recent long streak of correction for nine trading days calls for a look at the stock even as it has stabilised now. It's explained by stretched valuations and also the lowering of prices of Zepbound on LillyDirect. But there's much going on in favour of LLY too. 2026 could be good too, which is in line with the company's earlier resilience in the face of price cuts, which the company's outlook would clarify.", "url": "https://seekingalpha.com/article/4853299-eli-lilly-short-term-upside-exhausted-rating-downgrade"}}
{"date": "2025-12-15", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-15 04:10:00", "publisher": "The Motley Fool", "title": "Eli Lilly Just Delivered Fantastic News to Investors", "image": "https://images.financialmodelingprep.com/news/eli-lilly-just-delivered-fantastic-news-to-investors-20251215.jpg", "site": "fool.com", "text": "Eli Lilly's weight loss drugs have delivered blockbuster sales in recent quarters. The company is a leader in this market today and has a pipeline of promising candidates to potentially reinforce its position.", "url": "https://www.fool.com/investing/2025/12/15/eli-lilly-just-delivered-great-news-to-investors/"}}
{"date": "2025-12-14", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-14 05:04:48", "publisher": "Defense World", "title": "Castleark Management LLC Reduces Stock Position in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/castleark-management-llc-reduces-stock-position-in-eli-lilly-20251214.jpg", "site": "defenseworld.net", "text": "Castleark Management LLC decreased its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 42.1% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 46,168 shares of the company's stock after selling 33,524 shares during the", "url": "https://www.defenseworld.net/2025/12/14/castleark-management-llc-reduces-stock-position-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-13 14:37:00", "publisher": "The Motley Fool", "title": "My Top 3 Healthcare Stocks to Buy in 2026", "image": "https://images.financialmodelingprep.com/news/my-top-3-healthcare-stocks-to-buy-in-2026-20251213.jpg", "site": "fool.com", "text": "With its diverse product line, AbbVie is a terrific dividend stock with a solid underlying business. Eli Lilly is growing its top line incredibly rapidly and expanding into other therapeutic areas.", "url": "https://www.fool.com/investing/2025/12/13/my-top-3-healthcare-stocks-to-buy-in-2026/"}}
{"date": "2025-12-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-13 08:00:14", "publisher": "Investors Business Daily", "title": "Eli Lilly Leads Five Stocks Near Buy Points In Divided Market", "image": "https://images.financialmodelingprep.com/news/eli-lilly-leads-five-stocks-near-buy-points-in-20251213.jpg", "site": "investors.com", "text": "Eli Lilly, United Airlines and Urban Outfitters lead five stocks that are showing strength, near buy points, as AI stocks struggle.", "url": "https://www.investors.com/news/eli-lilly-united-airlines-urban-outfitters-buy-points/"}}
{"date": "2025-12-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-13 06:56:42", "publisher": "Defense World", "title": "Eli Lilly and Company $LLY Shares Sold by AQR Capital Management LLC", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-shares-sold-by-aqr-20251213.jpg", "site": "defenseworld.net", "text": "AQR Capital Management LLC lowered its stake in Eli Lilly and Company (NYSE: LLY) by 38.9% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 346,975 shares of the company's stock after selling 220,528 shares during the period. AQR Capital Management LLC's holdings in Eli Lilly", "url": "https://www.defenseworld.net/2025/12/13/eli-lilly-and-company-lly-shares-sold-by-aqr-capital-management-llc.html"}}
{"date": "2025-12-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-13 05:10:43", "publisher": "Defense World", "title": "Blue Capital Inc. Takes Position in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/blue-capital-inc-takes-position-in-eli-lilly-and-20251213.jpg", "site": "defenseworld.net", "text": "Blue Capital Inc. purchased a new stake in Eli Lilly and Company (NYSE: LLY) in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 3,879 shares of the company's stock, valued at approximately $3,024,000. Eli Lilly and Company makes", "url": "https://www.defenseworld.net/2025/12/13/blue-capital-inc-takes-position-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-13 05:10:43", "publisher": "Defense World", "title": "9,337 Shares in Eli Lilly and Company $LLY Bought by BlueCrest Capital Management Ltd", "image": "https://images.financialmodelingprep.com/news/9337-shares-in-eli-lilly-and-company-lly-bought-20251213.jpg", "site": "defenseworld.net", "text": "BlueCrest Capital Management Ltd acquired a new stake in Eli Lilly and Company (NYSE: LLY) during the second quarter, according to its most recent filing with the SEC. The firm acquired 9,337 shares of the company's stock, valued at approximately $7,278,000. A number of other large investors also recently bought and sold shares", "url": "https://www.defenseworld.net/2025/12/13/9337-shares-in-eli-lilly-and-company-lly-bought-by-bluecrest-capital-management-ltd.html"}}
{"date": "2025-12-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-13 04:33:24", "publisher": "Seeking Alpha", "title": "Eli Lilly: The Right Long-Term Strategy", "image": "https://images.financialmodelingprep.com/news/eli-lilly-the-right-longterm-strategy-20251213.jpg", "site": "seekingalpha.com", "text": "Eli Lilly is positioned for a secular growth trajectory, leveraging its duopoly in diabetes and obesity therapies while investing heavily in pipeline diversification. LLY faces intensifying competition and looming patent expirations, but is proactively expanding into oral, triple-agonist, and novel biologic modalities to sustain long-term revenue. Valuation risk is high in the near term, yet the robust pipeline support a buy rating for long-term investors.", "url": "https://seekingalpha.com/article/4853135-eli-lilly-right-long-term-strategy"}}
{"date": "2025-12-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-13 04:31:06", "publisher": "Defense World", "title": "Eli Lilly and Company $LLY Shares Sold by Ameriprise Financial Inc.", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-shares-sold-by-ameriprise-20251213.jpg", "site": "defenseworld.net", "text": "Ameriprise Financial Inc. lowered its holdings in Eli Lilly and Company (NYSE: LLY) by 1.4% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,918,070 shares of the company's stock after selling 41,585 shares during the period. Eli Lilly and Company", "url": "https://www.defenseworld.net/2025/12/13/eli-lilly-and-company-lly-shares-sold-by-ameriprise-financial-inc.html"}}
{"date": "2025-12-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-13 04:10:00", "publisher": "The Motley Fool", "title": "My Top 10 Stocks to Buy for 2026", "image": "https://images.financialmodelingprep.com/news/my-top-10-stocks-to-buy-for-2026-20251213.jpg", "site": "fool.com", "text": "Together, these stocks offer you a balanced mix of growth and safety. These companies span a number of industries, and many are leaders in their markets.", "url": "https://www.fool.com/investing/2025/12/13/my-top-10-stocks-to-buy-for-2026/"}}
{"date": "2025-12-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-13 03:56:56", "publisher": "Defense World", "title": "Bamco Inc. NY Buys 65,795 Shares of Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/bamco-inc-ny-buys-65795-shares-of-eli-lilly-20251213.jpg", "site": "defenseworld.net", "text": "Bamco Inc. NY grew its stake in shares of Eli Lilly and Company (NYSE: LLY) by 200.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 98,639 shares of the company's stock after purchasing an additional 65,795 shares during the period. Bamco", "url": "https://www.defenseworld.net/2025/12/13/bamco-inc-ny-buys-65795-shares-of-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-12 18:46:22", "publisher": "Zacks Investment Research", "title": "Why the Market Dipped But Eli Lilly (LLY) Gained Today", "image": "https://images.financialmodelingprep.com/news/why-the-market-dipped-but-eli-lilly-lly-gained-20251212.jpg", "site": "zacks.com", "text": "Eli Lilly (LLY) reached $1 at the closing of the latest trading day, reflecting a +1.8% change compared to its last close.", "url": "https://www.zacks.com/stock/news/2803978/why-the-market-dipped-but-eli-lilly-lly-gained-today?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2803978"}}
{"date": "2025-12-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-12 13:41:12", "publisher": "Benzinga", "title": "New Eli Lilly Results Suggest Major Delay To Chemotherapy For Breast Cancer Patients", "image": "https://images.financialmodelingprep.com/news/new-eli-lilly-results-suggest-major-delay-to-chemotherapy-20251212.jpeg", "site": "feeds.benzinga.com", "text": "Eli Lilly and Co shared updated results of Inluriyo (imlunestrant) from a Phase 3 study in previously treated breast cancer patients.", "url": "https://www.benzinga.com/news/health-care/25/12/49370844/new-eli-lilly-results-suggest-major-delay-to-chemotherapy-for-breast-cancer-patients"}}
{"date": "2025-12-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-12 12:20:21", "publisher": "Zacks Investment Research", "title": "Eli Lilly's Next-Generation Obesity Drug Secures First Phase III Win", "image": "https://images.financialmodelingprep.com/news/eli-lillys-nextgeneration-obesity-drug-secures-first-phase-iii-20251212.jpg", "site": "zacks.com", "text": "LLY's retatrutide posts strong weight-loss and pain-reduction results in its first Phase III study, boosting investor optimism.", "url": "https://www.zacks.com/stock/news/2803855/eli-lilly-s-next-generation-obesity-drug-secures-first-phase-iii-win?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2803855"}}
{"date": "2025-12-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-12 11:45:00", "publisher": "PRNewsWire", "title": "Updated data for Lilly's Inluriyo (imlunestrant) reinforce efficacy results as monotherapy and in combination with Verzenio (abemaciclib) in ER+, HER2- advanced breast cancer", "image": "https://images.financialmodelingprep.com/news/updated-data-for-lillys-inluriyo-imlunestrant-reinforce-efficacy-results-20251212.jpg", "site": "prnewswire.com", "text": "As monotherapy, imlunestrant demonstrated an 11.4-month numeric improvement in median OS versus endocrine therapy in patients with ESR1-mutated disease In all patients, the imlunestrant plus abemaciclib combination achieved a median PFS of 10.9 months, demonstrated a favorable OS trend, and extended time to chemotherapy by more than a year These data were published simultaneously in Annals of Oncology and will be presented today at the 2025 San Antonio Breast Cancer Symposium INDIANAPOLIS , Dec. 12, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced updated results from the Phase 3 EMBER-3 study of Inluriyo (imlunestrant), an oral estrogen receptor antagonist, in patients with estrogen receptor positive (ER+), human epidermal growth factor receptor 2negative (HER2) advanced or metastatic breast cancer (MBC), whose disease progressed on a prior aromatase inhibitor (AI), with or without a CDK4/6 inhibitor. As monotherapy, imlunestrant demonstrated a clinically meaningful 38% reduction in the risk of progression or death (median PFS 5.5 vs 3.8 months; HR=0.62 [95% CI 0.470.82]; nominal p=0.0007) and demonstrated an 11.4-month improvement in median OS (34.5 vs 23.1 months; HR=0.60 [95% CI 0.430.86]; p=0.0043; boundary for significance not met) versus endocrine therapy, in patients with ESR1-mutated disease.", "url": "https://www.prnewswire.com/news-releases/updated-data-for-lillys-inluriyo-imlunestrant-reinforce-efficacy-results-as-monotherapy-and-in-combination-with-verzenio-abemaciclib-in-er-her2-advanced-breast-cancer-302639719.html"}}
{"date": "2025-12-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-12 11:04:57", "publisher": "Investors Business Daily", "title": "Eli Lilly Rises, Again, After EMA Recommends Mounjaro For Children As Young As 10", "image": "https://images.financialmodelingprep.com/news/eli-lilly-rises-again-after-ema-recommends-mounjaro-for-20251212.jpg", "site": "investors.com", "text": "On Friday, Europe's drug regulator recommended extending the use of Eli Lilly's type 2 diabetes drug, Mounjaro, to children as young as 10.", "url": "https://www.investors.com/news/technology/eli-lilly-stock-ema-mounjaro-children/"}}
{"date": "2025-12-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-12 08:10:04", "publisher": "24/7 Wall Street", "title": "Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (Dec 2025)", "image": "https://images.financialmodelingprep.com/news/eli-lilly-nyse-lly-stock-price-prediction-and-forecast-20251212.jpg", "site": "247wallst.com", "text": "From late 2020 to the summer of 2024, Eli Lilly & Co. (NYSE: LLY) stock was on a tear, up more than 635%, before taking a breather and then heading higher.", "url": "https://247wallst.com/forecasts/2025/12/12/eli-lilly-lly-stock-price-prediction-and-forecast-2025-2030/"}}
{"date": "2025-12-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-12 07:30:00", "publisher": "Fool - Investing News", "title": "Breakfast News: Broadcom Guides Lower", "image": "https://images.financialmodelingprep.com/news/breakfast-news-broadcom-guides-lower-20251212.png", "site": "fool.com", "text": "Broadcom feels the heat of AI expectations, LULU soars over 10% on strong results, and more", "url": "https://www.fool.com/investing/breakfast-news/2025/12/12/breakfast-news-broadcom-guides-lower/"}}
{"date": "2025-12-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-12 06:42:00", "publisher": "The Motley Fool", "title": "Think Eli Lilly Is Expensive? This Metric Says Otherwise.", "image": "https://images.financialmodelingprep.com/news/think-eli-lilly-is-expensive-this-metric-says-otherwise-20251212.jpg", "site": "fool.com", "text": "Eli Lilly's shares may appear expensive at first glance, but a closer look reveals a different story. The company's outlook is strong, and the stock is a buy, even at current levels.", "url": "https://www.fool.com/investing/2025/12/12/think-eli-lilly-is-expensive-this-metric-says-othe/"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 17:26:07", "publisher": "Schwab Network", "title": "Thursday's Final Takeaways: LLY Positive Drug Trial, Home Prices Turn Negative", "image": "https://images.financialmodelingprep.com/news/thursdays-final-takeaways-lly-positive-drug-trial-home-prices-20251211.jpg", "site": "youtube.com", "text": "Marley Kayden and Sam Vadas discuss Eli Lilly's (LLY) positive weight loss drug trial and how home prices turned negative. They also note that jobless claims rose and the trade deficit narrowed.", "url": "https://www.youtube.com/watch?v=w2GaxUwyDXQ"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 12:00:24", "publisher": "Investopedia", "title": "Dow Jones Today: Dow Sets All-Time High But Nasdaq, S&P 500 Fall as Oracle Results Drag AI Shares", "image": "https://images.financialmodelingprep.com/news/dow-jones-today-dow-sets-alltime-high-but-nasdaq-20251211.jpg", "site": "investopedia.com", "text": "Major stock indexes were mixed Thursday, with the Dow Jones Industrial Average setting a new all-time high but the Nasdaq and S&P 500 falling as Oracle results dragged AI-tied shares.", "url": "https://www.investopedia.com/dow-jones-today-12112025-11866662"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 11:23:00", "publisher": "Barrons", "title": "Eli Lilly's Latest Obesity Drug Delivers Strong Results. It Might Work Too Well.", "image": "https://images.financialmodelingprep.com/news/eli-lillys-latest-obesity-drug-delivers-strong-results-it-20251211.jpg", "site": "barrons.com", "text": "The company said some patients had dropped out of the trial because they felt they were losing too much weight.", "url": "https://www.barrons.com/articles/eli-lilly-stock-obesity-weight-loss-drug-1bd03050"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 11:16:36", "publisher": "Schaeffers Research", "title": "2 Pharma Stocks Pop on Strong Obesity Drug Trial Results", "image": "https://images.financialmodelingprep.com/news/2-pharma-stocks-pop-on-strong-obesity-drug-trial-20251211.jpg", "site": "schaeffersresearch.com", "text": "Positive drug trial results are boosting pharmaceutical stocks today, with Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) and Eli Lilly & Co. (NYSE:LLY) drawing investor attention after encouraging developments for their latestobesity drugs.", "url": "https://www.schaeffersresearch.com/content/news/2025/12/11/2-pharma-stocks-pop-on-strong-obesity-drug-trial-results"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 11:15:00", "publisher": "GlobeNewsWire", "title": "Prison Fellowship Awarded $5 Million Grant From Lilly Endowment Inc. To Broaden Its Reach in Sharing Stories of Radical Restoration", "image": "https://images.financialmodelingprep.com/news/prison-fellowship-awarded-5-million-grant-from-lilly-endowment-20251211.jpg", "site": "globenewswire.com", "text": "WASHINGTON, D.C., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Prison Fellowship, the nation's largest Christian nonprofit serving currently and formerly incarcerated people and their families and a leading advocate for criminal justice reform, today announced that it has been awarded a $5 million grant from Lilly Endowment Inc. to help millions of people come to know and love God through seeing the transformative power of Jesus in the lives of those behind bars. The grant comes through the Endowment's National Storytelling Initiative on Christian Faith and Life 2025.", "url": "https://www.globenewswire.com/news-release/2025/12/11/3204119/0/en/Prison-Fellowship-Awarded-5-Million-Grant-From-Lilly-Endowment-Inc-To-Broaden-Its-Reach-in-Sharing-Stories-of-Radical-Restoration.html"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 10:59:54", "publisher": "Bloomberg Markets and Finance", "title": "New Lilly Shot Reduces Body Weight by 23% in Study", "image": "https://images.financialmodelingprep.com/news/new-lilly-shot-reduces-body-weight-by-23-in-20251211.jpg", "site": "youtube.com", "text": "A next-generation obesity shot from Eli Lilly helped patients lose nearly a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet. Madison Muller reports on Bloomberg Television.", "url": "https://www.youtube.com/watch?v=8KIHlPxvZjk"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 10:21:20", "publisher": "Proactive Investors", "title": "Eli Lilly reports positive Phase 3 trial results for obesity drug retatrutide", "image": "https://images.financialmodelingprep.com/news/eli-lilly-reports-positive-phase-3-trial-results-for-20251211.jpg", "site": "proactiveinvestors.com", "text": "Eli Lilly and Co (NYSE:LLY) has reported positive topline results from its Phase 3 TRIUMPH-4 trial evaluating its obesity treatment retatrutide in adults with obesity and knee osteoarthritis. The investigational drug, a once-weekly injectable targeting GLP1, GIP, and glucagon receptors, is designed to regulate appetite and metabolism through multiple hormone pathways.", "url": "https://www.proactiveinvestors.com/companies/news/1084262"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 10:15:27", "publisher": "Schwab Network", "title": "GOOGL Price Target Raise, SNPS Strong Guidance, LLY Retratrutide Results", "image": "https://images.financialmodelingprep.com/news/googl-price-target-raise-snps-strong-guidance-lly-retratrutide-20251211.jpg", "site": "youtube.com", "text": "Oracle (ORCL) weighed on markets Thursday morning but Diane King Hall turns to stocks seeing strength. Synopsys (SNPS) added muscle to the tech trade with an earnings beat and strong 2026 guidance that boosted bullish expectations from analysts.", "url": "https://www.youtube.com/watch?v=npBZec4jRaY"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 10:03:09", "publisher": "247 Wallst", "title": "Live Nasdaq Composite: Markets Retreat on AI Trade Fatigue", "image": "https://images.financialmodelingprep.com/news/live-nasdaq-composite-markets-retreat-on-ai-trade-fatigue-20251211.svg", "site": "247wallst.com", "text": "Live Updates AI Bubbles 12 minutes ago Live Deutsche Bank says AI is in not one but two bubbles and both are still in the early stages. One is driven by cash-rich Big Tech companies pouring profits into AI spending (ahem, Oracle), while the other sits in riskier, mostly private \"frontier\" businesses that are still... Live Nasdaq Composite: Markets Retreat on AI Trade Fatigue.", "url": "https://247wallst.com/investing/2025/12/11/live-nasdaq-composite-markets-retreat-on-ai-trade-fatigue/"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 09:15:00", "publisher": "Schaeffers Research", "title": "Oracle, AI Stocks Put a Dent in Sentiment", "image": "https://images.financialmodelingprep.com/news/oracle-ai-stocks-put-a-dent-in-sentiment-20251211.png", "site": "schaeffersresearch.com", "text": "Oracle (ORCL) is plummeting premarket, dragging the rest of the AI sector and weighing on the broader market", "url": "https://www.schaeffersresearch.com/content/ezines/2025/12/11/oracle-ai-stocks-put-a-dent-in-sentiment"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 07:55:00", "publisher": "Market Watch", "title": "Eli Lilly's newest weight-loss drug relieved pain in patients with knee osteoarthritis", "image": "https://images.financialmodelingprep.com/news/eli-lillys-newest-weightloss-drug-relieved-pain-in-patients-20251211.jpg", "site": "marketwatch.com", "text": "Eli Lilly's triple g drug helped patients lose about 28.7% of their body weight while also reducing pain associated with knee osteoarthritis in a Phase 3 trial.", "url": "https://www.marketwatch.com/story/eli-lillys-newest-weight-loss-drug-relieved-pain-in-patients-with-knee-osteoarthritis-b7a6bcd2"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 07:54:00", "publisher": "WSJ", "title": "Eli Lilly Reports Positive Results From Study of Weight Loss Drug", "image": "https://images.financialmodelingprep.com/news/eli-lilly-reports-positive-results-from-study-of-weight-20251211.jpg", "site": "wsj.com", "text": "Eli Lilly's experimental weight-loss drug retatrutide resulted in significant weight loss and reduced knee pain in a phase three trial involving patients with obesity and knee osteoarthritis.", "url": "https://www.wsj.com/health/pharma/eli-lilly-reports-positive-results-from-study-of-weight-loss-drug-c4cc3af7"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 07:39:46", "publisher": "CNBC", "title": "Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly", "image": "https://images.financialmodelingprep.com/news/danish-weight-loss-drug-maker-outlines-ambitious-2030-strategy-20251211.jpg", "site": "cnbc.com", "text": "Ahead of its Capital Markets Day Thursday, Zealand Pharma unveiled its \"Metabolic Frontier 2030\" strategy. The strategy comes as Zealand shares have dropped 29% year to date, with investors betting on the weight loss drug market to fragment.", "url": "https://www.cnbc.com/2025/12/11/zealand-pharma-unveils-2030-plan-as-weight-loss-competition-heats-up.html"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 07:12:41", "publisher": "Investors Business Daily", "title": "Eli Lilly's Experimental Obesity Drug Cut Weight By 23.7%", "image": "https://images.financialmodelingprep.com/news/eli-lillys-experimental-obesity-drug-cut-weight-by-237-20251211.jpg", "site": "investors.com", "text": "Eli Lily rose above a key level after saying its experimental obesity treatment delivered 23.7% weight loss in a late-stage trial.", "url": "https://www.investors.com/news/technology/eli-lillys-experimental-obesity-drug-cut-weight-by-23-7/"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 06:49:55", "publisher": "Reuters", "title": "Lilly's next-gen drug tops Zepbound on weight loss in late-stage osteoarthritis trial", "image": "https://images.financialmodelingprep.com/news/lillys-nextgen-drug-tops-zepbound-on-weight-loss-in-20251211.jpg", "site": "reuters.com", "text": "Eli Lilly said on Thursday its next-generation obesity drug helped patients lose an average of 28.7% of their weight in a late-stage trial, outperforming its blockbuster drug Zepbound and reinforcing the company's lead in the fast-growing market.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/lillys-next-gen-drug-tops-zepbound-weight-loss-late-stage-osteoarthritis-trial-2025-12-11/"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 06:45:25", "publisher": "CNBC", "title": "Eli Lilly's next-generation obesity drug delivers strong weight loss, reduces knee pain in late-stage trial", "image": "https://images.financialmodelingprep.com/news/eli-lillys-nextgeneration-obesity-drug-delivers-strong-weight-loss-20251211.jpg", "site": "cnbc.com", "text": "Eli Lilly said its next-generation obesity drug delivered strong weight loss and reduced knee arthritis pain in a late-stage study, clearing the first of several upcoming trials on the weekly injection. The drugmaker is betting big on the treatment, retatrutide, as the next pillar of its obesity portfolio after its weight loss injection Zepbound and its upcoming pill.", "url": "https://www.cnbc.com/2025/12/11/eli-lillys-weight-loss-drug-retatrutide-clears-first-late-stage-study.html"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 06:45:00", "publisher": "PRNewsWire", "title": "Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial", "image": "https://images.financialmodelingprep.com/news/lillys-triple-agonist-retatrutide-delivered-weight-loss-of-up-20251211.jpg", "site": "prnewswire.com", "text": "In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of their body weight at 68 weeks Retatrutide reducedWOMAC pain scores by up to an average of 4.5 points (75.8%) and significantly improved measures of physical function, with more than 1 out of 8 retatrutide-treated patients completely free from knee painat the end of the trial Seven additional Phase 3 trials evaluating the investigational once-weekly treatment in obesity and type 2 diabetes are expected to complete in 2026 INDIANAPOLIS , Dec. 11, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 TRIUMPH-4 clinical trialevaluating the safety and efficacy of the two highest investigational doses of retatrutide, a first-in-class GIP, GLP-1 and glucagon triple hormone receptor agonist, in adults with obesity or overweight and knee osteoarthritis, and without diabetes, as an adjunct to healthy diet and physical activity. In this global registration trial, where 84.0% of participants had a baselineBMI of 35 kg/m, each dose of retatrutide (9 mg and 12 mg) met all primary and key secondary endpoints, delivering significant weight loss and improvements in pain and physical function at 68 weeks using both the efficacy and treatment-regimen estimands.1,2 For the co-primary endpoints, retatrutide lowered weight by up to an average of 28.7% (71.2 lbs) and reduced pain by up to an average of 4.5 points (75.8%) using the Western Ontario and McMaster Universities Osteoarthritis Index(WOMAC) pain score.3 \"People with obesity and knee osteoarthritis often live with pain and restricted mobility, and may eventually require total joint replacement,\" said Kenneth Custer, Ph.D.", "url": "https://www.prnewswire.com/news-releases/lillys-triple-agonist-retatrutide-delivered-weight-loss-of-up-to-an-average-of-71-2-lbs-along-with-substantial-relief-from-osteoarthritis-pain-in-first-successful-phase-3-trial-302638804.html"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 05:24:43", "publisher": "Defense World", "title": "Eli Lilly and Company $LLY Shares Acquired by Becker Capital Management Inc.", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-shares-acquired-by-becker-20251211.jpg", "site": "defenseworld.net", "text": "Becker Capital Management Inc. boosted its holdings in Eli Lilly and Company (NYSE: LLY) by 372.4% during the undefined quarter, according to its most recent disclosure with the SEC. The firm owned 20,324 shares of the company's stock after buying an additional 16,022 shares during the period. Becker Capital Management Inc.'s holdings in", "url": "https://www.defenseworld.net/2025/12/11/eli-lilly-and-company-lly-shares-acquired-by-becker-capital-management-inc.html"}}
{"date": "2025-12-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-11 02:00:00", "publisher": "Barrons", "title": "Microsoft, Broadcom, Lilly, and Other Stocks That Define Quality' for This Pro", "image": "https://images.financialmodelingprep.com/news/microsoft-broadcom-lilly-and-other-stocks-that-define-quality-20251211.jpg", "site": "barrons.com", "text": "Tom Hancock, a portfolio manager at GMO, favors companies that consistently earn a high return on capital and reinvest in the business.", "url": "https://www.barrons.com/articles/microsoft-broadcom-lilly-stocks-f036c3cc"}}
{"date": "2025-12-10", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-10 16:45:49", "publisher": "Investopedia", "title": "Eli Lilly's Weight-Loss Drugs Drove Its Stock Higher This Year. A New Plant in Alabama Could Boost Production", "image": "https://images.financialmodelingprep.com/news/eli-lillys-weightloss-drugs-drove-its-stock-higher-this-20251210.jpg", "site": "investopedia.com", "text": "With demand for weight-loss drugs soaring and an agreement with the White House to produce more medicine in the U.S., Eli Lilly (LLY) is taking steps to boost its domestic output.", "url": "https://www.investopedia.com/eli-lilly-weight-loss-drugs-drove-its-stock-higher-this-year-a-new-plant-in-alabama-could-boost-production-lly-11865954"}}
{"date": "2025-12-10", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-10 11:02:13", "publisher": "Proactive Investors", "title": "Abivax stock pops on Eli Lilly takeover speculation", "image": "https://images.financialmodelingprep.com/news/abivax-stock-pops-on-eli-lilly-takeover-speculation-20251210.jpg", "site": "proactiveinvestors.com", "text": "Abivax SA (NASDAQ:ABVX, EPA:ABVX), a French biotechnology firm, saw its US-listed shares jumpmore than 11% on rumors it may be acquired by Eli Lilly and Co (NYSE:LLY). First reported by Reuters, neither Abivax nor Eli Lilly have confirmed the reports.", "url": "https://www.proactiveinvestors.com/companies/news/1084169"}}
{"date": "2025-12-10", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-10 05:52:02", "publisher": "Reuters", "title": "French biotech Abivax's shares climb on Eli Lilly bid rumors", "image": "https://images.financialmodelingprep.com/news/french-biotech-abivaxs-shares-climb-on-eli-lilly-bid-20251210.jpg", "site": "reuters.com", "text": "French biotech company Abivax's shares jumped by 20% on Wednesday on market rumours that U.S. pharma giant Eli Lilly might be interested in bidding for the business.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/french-biotech-abivaxs-shares-climb-eli-lilly-bid-rumors-2025-12-10/"}}
{"date": "2025-12-10", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-10 02:06:44", "publisher": "Defense World", "title": "Sen. John Boozman Sells iShares MSCI All Country Asia ex Japan ETF (NASDAQ:AAXJ) Stock", "image": "https://images.financialmodelingprep.com/news/sen-john-boozman-sells-ishares-msci-all-country-asia-20251210.png", "site": "defenseworld.net", "text": "Senator John Boozman (R-Arkansas) recently sold shares of iShares MSCI All Country Asia ex Japan ETF (NASDAQ: AAXJ). In a filing disclosed on December 08th, the Senator disclosed that they had sold between $1,001 and $15,000 in iShares MSCI All Country Asia ex Japan ETF stock on November 6th. Senator John Boozman also recently made the", "url": "https://www.defenseworld.net/2025/12/10/sen-john-boozman-sells-ishares-msci-all-country-asia-ex-japan-etf-nasdaqaaxj-stock.html"}}
{"date": "2025-12-10", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-10 02:06:44", "publisher": "Defense World", "title": "Sen. John Boozman Purchases Shares of Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA)", "image": "https://images.financialmodelingprep.com/news/sen-john-boozman-purchases-shares-of-vanguard-ftse-developed-20251210.jpg", "site": "defenseworld.net", "text": "Senator John Boozman (R-Arkansas) recently bought shares of Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA). In a filing disclosed on December 08th, the Senator disclosed that they had bought between $1,001 and $15,000 in Vanguard FTSE Developed Markets ETF stock on November 6th. Senator John Boozman also recently made the following trade(s): Sold $1,001 - $15,000", "url": "https://www.defenseworld.net/2025/12/10/sen-john-boozman-purchases-shares-of-vanguard-ftse-developed-markets-etf-nysearcavea.html"}}
{"date": "2025-12-10", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-10 02:06:43", "publisher": "Defense World", "title": "Sen. John Boozman Purchases Shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO)", "image": "https://images.financialmodelingprep.com/news/sen-john-boozman-purchases-shares-of-vanguard-ftse-emerging-20251210.png", "site": "defenseworld.net", "text": "Senator John Boozman (R-Arkansas) recently bought shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO). In a filing disclosed on December 08th, the Senator disclosed that they had bought between $1,001 and $15,000 in Vanguard FTSE Emerging Markets ETF stock on November 6th. Senator John Boozman also recently made the following trade(s): Sold $1,001 - $15,000", "url": "https://www.defenseworld.net/2025/12/10/sen-john-boozman-purchases-shares-of-vanguard-ftse-emerging-markets-etf-nysearcavwo.html"}}
{"date": "2025-12-10", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-10 02:06:43", "publisher": "Defense World", "title": "iShares MSCI EAFE ETF (NYSEARCA:EFA) Stock Unloaded Sen. John Boozman", "image": "https://images.financialmodelingprep.com/news/ishares-msci-eafe-etf-nysearcaefa-stock-unloaded-sen-john-20251210.png", "site": "defenseworld.net", "text": "Senator John Boozman (R-Arkansas) recently sold shares of iShares MSCI EAFE ETF (NYSEARCA:EFA). In a filing disclosed on December 08th, the Senator disclosed that they had sold between $1,001 and $15,000 in iShares MSCI EAFE ETF stock on November 20th. Senator John Boozman also recently made the following trade(s): Sold $1,001 - $15,000 in shares", "url": "https://www.defenseworld.net/2025/12/10/ishares-msci-eafe-etf-nysearcaefa-stock-unloaded-sen-john-boozman.html"}}
{"date": "2025-12-10", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-10 02:06:43", "publisher": "Defense World", "title": "Sen. John Boozman Purchases Shares of Arista Networks, Inc. (NYSE:ANET)", "image": "https://images.financialmodelingprep.com/news/sen-john-boozman-purchases-shares-of-arista-networks-inc-20251210.gif", "site": "defenseworld.net", "text": "Senator John Boozman (R-Arkansas) recently bought shares of Arista Networks, Inc. (NYSE: ANET). In a filing disclosed on December 08th, the Senator disclosed that they had bought between $1,001 and $15,000 in Arista Networks stock on November 13th. Senator John Boozman also recently made the following trade(s): Sold $1,001 - $15,000 in shares of Tortoise North", "url": "https://www.defenseworld.net/2025/12/10/sen-john-boozman-purchases-shares-of-arista-networks-inc-nyseanet.html"}}
{"date": "2025-12-09", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-09 15:59:00", "publisher": "WSJ", "title": "Eli Lilly to Build $6 Billion Alabama Plant as Part of U.S. Investment", "image": "https://images.financialmodelingprep.com/news/eli-lilly-to-build-6-billion-alabama-plant-as-part-20251209.jpg", "site": "wsj.com", "text": "The site is the third of four new facilities in the U.S. that the pharmaceutical company plans to announce, Eli Lilly said.", "url": "https://www.wsj.com/health/pharma/eli-lilly-to-build-6-billion-alabama-plant-as-part-of-u-s-investment-3544b6c2"}}
{"date": "2025-12-09", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-09 15:34:32", "publisher": "Reuters", "title": "Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push", "image": "https://images.financialmodelingprep.com/news/eli-lilly-to-build-6-billion-alabama-plant-as-20251209.jpg", "site": "reuters.com", "text": "Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-build-6-billion-alabama-plant-part-us-manufacturing-push-2025-12-09/"}}
{"date": "2025-12-09", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-09 15:30:01", "publisher": "CNBC", "title": "Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs", "image": "https://images.financialmodelingprep.com/news/eli-lilly-to-build-6-billion-manufacturing-plant-in-20251209.jpg", "site": "cnbc.com", "text": "Eli Lilly said it will spend $6 billion to build a manufacturing plant in Huntsville, Alabama, to help boost production of its closely watched experimental obesity pill, orforglipron, and other drugs. It is the third facility in a string of new planned U.S. investments by the drugmaker.", "url": "https://www.cnbc.com/2025/12/09/eli-lilly-6-billion-alabama-manufacturing-plant-obesity-pill.html"}}
{"date": "2025-12-09", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-09 15:30:00", "publisher": "PRNewsWire", "title": "Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama", "image": "https://images.financialmodelingprep.com/news/lilly-to-build-6-billion-facility-to-manufacture-active-20251209.jpg", "site": "prnewswire.com", "text": "Huntsville site will focus on domestic production of small molecule synthetic and peptide medicines, including Lilly's oral GLP-1, orforglipron Company plans to create 3,450 manufacturing and construction jobs at Lilly's ninth U.S. manufacturing site announced since 2020 INDIANAPOLIS , Dec. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced plans to invest more than $6 billion in a new manufacturing facility in Huntsville, Alabama. This next-generation synthetic medicine active pharmaceutical ingredient (API) facility, the third of four new U.S. sites Lilly plans to announce, will produce small molecule synthetic and peptide medicines.", "url": "https://www.prnewswire.com/news-releases/lilly-to-build-6-billion-facility-to-manufacture-active-pharmaceutical-ingredients-in-alabama-302635568.html"}}
{"date": "2025-12-09", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-09 13:15:00", "publisher": "The Motley Fool", "title": "Prediction: This Surprising Growth Stock Will Reach -- and Stay in -- the Trillion-Dollar Club in 2026.", "image": "https://images.financialmodelingprep.com/news/prediction-this-surprising-growth-stock-will-reach-and-stay-20251209.jpg", "site": "fool.com", "text": "This company is a leader in a market that may approach $100 billion in a few years. This player's key products are delivering billion-dollar revenue.", "url": "https://www.fool.com/investing/2025/12/09/prediction-growth-stock-reach-trillion-dollar-club/"}}
{"date": "2025-12-09", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-09 10:00:24", "publisher": "Zacks Investment Research", "title": "Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-is-a-trending-stock-20251209.jpg", "site": "zacks.com", "text": "Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.", "url": "https://www.zacks.com/stock/news/2801495/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2801495"}}
{"date": "2025-12-09", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-09 09:22:00", "publisher": "Fool - Investing News", "title": "5 Bold Predictions for the Stock Market in 2026", "image": "https://images.financialmodelingprep.com/news/5-bold-predictions-for-the-stock-market-in-2026-20251209.jpeg", "site": "fool.com", "text": "Here are some things I think are more likely to happen in 2026 than the experts seem to believe.", "url": "https://www.fool.com/investing/2025/12/09/5-bold-predictions-for-the-stock-market-in-2026/"}}
{"date": "2025-12-09", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-09 08:28:00", "publisher": "PRNewsWire", "title": "Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition", "image": "https://images.financialmodelingprep.com/news/lilly-and-adverum-announce-expiration-and-completion-of-adverum-tender-20251209.jpg", "site": "prnewswire.com", "text": "INDIANAPOLIS , Dec. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Adverum Biotechnologies, Inc. (NASDAQ: ADVM) today announced that the tender offer (the \"Offer\") by Flying Tigers Acquisition Corporation (\"Purchaser\"), a direct wholly-owned subsidiary of Lilly, to purchase all of the issued and outstanding shares (\"Shares\") of Adverum's common stock in exchange for (i) $3.56 per Share, net to the stockholder in cash, without interest and less any applicable tax withholding, plus (ii) one non-tradable contingent value right (\"CVR\") per Share, which represents the contractual right to receive up to two contingent cash payments of up to an aggregate of $8.91 per CVR, net to the stockholder in cash, without interest and less any applicable tax withholding, upon the achievement of specified milestones, expired as scheduled at one minute past 11:59 p.m., Eastern Time, on December 8, 2025 (such date and time, the \"Expiration Time\").", "url": "https://www.prnewswire.com/news-releases/lilly-and-adverum-announce-expiration-and-completion-of-adverum-tender-offer-and-acquisition-302636620.html"}}
{"date": "2025-12-09", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-09 07:30:00", "publisher": "PRNewsWire", "title": "Lilly's Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-nave CLL/SLL", "image": "https://images.financialmodelingprep.com/news/lillys-jaypirca-pirtobrutinib-significantly-improved-progressionfree-survival-reducing-the-20251209.jpg", "site": "prnewswire.com", "text": "The risk reduction observed in BRUIN CLL-313 is among the most compelling observed for a single agent BTK inhibitor in a front-line CLL study Thesedatawill be simultaneously published in the Journal of Clinical Oncologyand highlighted in a late-breaking oral presentationat the 2025American Society of Hematology Annual Meeting and Exposition, and were featured as part of the meeting's press program INDIANAPOLIS , Dec. 9, 2025 /PRNewswire/ --Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 BRUIN CLL-313 clinical trial of Jaypirca (pirtobrutinib), a non-covalent Bruton tyrosine kinase (BTK) inhibitor, versus bendamustine plus rituximab (BR), in treatment-nave patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) without 17p deletions.Pirtobrutinib met its primary endpoint demonstrating a reduction in the risk of disease progression or death by 80% (HR=0.20 [95% CI, 0.11-0.37]; p", "url": "https://www.prnewswire.com/news-releases/lillys-jaypirca-pirtobrutinib-significantly-improved-progression-free-survival-reducing-the-risk-of-progression-or-death-by-80-versus-chemoimmunotherapy-in-patients-with-treatment-naive-cllsll-302634418.html"}}
{"date": "2025-12-09", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-09 00:17:00", "publisher": "The Motley Fool", "title": "2 Potential Stock Splits to Watch for in 2026", "image": "https://images.financialmodelingprep.com/news/2-potential-stock-splits-to-watch-for-in-2026-20251209.jpg", "site": "fool.com", "text": "Stock splits may not alter a company's fundamentals, but keeping an eye on stocks that are likely to experience a split could be a profitable move. Dutch semiconductor manufacturing equipment maker ASML Holding now trades for over $1,100 per share.", "url": "https://www.fool.com/investing/2025/12/09/2-potential-stock-splits-to-watch-for-in-2026/"}}
{"date": "2025-12-08", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-08 21:03:44", "publisher": "Seeking Alpha", "title": "Top 50 High-Quality Dividend Growth Stocks For December 2025", "image": "https://images.financialmodelingprep.com/news/top-50-highquality-dividend-growth-stocks-for-december-2025-20251208.jpg", "site": "seekingalpha.com", "text": "I track a custom universe of 50 high-quality dividend growth stocks to identify timely, attractive investment opportunities based on valuation and forward return potential. 28 of these stocks currently offer estimated future returns of at least 10%, with 18 appearing potentially undervalued per my Free Cash Flow model. Top-ranked names like ResMed, Mastercard, and MSCI combine strong projected EPS growth with reasonable valuations.", "url": "https://seekingalpha.com/article/4851378-top-50-high-quality-dividend-growth-stocks-for-december-2025"}}
{"date": "2025-12-08", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-08 14:05:00", "publisher": "PRNewsWire", "title": "Lilly declares first-quarter 2026 dividend", "image": "https://images.financialmodelingprep.com/news/lilly-declares-firstquarter-2026-dividend-20251208.jpg", "site": "prnewswire.com", "text": "INDIANAPOLIS , Dec. 8, 2025 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the first quarter of 2026 of $1.73 per share on outstanding common stock. The dividend is payable on March 10, 2026, to shareholders of record at the close of business on February 13, 2026.", "url": "https://www.prnewswire.com/news-releases/lilly-declares-first-quarter-2026-dividend-302635673.html"}}
{"date": "2025-12-08", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-08 10:45:45", "publisher": "Zacks Investment Research", "title": "Why Eli Lilly (LLY) is a Top Growth Stock for the Long-Term", "image": "https://images.financialmodelingprep.com/news/why-eli-lilly-lly-is-a-top-growth-stock-20251208.jpg", "site": "zacks.com", "text": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.", "url": "https://www.zacks.com/stock/news/2800991/why-eli-lilly-lly-is-a-top-growth-stock-for-the-long-term?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_growth_score-2800991"}}
{"date": "2025-12-08", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-08 10:00:00", "publisher": "PRNewsWire", "title": "Carolyn Bertozzi returns to Lilly board of directors", "image": "https://images.financialmodelingprep.com/news/carolyn-bertozzi-returns-to-lilly-board-of-directors-20251208.jpg", "site": "prnewswire.com", "text": "INDIANAPOLIS , Dec. 8, 2025 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) elected Carolyn R. Bertozzi, Ph.D.", "url": "https://www.prnewswire.com/news-releases/carolyn-bertozzi-returns-to-lilly-board-of-directors-302634817.html"}}
{"date": "2025-12-08", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-08 08:49:10", "publisher": "Benzinga", "title": "Healthcare Relevancies Clashes With Premium Valuations For Direxion's LLY-Focused ELIL, ELIS ETFs", "image": "https://images.financialmodelingprep.com/news/healthcare-relevancies-clashes-with-premium-valuations-for-direxions-llyfocused-20251208.jpg", "site": "benzinga.com", "text": "In terms of sheer relevance, it's difficult to think of a more relevant sector than healthcare  and within this vast ecosystem, only an elite few occupy the same neighborhood as pharmaceutical giant Eli Lilly and Company (NYSE: LLY). In November 2025, Eli Lilly became the first trillion-dollar pharmaceutical company, mostly due to regulatory momentum for its blockbuster drugs.", "url": "https://www.benzinga.com/etfs/specialty-etfs/25/12/49255499/healthcare-relevancies-clashes-with-premium-valuations-for-direxions-lly-focused-elil-elis-etfs"}}
{"date": "2025-12-08", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-08 03:33:00", "publisher": "Defense World", "title": "Bank of Nova Scotia Grows Stock Holdings in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/bank-of-nova-scotia-grows-stock-holdings-in-eli-20251208.jpg", "site": "defenseworld.net", "text": "Bank of Nova Scotia boosted its holdings in Eli Lilly and Company (NYSE: LLY) by 0.6% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 248,260 shares of the company's stock after buying an additional 1,376 shares during the quarter. Bank of", "url": "https://www.defenseworld.net/2025/12/08/bank-of-nova-scotia-grows-stock-holdings-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-08", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-08 03:32:52", "publisher": "Defense World", "title": "Baker Avenue Asset Management LP Lowers Position in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/baker-avenue-asset-management-lp-lowers-position-in-eli-20251208.jpg", "site": "defenseworld.net", "text": "Baker Avenue Asset Management LP lessened its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 2.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 18,184 shares of the company's stock after selling 551 shares during", "url": "https://www.defenseworld.net/2025/12/08/baker-avenue-asset-management-lp-lowers-position-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-07", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-07 21:45:07", "publisher": "Reuters", "title": "Eli Lilly's Mounjaro added to China's state insurance list for diabetes treatment", "image": "https://images.financialmodelingprep.com/news/eli-lillys-mounjaro-added-to-chinas-state-insurance-list-20251207.jpg", "site": "reuters.com", "text": "Eli Lilly's popular drug Mounjaro will be added to China's state-run health insurance scheme from January 1 for patients with type 2 diabetes, the National Healthcare Security Administration said in a website notice on Sunday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lillys-mounjaro-added-chinas-state-insurance-list-diabetes-treatment-2025-12-08/"}}
{"date": "2025-12-07", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-07 16:30:00", "publisher": "PRNewsWire", "title": "Lilly's Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)", "image": "https://images.financialmodelingprep.com/news/lillys-jaypirca-pirtobrutinib-met-its-primary-endpoint-in-firstofitskind-20251207.jpg", "site": "prnewswire.com", "text": "In addition to meeting the primary endpoint of non-inferiority for overall response rate (ORR) in the BRUIN CLL-314 study, pirtobrutinib achieved a numerically higher ORR of 87.0% compared to 78.5% for ibrutinib in the intent-to-treat (ITT) population Progression-free survival data were immature but trended in favor of pirtobrutinib with a 43% reduction of the risk of disease progression or death in the ITT population, and the treatment-nave subgroup, which had the longest follow up, showed a 76% reduction These data will be simultaneously published in the Journal of Clinical Oncology and presented at the 2025 American Society of Hematology Annual Meeting and Exposition, as well as featured as part of the meeting's press program INDIANAPOLIS , Dec. 7, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced results from the Phase 3 BRUIN CLL-314 clinical trial evaluating Jaypirca (pirtobrutinib), a non-covalent (reversible) Bruton tyrosine kinase (BTK) inhibitor,versus Imbruvica (ibrutinib), a covalent BTK inhibitor, in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who were treatment-nave or were BTK inhibitor-nave. Pirtobrutinib met its primary endpoint of non-inferiority on overall response rate (ORR) compared to ibrutinib (87.0% [95% CI, 82.90-90.44] versus 78.5% [95% CI, 73.73-82.85]; p1% of patients included pneumonia.", "url": "https://www.prnewswire.com/news-releases/lillys-jaypirca-pirtobrutinib-met-its-primary-endpoint-in-first-of-its-kind-head-to-head-phase-3-study-versus-imbruvica-ibrutinib-302634417.html"}}
{"date": "2025-12-07", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-07 05:46:44", "publisher": "Defense World", "title": "Cerity Partners LLC Purchases 7,068 Shares of Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/cerity-partners-llc-purchases-7068-shares-of-eli-lilly-20251207.jpg", "site": "defenseworld.net", "text": "Cerity Partners LLC boosted its position in shares of Eli Lilly and Company (NYSE: LLY) by 1.2% during the undefined quarter, according to its most recent 13F filing with the SEC. The fund owned 607,198 shares of the company's stock after purchasing an additional 7,068 shares during the quarter. Eli Lilly and Company", "url": "https://www.defenseworld.net/2025/12/07/cerity-partners-llc-purchases-7068-shares-of-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-07", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-07 05:46:44", "publisher": "Defense World", "title": "Daner Wealth Management LLC Makes New $564,000 Investment in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/daner-wealth-management-llc-makes-new-564000-investment-in-20251207.jpg", "site": "defenseworld.net", "text": "Daner Wealth Management LLC acquired a new stake in Eli Lilly and Company (NYSE: LLY) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 724 shares of the company's stock, valued at approximately $564,000. Other institutional investors and hedge funds also", "url": "https://www.defenseworld.net/2025/12/07/daner-wealth-management-llc-makes-new-564000-investment-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-07", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-07 05:46:43", "publisher": "Defense World", "title": "Dnca Finance Has $1.64 Million Stake in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/dnca-finance-has-164-million-stake-in-eli-lilly-20251207.jpg", "site": "defenseworld.net", "text": "Dnca Finance lowered its stake in shares of Eli Lilly and Company (NYSE: LLY) by 74.4% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,100 shares of the company's stock after selling 6,100 shares during the period. Dnca Finance's", "url": "https://www.defenseworld.net/2025/12/07/dnca-finance-has-1-64-million-stake-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-06 17:07:00", "publisher": "The Motley Fool", "title": "Eli Lilly's Stock Drops as It Slashes the Price of Zepbound: Time to Buy the Dip?", "image": "https://images.financialmodelingprep.com/news/eli-lillys-stock-drops-as-it-slashes-the-price-20251206.jpg", "site": "fool.com", "text": "Eli Lilly's decision to reduce the price of its popular weight loss drug makes more sense than it appears at first. The company still has a robust business that is delivering excellent results and some upcoming catalysts.", "url": "https://www.fool.com/investing/2025/12/06/eli-lillys-stock-drops-as-it-slashes-the-price-of/"}}
{"date": "2025-12-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-06 04:46:43", "publisher": "Defense World", "title": "Brown Advisory Inc. Has $85.05 Million Holdings in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/brown-advisory-inc-has-8505-million-holdings-in-eli-20251206.jpg", "site": "defenseworld.net", "text": "Brown Advisory Inc. increased its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 1.0% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 109,103 shares of the company's stock after purchasing an additional 1,122 shares during the quarter. Brown Advisory", "url": "https://www.defenseworld.net/2025/12/06/brown-advisory-inc-has-85-05-million-holdings-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-06 04:10:56", "publisher": "Defense World", "title": "Edgestream Partners L.P. Has $1.57 Million Holdings in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/edgestream-partners-lp-has-157-million-holdings-in-eli-20251206.jpg", "site": "defenseworld.net", "text": "Edgestream Partners L.P. trimmed its stake in shares of Eli Lilly and Company (NYSE: LLY) by 74.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,014 shares of the company's stock after selling 5,771 shares during the period. Edgestream", "url": "https://www.defenseworld.net/2025/12/06/edgestream-partners-l-p-has-1-57-million-holdings-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-05", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-05 08:00:37", "publisher": "Investors Business Daily", "title": "Eli Lilly, Alphabet Among Megacap Leaders On This Growth List", "image": "https://images.financialmodelingprep.com/news/eli-lilly-alphabet-among-megacap-leaders-on-this-growth-20251205.jpg", "site": "investors.com", "text": "Eli Lilly, Alphabet are among leading stocks in the IBD 50 list of growth stocks. Taiwan Semiconductor and AppLovin are near buy points.", "url": "https://www.investors.com/stock-lists/ibd-50/alphabet-googl-stock-taiwan-semiconductor-tsm-market/"}}
{"date": "2025-12-05", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-05 02:34:42", "publisher": "Defense World", "title": "Paychex (NASDAQ:PAYX) Stock Unloaded Sen. Shelley Moore Capito", "image": "https://images.financialmodelingprep.com/news/paychex-nasdaqpayx-stock-unloaded-sen-shelley-moore-capito-20251205.png", "site": "defenseworld.net", "text": "Senator Shelley Moore Capito (R-West Virginia) recently sold shares of Paychex, Inc. (NASDAQ: PAYX). In a filing disclosed on December 04th, the Senator disclosed that they had sold between $1,001 and $15,000 in Paychex stock on November 13th. Senator Shelley Moore Capito also recently made the following trade(s): Purchased $1,001 - $15,000 in shares of Meta", "url": "https://www.defenseworld.net/2025/12/05/paychex-nasdaqpayx-stock-unloaded-sen-shelley-moore-capito.html"}}
{"date": "2025-12-05", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-05 02:32:44", "publisher": "Defense World", "title": "Meta Platforms (NASDAQ:META) Shares Acquired Sen. Shelley Moore Capito", "image": "https://images.financialmodelingprep.com/news/meta-platforms-nasdaqmeta-shares-acquired-sen-shelley-moore-capito-20251205.png", "site": "defenseworld.net", "text": "Senator Shelley Moore Capito (R-West Virginia) recently bought shares of Meta Platforms, Inc. (NASDAQ: META). In a filing disclosed on December 04th, the Senator disclosed that they had bought between $1,001 and $15,000 in Meta Platforms stock on November 13th. Senator Shelley Moore Capito also recently made the following trade(s): Sold $1,001 - $15,000 in shares", "url": "https://www.defenseworld.net/2025/12/05/meta-platforms-nasdaqmeta-shares-acquired-sen-shelley-moore-capito.html"}}
{"date": "2025-12-05", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-05 02:30:00", "publisher": "The Motley Fool", "title": "With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026", "image": "https://images.financialmodelingprep.com/news/with-netflixs-10for1-stock-split-complete-here-are-3-20251205.jpg", "site": "fool.com", "text": "Meta Platforms generates high cash flow and can afford to take risks on AI spending. ASML's lithography machines are essential for manufacturing advanced AI chips.", "url": "https://www.fool.com/investing/2025/12/05/netflix-stock-split-meta-asml-eli-lilly/"}}
{"date": "2025-12-05", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-05 02:02:42", "publisher": "Defense World", "title": "Sen. Shelley Moore Capito Sells Lowes Companies, Inc. (NYSE:LOW) Stock", "image": "https://images.financialmodelingprep.com/news/sen-shelley-moore-capito-sells-lowes-companies-inc-nyselow-20251205.jpg", "site": "defenseworld.net", "text": "Senator Shelley Moore Capito (R-West Virginia) recently sold shares of Lowe's Companies, Inc. (NYSE: LOW). In a filing disclosed on December 04th, the Senator disclosed that they had sold between $1,001 and $15,000 in Lowe's Companies stock on November 13th. Senator Shelley Moore Capito also recently made the following trade(s): Purchased $1,001 - $15,000 in shares", "url": "https://www.defenseworld.net/2025/12/05/sen-shelley-moore-capito-sells-lowes-companies-inc-nyselow-stock-2.html"}}
{"date": "2025-12-04", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-04 10:31:38", "publisher": "Zacks Investment Research", "title": "3 Large Drug Stocks to Watch as the Industry Shows Some Recovery", "image": "https://images.financialmodelingprep.com/news/3-large-drug-stocks-to-watch-as-the-industry-20251204.jpg", "site": "zacks.com", "text": "In the Large-Cap Pharmaceuticals industry, Lilly, J&J and Sanofi are worth retaining as the industry shows some recovery.", "url": "https://www.zacks.com/commentary/2799269/3-large-drug-stocks-to-watch-as-the-industry-shows-some-recovery?cid=CS-STOCKNEWSAPI-FT-industry_outlook-2799269"}}
{"date": "2025-12-03", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-03 15:10:04", "publisher": "Forbes", "title": "Companies Cut Prices For Blockbuster Weight-Loss Drugs", "image": "https://images.financialmodelingprep.com/news/companies-cut-prices-for-blockbuster-weightloss-drugs-20251203.jpg", "site": "forbes.com", "text": "In this week's edition of InnovationRx, we look at the price cuts for blockbuster weight-loss drugs, the Forbes 30 Under 30 Healthcare list, the coming barriers to getting vaccines, and more. To get it in your inbox, subscribe here.", "url": "https://www.forbes.com/sites/innovationrx/2025/12/03/companies-cut-prices-for-blockbuster-weight-loss-drugs/"}}
{"date": "2025-12-03", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-03 13:10:00", "publisher": "The Motley Fool", "title": "1 Reason to Buy Eli Lilly Hand Over Fist Before the New Year", "image": "https://images.financialmodelingprep.com/news/1-reason-to-buy-eli-lilly-hand-over-fist-20251203.jpg", "site": "fool.com", "text": "Eli Lilly has seen revenue soar thanks to its blockbuster weight loss drug portfolio. Lilly and Novo Nordisk dominate this market, which has seen high demand.", "url": "https://www.fool.com/investing/2025/12/03/1-reason-to-buy-eli-lilly-hand-over-fist/"}}
{"date": "2025-12-03", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-03 12:59:00", "publisher": "PRNewsWire", "title": "U.S. FDA approves expanded indication for Lilly's Jaypirca (pirtobrutinib), the first and only non-covalent (reversible) BTK inhibitor, for adults with relapsed or refractory CLL/SLL previously treated with a covalent BTK inhibitor", "image": "https://images.financialmodelingprep.com/news/us-fda-approves-expanded-indication-for-lillys-jaypirca-pirtobrutinib-20251203.jpg", "site": "prnewswire.com", "text": "Approval is based on results from the BRUIN CLL-321 trial, the only randomized Phase 3 study in CLL/SLL in which all patients were previously treated with a covalent BTK inhibitor This expanded indication represents a substantial increase in the number of CLL/SLL patients who may benefit from Jaypirca and aligns with the patient population endorsed by the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) INDIANAPOLIS , Dec. 3, 2025 /PRNewswire/ --Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration(FDA) has granted approval to Jaypirca (pirtobrutinib, 100 mg & 50 mg tablets) for the treatment of adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who have previously been treated with a covalent Bruton tyrosine kinase (BTK)inhibitor. This FDA action expands the Jaypirca label to include patients earlier in their treatment course and also converts the December 2023 accelerated approval for later-line CLL/SLL to a traditional approval.1 \"Pirtobrutinib is the only medicine in CLL or SLL that has been prospectively studied in a randomized trial of patients previously treated with a covalent BTK inhibitor, and I am excited to see this expanded FDA approval recognize the benefit it can deliver to this broader group of patients,\" said JeffSharman, M.D.", "url": "https://www.prnewswire.com/news-releases/us-fda-approves-expanded-indication-for-lillys-jaypirca-pirtobrutinib-the-first-and-only-non-covalent-reversible-btk-inhibitor-for-adults-with-relapsed-or-refractory-cllsll-previously-treated-with-a-covalent-btk-inhibito-302632101.html"}}
{"date": "2025-12-03", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-03 10:46:00", "publisher": "Business Wire", "title": "GXP-Storage Appoints Former Eli Lilly Global Clinical Research Executive Chris Otto to Board of Directors", "image": "https://images.financialmodelingprep.com/news/gxpstorage-appoints-former-eli-lilly-global-clinical-research-executive-20251203.jpg", "site": "businesswire.com", "text": "RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Chris Otto brings over three decades of global clinical research experience to the Board of Directors of GXP-Storage.", "url": "https://www.businesswire.com/news/home/20251203493633/en/GXP-Storage-Appoints-Former-Eli-Lilly-Global-Clinical-Research-Executive-Chris-Otto-to-Board-of-Directors/"}}
{"date": "2025-12-03", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-03 06:45:00", "publisher": "The Motley Fool", "title": "2 Trillion-Dollar Dividend Stocks to Buy and Hold for 10 Years", "image": "https://images.financialmodelingprep.com/news/2-trilliondollar-dividend-stocks-to-buy-and-hold-for-20251203.jpg", "site": "fool.com", "text": "These two market leaders boast significant growth prospects in their niches. They increased their payouts at a good clip over the past decade.", "url": "https://www.fool.com/investing/2025/12/03/2-trillion-dollar-dividend-stocks-to-buy-and-hold/"}}
{"date": "2025-12-02", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-02 13:43:27", "publisher": "Seeking Alpha", "title": "Eli Lilly and Company (LLY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-presents-at-citi-annual-20251202.jpg", "site": "seekingalpha.com", "text": "Eli Lilly and Company (LLY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript", "url": "https://seekingalpha.com/article/4849440-eli-lilly-and-company-lly-presents-at-citi-annual-global-healthcare-conference-2025"}}
{"date": "2025-12-02", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-02 13:31:13", "publisher": "Zacks Investment Research", "title": "LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website", "image": "https://images.financialmodelingprep.com/news/lly-lowers-prices-of-zepbound-vials-for-cash-buyers-20251202.jpg", "site": "zacks.com", "text": "Eli Lilly trims Zepbound vial prices on LillyDirect, offering lower monthly costs for self-paying patients across multiple doses.", "url": "https://www.zacks.com/stock/news/2798529/lly-lowers-prices-of-zepbound-vials-for-cash-buyers-on-dtc-website?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2798529"}}
{"date": "2025-12-02", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-02 13:22:00", "publisher": "GlobeNewsWire", "title": "Howard University Receives $10M Gift from Lilly Endowment to Support Efforts to Advance Over 155 Years of Black Theological Education", "image": "https://images.financialmodelingprep.com/news/howard-university-receives-10m-gift-from-lilly-endowment-to-20251202.jpg", "site": "globenewswire.com", "text": "Washington, D.C., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Howard Universityhasreceivedagrantof $10 millionfromLilly Endowment Inc. through its Pathways for Tomorrow Initiative. The funding will help the University's School of DivinitylaunchWisdom Keepers, Hope Seekers (WKHS) a groundbreaking alliance to solve critical challenges and transform pastoral leadership development by uniting seven historically Black theological institutions (HBTIs), including the Hampton University School of Religion, Hood Theological Seminary, Interdenominational Theological Center, Payne Theological Seminary, Virginia Union University Samuel DeWitt Proctor School of Theology, and Shaw University School of Divinity.", "url": "https://www.globenewswire.com/news-release/2025/12/02/3198365/0/en/Howard-University-Receives-10M-Gift-from-Lilly-Endowment-to-Support-Efforts-to-Advance-Over-155-Years-of-Black-Theological-Education.html"}}
{"date": "2025-12-02", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-02 10:30:55", "publisher": "24/7 Wall Street", "title": "Wall Street Bulls are Pounding the Table Over Amazon, Eli Lilly, and Apple", "image": "https://images.financialmodelingprep.com/news/wall-street-bulls-are-pounding-the-table-over-amazon-20251202.jpg", "site": "247wallst.com", "text": "Analysts at Bernstein just reiterated an outperform rating on Apple (", "url": "https://247wallst.com/investing/2025/12/02/wall-street-bulls-are-pounding-the-table-over-amazon-eli-lilly-and-apple/"}}
{"date": "2025-12-02", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-02 10:30:28", "publisher": "Schwab Network", "title": "BA Flies on Strong Commentary, WDC & STX Price Target Hikes, LLY Boost", "image": "https://images.financialmodelingprep.com/news/ba-flies-on-strong-commentary-wdc-stx-price-target-20251202.jpg", "site": "youtube.com", "text": "Boeing (BA) opened Tuesday's trading action as the stronger performer in the SPX. Diane King Hall points to commentary from the company on returning to positive free cash flow lifting the plane manufacturer.", "url": "https://www.youtube.com/watch?v=W1Y3xJ1XNuU"}}
{"date": "2025-12-02", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-02 04:14:53", "publisher": "Defense World", "title": "Beacon Pointe Advisors LLC Sells 34,192 Shares of Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/beacon-pointe-advisors-llc-sells-34192-shares-of-eli-20251202.jpg", "site": "defenseworld.net", "text": "Beacon Pointe Advisors LLC trimmed its position in Eli Lilly and Company (NYSE: LLY) by 43.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 45,228 shares of the company's stock after selling 34,192 shares during the period. Beacon Pointe Advisors", "url": "https://www.defenseworld.net/2025/12/02/beacon-pointe-advisors-llc-sells-34192-shares-of-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-01 17:05:44", "publisher": "Investopedia", "title": "Eli Lilly Trims Price of Popular Weight-Loss Drug on Its Site a Month After Trump Deal", "image": "https://images.financialmodelingprep.com/news/eli-lilly-trims-price-of-popular-weightloss-drug-on-20251201.jpg", "site": "investopedia.com", "text": "Eli Lilly (LLY) said Monday that it's lowering the price of its popular weight-loss drug Zepbound, about a month after striking a deal with the Trump administration to lower drug costs.", "url": "https://www.investopedia.com/eli-lilly-trims-price-of-popular-weight-loss-drug-on-its-site-a-month-after-trump-deal-lly-11859437"}}
{"date": "2025-12-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-01 17:00:18", "publisher": "CNBC Television", "title": "Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site", "image": "https://images.financialmodelingprep.com/news/eli-lilly-cuts-cash-prices-of-zepbound-weight-loss-drug-20251201.jpg", "site": "youtube.com", "text": "Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect.", "url": "https://www.youtube.com/shorts/9yzthYsK1NA"}}
{"date": "2025-12-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-01 16:33:48", "publisher": "Benzinga", "title": "History Says These 7 S&P 500 Stocks Often Rally In December", "image": "https://images.financialmodelingprep.com/news/history-says-these-7-sp-500-stocks-often-rally-20251201.jpeg", "site": "feeds.benzinga.com", "text": "The calendar flipped to December with investors hoping the market's most reliable month delivers again as several S&P 500 stocks show decades of strong seasonal gains.", "url": "https://www.benzinga.com/markets/equities/25/12/49148971/seasonality-best-stocks-to-buy-in-december-seasonal-month-sp-500"}}
{"date": "2025-12-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-01 11:23:04", "publisher": "Proactive Investors", "title": "Eli Lilly cuts price of Zepbound in heightened weight-loss drug competition", "image": "https://images.financialmodelingprep.com/news/eli-lilly-cuts-price-of-zepbound-in-heightened-weightloss-20251201.jpg", "site": "proactiveinvestors.com", "text": "Eli Lilly and Co (NYSE:LLY) said on Monday it is lowering the cash prices of its weight-loss drug Zepbound, marking the latest move in a growing price battle with rival Novo Nordisk. The US pharmaceutical giant said single-dose vials of Zepbound will now be available on its direct-to-consumer platform, LillyDirect, at reduced prices.", "url": "https://www.proactiveinvestors.com/companies/news/1083520"}}
{"date": "2025-12-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-01 10:56:14", "publisher": "Schaeffers Research", "title": "Eli Lilly Stock in Focus After Slashing Cost of Popular Drug", "image": "https://images.financialmodelingprep.com/news/eli-lilly-stock-in-focus-after-slashing-cost-of-20251201.jpg", "site": "schaeffersresearch.com", "text": "Shares of Eli Lilly and Co (NYSE:LLY) are sliding into the red, down 0.8% to trade at $1,066.96 at last check, amid news the pharma giant cut prices on popular weight loss drug Zepbound.", "url": "https://www.schaeffersresearch.com/content/news/2025/12/01/eli-lilly-stock-in-focus-after-slashing-cost-of-popular-drug"}}
{"date": "2025-12-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-01 10:12:53", "publisher": "Bloomberg Markets and Finance", "title": "Lilly Cuts Prices for Cash Buyers of Weight-Loss Drug Zepbound", "image": "https://images.financialmodelingprep.com/news/lilly-cuts-prices-for-cash-buyers-of-weightloss-drug-20251201.jpg", "site": "youtube.com", "text": "Eli Lilly is cutting prices again for those who pay cash for introductory doses of the weight-loss drug Zepbound. The lowest dose vial will cost $299 a month, that would be a saving of about $50.", "url": "https://www.youtube.com/watch?v=slg5RRSVkkE"}}
{"date": "2025-12-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-01 09:25:00", "publisher": "Schaeffers Research", "title": "Stock Futures Struggle as Bitcoin Barrels Lower", "image": "https://images.financialmodelingprep.com/news/stock-futures-struggle-as-bitcoin-barrels-lower-20251201.png", "site": "schaeffersresearch.com", "text": "Stock futures are sliding as December trading gets underway and investors parse through Bitcoin's (BTC) pullback", "url": "https://www.schaeffersresearch.com/content/ezines/2025/12/01/stock-futures-struggle-as-bitcoin-barrels-lower"}}
{"date": "2025-12-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-01 08:05:43", "publisher": "CNBC", "title": "Eli Lilly's price cut, Thanksgiving box office, trouble for gravestone makers and more in Morning Squawk", "image": "https://images.financialmodelingprep.com/news/eli-lillys-price-cut-thanksgiving-box-office-trouble-for-20251201.jpg", "site": "cnbc.com", "text": "Eli Lilly cut prices for Zepbound on its direct-to-consumer platform. The Nasdaq Composite is coming off a losing month amid AI spending concerns.", "url": "https://www.cnbc.com/2025/12/01/5-things-to-know-before-the-stock-market-opens.html"}}
{"date": "2025-12-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-01 08:03:16", "publisher": "Reuters", "title": "Eli Lilly cuts Zepbound price to widen access for obesity drug", "image": "https://images.financialmodelingprep.com/news/eli-lilly-cuts-zepbound-price-to-widen-access-for-20251201.jpg", "site": "reuters.com", "text": "Eli Lilly said on Monday it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the treatment more affordable for U.S. patients, as demand for weight-loss therapies surge.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-cuts-zepbound-price-widen-access-obesity-drug-2025-12-01/"}}
{"date": "2025-12-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-01 08:00:01", "publisher": "CNBC", "title": "Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site", "image": "https://images.financialmodelingprep.com/news/eli-lilly-cuts-cash-prices-of-zepbound-weight-loss-20251201.jpg", "site": "cnbc.com", "text": "Eli Lilly said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect. Starting Dec. 1, cash-paying patients with a valid prescription can pay $299 to $449 per month for Zepbound vials on LillyDirect, depending on the dose, down from a previous range of $349 to $499 per month.", "url": "https://www.cnbc.com/2025/12/01/eli-lilly-prices-zepbound-weight-loss-drug-vials.html"}}
{"date": "2025-12-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-01 04:15:00", "publisher": "Defense World", "title": "Brentview Investment Management LLC Acquires 1,500 Shares of Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/brentview-investment-management-llc-acquires-1500-shares-of-eli-20251201.jpg", "site": "defenseworld.net", "text": "Brentview Investment Management LLC boosted its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 38.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 5,374 shares of the company's stock after purchasing an additional 1,500 shares", "url": "https://www.defenseworld.net/2025/12/01/brentview-investment-management-llc-acquires-1500-shares-of-eli-lilly-and-company-lly.html"}}
{"date": "2025-12-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-12-01 03:31:00", "publisher": "Defense World", "title": "Boston Family Office LLC Acquires 3,755 Shares of Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/boston-family-office-llc-acquires-3755-shares-of-eli-20251201.jpg", "site": "defenseworld.net", "text": "Boston Family Office LLC increased its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 71.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,037 shares of the company's stock after buying an additional", "url": "https://www.defenseworld.net/2025/12/01/boston-family-office-llc-acquires-3755-shares-of-eli-lilly-and-company-lly.html"}}
{"date": "2025-11-29", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-29 11:30:00", "publisher": "The Motley Fool", "title": "These Are 2 of the Smartest Growth Stocks to Invest $5,000 in Today", "image": "https://images.financialmodelingprep.com/news/these-are-2-of-the-smartest-growth-stocks-to-20251129.jpg", "site": "fool.com", "text": "Both of these stocks are growing by leaps and bounds. MercadoLibre boasts a cohesive ecosystem that is driving revenue and profits forward.", "url": "https://www.fool.com/investing/2025/11/29/these-are-2-of-the-smartest-growth-stocks-to-inves/"}}
{"date": "2025-11-29", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-29 03:26:51", "publisher": "Defense World", "title": "Eli Lilly and Company $LLY Shares Sold by Aspire Growth Partners LLC", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-shares-sold-by-aspire-20251129.jpg", "site": "defenseworld.net", "text": "Aspire Growth Partners LLC lowered its position in Eli Lilly and Company (NYSE: LLY) by 4.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,158 shares of the company's stock after selling 54 shares during the", "url": "https://www.defenseworld.net/2025/11/29/eli-lilly-and-company-lly-shares-sold-by-aspire-growth-partners-llc.html"}}
{"date": "2025-11-28", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-28 14:55:36", "publisher": "Investopedia", "title": "S&P 500 Gains and Losses Today: Intel Soars Amid Apple Deal Rumors; Eli Lilly Stock Slides", "image": "https://images.financialmodelingprep.com/news/sp-500-gains-and-losses-today-intel-soars-amid-20251128.jpg", "site": "investopedia.com", "text": "A major U.S. chipmaker got a boost from speculation that it could win a new Big Tech customer, while a high-flying pharmaceutical stock reversed some of its recent gains.", "url": "https://www.investopedia.com/s-and-p-500-gains-and-losses-today-intel-soars-amid-apple-deal-rumors-eli-lilly-stock-slides-intc-lly-11858650"}}
{"date": "2025-11-28", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-28 10:01:16", "publisher": "Zacks Investment Research", "title": "Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know", "image": "https://images.financialmodelingprep.com/news/investors-heavily-search-eli-lilly-and-company-lly-here-20251128.jpg", "site": "zacks.com", "text": "Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.", "url": "https://www.zacks.com/stock/news/2796999/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2796999"}}
{"date": "2025-11-28", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-28 09:23:18", "publisher": "Invezz", "title": "Don't expect much from Eli Lilly stock anymore, says Len Yaffee", "image": "https://images.financialmodelingprep.com/news/dont-expect-much-from-eli-lilly-stock-anymore-says-20251128.jpg", "site": "invezz.com", "text": "Market expert Len Yaffee says it would be increasingly difficult for Eli Lilly (NYSE: LLY) to push higher from current levels  at least in the near-term. LLY shares have been standout performers in 2025  riding the wave of investor enthusiasm around its obesity and diabetes drugs (Zepbound and Mounjaro).", "url": "https://invezz.com/news/2025/11/28/dont-expect-much-from-eli-lilly-stock-anymore-says-len-yaffee/"}}
{"date": "2025-11-27", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-27 07:18:00", "publisher": "The Motley Fool", "title": "Prediction: This Growth Stock Could Hit a $2 Trillion Valuation by 2031", "image": "https://images.financialmodelingprep.com/news/prediction-this-growth-stock-could-hit-a-2-trillion-20251127.jpeg", "site": "fool.com", "text": "Eli Lilly's valuation may suggest that its market-beating days are behind it. However, the pharmaceutical giant still has significant momentum.", "url": "https://www.fool.com/investing/2025/11/27/prediction-this-growth-stock-could-hit-2-trillion/"}}
{"date": "2025-11-27", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-27 06:54:43", "publisher": "Defense World", "title": "Baltimore Washington Financial Advisors Inc. Has $700,000 Stock Position in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/baltimore-washington-financial-advisors-inc-has-700000-stock-position-20251127.jpg", "site": "defenseworld.net", "text": "Baltimore Washington Financial Advisors Inc. raised its position in Eli Lilly and Company (NYSE: LLY) by 5.8% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 898 shares of the company's stock after acquiring an additional 49 shares during the period. Baltimore Washington Financial Advisors Inc.'s", "url": "https://www.defenseworld.net/2025/11/27/baltimore-washington-financial-advisors-inc-has-700000-stock-position-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-11-27", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-27 05:24:42", "publisher": "Defense World", "title": "Eli Lilly and Company $LLY Shares Acquired by Bell Asset Management Ltd", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-shares-acquired-by-bell-20251127.jpg", "site": "defenseworld.net", "text": "Bell Asset Management Ltd increased its holdings in Eli Lilly and Company (NYSE: LLY) by 8.4% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,354 shares of the company's stock after buying an additional 877 shares during the period. Eli", "url": "https://www.defenseworld.net/2025/11/27/eli-lilly-and-company-lly-shares-acquired-by-bell-asset-management-ltd.html"}}
{"date": "2025-11-26", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-26 18:19:12", "publisher": "CNBC Television", "title": "Hard for Eli Lilly to move significantly higher from here in the short-term: Kessef Capital's Yaffee", "image": "https://images.financialmodelingprep.com/news/hard-for-eli-lilly-to-move-significantly-higher-from-20251126.jpg", "site": "youtube.com", "text": "Len Yaffee, Kessef Capital, join 'Fast Money' to talk Amgen's obesity drug, Eli Lilly's current stock action, and much more.", "url": "https://www.youtube.com/watch?v=qQGG59bNB9g"}}
{"date": "2025-11-26", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-26 17:35:00", "publisher": "GuruFocus", "title": "Market Today: Stocks Rally, Tesla Robotaxi and Nvidia Scrutiny", "image": "https://images.financialmodelingprep.com/news/market-today-stocks-rally-tesla-robotaxi-and-nvidia-scrutiny-20251126.png", "site": "gurufocus.com", "text": "Stock News Campbell's exec ousted after viral recording: Campbell Soup (CPB) said it terminated IT VP Martin Bally after an internal review concluded he was the", "url": "https://www.gurufocus.com/news/3226287/market-today-stocks-rally-tesla-robotaxi-and-nvidia-scrutiny"}}
{"date": "2025-11-26", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-26 12:35:17", "publisher": "Zacks Investment Research", "title": "Lilly's Moment: AI-Powered Pipeline Positions Shares to Surge in 2026", "image": "https://images.financialmodelingprep.com/news/lillys-moment-aipowered-pipeline-positions-shares-to-surge-in-20251126.jpg", "site": "zacks.com", "text": "Eli Lilly's stock is surging amid a flurry of AI deals. Our proprietary Zacks Rank system confirms the trend.", "url": "https://www.zacks.com/commentary/2796101/lilly-s-moment-ai-powered-pipeline-positions-shares-to-surge-in-2026?cid=CS-STOCKNEWSAPI-FT-investment_ideas-2796101"}}
{"date": "2025-11-26", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-26 10:30:00", "publisher": "Fool - Investing News", "title": "Stock Split Watch: Is Eli Lilly Next?", "image": "https://images.financialmodelingprep.com/news/stock-split-watch-is-eli-lilly-next-20251126.jpeg", "site": "fool.com", "text": "The stock recently reached beyond $1,000.", "url": "https://www.fool.com/investing/2025/11/26/stock-split-watch-is-eli-lilly-next/"}}
{"date": "2025-11-26", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-26 07:39:00", "publisher": "GuruFocus", "title": "First Look: Campbell Soup fallout, Alphabet AI strength, Nvidia rebuttal", "image": "https://images.financialmodelingprep.com/news/first-look-campbell-soup-fallout-alphabet-ai-strength-nvidia-20251126.png", "site": "gurufocus.com", "text": "Stock News Campbell puts exec on leave: Campbell's Co. (CPB) sidelined a senior IT executive after a lawsuit and leaked audio alleged he disparaged customers an", "url": "https://www.gurufocus.com/news/3225411/first-look-campbell-soup-fallout-alphabet-ai-strength-nvidia-rebuttal"}}
{"date": "2025-11-25", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-25 18:00:00", "publisher": "GuruFocus", "title": "Market Today: Stocks Rise on Fed Cut Bets; Alphabet, Apple Hit Records", "image": "https://images.financialmodelingprep.com/news/market-today-stocks-rise-on-fed-cut-bets-alphabet-20251125.png", "site": "gurufocus.com", "text": "Guru Stock PicksJefferies Group has made the following transactions:Reduce in CLDX by 12.28%Sold out in UNFIAdd in SMH by 25.28%New position in XNCRT Rowe Price", "url": "https://www.gurufocus.com/news/3224917/market-today-stocks-rise-on-fed-cut-bets-alphabet-apple-hit-records"}}
{"date": "2025-11-25", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-25 15:14:52", "publisher": "Benzinga", "title": "AI Just Sparked Biotech's Biggest Rally Since 2004  Why Isn't Anyone Talking About It?", "image": "https://images.financialmodelingprep.com/news/ai-just-sparked-biotechs-biggest-rally-since-2004-why-20251125.png", "site": "feeds.benzinga.com", "text": "While most eyes are on tech and chipmakers, biotech is quietly staging its biggest rally in over two decades.", "url": "https://www.benzinga.com/markets/biotech/25/11/49069551/biotech-stocks-ai-artificial-intelligence-analysis-sector-outlook-eli-lilly-moderna"}}
{"date": "2025-11-25", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-25 08:40:13", "publisher": "MarketBeat", "title": "A Trillion-Dollar Pill: Eli Lilly Broke the Healthcare Ceiling", "image": "https://images.financialmodelingprep.com/news/a-trilliondollar-pill-eli-lilly-broke-the-healthcare-ceiling-20251125.jpg", "site": "marketbeat.com", "text": "In the last part of November 2025, Eli Lilly and Company NYSE: LLY shattered a historic ceiling. The Indianapolis-based drugmaker became the first pharmaceutical company to reach a market capitalization of $1 trillion.", "url": "https://www.marketbeat.com/originals/a-trillion-dollar-pill-eli-lilly-broke-the-healthcare-ceiling/"}}
{"date": "2025-11-25", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-25 04:10:47", "publisher": "Defense World", "title": "Advisors Asset Management Inc. Has $18.78 Million Position in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/advisors-asset-management-inc-has-1878-million-position-in-20251125.jpg", "site": "defenseworld.net", "text": "Advisors Asset Management Inc. trimmed its stake in shares of Eli Lilly and Company (NYSE: LLY) by 7.7% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 24,096 shares of the company's stock after selling 2,016 shares during the quarter. Advisors Asset Management", "url": "https://www.defenseworld.net/2025/11/25/advisors-asset-management-inc-has-18-78-million-position-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-11-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-24 16:30:00", "publisher": "PRNewsWire", "title": "Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast Cancer Symposium", "image": "https://images.financialmodelingprep.com/news/lilly-to-highlight-progress-across-key-programs-in-early-20251124.jpg", "site": "prnewswire.com", "text": "Updated results from the Phase 3 EMBER-3 trial for Inluriyo (imlunestrant) alone and in combination with Verzenio (abemaciclib) in ER+, HER2 metastatic breast cancer to be presented as a late-breaking oral presentation Updated safety and efficacy data to be presented from PIKALO-1, the Phase 1/2 trial of Lilly's pan-mutant-selective PI3K inhibitor, which will be advanced into the Phase 3 PIKALO-2 study New subgroup analysis from the Phase 3 monarchE trial that explores outcomes by nodal status for Verzenio plus endocrine therapy in HR+, HER2 high-risk early breast cancer INDIANAPOLIS , Nov. 24, 2025 /PRNewswire/ --Eli Lilly and Company (NYSE: LLY) today announced that new data from across its breast oncology portfolio and pipeline will be featured at the San Antonio Breast Cancer Symposium (SABCS), taking place December 912 in San Antonio, Texas. These updates reflect Lilly's continued progress across key pathways in hormone receptorpositive (HR+), human epidermal growth factor receptor 2-negative (HER2) breast cancer, the most common form of breast cancer.1 Presentation Highlights Inluriyo (imlunestrant; estrogen receptor antagonist) In a late-breaking oral presentation, Lilly will share updated results from the Phase 3 EMBER-3 trial evaluating Inluriyo (imlunestrant) alone and in combination with Verzenio (abemaciclib), in patients with ER+, HER2 advanced or metastatic breast cancer.", "url": "https://www.prnewswire.com/news-releases/lilly-to-highlight-progress-across-key-programs-in-early-and-advanced-hormone-receptor-positive-breast-cancer-at-the-2025-san-antonio-breast-cancer-symposium-302624563.html"}}
{"date": "2025-11-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-24 14:12:02", "publisher": "CNBC Television", "title": "Eli Lilly is better at executing now than Novo Nordisk, says BMO's Evan Seigerman", "image": "https://images.financialmodelingprep.com/news/eli-lilly-is-better-at-executing-now-than-novo-20251124.jpg", "site": "youtube.com", "text": "Evan Seigerman, BMO head of health care research, joins 'The Exchange' to discuss the gap between Novo Nordisk and Eli Lilly, the valuation gap between the stocks and much more.", "url": "https://www.youtube.com/watch?v=E4Y4DK17tGU"}}
{"date": "2025-11-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-24 12:00:00", "publisher": "PRNewsWire", "title": "Lilly to present data from two positive Phase 3 studies of Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia at the 2025 American Society of Hematology (ASH) Annual Meeting", "image": "https://images.financialmodelingprep.com/news/lilly-to-present-data-from-two-positive-phase-3-20251124.jpg", "site": "prnewswire.com", "text": "Results from the BRUIN CLL-314 study comparing Jaypirca (pirtobrutinib) to Imbruvica (ibrutinib)  the first-ever head-to-head Phase 3 study versus a covalent BTK inhibitor to include treatment-nave CLL/SLL patients  will be presented as an oral presentation Results from the Phase 3 BRUIN CLL-313 study of pirtobrutinib in patients with treatment-nave CLL/SLL will be featured as a late-breaking oral presentation Both BRUIN CLL-314 and BRUIN CLL-313 were selected to be part of the official ASH press program INDIANAPOLIS , Nov. 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) Bruton tyrosine kinase (BTK) inhibitor, will be presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place Dec. 6-9 in Orlando, Florida. Key data presentations for Jaypirca include: In an oral presentation, Lilly will share results from the BRUIN CLL-314 study, comparing pirtobrutinib to Imbruvica (ibrutinib), a covalent BTK inhibitor, in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL).", "url": "https://www.prnewswire.com/news-releases/lilly-to-present-data-from-two-positive-phase-3-studies-of-jaypirca-pirtobrutinib-in-chronic-lymphocytic-leukemia-at-the-2025-american-society-of-hematology-ash-annual-meeting-302623695.html"}}
{"date": "2025-11-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-24 12:00:00", "publisher": "GuruFocus", "title": "Elfun Trusts Significantly Reduces Stake in Broadcom Inc by 60.7%", "image": "https://images.financialmodelingprep.com/news/elfun-trusts-significantly-reduces-stake-in-broadcom-inc-by-20251124.png", "site": "gurufocus.com", "text": "Exploring Elfun Trusts (Trades, Portfolio)' Strategic Moves in Q3 2025 Elfun Trusts (Trades, Portfolio) recently submitted its N-PORT filing for the third quar", "url": "https://www.gurufocus.com/news/3222425/elfun-trusts-significantly-reduces-stake-in-broadcom-inc-by-607"}}
{"date": "2025-11-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-24 07:37:00", "publisher": "GuruFocus", "title": "First Look: BHP ends Anglo bid, Novo miss, Black Friday", "image": "https://images.financialmodelingprep.com/news/first-look-bhp-ends-anglo-bid-novo-miss-black-20251124.png", "site": "gurufocus.com", "text": "Stock News Wall Street steadies; AI and pharma in focus: U.S. stocks rebounded Friday but closed the week lower as rate-cut odds rose after New York Fed Preside", "url": "https://www.gurufocus.com/news/3221611/first-look-bhp-ends-anglo-bid-novo-miss-black-friday"}}
{"date": "2025-11-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-24 04:14:42", "publisher": "Defense World", "title": "Burk Holdings LLC Acquires Shares of 582 Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/burk-holdings-llc-acquires-shares-of-582-eli-lilly-20251124.jpg", "site": "defenseworld.net", "text": "Burk Holdings LLC bought a new stake in Eli Lilly and Company (NYSE: LLY) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 582 shares of the company's stock, valued at approximately $454,000. A number of other institutional investors also recently modified their", "url": "https://www.defenseworld.net/2025/11/24/burk-holdings-llc-acquires-shares-of-582-eli-lilly-and-company-lly.html"}}
{"date": "2025-11-23", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-23 14:05:00", "publisher": "The Motley Fool", "title": "2 Top Dividend Stocks for Growth-Oriented Investors", "image": "https://images.financialmodelingprep.com/news/2-top-dividend-stocks-for-growthoriented-investors-20251123.jpg", "site": "fool.com", "text": "Alphabet's dividend is still new but looks secure given its fantastic business and growth prospects. Eli Lilly is increasing its top line at a dizzying pace and has a strong dividend growth record over the past decade.", "url": "https://www.fool.com/investing/2025/11/23/2-top-dividend-stocks-for-growth-oriented-investor/"}}
{"date": "2025-11-23", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-23 04:59:02", "publisher": "Defense World", "title": "Barings LLC Boosts Stock Position in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/barings-llc-boosts-stock-position-in-eli-lilly-and-20251123.jpg", "site": "defenseworld.net", "text": "Barings LLC increased its position in Eli Lilly and Company (NYSE: LLY) by 4.6% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,246 shares of the company's stock after acquiring an additional 55 shares during the quarter. Barings LLC's holdings", "url": "https://www.defenseworld.net/2025/11/23/barings-llc-boosts-stock-position-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-11-23", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-23 04:12:43", "publisher": "Defense World", "title": "Bank Julius Baer & Co. Ltd Zurich Has $524,000 Holdings in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/bank-julius-baer-co-ltd-zurich-has-524000-holdings-20251123.jpg", "site": "defenseworld.net", "text": "Bank Julius Baer and Co. Ltd Zurich reduced its holdings in Eli Lilly and Company (NYSE: LLY) by 8.0% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 671,712 shares of the company's stock after selling 58,498 shares during the quarter.", "url": "https://www.defenseworld.net/2025/11/23/bank-julius-baer-co-ltd-zurich-has-524000-holdings-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-11-22", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-22 11:10:03", "publisher": "Forbes", "title": "Eli Lilly Stock Value Tops $1 Trillion. Learn Why And If To Buy $LLY", "image": "https://images.financialmodelingprep.com/news/eli-lilly-stock-value-tops-1-trillion-learn-why-20251122.jpg", "site": "forbes.com", "text": "Eli Lilly stock has risen 36% this year to reach a $1 trillion market capitalization  the first health-care company to reach this milestone, according to CNBC.", "url": "https://www.forbes.com/sites/petercohan/2025/11/22/eli-lilly-stock-up-36-to-1-trillion-learn-why-and-if-to-buy-lly/"}}
{"date": "2025-11-22", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-22 05:44:23", "publisher": "Seeking Alpha", "title": "Eli Lilly: The Weight-Loss Leader With More Upside If Execution Holds", "image": "https://images.financialmodelingprep.com/news/eli-lilly-the-weightloss-leader-with-more-upside-if-20251122.jpg", "site": "seekingalpha.com", "text": "Eli Lilly has surged 47% since my last article, exceeding my previous $800 price target and reaching all-time highs near $1,030. LLY's leadership in the obesity treatment market continues to drive top- and bottom-line growth, reinforcing its bullish long-term outlook. The company offers stability amid market volatility, with strong U.S. dominance, premium margins, and potential undervaluation if growth targets are met.", "url": "https://seekingalpha.com/article/4846851-eli-lilly-the-weight-loss-leader-with-more-upside-if-execution-holds"}}
{"date": "2025-11-22", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-22 05:20:43", "publisher": "Defense World", "title": "Bahl & Gaynor Inc. Reduces Stock Holdings in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/bahl-gaynor-inc-reduces-stock-holdings-in-eli-lilly-20251122.jpg", "site": "defenseworld.net", "text": "Bahl and Gaynor Inc. trimmed its stake in Eli Lilly and Company (NYSE: LLY) by 1.5% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 831,489 shares of the company's stock after selling 12,911 shares during the period. Eli", "url": "https://www.defenseworld.net/2025/11/22/bahl-gaynor-inc-reduces-stock-holdings-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-11-22", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-22 04:42:44", "publisher": "Defense World", "title": "Eli Lilly and Company $LLY Shares Sold by Artisan Partners Limited Partnership", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-shares-sold-by-artisan-20251122.jpg", "site": "defenseworld.net", "text": "Artisan Partners Limited Partnership decreased its stake in shares of Eli Lilly and Company (NYSE: LLY) by 22.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,280 shares of the company's stock after selling 8,759 shares during the quarter. Artisan", "url": "https://www.defenseworld.net/2025/11/22/eli-lilly-and-company-lly-shares-sold-by-artisan-partners-limited-partnership.html"}}
{"date": "2025-11-22", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-22 04:14:40", "publisher": "Seeking Alpha", "title": "When Investors Panic, I Buy Eli Lilly", "image": "https://images.financialmodelingprep.com/news/when-investors-panic-i-buy-eli-lilly-20251122.jpg", "site": "seekingalpha.com", "text": "Eli Lilly delivered 54% revenue growth in Q3 2025, raised full-year guidance, and remains a defensive haven amid market volatility. LLY's obesity and diabetes franchise, led by Zepbound, Mounjaro, and upcoming orforglipron, drives robust international growth and pipeline expansion. Massive manufacturing investments and a deep late-stage pipeline, including orforglipron and retatrutide, reinforce LLY's durable competitive moat.", "url": "https://seekingalpha.com/article/4846841-when-investors-panic-i-buy-eli-lilly"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 17:34:00", "publisher": "GuruFocus", "title": "Market Today: Nvidia whipsaws, WBD draws bids, Lilly tops $1T", "image": "https://images.financialmodelingprep.com/news/market-today-nvidia-whipsaws-wbd-draws-bids-lilly-tops-20251121.png", "site": "gurufocus.com", "text": "Stock News AI-led whipsaws hit Wall Street: Nvidia (NVDA) reversed from a post-earnings pop to a sharp drop, fueling a turbulent week in which major indexes fin", "url": "https://www.gurufocus.com/news/3221023/market-today-nvidia-whipsaws-wbd-draws-bids-lilly-tops-1t"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 17:16:00", "publisher": "WSJ", "title": "The Score: Nvidia, Constellation, Eli Lilly, Gap and More Stocks That Defined the Week", "image": "https://images.financialmodelingprep.com/news/the-score-nvidia-constellation-eli-lilly-gap-and-more-20251121.jpg", "site": "wsj.com", "text": "The Score is a weekly review of the biggest stock moves and the news that drove them.", "url": "https://www.wsj.com/finance/stocks/nvidia-constellation-eli-lilly-gap-target-lowes-home-depot-stock-1916e192"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 16:00:14", "publisher": "Schwab Network", "title": "LLY Becomes Biggest Healthcare Company: Analyzing Stock's Stunning Rally", "image": "https://images.financialmodelingprep.com/news/lly-becomes-biggest-healthcare-company-analyzing-stocks-stunning-rally-20251121.jpg", "site": "youtube.com", "text": "Eli Lilly (LLY) became the 10th U.S. company to tap $1 trillion in market cap and has outperformed most of its peers, particularly its biggest rival, Novo Nordisk (NVO). Rick Ducat shows just how massive the Eli Lilly's run is and highlights how the \"red-hot\" stock will have to build up its bullish base.", "url": "https://www.youtube.com/watch?v=MOm4mGNhD7k"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 15:11:18", "publisher": "Fast Company", "title": "Eli Lilly becomes first health-care company to hit $1 trillion", "image": "https://images.financialmodelingprep.com/news/eli-lilly-becomes-first-healthcare-company-to-hit-1-20251121.jpg", "site": "fastcompany.com", "text": "Silicon Valley's giants crowd the list of the world's most valuable companies, but drugmaker Eli Lilly is hot on their heels. The company topped a market capitalization of one trillion dollars on Friday, becoming the first business in the health industry to hit that milestone.", "url": "https://www.fastcompany.com/91447196/eli-lilly-becomes-first-health-care-company-to-hit-1-trillion"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 13:58:51", "publisher": "Benzinga", "title": "3 Weight-Loss Drug Stocks To Consider For 2026", "image": "https://images.financialmodelingprep.com/news/3-weightloss-drug-stocks-to-consider-for-2026-20251121.jpg", "site": "benzinga.com", "text": "The global weight loss drug market, perhaps ironically, is growing like gangbusters these days. Globally, it's set to expand from $15 billion in 2024 to $150 billion by 2035, according to Morgan Stanley.", "url": "https://www.benzinga.com/news/25/11/49012717/3-weight-loss-drug-stocks-to-consider-for-2026"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 11:52:07", "publisher": "Reuters", "title": "Lilly becomes first healthcare firm to join trillion-dollar club, Wall Street reacts", "image": "https://images.financialmodelingprep.com/news/lilly-becomes-first-healthcare-firm-to-join-trilliondollar-club-20251121.jpg", "site": "reuters.com", "text": "Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.", "url": "https://www.reuters.com/business/finance/lilly-becomes-first-healthcare-firm-join-trillion-dollar-club-wall-street-reacts-2025-11-21/"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 11:32:00", "publisher": "GuruFocus", "title": "Eli Lilly reaches $1 trillion market value for first time", "image": "https://images.financialmodelingprep.com/news/eli-lilly-reaches-1-trillion-market-value-for-first-time-20251121.png", "site": "gurufocus.com", "text": "Eli Lilly (LLY, Financials) became the first health-care business to enter a club usually only open to technology titans when its market value hit $1 trillion f", "url": "https://www.gurufocus.com/news/3220601/eli-lilly-reaches-1-trillion-market-value-for-first-time"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 11:29:00", "publisher": "Barrons", "title": "Eli Lilly's Market Cap Breaks $1 Trillion After Climbing $400 Billion in 3 Months", "image": "https://images.financialmodelingprep.com/news/eli-lillys-market-cap-breaks-1-trillion-after-climbing-20251121.jpg", "site": "barrons.com", "text": "It's the only drug company ever to have a $1 trillion capitalization value; the other U.S. companies are tech giants and Berkshire Hathaway.", "url": "https://www.barrons.com/articles/eli-lillys-stock-trillion-zepbound-92d443bc"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 11:19:07", "publisher": "Proactive Investors", "title": "Eli Lilly first healthcare company to hit $1T market capitalization", "image": "https://images.financialmodelingprep.com/news/eli-lilly-first-healthcare-company-to-hit-1t-market-20251121.jpg", "site": "proactiveinvestors.com", "text": "Eli Lilly and Co (NYSE:LLY) briefly reached a market capitalization of $1 trillion during trading on Friday, making it the first healthcare company to achieve this milestone. Shares of the Indianapolis-based drugmaker rose as much as 1.7% just shy of $1,060, bringing its market value to roughly $1 trillion before retreating slightly, with stock trading near $1,050 per share later in the session.", "url": "https://www.proactiveinvestors.com/companies/news/1083005"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 11:14:33", "publisher": "New York Post", "title": "Zepbound maker EliLilly hits $1T market cap  becoming first drug company to reach milestone", "image": "https://images.financialmodelingprep.com/news/zepbound-maker-elililly-hits-1t-market-cap-becoming-first-20251121.jpg", "site": "nypost.com", "text": "A more than 35% rally in the company's stock this year has largely been driven by the explosive growth of the weight-loss drug market.", "url": "https://nypost.com/2025/11/21/business/eli-lilly-hits-1t-market-cap-first-drugmaker-to-reach-milestone/"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 11:05:45", "publisher": "Investopedia", "title": "This Month's Stock Trend Hasn't Been AI. Here's What's Been Climbing Instead", "image": "https://images.financialmodelingprep.com/news/this-months-stock-trend-hasnt-been-ai-heres-whats-been-20251121.jpg", "site": "investopedia.com", "text": "November's Wall Street obsession hasn't been AI. It's been healthcare.", "url": "https://www.investopedia.com/this-month-s-stock-trend-hasn-t-been-ai-here-s-what-s-been-climbing-instead-healthcare-lly-regn-11854186"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 10:51:12", "publisher": "Zacks Investment Research", "title": "Here's Why Eli Lilly (LLY) is a Strong Momentum Stock", "image": "https://images.financialmodelingprep.com/news/heres-why-eli-lilly-lly-is-a-strong-momentum-20251121.jpg", "site": "zacks.com", "text": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.", "url": "https://www.zacks.com/stock/news/2794223/here-s-why-eli-lilly-lly-is-a-strong-momentum-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_momentum_score-2794223"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 10:45:09", "publisher": "Invezz", "title": "Wall Street's new darling: Eli Lilly becomes healthcare's first $1 trillion powerhouse", "image": "https://images.financialmodelingprep.com/news/wall-streets-new-darling-eli-lilly-becomes-healthcares-first-20251121.jpg", "site": "invezz.com", "text": "Eli Lilly crossed into historic territory on Friday, becoming the first healthcare company ever to hit a $1 trillion market valuation. Shares rose 1.7% to mark the milestone, cementing the Indianapolis pharmaceutical giant as Wall Street's newest mega-cap champion.", "url": "https://invezz.com/news/2025/11/21/wall-streets-new-darling-eli-lilly-becomes-healthcares-first-1-trillion-powerhouse/"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 10:22:00", "publisher": "WSJ", "title": "Weight-loss drugmaker Eli Lilly hit a $1 trillion market cap, joining a select group of mostly tech companies", "image": "https://images.financialmodelingprep.com/news/weightloss-drugmaker-eli-lilly-hit-a-1-trillion-market-20251121.jpg", "site": "wsj.com", "text": "Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.", "url": "https://www.wsj.com/health/pharma/eli-lilly-reaches-1-trillion-market-cap-on-booming-weight-loss-drugs-f4664fa9"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 10:07:18", "publisher": "CNBC", "title": "Eli Lilly hits $1 trillion market value, a first for a health-care company", "image": "https://images.financialmodelingprep.com/news/eli-lilly-hits-1-trillion-market-value-a-first-20251121.jpg", "site": "cnbc.com", "text": "Drugmaker Eli Lilly reached a $1 trillion market capitalization, the first health-care company in the world to join the exclusive club dominated by tech firms. The pharmaceutical giant's stock has been riding the skyrocketing demand for its weight loss injection Zepbound and diabetes treatment Mounjaro.", "url": "https://www.cnbc.com/2025/11/21/eli-lilly-hits-1-trillion-market-value-first-for-health-care-company.html"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 09:55:41", "publisher": "Reuters", "title": "Lilly becomes first drugmaker to join trillion-dollar club on weight-loss demand boom", "image": "https://images.financialmodelingprep.com/news/lilly-becomes-first-drugmaker-to-join-trilliondollar-club-on-20251121.jpg", "site": "reuters.com", "text": "Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-becomes-first-drugmaker-join-trillion-dollar-club-weight-loss-demand-boom-2025-11-21/"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 09:55:00", "publisher": "WSJ", "title": "ADHD pills lead to other drugs, hormone therapy guidelines have been updated and Novo Nordisk and Eli Lilly cut obesity drug prices. Read more in this week's WSJ Health newsletter:", "image": "https://images.financialmodelingprep.com/news/adhd-pills-lead-to-other-drugs-hormone-therapy-guidelines-20251121.jpg", "site": "wsj.com", "text": "Plus, new hormone therapy guidelines, breast-cancer pills and obesity drug price cuts, in this edition of the WSJ Health newsletter.", "url": "https://www.wsj.com/health/pharma/for-kids-adhd-pills-are-often-just-the-start-37172f50"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 09:00:26", "publisher": "Reuters", "title": "Novo, Lilly collaborate with Waltz Health to sell weight-loss drugs directly to employers", "image": "https://images.financialmodelingprep.com/news/novo-lilly-collaborate-with-waltz-health-to-sell-weightloss-20251121.jpg", "site": "reuters.com", "text": "Digital health company Waltz Health said on Friday it has launched a program to offer popular weight-loss drugs from Novo Nordisk and Eli Lilly directly to employers, bypassing traditional drug sales channels.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/novo-lilly-collaborate-with-waltz-health-sell-weight-loss-drugs-directly-2025-11-21/"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 09:00:00", "publisher": "Business Wire", "title": "Ilant Health Enhances Comprehensive Cardiometabolic Care with Direct Contracting for Obesity Management Medicine for Employers", "image": "https://images.financialmodelingprep.com/news/ilant-health-enhances-comprehensive-cardiometabolic-care-with-direct-contracting-20251121.jpg", "site": "businesswire.com", "text": "NEW YORK--(BUSINESS WIRE)---- $LLY #GLP1--Ilant Health announced that it will offer employers direct contracting and transparent pricing of Eli Lilly and Company (Lilly) obesity management medicines. Employers working with Ilant Health will have the option of accessing obesity management medicines at a transparent and predictable price point starting in early 2026. Medications obtained through this collaboration will be fulfilled by a licensed mail-order pharmacy, supporting convenience, continuity, and a sea.", "url": "https://www.businesswire.com/news/home/20251121143297/en/Ilant-Health-Enhances-Comprehensive-Cardiometabolic-Care-with-Direct-Contracting-for-Obesity-Management-Medicine-for-Employers/"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 04:42:59", "publisher": "Defense World", "title": "ABN AMRO Bank N.V. Invests $157.48 Million in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/abn-amro-bank-nv-invests-15748-million-in-eli-20251121.jpg", "site": "defenseworld.net", "text": "ABN AMRO Bank N.V. acquired a new stake in Eli Lilly and Company (NYSE: LLY) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 200,899 shares of the company's stock, valued at approximately $157,481,000. Eli Lilly and Company comprises about 2.1%", "url": "https://www.defenseworld.net/2025/11/21/abn-amro-bank-n-v-invests-157-48-million-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-11-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-21 03:56:55", "publisher": "Defense World", "title": "Archvest Wealth Advisors Inc. Has $1.74 Million Stock Position in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/archvest-wealth-advisors-inc-has-174-million-stock-position-20251121.jpg", "site": "defenseworld.net", "text": "Archvest Wealth Advisors Inc. grew its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 4.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,235 shares of the company's stock after purchasing an additional 101 shares during the quarter.", "url": "https://www.defenseworld.net/2025/11/21/archvest-wealth-advisors-inc-has-1-74-million-stock-position-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-11-20", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-20 10:46:10", "publisher": "Zacks Investment Research", "title": "Here's Why Eli Lilly (LLY) is a Strong Growth Stock", "image": "https://images.financialmodelingprep.com/news/heres-why-eli-lilly-lly-is-a-strong-growth-20251120.jpg", "site": "zacks.com", "text": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.", "url": "https://www.zacks.com/stock/news/2793661/here-s-why-eli-lilly-lly-is-a-strong-growth-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_growth_score-2793661"}}
{"date": "2025-11-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-19 09:53:00", "publisher": "The Motley Fool", "title": "Stock Split Watch: Could This Unstoppable Growth Stock Be Next?", "image": "https://images.financialmodelingprep.com/news/stock-split-watch-could-this-unstoppable-growth-stock-be-20251119.jpg", "site": "fool.com", "text": "Eli Lilly's share price now stands above $1,000. The company's outlook through the next few years seems strong.", "url": "https://www.fool.com/investing/2025/11/19/stock-split-watch-could-this-unstoppable-growth/"}}
{"date": "2025-11-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-19 08:25:00", "publisher": "MarketBeat", "title": "Healthcare Rotation Underway: 3 Stocks Leading the Charge", "image": "https://images.financialmodelingprep.com/news/healthcare-rotation-underway-3-stocks-leading-the-charge-20251119.jpg", "site": "marketbeat.com", "text": "Is the artificial intelligence revolution hitting its first roadblock? For the first time since the AI boom began in 2023, the industry is starting to feel the weight of expectations, and many of the tech sector's biggest winners have been struggling amidst a volatile market.", "url": "https://www.marketbeat.com/originals/healthcare-rotation-underway-3-stocks-leading-the-charge/"}}
{"date": "2025-11-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-19 06:45:00", "publisher": "PRNewsWire", "title": "Lilly announces plans to open Lilly Gateway Labs site in Philadelphia", "image": "https://images.financialmodelingprep.com/news/lilly-announces-plans-to-open-lilly-gateway-labs-site-20251119.jpg", "site": "prnewswire.com", "text": "Gateway Labs model provides lab space and tailored scientific engagement to fuel next-generation medicines New Center City site, in partnership with Breakthrough Properties, will host a select group of early-stage biotech companies INDIANAPOLIS , Nov. 19, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to open a new Lilly Gateway Labs (LGL) site in Philadelphia, bringing its distinctive model of scientific partnership to a city known for shaping the future of medicine. The new Gateway Labs site will occupy 44,000 square feet of 2300 Market, a life sciences facility in Center City newly developed and operated by Breakthrough Properties.", "url": "https://www.prnewswire.com/news-releases/lilly-announces-plans-to-open-lilly-gateway-labs-site-in-philadelphia-302619234.html"}}
{"date": "2025-11-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-19 06:44:16", "publisher": "FXEmpire", "title": "Eli Lilly Gains from Big Earnings, Bullish Inflows", "image": "https://images.financialmodelingprep.com/news/eli-lilly-gains-from-big-earnings-bullish-inflows-20251119.jpg", "site": "fxempire.com", "text": "Eli Lilly and Company (LLY) shares up 15,892% since Big Money bought big in 1990.", "url": "https://www.fxempire.com/forecasts/article/eli-lilly-gains-from-big-earnings-bullish-inflows-1562098"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-18 13:36:00", "publisher": "GuruFocus", "title": "Lilly's Donanemab Wins India Approval For Alzheimer's", "image": "https://images.financialmodelingprep.com/news/lillys-donanemab-wins-india-approval-for-alzheimers-20251118.png", "site": "gurufocus.com", "text": "Eli Lilly (LLY) just landed a meaningful international win after India's drug regulator approved donanemab, the company's Alzheimer's treatment for people in th", "url": "https://www.gurufocus.com/news/3214650/lillys-donanemab-wins-india-approval-for-alzheimers"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-18 10:06:00", "publisher": "Seeking Alpha", "title": "Baron Opportunity Fund Q3 2025 Portfolio Update", "image": "https://images.financialmodelingprep.com/news/baron-opportunity-fund-q3-2025-portfolio-update-20251118.jpg", "site": "seekingalpha.com", "text": "This quarter, we re-established a position in Arista Networks, a leading provider of high-performance networking solutions for data centers, cloud providers, and enterprises. We initiated a starter position in Synopsys after shares sold off following the company's third quarter earnings report and our in-person meeting with management. We exited our CyberArk Software Ltd. position after its acquisition by Palo Alto Networks was announced.", "url": "https://seekingalpha.com/article/4845053-baron-opportunity-fund-q3-2025-portfolio-update"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-18 10:00:00", "publisher": "PRNewsWire", "title": "Lilly to participate in Citi's 2025 Global Healthcare Conference", "image": "https://images.financialmodelingprep.com/news/lilly-to-participate-in-citis-2025-global-healthcare-conference-20251118.jpg", "site": "prnewswire.com", "text": "INDIANAPOLIS , Nov. 18, 2025 /PRNewswire/ --Eli Lilly and Company (NYSE:LLY) will participate in the Citi's 2025 Global Healthcare Conference on December 2, 2025. Ilya Yuffa, executive vice president and president Lilly USA and Global Customer Capabilities, will take part in a fireside chat at 10:30 a.m.", "url": "https://www.prnewswire.com/news-releases/lilly-to-participate-in-citis-2025-global-healthcare-conference-302617897.html"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-18 09:10:03", "publisher": "Forbes", "title": "Eli Lilly Stock To $1,330?", "image": "https://images.financialmodelingprep.com/news/eli-lilly-stock-to-1330-20251118.jpg", "site": "forbes.com", "text": "Eli Lilly's stock (NYSE: LLY) has recently surged 27% over the past month, reaching a current price of $1,022. This rally is fueled by several powerful factors, including robust sales of its weight-loss drug Zepbound and diabetes drug Mounjaro, strong third-quarter financial results, and a recent government agreement regarding Medicare drug price negotiation.", "url": "https://www.forbes.com/sites/greatspeculations/2025/11/18/eli-lilly-stock-to-1330/"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-18 04:24:54", "publisher": "Defense World", "title": "Bridger Management LLC Makes New $5.70 Million Investment in Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/bridger-management-llc-makes-new-570-million-investment-in-eli-20251118.jpg", "site": "defenseworld.net", "text": "Bridger Management LLC acquired a new stake in Eli Lilly and Company (NYSE: LLY) in the undefined quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 7,307 shares of the company's stock, valued at approximately $5,696,000. Eli Lilly and Company makes up approximately 3.4% of", "url": "https://www.defenseworld.net/2025/11/18/bridger-management-llc-makes-new-5-70-million-investment-in-eli-lilly-and-company-lly.html"}}
{"date": "2025-11-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-18 02:20:00", "publisher": "Seeking Alpha", "title": "Alger Growth & Income Fund Q3 2025 Portfolio Update", "image": "https://images.financialmodelingprep.com/news/alger-growth-income-fund-q3-2025-portfolio-update-20251118.jpg", "site": "seekingalpha.com", "text": "Class A shares of the Alger Growth & Income Fund outperformed the S&P 500 Index during the third quarter of 2025. Apple Inc., Broadcom Inc., and Alphabet Inc. were among the top contributors to performance. Honeywell International Inc., Eli Lilly and Company, and TransDigm Group Incorporated were among the top detractors from performance.", "url": "https://seekingalpha.com/article/4844900-alger-growth-and-income-fund-q3-2025-portfolio-update"}}
{"date": "2025-11-17", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-17 11:22:00", "publisher": "Barrons", "title": "Novo Nordisk, Eli Lilly Weight Loss Price War Heats Up. Why It's a Worry for the Stocks.", "image": "https://images.financialmodelingprep.com/news/novo-nordisk-eli-lilly-weight-loss-price-war-heats-20251117.jpg", "site": "barrons.com", "text": "Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.", "url": "https://www.barrons.com/articles/novo-nordisk-eli-lilly-stocks-price-war-94e485fc"}}
{"date": "2025-11-17", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-17 10:03:09", "publisher": "Zacks Investment Research", "title": "Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock", "image": "https://images.financialmodelingprep.com/news/here-is-what-to-know-beyond-why-eli-lilly-20251117.jpg", "site": "zacks.com", "text": "Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.", "url": "https://www.zacks.com/stock/news/2791772/here-is-what-to-know-beyond-why-eli-lilly-and-company-lly-is-a-trending-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2791772"}}
{"date": "2025-11-16", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-16 11:33:00", "publisher": "The Motley Fool", "title": "Prediction: This Will Be Wall Street's Next Trillion-Dollar Stock", "image": "https://images.financialmodelingprep.com/news/prediction-this-will-be-wall-streets-next-trilliondollar-stock-20251116.jpg", "site": "fool.com", "text": "After a rapid rise, Eli Lilly needs only an 11% gain to hit $1 trillion in market value. Revenue is expected to rise 26% next year, helped by its weight-loss products.", "url": "https://www.fool.com/investing/2025/11/16/prediction-this-will-be-wall-streets-next-trillion/"}}
{"date": "2025-11-16", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-16 04:46:43", "publisher": "Defense World", "title": "Alberta Investment Management Corp Acquires 5,000 Shares of Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/alberta-investment-management-corp-acquires-5000-shares-of-eli-20251116.jpg", "site": "defenseworld.net", "text": "Alberta Investment Management Corp raised its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 38.8% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,900 shares of the company's stock after buying an additional 5,000 shares during", "url": "https://www.defenseworld.net/2025/11/16/alberta-investment-management-corp-acquires-5000-shares-of-eli-lilly-and-company-lly.html"}}
{"date": "2025-11-15", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-15 08:00:00", "publisher": "Seeking Alpha", "title": "Our Top 10 High Growth Dividend Stocks - November 2025", "image": "https://images.financialmodelingprep.com/news/our-top-10-high-growth-dividend-stocks-november-2025-20251115.jpg", "site": "seekingalpha.com", "text": "The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rate both quantitatively and qualitatively and select the top 10 names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and positive momentum, and is suitable for investors in the accumulation phase.", "url": "https://seekingalpha.com/article/4842108-our-top-10-high-growth-dividend-stocks-november-2025"}}
{"date": "2025-11-15", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-15 06:36:42", "publisher": "Defense World", "title": "Arcadia Investment Management Corp MI Acquires 2,740 Shares of Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/arcadia-investment-management-corp-mi-acquires-2740-shares-of-eli-20251115.jpg", "site": "defenseworld.net", "text": "Arcadia Investment Management Corp MI increased its stake in Eli Lilly and Company (NYSE: LLY) by 64.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,023 shares of the company's stock after acquiring an additional 2,740 shares during the quarter.", "url": "https://www.defenseworld.net/2025/11/15/arcadia-investment-management-corp-mi-acquires-2740-shares-of-eli-lilly-and-company-lly.html"}}
{"date": "2025-11-15", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-15 04:00:46", "publisher": "Defense World", "title": "Advisory Resource Group Acquires 82 Shares of Eli Lilly and Company $LLY", "image": "https://images.financialmodelingprep.com/news/advisory-resource-group-acquires-82-shares-of-eli-lilly-and-20251115.jpg", "site": "defenseworld.net", "text": "Advisory Resource Group boosted its stake in Eli Lilly and Company (NYSE: LLY) by 4.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,014 shares of the company's stock after purchasing an additional 82 shares during the period. Advisory Resource", "url": "https://www.defenseworld.net/2025/11/15/advisory-resource-group-acquires-82-shares-of-eli-lilly-and-company-lly.html"}}
{"date": "2025-11-14", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-14 16:01:00", "publisher": "GuruFocus", "title": "Philippe Laffont's Strategic Moves: CoreWeave Inc Faces a -5.03% Portfolio Impact", "image": "https://images.financialmodelingprep.com/news/philippe-laffonts-strategic-moves-coreweave-inc-faces-a-503-20251114.png", "site": "gurufocus.com", "text": "Exploring the Latest 13F Filing and Investment Adjustments Introduction to Philippe Laffont (Trades, Portfolio) and Coatue Management Philippe Laffont (Trades,", "url": "https://www.gurufocus.com/news/3210266/philippe-laffonts-strategic-moves-coreweave-inc-faces-a-503-portfolio-impact"}}
{"date": "2025-11-14", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-14 15:04:00", "publisher": "GuruFocus", "title": "Chase Coleman's Strategic Moves: Meta Platforms Inc. Sees Significant Reduction", "image": "https://images.financialmodelingprep.com/news/chase-colemans-strategic-moves-meta-platforms-inc-sees-significant-reduction-20251114.png", "site": "gurufocus.com", "text": "Exploring the Third Quarter 2025 13F Filing of Tiger Global Management Chase Coleman (Trades, Portfolio) recently submitted the 13F filing for the third quarte", "url": "https://www.gurufocus.com/news/3210163/chase-colemans-strategic-moves-meta-platforms-inc-sees-significant-reduction"}}
{"date": "2025-11-14", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-14 13:02:30", "publisher": "MarketBeat", "title": "Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since", "image": "https://images.financialmodelingprep.com/news/eli-lilly-strikes-deal-with-trump-why-shares-are-20251114.jpg", "site": "marketbeat.com", "text": "The world's most valuable healthcare stock, Eli Lilly and Company NYSE: LLY, just dropped huge news. LikePfizer NYSE: PFE, Lilly announced a drug pricing deal with the Trump Administration.", "url": "https://www.marketbeat.com/originals/eli-lilly-strikes-deal-with-trump-why-shares-are-up-10-since/"}}
{"date": "2025-11-14", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-14 12:56:43", "publisher": "Investors Business Daily", "title": "Eli Lilly Leads Three Stocks Near Buy Points", "image": "https://images.financialmodelingprep.com/news/eli-lilly-leads-three-stocks-near-buy-points-20251114.jpg", "site": "investors.com", "text": "Eli Lilly stock hit an all-time high in Friday's stock market.", "url": "https://www.investors.com/stock-lists/new-highs/eli-lilly-stock-lly/"}}
{"date": "2025-11-14", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-14 10:02:00", "publisher": "Zacks Investment Research", "title": "Can Lilly's Next-Gen Obesity Drugs Help Sustain Its Market Dominance?", "image": "https://images.financialmodelingprep.com/news/can-lillys-nextgen-obesity-drugs-help-sustain-its-market-20251114.jpg", "site": "zacks.com", "text": "Eli Lilly's next-gen obesity drugs, led by oral orforglipron and triple-acting retatrutide, aim to reshape the fast-growing weight-loss market.", "url": "https://www.zacks.com/stock/news/2791155/can-lilly-s-next-gen-obesity-drugs-help-sustain-its-market-dominance?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2791155"}}
{"date": "2025-11-14", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-14 07:06:18", "publisher": "Reuters", "title": "Health Rounds: Lilly blood thinner tops AstraZeneca's for heart procedure patients with diabetes", "image": "https://images.financialmodelingprep.com/news/health-rounds-lilly-blood-thinner-tops-astrazenecas-for-heart-20251114.jpg", "site": "reuters.com", "text": "Blood-thinning drugs that doctors often prescribe interchangeably after procedures to reopen narrowed heart arteries don't work equally well in patients with diabetes, a study from India found.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/health-rounds-lilly-blood-thinner-tops-astrazenecas-heart-procedure-patients-2025-11-14/"}}
{"date": "2025-11-14", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-14 02:22:51", "publisher": "Seeking Alpha", "title": "It Looks Like Eli Lilly Will Become The Next Trillion Dollar Baby", "image": "https://images.financialmodelingprep.com/news/it-looks-like-eli-lilly-will-become-the-next-20251114.jpg", "site": "seekingalpha.com", "text": "Eli Lilly is poised to become the first $1 trillion pharmaceutical company, driven by explosive growth in its weight-loss drug, Mounjaro. LLY's earnings and sales growth have been exceptional, with quarterly earnings up 495% and sales up 38% year-over-year, outpacing industry peers. The stock boasts a stellar long-term performance record, outperforming the S&P 500 and earning top momentum and performance grades in the analyst's system.", "url": "https://seekingalpha.com/article/4843685-looks-like-eli-lilly-will-become-next-trillion-dollar-baby"}}
{"date": "2025-11-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-13 14:04:16", "publisher": "Reuters", "title": "Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs", "image": "https://images.financialmodelingprep.com/news/novo-nordisk-lilly-deny-partnership-with-mangoceuticals-on-obesity-20251113.jpg", "site": "reuters.com", "text": "Novo Nordisk and Eli Lilly do not have a weight-loss drug partnership with telehealth website Mangoceuticals Inc , spokespeople for both companies said, rejecting a press release issued by the company on Thursday that described arrangements with the two leading drugmakers.", "url": "https://www.reuters.com/legal/litigation/novo-nordisk-lilly-deny-partnership-with-mangoceuticals-obesity-drugs-2025-11-13/"}}
{"date": "2025-11-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-13 13:51:07", "publisher": "Zacks Investment Research", "title": "Can Equities Stabilize after the Government Reopens?", "image": "https://images.financialmodelingprep.com/news/can-equities-stabilize-after-the-government-reopens-20251113.webp", "site": "zacks.com", "text": "As traders position for year-end, the government shutdown is over, major market indices are filling gaps, and seasonal momentum looms.", "url": "https://www.zacks.com/commentary/2790817/can-equities-stabilize-after-the-government-reopens?cid=CS-STOCKNEWSAPI-FT-investment_ideas-2790817"}}
{"date": "2025-11-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-13 11:03:00", "publisher": "GuruFocus", "title": "Jefferies Group's Strategic Move: Vanguard Information Technology ETF Takes Center Stage", "image": "https://images.financialmodelingprep.com/news/jefferies-groups-strategic-move-vanguard-information-technology-etf-takes-center-20251113.png", "site": "gurufocus.com", "text": "Jefferies Group (Trades, Portfolio)'s Latest 13F Filing Reveals Strategic Portfolio Adjustments Jefferies Group (Trades, Portfolio) recently submitted its 13F", "url": "https://www.gurufocus.com/news/3207102/jefferies-groups-strategic-move-vanguard-information-technology-etf-takes-center-stage"}}
{"date": "2025-11-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-13 07:15:41", "publisher": "Reuters", "title": "Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs", "image": "https://images.financialmodelingprep.com/news/mangoceuticals-partners-with-lilly-novo-nordisk-to-sell-weightloss-20251113.jpg", "site": "reuters.com", "text": "Telehealth company Mangoceuticals said on Thursday it has partnered with Eli Lilly and Novo Nordisk to sell the drugmakers' blockbuster weight-loss drugs through its platform.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/mangoceuticals-partners-with-lilly-novo-nordisk-sell-weight-loss-drugs-2025-11-13/"}}
{"date": "2025-11-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-13 04:25:00", "publisher": "The Motley Fool", "title": "1 Incredible Reason to Buy LLY's Stock in November", "image": "https://images.financialmodelingprep.com/news/1-incredible-reason-to-buy-llys-stock-in-november-20251113.jpg", "site": "fool.com", "text": "Eli Lilly is the market-share leader for weight-loss drugs. Coverage by government insurance programs is a huge win for the company.", "url": "https://www.fool.com/investing/2025/11/13/incredible-reason-buy-lilly-stock-november-lly/"}}
{"date": "2025-11-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-13 01:17:00", "publisher": "GlobeNewsWire", "title": "Bitget Lists LLY, MA, UNH Stock Index Perpetual Futures as Cumulative Trading Volume on Bitget hits $3 Billion", "image": "https://images.financialmodelingprep.com/news/bitget-lists-lly-ma-unh-stock-index-perpetual-futures-20251113.png", "site": "globenewswire.com", "text": "VICTORIA, Seychelles, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bitget, the world's largest Universal Exchange (UEX), has announced the official addition of LLYUSDT, MAUSDT, UNHUSDT stock index perpetual futures, expanding its range of Real World Asset (RWA) products for global traders. Bitget users can access these contracts with leverage of up to 10x.", "url": "https://www.globenewswire.com/news-release/2025/11/13/3187009/0/en/Bitget-Lists-LLY-MA-UNH-Stock-Index-Perpetual-Futures-as-Cumulative-Trading-Volume-on-Bitget-hits-3-Billion.html"}}
{"date": "2025-11-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-12 15:30:30", "publisher": "Seeking Alpha", "title": "MeiraGTx: Latest Eli Lilly Partnership Ignites Riboswitch Technology Potential", "image": "https://images.financialmodelingprep.com/news/meiragtx-latest-eli-lilly-partnership-ignites-riboswitch-technology-potential-20251112.jpg", "site": "seekingalpha.com", "text": "MeiraGTx Holdings plc secures a transformative partnership with Eli Lilly, granting worldwide rights to its AAV-AIPL1 gene therapy for LCA4. MGTX receives $75 million upfront, up to $400 million in milestones, and tiered royalties, strengthening its financial position and reducing near-term dilution risk. The company's riboswitch technology and multiple collaborations, including with Johnson & Johnson and Hologen, highlight its innovation and diversified pipeline.", "url": "https://seekingalpha.com/article/4842666-meiragtx-latest-eli-lilly-partnership-ignites-riboswitch-technology-potential"}}
{"date": "2025-11-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-12 11:42:44", "publisher": "Investors Business Daily", "title": "Eli Lilly Stock: This Trade On The Rising Stock Holds $1,415 In Profit Potential", "image": "https://images.financialmodelingprep.com/news/eli-lilly-stock-this-trade-on-the-rising-stock-20251112.jpg", "site": "investors.com", "text": "Eli Lilly's strong price action and high ratings present a bull call spread trading opportunity with large profit potential and clearly defined risk parameters.", "url": "https://www.investors.com/research/options/eli-lilly-stock-lly-options-bull-call-spread-pharma-drugs-investing-markets/"}}
{"date": "2025-11-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-12 10:20:08", "publisher": "Forbes", "title": "Is Eli Lilly Stock's Run Too Hot? Here Is How It Can Crash", "image": "https://images.financialmodelingprep.com/news/is-eli-lilly-stocks-run-too-hot-here-is-20251112.jpg", "site": "forbes.com", "text": "Eli Lilly stock (NYSE: LLY) has surged by 21% this month, driven by strong third-quarter earnings and a favorable obesity drug pricing deal with the U.S. government. However, this recent success doesn't mean the company is invulnerable to challenges.", "url": "https://www.forbes.com/sites/greatspeculations/2025/11/12/is-eli-lilly-stocks-run-too-hot-here-is-how-it-can-crash/"}}
{"date": "2025-11-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-12 10:01:52", "publisher": "Schwab Network", "title": "IBM's Quantum Push Intensifies, LLY Price Target Hike, ONON Soars 20% on Earnings", "image": "https://images.financialmodelingprep.com/news/ibms-quantum-push-intensifies-lly-price-target-hike-onon-soars-20251112.jpg", "site": "youtube.com", "text": "ON Holding (ONON) jumped higher with an earnings beat and guidance raise giving shares a platform to rally. Diane King Hall points to sales doubling in the Asia-Pacific region as a big catalyst.", "url": "https://www.youtube.com/watch?v=t00FQnRTHWM"}}
{"date": "2025-11-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-12 09:54:40", "publisher": "CNBC Television", "title": "Cramer's Mad Dash: Eli Lilly", "image": "https://images.financialmodelingprep.com/news/cramers-mad-dash-eli-lilly-20251112.jpg", "site": "youtube.com", "text": "Jim Cramer breaks down why he's keeping an eye on shares of Eli Lilly.", "url": "https://www.youtube.com/watch?v=FTOYFD8WcYc"}}
{"date": "2025-11-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-12 09:45:00", "publisher": "The Motley Fool", "title": "Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock", "image": "https://images.financialmodelingprep.com/news/forget-recursion-pharmaceuticals-this-could-be-an-even-better-20251112.jpg", "site": "fool.com", "text": "Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed.", "url": "https://www.fool.com/investing/2025/11/12/forget-recursion-pharmaceuticals-this-could-be-an/"}}
{"date": "2025-11-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-12 08:20:04", "publisher": "24/7 Wall Street", "title": "Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (Nov 2025)", "image": "https://images.financialmodelingprep.com/news/eli-lilly-nyse-lly-stock-price-prediction-and-forecast-20251112.jpg", "site": "247wallst.com", "text": "From late 2020 to the summer of 2024, Eli Lilly & Co. (NYSE: LLY) stock was on a tear, up more than 635%, before taking a breather this year.", "url": "https://247wallst.com/forecasts/2025/11/12/eli-lilly-lly-stock-price-prediction-and-forecast-2025-2030/"}}
{"date": "2025-11-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-12 07:01:00", "publisher": "GuruFocus", "title": "PRIMECAP Management's Strategic Moves: Hess Corp Exit and Chevron Corp Addition", "image": "https://images.financialmodelingprep.com/news/primecap-managements-strategic-moves-hess-corp-exit-and-chevron-corp-20251112.png", "site": "gurufocus.com", "text": "Analyzing the Third Quarter 2025 13F Filing PRIMECAP Management (Trades, Portfolio) recently submitted its 13F filing for the third quarter of 2025, offering a", "url": "https://www.gurufocus.com/news/3203110/primecap-managements-strategic-moves-hess-corp-exit-and-chevron-corp-addition"}}
{"date": "2025-11-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-12 04:22:00", "publisher": "The Motley Fool", "title": "This Unstoppable Growth Stock Just Delivered More Good News: Time to Buy?", "image": "https://images.financialmodelingprep.com/news/this-unstoppable-growth-stock-just-delivered-more-good-news-20251112.jpg", "site": "fool.com", "text": "Eli Lilly released more positive mid-stage clinical trial results for a weight management candidate. The company should dominate this area through the end of the decade, at least, despite the competition.", "url": "https://www.fool.com/investing/2025/11/12/this-unstoppable-growth-stock-just-delivered-more/"}}
{"date": "2025-11-12", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-12 04:12:49", "publisher": "Defense World", "title": "Eli Lilly and Company $LLY Stake Boosted by Accredited Investors Inc.", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-stake-boosted-by-accredited-20251112.jpg", "site": "defenseworld.net", "text": "Accredited Investors Inc. increased its position in shares of Eli Lilly and Company (NYSE: LLY) by 17.1% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,851 shares of the company's stock after acquiring an additional 561", "url": "https://www.defenseworld.net/2025/11/12/eli-lilly-and-company-lly-stake-boosted-by-accredited-investors-inc.html"}}
{"date": "2025-11-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-11 21:34:47", "publisher": "Reuters", "title": "Eli Lilly drops CVS drug plan for workers after Novo obesity deal, Bloomberg News reports", "image": "https://images.financialmodelingprep.com/news/eli-lilly-drops-cvs-drug-plan-for-workers-after-20251111.jpg", "site": "reuters.com", "text": "Eli Lilly is dropping CVS Health's drug benefit plan for its employees after CVS stopped covering its weight-loss drug in favor of a rival medication from Novo Nordisk , Bloomberg News reported on Tuesday, citing people familiar with the matter.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-drops-cvs-drug-plan-workers-after-novo-obesity-deal-bloomberg-news-2025-11-12/"}}
{"date": "2025-11-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-11 15:20:00", "publisher": "Market Watch", "title": "Why cutting drug prices is pushing Eli Lilly's stock toward an all-time high", "image": "https://images.financialmodelingprep.com/news/why-cutting-drug-prices-is-pushing-eli-lillys-stock-toward-20251111.jpg", "site": "marketwatch.com", "text": "Even by dramatically lowering the prices of some of its medications, the drug giant is still outpacing its rivals and nearing a trillion-dollar valuation.", "url": "https://www.marketwatch.com/story/why-cutting-drug-prices-is-pushing-eli-lillys-stock-toward-an-all-time-high-edc0c453"}}
{"date": "2025-11-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-11 11:10:20", "publisher": "Zacks Investment Research", "title": "Lilly Up 18% in a Month: Should You Buy, Sell or Hold the Stock?", "image": "https://images.financialmodelingprep.com/news/lilly-up-18-in-a-month-should-you-buy-20251111.jpg", "site": "zacks.com", "text": "Eli Lilly stock jumps 18% in a month as strong Q3 results, upgraded guidance and rising demand for Mounjaro and Zepbound fuel investor optimism.", "url": "https://www.zacks.com/stock/news/2789366/lilly-up-18-in-a-month-should-you-buy-sell-or-hold-the-stock?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2789366"}}
{"date": "2025-11-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-11 10:50:08", "publisher": "The Motley Fool", "title": "Three Healthcare Buys That Wall Street Loves", "image": "https://images.financialmodelingprep.com/news/three-healthcare-buys-that-wall-street-loves-20251111.jpg", "site": "fool.com", "text": "New technologies and an aging population are lifting the healthcare sector. Immunotherapy and anti-obesity drugs are leading the way.", "url": "https://www.fool.com/investing/2025/11/11/three-healthcare-buys-that-wall-street-loves/"}}
{"date": "2025-11-10", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-10 12:45:38", "publisher": "24/7 Wall Street", "title": "Wall Street is Pounding the Table Over NVDA, RUN, LLY", "image": "https://images.financialmodelingprep.com/news/wall-street-is-pounding-the-table-over-nvda-run-20251110.jpg", "site": "247wallst.com", "text": "In addition, according to analysts at UBS, it sees Nvidia guiding fourth quarter revenue to a range of $63 billion to $64 billion.", "url": "https://247wallst.com/investing/2025/11/10/wall-street-is-pounding-the-table-over-nvda-run-lly/"}}
{"date": "2025-11-10", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-10 09:10:45", "publisher": "Reuters", "title": "Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease", "image": "https://images.financialmodelingprep.com/news/eli-lilly-signs-deal-for-meiragtxs-gene-therapy-for-severe-20251110.jpg", "site": "reuters.com", "text": "MeiraGTx Holdings has signed a deal with Eli Lilly , potentially worth over $475 million, granting the pharma giant rights to its experimental gene therapy for a rare, inherited disorder that causes severe vision loss from birth.", "url": "https://www.reuters.com/legal/transactional/eli-lilly-signs-deal-meiragtxs-gene-therapy-severe-eye-disease-2025-11-10/"}}
{"date": "2025-11-10", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-10 08:11:02", "publisher": "24/7 Wall Street", "title": "Here Are Monday's Top Wall Street Analyst Research Calls: Advanced Micro Devices, Alphabet, Apple, Eli Lilly, CarMax, HubSpot, and More", "image": "https://images.financialmodelingprep.com/news/here-are-mondays-top-wall-street-analyst-research-calls-20251110.jpg", "site": "247wallst.com", "text": "The futures are trading higher as the new week begins, with most investors and traders relieved that last week has come to a close.", "url": "https://247wallst.com/investing/2025/11/10/here-are-mondays-top-wall-street-analyst-research-calls-advanced-micro-devices-alphabet-apple-eli-lilly-carmax-hubspot-and-more/"}}
{"date": "2025-11-09", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-09 05:31:00", "publisher": "The Motley Fool", "title": "Huge News for Eli Lilly Stock and Novo Nordisk Stock Investors as Companies Make Deal With Trump", "image": "https://images.financialmodelingprep.com/news/huge-news-for-eli-lilly-stock-and-novo-nordisk-20251109.jpg", "site": "fool.com", "text": "Eli Lilly (LLY 1.39%) and Novo Nordisk (NVO 1.89%) agreed to lower prices for their weight loss treatments in exchange for lower tariffs and expanded access.", "url": "https://www.fool.com/investing/2025/11/09/huge-news-for-eli-lilly-stock-and-novo-nordisk-sto/"}}
{"date": "2025-11-08", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-08 11:50:45", "publisher": "Investors Business Daily", "title": "Eli Lilly And These AI Plays Lead 5 Stocks Near Buy Points", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-these-ai-plays-lead-5-stocks-near-20251108.jpg", "site": "investors.com", "text": "The watchlist stocks have bucked the market's recent volatility.", "url": "https://www.investors.com/news/eli-lilly-ai-plays-5-stocks-near-buy-points/"}}
{"date": "2025-11-08", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-08 10:30:00", "publisher": "The Motley Fool", "title": "This Unstoppable Growth Stock Just Gave Investors More Reasons to Buy", "image": "https://images.financialmodelingprep.com/news/this-unstoppable-growth-stock-just-gave-investors-more-reasons-20251108.jpg", "site": "fool.com", "text": "Eli Lilly delivered fantastic third-quarter results, largely thanks to tirzepatide. The company's current lineup and pipeline make the stock attractive.", "url": "https://www.fool.com/investing/2025/11/08/this-unstoppable-growth-stock-just-gave-investors/"}}
{"date": "2025-11-08", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-08 05:10:00", "publisher": "The Motley Fool", "title": "Prediction: Eli Lilly Will Be Worth More Than Berkshire Hathaway by 2030", "image": "https://images.financialmodelingprep.com/news/prediction-eli-lilly-will-be-worth-more-than-berkshire-20251108.jpg", "site": "fool.com", "text": "Eli Lilly has plenty of medium-term catalysts that should power a strong performance through 2030. Berkshire Hathaway, by contrast, is facing some headwinds that may limit its upside.", "url": "https://www.fool.com/investing/2025/11/08/prediction-eli-lilly-will-be-worth-more-than-berks/"}}
{"date": "2025-11-08", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-08 03:45:00", "publisher": "The Motley Fool", "title": "Eli Lilly Strikes a Landmark Pricing Deal With the U.S. for Its Billion-Dollar Weight Loss Drugs. Here's What This Means for Investors.", "image": "https://images.financialmodelingprep.com/news/eli-lilly-strikes-a-landmark-pricing-deal-with-the-us-20251108.jpg", "site": "fool.com", "text": "Eli Lilly struck a deal with President Donald Trump, lowering the prices of its blockbuster weight loss drugs. In return, Lilly gains exemption from import tariffs and other benefits.", "url": "https://www.fool.com/investing/2025/11/08/eli-lilly-strikes-a-landmark-pricing-deal-with-the/"}}
{"date": "2025-11-07", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-07 12:33:23", "publisher": "Benzinga", "title": "Eli Lilly's Investigational Obesity Drug Shows Up To 20% Weight Loss In Phase 2 Study, Analyst Sees It As Emerging Cornerstone In Obesity Treatment", "image": "https://images.financialmodelingprep.com/news/eli-lillys-investigational-obesity-drug-shows-up-to-20-weight-20251107.jpeg", "site": "benzinga.com", "text": "On Thursday, Eli Lilly and Co. (NYSE:LLY) released data from a Phase 2 trial evaluating the safety and efficacy of eloralintide, an investigational once-weekly, selective amylin receptor agonist, in 263 obese adults with at least one obesity-related health issue and without type 2 diabetes.", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/11/48727525/eli-lillys-investigational-obesity-drug-shows-up-to-20-weight-loss-in-phase-2-study-analyst-sees-it-as-emerging-cornerstone-in-obesity-treatment"}}
{"date": "2025-11-07", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-07 00:51:57", "publisher": "Reuters", "title": "Lilly's obesity drug Mounjaro becomes India's top-selling drug by value in October", "image": "https://images.financialmodelingprep.com/news/lillys-obesity-drug-mounjaro-becomes-indias-topselling-drug-by-value-20251107.jpg", "site": "reuters.com", "text": "Eli Lilly's blockbuster obesity drug Mounjaro became India's top-selling drug by value for the month of October with sales hitting 1 billion rupees ($11.38 million), research firm Pharmarack said on Friday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/lillys-obesity-drug-mounjaro-becomes-indias-top-selling-drug-by-value-october-2025-11-07/"}}
{"date": "2025-11-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-06 16:48:55", "publisher": "Reuters", "title": "Eli Lilly expects US FDA approval for oral obesity drug in March 2026", "image": "https://images.financialmodelingprep.com/news/eli-lilly-expects-us-fda-approval-for-oral-obesity-20251106.jpg", "site": "reuters.com", "text": "Eli Lilly expects the U.S. Food and Drug Administration to approve its experimental oral obesity drug, orforglipron, by March 2026, its chief executive said on Thursday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-expects-us-fda-approval-oral-obesity-drug-march-2026-2025-11-06/"}}
{"date": "2025-11-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-06 16:05:00", "publisher": "PRNewsWire", "title": "Lilly announces two new Executive Committee members and expansion of leadership roles to prepare for next wave of growth", "image": "https://images.financialmodelingprep.com/news/lilly-announces-two-new-executive-committee-members-and-expansion-20251106.jpg", "site": "prnewswire.com", "text": "INDIANAPOLIS , Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of two new Executive Committee members and the expansion of other senior leaders' roles designed to accelerate one of the industry's most ambitious pipelines, generate new portfolio opportunities, and strengthen patient access to its medicines. Carole Ho, M.D.", "url": "https://www.prnewswire.com/news-releases/lilly-announces-two-new-executive-committee-members-and-expansion-of-leadership-roles-to-prepare-for-next-wave-of-growth-302606052.html"}}
{"date": "2025-11-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-06 14:42:36", "publisher": "CNBC", "title": "Here's how much weight loss drugs could cost you under Trump's deals with Eli Lilly, Novo Nordisk", "image": "https://images.financialmodelingprep.com/news/heres-how-much-weight-loss-drugs-could-cost-you-20251106.jpg", "site": "cnbc.com", "text": "President Donald Trump struck landmark deals with Eli Lilly and Novo Nordisk to slash the prices of their blockbuster weight loss drugs. Under the agreements, the monthly out-of-pocket cost of popular injections and upcoming pills could range from $50 to $350, depending on the dosage and insurance coverage a patient has.", "url": "https://www.cnbc.com/2025/11/06/obesity-drug-prices-trump-deals-eli-lilly-novo-nordisk.html"}}
{"date": "2025-11-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-06 13:54:00", "publisher": "PRNewsWire", "title": "Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans", "image": "https://images.financialmodelingprep.com/news/lilly-and-us-government-agree-to-expand-access-to-obesity-20251106.jpg", "site": "prnewswire.com", "text": "Medicare beneficiaries with obesity or overweight will have access to Zepbound and orforglipron, if approved, at $50 a month INDIANAPOLIS , Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced an agreement with the U.S. government to expand access to its obesity medicines and reduce patient costs. The agreement builds on Lilly's longstanding commitment to finding solutions with policymakers that improve access to life-changing medicines.", "url": "https://www.prnewswire.com/news-releases/lilly-and-us-government-agree-to-expand-access-to-obesity-medicines-to-millions-of-americans-302607652.html"}}
{"date": "2025-11-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-06 13:02:59", "publisher": "Bloomberg Markets and Finance", "title": "Lilly, Novo Will Lower Obesity Drug Prices in Trump Deal", "image": "https://images.financialmodelingprep.com/news/lilly-novo-will-lower-obesity-drug-prices-in-trump-20251106.jpg", "site": "youtube.com", "text": "Eli Lilly & Co.andNovo Nordisk A/S cut a deal with the Trump administration to lower prices on their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients.President Donald Trump spoke about it in the Oval Office.", "url": "https://www.youtube.com/watch?v=vYRDaIMX2Gc"}}
{"date": "2025-11-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-06 12:49:03", "publisher": "CNBC Television", "title": "President Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices", "image": "https://images.financialmodelingprep.com/news/president-trump-announces-deals-with-eli-lilly-novo-nordisk-20251106.jpg", "site": "youtube.com", "text": "President Donald Trump announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, including upcoming pills, in a landmark effort to expand access to the costly blockbuster treatments.", "url": "https://www.youtube.com/watch?v=Ku3Yb77pjZE"}}
{"date": "2025-11-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-06 06:49:13", "publisher": "Reuters", "title": "Lilly's experimental drug shows promise with 20.1% weight loss in mid-stage trial", "image": "https://images.financialmodelingprep.com/news/lillys-experimental-drug-shows-promise-with-201-weight-loss-20251106.jpg", "site": "reuters.com", "text": "Eli Lilly said on Thursday its experimental obesity drug helped patients lose as much as 20.1% of their weight in a mid-stage trial.", "url": "https://www.reuters.com/sustainability/boards-policy-regulation/lillys-experimental-drug-shows-promise-with-201-weight-loss-mid-stage-trial-2025-11-06/"}}
{"date": "2025-11-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-06 06:45:01", "publisher": "CNBC", "title": "Eli Lilly to start late-stage trials on amylin obesity drug after it shows up to 20% weight loss in study", "image": "https://images.financialmodelingprep.com/news/eli-lilly-to-start-latestage-trials-on-amylin-obesity-20251106.jpg", "site": "cnbc.com", "text": "Eli Lilly said it will start late-stage trials on its experimental amylin obesity drug next month after it showed encouraging results in a mid-stage study. The highest dose of the weekly injection, called eloralintide, helped patients with obesity or who are overweight lose 20.1% of their body weight on average at 48 weeks.", "url": "https://www.cnbc.com/2025/11/06/eli-lilly-amylin-obesity-drug-study-weight-loss-trials.html"}}
{"date": "2025-11-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-06 06:45:00", "publisher": "PRNewsWire", "title": "Lilly's selective amylin agonist, eloralintide, demonstrated meaningful weight loss and favorable tolerability in a Phase 2 study of adults with obesity or overweight", "image": "https://images.financialmodelingprep.com/news/lillys-selective-amylin-agonist-eloralintide-demonstrated-meaningful-weight-loss-20251106.jpg", "site": "prnewswire.com", "text": "Based on these trial results, Lilly will begin enrolling Phase 3 clinical studies for the treatment of obesity next month INDIANAPOLIS , Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive results from a Phase 2 trial evaluating the safety and efficacy of eloralintide, an investigational once-weekly, selective amylin receptor agonist, in 263 adults with obesity or overweight with at least one obesity-related comorbidity and without type 2 diabetes. At 48 weeks, all treatment arms of eloralintide met the primary endpoint, demonstrating superior mean weight reductions from 9.5% to 20.1% compared to 0.4% with placebo using the efficacy estimand.1 Results from the trial were presented at ObesityWeek 2025 and simultaneously published inThe Lancet.", "url": "https://www.prnewswire.com/news-releases/lillys-selective-amylin-agonist-eloralintide-demonstrated-meaningful-weight-loss-and-favorable-tolerability-in-a-phase-2-study-of-adults-with-obesity-or-overweight-302607061.html"}}
{"date": "2025-11-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-06 06:40:39", "publisher": "Reuters", "title": "Novo, Lilly shares rise as Trump obesity drug deal nears", "image": "https://images.financialmodelingprep.com/news/novo-lilly-shares-rise-as-trump-obesity-drug-deal-20251106.jpg", "site": "reuters.com", "text": "Shares of obesity drugmakers Eli Lilly and Novo Nordisk rose early on Thursday in anticipation of a White House deal that would reduce prices of their blockbuster weight-loss treatments in return for expanded market access.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/novo-lilly-shares-rise-trump-obesity-drug-deal-nears-2025-11-06/"}}
{"date": "2025-11-05", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-05 13:16:21", "publisher": "Reuters", "title": "Trump, Eli Lilly to announce weight loss drug price cut on Thursday, CBS reports", "image": "https://images.financialmodelingprep.com/news/trump-eli-lilly-to-announce-weight-loss-drug-price-20251105.jpg", "site": "reuters.com", "text": "U.S. President Donald Trump on Thursday is expected to announce a deal with officials from Eli Lilly and Novo Nordisk cutting the price of weight loss drugs in some cases to $150 a month, CBS reported on Wednesday, citing sources.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/trump-eli-lilly-announce-weight-loss-drug-price-cut-thursday-cbs-reports-2025-11-05/"}}
{"date": "2025-11-05", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-05 10:51:11", "publisher": "Zacks Investment Research", "title": "Here's Why Eli Lilly (LLY) is a Strong Momentum Stock", "image": "https://images.financialmodelingprep.com/news/heres-why-eli-lilly-lly-is-a-strong-momentum-20251105.jpg", "site": "zacks.com", "text": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.", "url": "https://www.zacks.com/stock/news/2785762/here-s-why-eli-lilly-lly-is-a-strong-momentum-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_momentum_score-2785762"}}
{"date": "2025-11-05", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-05 07:13:08", "publisher": "CNBC Television", "title": "White House speaking with Novo Nordisk, Eli Lilly about selling some obesity drugs for $149/mo: WSJ", "image": "https://images.financialmodelingprep.com/news/white-house-speaking-with-novo-nordisk-eli-lilly-about-20251105.jpg", "site": "youtube.com", "text": "CNBC's Andrew Ross Sorkin reports on the latest news.", "url": "https://www.youtube.com/watch?v=fzlwUHKi9-o"}}
{"date": "2025-11-05", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-05 06:30:00", "publisher": "The Motley Fool", "title": "This Company Now Has the World's No. 1 Drug. Should You Invest $1,000?", "image": "https://images.financialmodelingprep.com/news/this-company-now-has-the-worlds-no-1-drug-should-20251105.jpg", "site": "fool.com", "text": "Tirzepatide is used to treat both diabetes and obesity. Eli Lilly just struck a major deal with the world's largest retailer.", "url": "https://www.fool.com/investing/2025/11/05/this-company-now-has-the-worlds-1-drug-should-you/"}}
{"date": "2025-11-05", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-05 05:00:00", "publisher": "PRNewsWire", "title": "XtalPi Subsidiary Ailux Announces Strategic Collaboration with Lilly to Advance Bispecific Antibody Development", "image": "https://images.financialmodelingprep.com/news/xtalpi-subsidiary-ailux-announces-strategic-collaboration-with-lilly-to-20251105.jpg", "site": "prnewswire.com", "text": "SHANGHAI , Nov. 5, 2025 /PRNewswire/ --Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi (2228.HK), a global leader in AI drug discovery, today announced a strategic platform-based collaboration with Eli Lilly and Company (\"Lilly\") to accelerate the discovery and development of bispecific antibodies for the treatment of various diseases. Through this collaboration, Lilly will gain access to Ailux's AI-powered bispecific antibody engineering platform, which integrates advanced structural modeling, generative design, and developability analytics to deliver therapeutic constructs with novel function, optimal efficacy and drug-like properties.", "url": "https://www.prnewswire.com/news-releases/xtalpi-subsidiary-ailux-announces-strategic-collaboration-with-lilly-to-advance-bispecific-antibody-development-302605279.html"}}
{"date": "2025-11-04", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-04 20:10:00", "publisher": "The Motley Fool", "title": "Billionaire Stanley Druckenmiller Dropped Nvidia and Palantir Stock and Is Piling into 2 Stocks Set to Win in One of the Decade's Hottest Growth Markets.", "image": "https://images.financialmodelingprep.com/news/billionaire-stanley-druckenmiller-dropped-nvidia-and-palantir-stock-and-20251104.jpg", "site": "fool.com", "text": "Stanley Druckenmiller has a fantastic investing track record, delivering a double-digit average annual return over time. The billionaire sold artificial intelligence (AI) leaders Nvidia and Palantir -- stocks that have advanced more than 1,000% over the past few years.", "url": "https://www.fool.com/investing/2025/11/04/billionaire-stanley-druckenmiller-dropped-nvidia-a/"}}
{"date": "2025-11-04", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-04 17:29:00", "publisher": "Market Watch", "title": "Obesity drugs may get Medicare access under deal with White House: reports", "image": "https://images.financialmodelingprep.com/news/obesity-drugs-may-get-medicare-access-under-deal-with-20251104.jpg", "site": "marketwatch.com", "text": "The White House is close to announcing a deal with drugmakers Eli Lilly and Novo Nordisk that would cut the price of obesity drugs to $149 per month in some cases and extend coverage to certain Medicare and Medicaid beneficiaries, according to media reports Tuesday.", "url": "https://www.marketwatch.com/story/obesity-drugs-may-get-medicare-access-under-deal-with-white-house-reports-e0472b38"}}
{"date": "2025-11-04", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-04 10:46:05", "publisher": "Zacks Investment Research", "title": "Why Eli Lilly (LLY) is a Top Growth Stock for the Long-Term", "image": "https://images.financialmodelingprep.com/news/why-eli-lilly-lly-is-a-top-growth-stock-20251104.jpg", "site": "zacks.com", "text": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.", "url": "https://www.zacks.com/stock/news/2784619/why-eli-lilly-lly-is-a-top-growth-stock-for-the-long-term?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_growth_score-2784619"}}
{"date": "2025-11-04", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-04 10:44:17", "publisher": "Reuters", "title": "Lilly and Novo Nordisk near White House deal on obesity drug prices, Endpoints New reports", "image": "https://images.financialmodelingprep.com/news/lilly-and-novo-nordisk-near-white-house-deal-on-20251104.jpg", "site": "reuters.com", "text": "Eli Lilly and Novo Nordisk are preparing to announce new drug pricing deals with the White House, including for their blockbuster weight loss drugs, in return for coverage of products under Medicare, Endpoints New reported on Tuesday, citing sources familiar with the matter.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-novo-nordisk-near-white-house-deal-obesity-drug-prices-endpoints-new-2025-11-04/"}}
{"date": "2025-11-04", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-04 10:16:06", "publisher": "Zacks Investment Research", "title": "International Markets and Lilly (LLY): A Deep Dive for Investors", "image": "https://images.financialmodelingprep.com/news/international-markets-and-lilly-lly-a-deep-dive-for-20251104.jpg", "site": "zacks.com", "text": "Explore how Lilly's (LLY) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.", "url": "https://www.zacks.com/stock/news/2784463/international-markets-and-lilly-lly-a-deep-dive-for-investors?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm_international_revenues-2784463"}}
{"date": "2025-11-04", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-04 10:01:05", "publisher": "Zacks Investment Research", "title": "Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-is-attracting-investor-attention-20251104.jpg", "site": "zacks.com", "text": "Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.", "url": "https://www.zacks.com/stock/news/2784395/eli-lilly-and-company-lly-is-attracting-investor-attention-here-is-what-you-should-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2784395"}}
{"date": "2025-11-04", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-04 03:05:04", "publisher": "Defense World", "title": "Best Medical Stocks To Watch Today  November 2nd", "image": "https://images.financialmodelingprep.com/news/best-medical-stocks-to-watch-today-november-2nd-20251104.jpg", "site": "defenseworld.net", "text": "Eli Lilly and Company, Pfizer, UnitedHealth Group, AbbVie, and Johnson and Johnson are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. \"Medical stocks\" are shares of publicly traded companies that operate in the healthcare sector, including pharmaceutical and biotechnology firms, medical device makers, hospitals, diagnostic labs, and health services providers.", "url": "https://www.defenseworld.net/2025/11/04/best-medical-stocks-to-watch-today-november-2nd.html"}}
{"date": "2025-11-04", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-04 03:05:01", "publisher": "Defense World", "title": "Top Pharmaceutical Stocks To Follow Now  November 2nd", "image": "https://images.financialmodelingprep.com/news/top-pharmaceutical-stocks-to-follow-now-november-2nd-20251104.jpg", "site": "defenseworld.net", "text": "Eli Lilly and Company, Pfizer, and AbbVie are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufacture, and commercialize prescription drugs, vaccines, and related therapies. For investors, they offer exposure to significant R&D and regulatory risk-stock performance is heavily", "url": "https://www.defenseworld.net/2025/11/04/top-pharmaceutical-stocks-to-follow-now-november-2nd.html"}}
{"date": "2025-11-03", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-03 08:32:48", "publisher": "Reuters", "title": "Lilly to build $3 billion Dutch plant to boost weight-loss pill production", "image": "https://images.financialmodelingprep.com/news/lilly-to-build-3-billion-dutch-plant-to-boost-20251103.jpg", "site": "reuters.com", "text": "Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand the production capacity for its keenly watched weight-loss pill, orforglipron, and other oral medicines.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-build-3-billion-dutch-plant-boost-weight-loss-pill-production-2025-11-03/"}}
{"date": "2025-11-03", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-03 08:30:00", "publisher": "PRNewsWire", "title": "Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide", "image": "https://images.financialmodelingprep.com/news/lilly-plans-to-build-a-new-3-billion-facility-20251103.jpg", "site": "prnewswire.com", "text": "Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain INDIANAPOLIS , Nov. 3, 2025 /PRNewswire/ --Eli Lilly and Company (NYSE:LLY) announced today plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands, located within the Leiden Bio Science Park. This major project will expand Lilly's capacity to produce oral medicines and strengthen the company's global supply chain.", "url": "https://www.prnewswire.com/news-releases/lilly-plans-to-build-a-new-3-billion-facility-to-boost-oral-medicine-manufacturing-capacity-in-europe-for-patients-worldwide-302600462.html"}}
{"date": "2025-11-02", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-02 08:00:01", "publisher": "CNBC", "title": "Where the blockbuster weight loss drug market stands today  and what's coming next", "image": "https://images.financialmodelingprep.com/news/where-the-blockbuster-weight-loss-drug-market-stands-today-20251102.jpg", "site": "cnbc.com", "text": "The blockbuster weight loss drug market is entering a new chapter of growth. Eli Lilly and Novo Nordisk are both focused on fighting for market share, ramping up supply, testing new uses for their medicines and bringing the next wave of obesity drugs to patients.", "url": "https://www.cnbc.com/2025/11/02/whats-next-for-the-weight-loss-drug-market-pills-rivals-insurance.html"}}
{"date": "2025-11-02", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-02 01:35:55", "publisher": "Defense World", "title": "Top Medical Stocks To Keep An Eye On  October 31st", "image": "https://images.financialmodelingprep.com/news/top-medical-stocks-to-keep-an-eye-on-october-31st-20251102.jpg", "site": "defenseworld.net", "text": "Eli Lilly and Company, Pfizer, and UnitedHealth Group are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies whose primary business is healthcare - including pharmaceutical and biotech firms, medical device and diagnostic manufacturers, and healthcare service providers like hospitals and insurers. Investors", "url": "https://www.defenseworld.net/2025/11/02/top-medical-stocks-to-keep-an-eye-on-october-31st.html"}}
{"date": "2025-11-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-01 23:00:50", "publisher": "Seeking Alpha", "title": "Top 15 High-Growth Dividend Stocks For November 2025", "image": "https://images.financialmodelingprep.com/news/top-15-highgrowth-dividend-stocks-for-november-2025-20251101.jpg", "site": "seekingalpha.com", "text": "The Top 15 High-Growth Dividend Stock list for November 2025 offers a 1.39% yield and 19.88% five-year dividend growth. Despite underperforming SPY and VIG in October, the watchlist targets a long-term 12% annual return and remains a strong starting point for research. Stocks are selected using Quality and Value tilts, aiming for higher yields, growth, and undervaluation, with an average 31% discount to fair value.", "url": "https://seekingalpha.com/article/4836707-top-15-high-growth-dividend-stocks-for-november-2025"}}
{"date": "2025-11-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-01 08:00:23", "publisher": "Investors Business Daily", "title": "S&P 500 Giants JPMorgan, Eli Lilly Lead Five Stocks Near Buy Points", "image": "https://images.financialmodelingprep.com/news/sp-500-giants-jpmorgan-eli-lilly-lead-five-stocks-20251101.jpg", "site": "investors.com", "text": "Three S&P 500 components, including JPMorgan Chase and Eli Lilly, are among five stocks near buy points.", "url": "https://www.investors.com/news/sp-500-jpmorgan-eli-lilly-stocks-buy-points/"}}
{"date": "2025-11-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-11-01 05:47:08", "publisher": "Defense World", "title": "Medical Stocks To Watch Now  October 30th", "image": "https://images.financialmodelingprep.com/news/medical-stocks-to-watch-now-october-30th-20251101.jpg", "site": "defenseworld.net", "text": "Eli Lilly and Company, UnitedHealth Group, and Pfizer are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies that develop, manufacture, or deliver medical products and services - including pharmaceutical and biotech firms, medical device makers, diagnostic companies, hospitals, and healthcare insurers. Investors", "url": "https://www.defenseworld.net/2025/11/01/medical-stocks-to-watch-now-october-30th.html"}}
{"date": "2025-10-31", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-31 14:46:11", "publisher": "Benzinga", "title": "Eli Lilly Seen In 'Pole Position' For Growth, Analysts Say", "image": "https://images.financialmodelingprep.com/news/eli-lilly-seen-in-pole-position-for-growth-analysts-20251031.jpg", "site": "benzinga.com", "text": "Eli Lilly and Co. (NYSE:LLY) reported better-than-expected third-quarter earnings on Thursday and boosted its annual forecast, sending the stock higher.", "url": "https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/10/48571020/eli-lilly-seen-in-pole-position-for-growth-analysts-say"}}
{"date": "2025-10-31", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-31 10:52:20", "publisher": "Seeking Alpha", "title": "Eli Lilly Has A Solid Upside Now After Its Q3 Earnings", "image": "https://images.financialmodelingprep.com/news/eli-lilly-has-a-solid-upside-now-after-its-20251031.jpg", "site": "seekingalpha.com", "text": "Eli Lilly remains a top GARP opportunity, with Q3 results reinforcing its robust business growth and dominance in incretin analogs. LLY posted a 54% YoY revenue jump and a 19% EPS beat, with management raising both sales and EPS guidance for the year. A strengthened drug pipeline, particularly for orforglipron's Phase III success, de-risks future earnings and promises sustained growth beyond 2027.", "url": "https://seekingalpha.com/article/4836307-eli-lilly-has-a-solid-upside-now-after-its-q3-earnings"}}
{"date": "2025-10-31", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-31 10:11:15", "publisher": "Fast Company", "title": "Eli Lilly's obesity and diabetes treatments fuel growth and spark bidding war", "image": "https://images.financialmodelingprep.com/news/eli-lillys-obesity-and-diabetes-treatments-fuel-growth-and-20251031.jpg", "site": "fastcompany.com", "text": "The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.", "url": "https://www.fastcompany.com/91432558/eli-lilly-mounjaro-zepbound-obesity-diabetes"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 18:00:00", "publisher": "WSJ", "title": "Two developments ThursdayEli Lilly's strong quarterly performance and Novo Nordisk's unsolicited $9 billion bid for a startupshow why drugmakers can't get enough of weight loss", "image": "https://images.financialmodelingprep.com/news/two-developments-thursdayeli-lillys-strong-quarterly-performance-and-novo-20251030.jpg", "site": "wsj.com", "text": "Lilly's quarterly results Thursday, combined with Novo Nordisk's unsolicited offer for a startup, confirm the $72 billion anti-obesity market is among pharma's hottest.", "url": "https://www.wsj.com/health/pharma/the-day-pharmas-weight-loss-gold-rush-intensified-c5c32c11"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 16:58:14", "publisher": "Seeking Alpha", "title": "Eli Lilly: The Price Upside Just Increased", "image": "https://images.financialmodelingprep.com/news/eli-lilly-the-price-upside-just-increased-20251030.jpg", "site": "seekingalpha.com", "text": "Eli Lilly delivered robust Q3 2025 results and guidance for non-GAAP EPS for the second consecutive quarter. When I last checked on the stock, there was still 20% upside to LLY for the remainder of 2025. With higher guidance, this upside has risen too. Risks persist for the stock in terms of the policy environment, though. Its expected agreement with the US government is still pending, which could affect earnings.", "url": "https://seekingalpha.com/article/4835836-eli-lilly-the-price-upside-just-increased"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 14:46:25", "publisher": "Seeking Alpha", "title": "Eli Lilly and Company (LLY) Q3 2025 Earnings Call Transcript", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-q3-2025-earnings-call-20251030.jpg", "site": "seekingalpha.com", "text": "Eli Lilly and Company ( LLY ) Q3 2025 Earnings Call October 30, 2025 10:00 AM EDT Company Participants Mike Czapar - Director of Investor Relations David Ricks - Chairman, CEO & President Lucas Montarce - Executive VP & CFO Daniel Skovronsky - EVP, Chief Scientific Officer and President of Lilly Research Laboratories & Lilly immunology Patrik Jonsson - Executive VP & President of Lilly International Ilya Yuffa - Executive VP and President of Lilly USA & Global Customer Capabilities Anne White - Executive VP & President of Lilly Neuroscience Kenneth Custer - Executive VP & President of Lilly Cardiometabolic Health Conference Call Participants Terence Flynn - Morgan Stanley, Research Division Christopher Schott - JPMorgan Chase & Co, Research Division Seamus Fernandez - Guggenheim Securities, LLC, Research Division James Shin - Deutsche Bank AG, Research Division Geoffrey Meacham - Citigroup Inc., Research Division Steve Scala - TD Cowen, Research Division Mohit Bansal - Wells Fargo Securities, LLC, Research Division Courtney Breen - Sanford C. Bernstein & Co., LLC.", "url": "https://seekingalpha.com/article/4835587-eli-lilly-and-company-lly-q3-2025-earnings-call-transcript"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 14:01:16", "publisher": "Zacks Investment Research", "title": "Lilly Beats on Q3 Earnings, Ups View, Mounjaro, Zepbound Drive Sales", "image": "https://images.financialmodelingprep.com/news/lilly-beats-on-q3-earnings-ups-view-mounjaro-zepbound-20251030.jpg", "site": "zacks.com", "text": "Lilly tops Q3 estimates as Mounjaro and Zepbound fuel a 54% revenue surge, prompting the drugmaker to raise its full-year sales and earnings outlook.", "url": "https://www.zacks.com/stock/news/2781842/lilly-beats-on-q3-earnings-ups-view-mounjaro-zepbound-drive-sales?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_article-2781842"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 11:30:18", "publisher": "Zacks Investment Research", "title": "Compared to Estimates, Lilly (LLY) Q3 Earnings: A Look at Key Metrics", "image": "https://images.financialmodelingprep.com/news/compared-to-estimates-lilly-lly-q3-earnings-a-look-20251030.jpg", "site": "zacks.com", "text": "The headline numbers for Lilly (LLY) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.", "url": "https://www.zacks.com/stock/news/2781673/compared-to-estimates-lilly-lly-q3-earnings-a-look-at-key-metrics?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm-2781673"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 11:25:42", "publisher": "Investopedia", "title": "Eli Lilly Boosts Its Outlook on High Demand for Popular Weight-Loss Drugs", "image": "https://images.financialmodelingprep.com/news/eli-lilly-boosts-its-outlook-on-high-demand-for-20251030.jpg", "site": "investopedia.com", "text": "Strong sales of Eli Lilly's weight-loss treatments Mounjaro and Zepbound helped power strong quarterly earnings, and the drugmaker boosted its outlook.", "url": "https://www.investopedia.com/eli-lilly-boosts-its-outlook-on-high-demand-for-popular-weight-loss-drugs-11840143"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 10:13:57", "publisher": "CNBC Television", "title": "Eli Lilly CEO: Seeing global demand for weight loss drug Mounjaro", "image": "https://images.financialmodelingprep.com/news/eli-lilly-ceo-seeing-global-demand-for-weight-loss-20251030.jpg", "site": "youtube.com", "text": "Eli Lilly chairman and CEO David Ricks joins CNBC's Squawk on the Street team to discuss its quarterly earnings report that beat estimates, weight loss drug demand, its drug pipeline and more.", "url": "https://www.youtube.com/watch?v=Av51Q4RehYU"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 10:05:19", "publisher": "Benzinga", "title": "Mounjaro And Zepbound Power Eli Lilly's 54% Revenue Jump In Q3, Hikes 2025 Forecast", "image": "https://images.financialmodelingprep.com/news/mounjaro-and-zepbound-power-eli-lillys-54-revenue-jump-20251030.jpg", "site": "benzinga.com", "text": "Eli Lilly and Co. (NYSE:LLY) on Thursday reported better-than-expected third-quarter earnings and boosted its annual forecast, sending the stock higher.", "url": "https://www.benzinga.com/markets/earnings/25/10/48529099/mounjaro-and-zepbound-power-eli-lillys-54-revenue-jump-in-q3-hikes-2025-forecast"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 09:58:28", "publisher": "Proactive Investors", "title": "Eli Lilly Q3 earnings and revenue top estimates, boosted by weight loss drug demand", "image": "https://images.financialmodelingprep.com/news/eli-lilly-q3-earnings-and-revenue-top-estimates-boosted-by-20251030.jpg", "site": "proactiveinvestors.com", "text": "Eli Lilly and Co (NYSE:LLY) on Thursdayreported third quarter 2025 financial results that handily beat Wall Street forecasts,as the company continued to see strong demand forits weightloss drugZepboundand diabetes treatmentMounjaro. The pharmaceutical giant's revenue for thequarterrose 54% year over year to$17.60 billion,surpassing the analyst consensus estimateof$16.01 billion, according to data provided by LSEG.", "url": "https://www.proactiveinvestors.com/companies/news/1081457"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 09:25:52", "publisher": "24/7 Wall Street", "title": "Eli Lilly Blows Away Q3 Earnings Expectations", "image": "https://images.financialmodelingprep.com/news/eli-lilly-blows-away-q3-earnings-expectations-20251030.jpg", "site": "247wallst.com", "text": "Eli Lilly (NYSE: LLY) delivered a commanding third quarter, posting earnings and revenue that significantly exceeded expectations while raising full-year guidance.", "url": "https://247wallst.com/investing/2025/10/30/eli-lilly-blows-away-q3-earnings-expectations/"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 09:12:09", "publisher": "Invezz", "title": "Eli Lilly shares jump as blowout earnings, obesity drug demand fuel profit upgrade", "image": "https://images.financialmodelingprep.com/news/eli-lilly-shares-jump-as-blowout-earnings-obesity-drug-demand-20251030.jpg", "site": "invezz.com", "text": "Shares of Eli Lilly rose nearly 4% in premarket trading on Thursday after the pharmaceutical company reported third-quarter earnings that exceeded expectations and lifted its annual profit forecast. The company posted adjusted earnings of $7.02 per share for the quarter, well ahead of analysts' consensus estimate of $5.89.", "url": "https://invezz.com/news/2025/10/30/eli-lilly-shares-jump-as-blowout-earnings-obesity-drug-demand-fuel-profit-upgrade/"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 09:05:12", "publisher": "Forbes", "title": "20% Upside For Eli Lilly Stock?", "image": "https://images.financialmodelingprep.com/news/20-upside-for-eli-lilly-stock-20251030.jpg", "site": "forbes.com", "text": "Eli Lilly stock (NYSE: LLY) is up 7% in a month, warranting investor attention following a key corporate development. Eli Lilly recently announced a significant partnership with Walmart to sell its popular weight-loss drug, Zepbound, at a discounted retail price through Walmart pharmacies.", "url": "https://www.forbes.com/sites/greatspeculations/2025/10/30/20-upside-for-eli-lilly-stock/"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 08:55:30", "publisher": "Zacks Investment Research", "title": "Eli Lilly (LLY) Q3 Earnings and Revenues Surpass Estimates", "image": "https://images.financialmodelingprep.com/news/eli-lilly-lly-q3-earnings-and-revenues-surpass-estimates-20251030.jpg", "site": "zacks.com", "text": "Eli Lilly (LLY) came out with quarterly earnings of $7.02 per share, beating the Zacks Consensus Estimate of $6.02 per share. This compares to earnings of $1.18 per share a year ago.", "url": "https://www.zacks.com/stock/news/2781079/eli-lilly-lly-q3-earnings-and-revenues-surpass-estimates?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_4-2781079"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 08:50:46", "publisher": "Investopedia", "title": "5 Things to Know Before the Stock Market Opens", "image": "https://images.financialmodelingprep.com/news/5-things-to-know-before-the-stock-market-opens-20251030.jpg", "site": "investopedia.com", "text": "Stock futures are losing ground amid a barrage of earnings reports from major companies, as investors assess the latest developments in trade talks and Federal Reserve Chair Jerome Powell's warning that more rate cuts aren't a certainty; President Donald Trump said his meeting with Chinese leader Xi Jinping resulted in a rare earths mineral agreement and a reduction in certain tariffs on China; shares of Meta (META) and Microsoft (MSFT) are losing ground after the Magnificent Seven members reported results late yesterday, while Alphabet (GOOG) shares are surging after the Google parent reported more than $100 billion in quarterly sales; Apple (AAPL) and Amazon (AMZN) are due to release their quarterly reports after the closing bell; and Eli Lilly (LLY) shares are rising after the company reported strong sales of weight loss drug Zepbound and diabetes treatment Mounjaro. Here's what you need to know today.", "url": "https://www.investopedia.com/5-things-to-know-before-the-stock-market-opens-october-30-2025-11840105"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 08:09:00", "publisher": "Market Watch", "title": "Eli Lilly's stock jumps as Zepbound sales nearly triple at lower prices", "image": "https://images.financialmodelingprep.com/news/eli-lillys-stock-jumps-as-zepbound-sales-nearly-triple-at-20251030.jpg", "site": "marketwatch.com", "text": "Eli Lilly's stock rallies, as Zepbound sales nearly tripled, leading to record revenue and a raised full-year outlook.", "url": "https://www.marketwatch.com/story/eli-lillys-stock-jumps-as-zepbound-sales-nearly-triple-at-lower-prices-1c084836"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 06:45:00", "publisher": "PRNewsWire", "title": "Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance", "image": "https://images.financialmodelingprep.com/news/lilly-reports-thirdquarter-2025-financial-results-highlights-rd-pipeline-momentum-20251030.jpg", "site": "prnewswire.com", "text": "Revenue in Q3 2025 increased 54% to $17.60 billion driven by volume growth from Mounjaro and Zepbound. Q3 2025 EPS increased by $5.14 to $6.21 on a reported basis and increased by $5.84 to $7.02 on a non-GAAP basis.", "url": "https://www.prnewswire.com/news-releases/lilly-reports-third-quarter-2025-financial-results-highlights-rd-pipeline-momentum-and-raises-2025-guidance-302599148.html"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 02:09:35", "publisher": "Defense World", "title": "Pharmaceutical Stocks To Keep An Eye On  October 28th", "image": "https://images.financialmodelingprep.com/news/pharmaceutical-stocks-to-keep-an-eye-on-october-28th-20251030.jpeg", "site": "defenseworld.net", "text": "Avidity Biosciences, Eli Lilly and Company, Regeneron Pharmaceuticals, Pfizer, Incyte, AbbVie, and Novo Nordisk A/S are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies whose primary business is researching, developing, manufacturing, and marketing prescription drugs and related therapies. For investors, these stocks", "url": "https://www.defenseworld.net/2025/10/30/pharmaceutical-stocks-to-keep-an-eye-on-october-28th.html"}}
{"date": "2025-10-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-30 02:09:33", "publisher": "Defense World", "title": "Top Medical Stocks To Research  October 28th", "image": "https://images.financialmodelingprep.com/news/top-medical-stocks-to-research-october-28th-20251030.png", "site": "defenseworld.net", "text": "UnitedHealth Group, Avidity Biosciences, Eli Lilly and Company, Regeneron Pharmaceuticals, and Johnson and Johnson are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. \"Medical stocks\" are publicly traded companies whose primary business is healthcare - including pharmaceuticals, biotechnology, medical-device manufacturers, hospitals and clinics, diagnostics, and related suppliers and service providers.", "url": "https://www.defenseworld.net/2025/10/30/top-medical-stocks-to-research-october-28th.html"}}
{"date": "2025-10-29", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-29 16:45:00", "publisher": "Barrons", "title": "Eli Lilly Reports Earnings Thursday as Investors Await Trump Drug Pricing Deal", "image": "https://images.financialmodelingprep.com/news/eli-lilly-reports-earnings-thursday-as-investors-await-trump-drug-20251029.jpg", "site": "barrons.com", "text": "The drugmaker Eli Lilly reports its third-quarter results early Thursday, as questions loom about what kind of deal it will reach with the Trump administration over the price of its weight-loss drug.", "url": "https://www.barrons.com/articles/eli-lilly-earnings-stock-price-99b5da9b"}}
{"date": "2025-10-29", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-29 14:19:31", "publisher": "CNBC", "title": "Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug Zepbound", "image": "https://images.financialmodelingprep.com/news/eli-lilly-walmart-to-offer-first-retail-pickup-option-for-20251029.jpeg", "site": "cnbc.com", "text": "Eli Lilly and Walmart said they have teamed up to boost access to the pharma giant's weight loss drug Zepbound, allowing U.S. patients to access vials of the blockbuster injection at direct-to-consumer prices through retail locations for the first time. Starting in mid-November, cash-paying patients with a prescription can purchase single-dose vials of Zepbound at discounts of 50% or more through the retailer's nearly 4,600 pharmacy locations or via home delivery.", "url": "https://www.cnbc.com/2025/10/29/eli-lilly-walmart-to-offer-discounted-retail-option-for-zepbound.html"}}
{"date": "2025-10-29", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-29 10:33:43", "publisher": "Reuters", "title": "Eli Lilly to invest $1.2 billion in Puerto Rico as part of US manufacturing push", "image": "https://images.financialmodelingprep.com/news/eli-lilly-to-invest-12-billion-in-puerto-rico-20251029.jpg", "site": "reuters.com", "text": "Eli Lilly said on Wednesday it will invest more than $1.2 billion to expand its manufacturing site in Puerto Rico, as the drugmaker looks to increase its U.S. production capacity to hedge against potential tariffs.", "url": "https://www.reuters.com/sustainability/boards-policy-regulation/eli-lilly-invest-12-billion-puerto-rico-part-us-manufacturing-push-2025-10-29/"}}
{"date": "2025-10-29", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-29 10:30:00", "publisher": "PRNewsWire", "title": "Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States", "image": "https://images.financialmodelingprep.com/news/lilly-announces-more-than-12-billion-investment-in-puerto-20251029.jpg", "site": "prnewswire.com", "text": "Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs INDIANAPOLIS , Oct. 29, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today a planned investment of more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico. This new investment will integrate advanced technologies and expand production capacity within the existing campus to support the company's growing portfolio of oral solid medicines in cardiometabolic health, neuroscience, oncology and immunology.", "url": "https://www.prnewswire.com/news-releases/lilly-announces-more-than-1-2-billion-investment-in-puerto-rico-facility-to-boost-oral-medicine-manufacturing-capacity-in-the-united-states-302597678.html"}}
{"date": "2025-10-29", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-29 10:06:33", "publisher": "Reuters", "title": "In Lilly vs Novo obesity drug battle, Trump price talks grab focus", "image": "https://images.financialmodelingprep.com/news/in-lilly-vs-novo-obesity-drug-battle-trump-price-20251029.jpg", "site": "reuters.com", "text": "As obesity drug heavyweights Eli Lilly and Novo Nordisk gear up to release results for the third quarter, investors are looking elsewhere: high-stakes price talks with U.S. President Donald Trump.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-vs-novo-obesity-drug-battle-trump-price-talks-grab-focus-2025-10-29/"}}
{"date": "2025-10-29", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-29 09:25:22", "publisher": "Zacks Investment Research", "title": "What's the Driving Force Behind Eli Lilly's Recent Acquisition Spree?", "image": "https://images.financialmodelingprep.com/news/whats-the-driving-force-behind-eli-lillys-recent-acquisition-20251029.jpg", "site": "zacks.com", "text": "LLY's rapid dealmaking spree across biotech and gene therapy aims to expand its pipeline beyond cardiometabolic drugs and fuel long-term growth.", "url": "https://www.zacks.com/stock/news/2779881/what-s-the-driving-force-behind-eli-lilly-s-recent-acquisition-spree?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2779881"}}
{"date": "2025-10-29", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-29 07:11:36", "publisher": "Reuters", "title": "Lilly and Walmart launch first retail pick-up option for weight-loss drug", "image": "https://images.financialmodelingprep.com/news/lilly-and-walmart-launch-first-retail-pickup-option-for-20251029.jpg", "site": "reuters.com", "text": "Eli Lilly and Walmart said on Wednesday they are partnering to expand access to single-dose vials of Lilly's weight-loss drug Zepbound, which will be offered for pick-up at Walmart pharmacies nationwide by mid-November.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-walmart-launch-first-retail-pick-up-option-weight-loss-drug-2025-10-29/"}}
{"date": "2025-10-29", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-29 07:00:00", "publisher": "PRNewsWire", "title": "LillyDirect and Walmart Pharmacy launch first retail pick-up option with direct-to-consumer pricing for Zepbound", "image": "https://images.financialmodelingprep.com/news/lillydirect-and-walmart-pharmacy-launch-first-retail-pickup-option-20251029.jpg", "site": "prnewswire.com", "text": "Walmart, with nearly 4,600 pharmacies nationwide, will serve as the first in-store pickup pharmacy for LillyDirect's self-pay single-dose vials Strategic collaboration marks the first time patients using LillyDirect, Lilly's direct-to-consumer healthcare platform, can access self-pay pricing for Zepbound vials at a retail pharmacy location LillyDirect pick-up option at Walmart offers millions of Americans living with obesity additional convenience, access and choice in how they get their medication INDIANAPOLIS , Oct. 29, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Walmart Inc. (NYSE: WMT) today announced a collaboration to expand access to direct-to-consumer pricing for Zepbound (tirzepatide) single-dose vials available through LillyDirect. Zepbound (ZEHP-bownd) vials will be offered for pick-up at Walmart pharmacies nationwide by mid-November.", "url": "https://www.prnewswire.com/news-releases/lillydirect-and-walmart-pharmacy-launch-first-retail-pick-up-option-with-direct-to-consumer-pricing-for-zepbound-302597663.html"}}
{"date": "2025-10-28", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-28 20:10:00", "publisher": "The Motley Fool", "title": "1 Undervalued Growth Stock Down 8% to Buy Before 2026", "image": "https://images.financialmodelingprep.com/news/1-undervalued-growth-stock-down-8-to-buy-before-20251028.jpg", "site": "fool.com", "text": "Eli Lilly's performance over the past year hasn't been as strong as usual. The company's growth prospects justify its higher-than-average valuation.", "url": "https://www.fool.com/investing/2025/10/28/1-undervalued-growth-stock-down-8-buy-before-2026/"}}
{"date": "2025-10-28", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-28 14:31:46", "publisher": "Reuters", "title": "Lilly partners with Nvidia on AI supercomputer to speed up drug development", "image": "https://images.financialmodelingprep.com/news/lilly-partners-with-nvidia-on-ai-supercomputer-to-speed-20251028.jpg", "site": "reuters.com", "text": "Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer to help with drug discovery and shorten development cycles, getting medicines to people faster.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-partners-with-nvidia-ai-supercomputer-speed-up-drug-development-2025-10-28/"}}
{"date": "2025-10-28", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-28 14:30:59", "publisher": "CNBC", "title": "Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and development", "image": "https://images.financialmodelingprep.com/news/eli-lilly-nvidia-partner-to-build-supercomputer-ai-factory-20251028.jpg", "site": "cnbc.com", "text": "Eli Lilly and Nvidia are partnering to build what the companies call the pharmaceutical industry's \"most powerful\" supercomputer and so-called AI factory to help accelerate drug discovery and development across the broader sector. It's the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to shorten the time it takes to bring cures to patients, while reducing costs at every stage of the drug discovery and development process.", "url": "https://www.cnbc.com/2025/10/28/eli-lilly-nvidia-supercomputer-ai-factory-drug-discovery.html"}}
{"date": "2025-10-28", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-28 14:30:00", "publisher": "PRNewsWire", "title": "Lilly partners with NVIDIA to build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patients", "image": "https://images.financialmodelingprep.com/news/lilly-partners-with-nvidia-to-build-the-industrys-most-20251028.jpg", "site": "prnewswire.com", "text": "New AI capabilities will help scientists identify, optimize and validate new molecules Additional applications include manufacturing, medical imaging and enterprise AI agents INDIANAPOLIS , Oct.28, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced it is building the most powerful supercomputer owned and operated by a pharmaceutical company, in collaboration with NVIDIA.The supercomputer will power an \"AI factory,\" a specialized computing infrastructure that manages the entire AI lifecycle from data ingestion and training to fine-tuning and high-volume inference.", "url": "https://www.prnewswire.com/news-releases/lilly-partners-with-nvidia-to-build-the-industrys-most-powerful-ai-supercomputer-supercharging-medicine-discovery-and-delivery-for-patients-302597285.html"}}
{"date": "2025-10-28", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-28 14:30:00", "publisher": "WSJ", "title": "Eli Lilly Partners With Nvidia to Build AI Supercomputer for Drug Discovery", "image": "https://images.financialmodelingprep.com/news/eli-lilly-partners-with-nvidia-to-build-ai-supercomputer-20251028.jpg", "site": "wsj.com", "text": "The drugmaker hopes an Nvidia-chip powered supercomputer will help it find new drugs and accelerate lengthy R&D timelines.", "url": "https://www.wsj.com/tech/ai/eli-lilly-partners-with-nvidia-to-build-ai-supercomputer-for-drug-discovery-e37247b3"}}
{"date": "2025-10-28", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-28 10:40:55", "publisher": "CNBC", "title": "Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings", "image": "https://images.financialmodelingprep.com/news/healthy-returns-what-to-expect-from-eli-lilly-merck-20251028.jpg", "site": "cnbc.com", "text": "Eli Lilly, Merck, Gilead, Bristol Myers Squibb and AbbVie, among other pharmaceutical companies, are slated to report third-quarter earnings this week.", "url": "https://www.cnbc.com/2025/10/28/healthy-returns-eli-lilly-merck-gilead-and-abbvie-earnings-preview.html"}}
{"date": "2025-10-28", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-28 10:30:44", "publisher": "Zacks Investment Research", "title": "Is It Worth Investing in Lilly (LLY) Based on Wall Street's Bullish Views?", "image": "https://images.financialmodelingprep.com/news/is-it-worth-investing-in-lilly-lly-based-on-20251028.jpg", "site": "zacks.com", "text": "When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?", "url": "https://www.zacks.com/stock/news/2778887/is-it-worth-investing-in-lilly-lly-based-on-wall-street-s-bullish-views?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|average_broker_rating-2778887"}}
{"date": "2025-10-27", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-27 16:05:00", "publisher": "PRNewsWire", "title": "Lilly's Omvoh (mirikizumab-mrkz) approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitis", "image": "https://images.financialmodelingprep.com/news/lillys-omvoh-mirikizumabmrkz-approved-by-us-fda-as-a-singleinjection-20251027.jpg", "site": "prnewswire.com", "text": "Omvoh now offers patients a simplified maintenance experience with one monthly injection, replacing the previous two-injection regimen Omvoh single-injection dosing will be available for U.S. patients in early 2026 This is the third FDA approval for Omvoh this year, following approvals for Crohn's disease and a citrate-free formulation INDIANAPOLIS , Oct. 27, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) approved a single-injection, once-monthly maintenance regimen (200 mg/2 mL) of Omvoh (mirikizumab-mrkz) for subcutaneous use in adults with moderately to severely active ulcerative colitis (UC). \"In clinical practice, we see that simplifying maintenance treatment can make a difference in the overall patient experience,\" said Miguel Regueiro, M.D.", "url": "https://www.prnewswire.com/news-releases/lillys-omvoh-mirikizumab-mrkz-approved-by-us-fda-as-a-single-injection-maintenance-regimen-in-adults-with-ulcerative-colitis-302595733.html"}}
{"date": "2025-10-27", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-27 14:00:00", "publisher": "PRNewsWire", "title": "Lilly declares fourth-quarter 2025 dividend", "image": "https://images.financialmodelingprep.com/news/lilly-declares-fourthquarter-2025-dividend-20251027.jpg", "site": "prnewswire.com", "text": "INDIANAPOLIS , Oct. 27, 2025 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2025 of $1.50 per share on outstanding common stock. The dividend is payable on December 10, 2025, to shareholders of record at the close of business on November 14, 2025.", "url": "https://www.prnewswire.com/news-releases/lilly-declares-fourth-quarter-2025-dividend-302595631.html"}}
{"date": "2025-10-27", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-27 13:27:00", "publisher": "Seeking Alpha", "title": "Baron Health Care Fund Q3 2025 Top Contributors And Detractors", "image": "https://images.financialmodelingprep.com/news/baron-health-care-fund-q3-2025-top-contributors-and-20251027.jpg", "site": "seekingalpha.com", "text": "Argenx SE is a biotechnology company best known for developing Vyvgart, the leading FcRn inhibitor for the treatment of autoimmune conditions. RadNet, Inc. is the largest operator of outpatient diagnostic imaging services and related solutions in the U.S. Intuitive Surgical, Inc. manufactures the da Vinci Surgical System, a robotic surgical system used for minimally invasive surgical procedures.", "url": "https://seekingalpha.com/article/4833710-baron-health-care-fund-q3-2025-top-contributors-and-detractors"}}
{"date": "2025-10-27", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-27 12:36:04", "publisher": "The Motley Fool", "title": "BDF-GESTION Trims Its Eli Lilly (LLY) Stake by 4,149 Shares", "image": "https://images.financialmodelingprep.com/news/bdfgestion-trims-its-eli-lilly-lly-stake-by-4149-20251027.png", "site": "fool.com", "text": "BDF-GESTION sold 4,149 shares of Eli Lilly and Company; Transaction value was $3.1 million Transaction represents 0.37% of BDF-GESTION's 13F reportable assets under management Post-trade stake: 19,949 shares valued at $15.22 million as of September 30, 2025 Position now represents 1.8% of fund AUM, which places it outside the fund's top five holdings", "url": "https://www.fool.com/coverage/filings/2025/10/27/bdf-gestion-dumps-4100-lly-shares-worth-31-million/"}}
{"date": "2025-10-27", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-27 12:06:06", "publisher": "Zacks Investment Research", "title": "What's in Store for These 5 Pharma Bigwigs This Earnings Season?", "image": "https://images.financialmodelingprep.com/news/whats-in-store-for-these-5-pharma-bigwigs-this-earnings-20251027.jpg", "site": "zacks.com", "text": "As earnings season accelerates, pharma heavyweights LLY, MRK, ABBV, BMY and GILD prepare to reveal their Q3 results amid a strong sector start.", "url": "https://www.zacks.com/stock/news/2777998/what-s-in-store-for-these-5-pharma-bigwigs-this-earnings-season?cid=CS-STOCKNEWSAPI-FT-analyst_blog|earnings_preview_esp-2777998"}}
{"date": "2025-10-27", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-27 11:00:00", "publisher": "The Motley Fool", "title": "Down 15%, Should You Buy the Dip on Eli Lilly?", "image": "https://images.financialmodelingprep.com/news/down-15-should-you-buy-the-dip-on-eli-20251027.jpg", "site": "fool.com", "text": "Eli Lilly is one of the largest drug companies in the world. The pharmaceutical giant's stock price is 15% below its 2024 high-water mark.", "url": "https://www.fool.com/investing/2025/10/27/down-15-should-you-buy-the-dip-on-eli-lilly/"}}
{"date": "2025-10-27", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-27 10:56:17", "publisher": "Zacks Investment Research", "title": "Buy, Sell or Hold Lilly Stock? Key Tips Ahead of Q3 Earnings", "image": "https://images.financialmodelingprep.com/news/buy-sell-or-hold-lilly-stock-key-tips-ahead-20251027.jpg", "site": "zacks.com", "text": "Eli Lilly's Q3 results hinge on strong demand for Mounjaro and Zepbound as investors weigh growth drivers against the pressure of pricing and competition.", "url": "https://www.zacks.com/stock/news/2777853/buy-sell-or-hold-lilly-stock-key-tips-ahead-of-q3-earnings?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2777853"}}
{"date": "2025-10-27", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-27 10:17:00", "publisher": "Zacks Investment Research", "title": "Seeking Clues to Lilly (LLY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics", "image": "https://images.financialmodelingprep.com/news/seeking-clues-to-lilly-lly-q3-earnings-a-peek-20251027.jpg", "site": "zacks.com", "text": "Besides Wall Street's top-and-bottom-line estimates for Lilly (LLY), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.", "url": "https://www.zacks.com/stock/news/2777661/seeking-clues-to-lilly-lly-q3-earnings-a-peek-into-wall-street-projections-for-key-metrics?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|nfm_preview-2777661"}}
{"date": "2025-10-27", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-27 09:25:03", "publisher": "Forbes", "title": "LLY Stock To $1,100?", "image": "https://images.financialmodelingprep.com/news/lly-stock-to-1100-20251027.jpg", "site": "forbes.com", "text": "Eli Lilly (LLY) shares have surged by 16% over the last month and are currently priced at $825. U.S. pharmaceutical stocks have done well of late, as large drugmakers such as Pfizer and AstraZeneca signed drug pricing agreements with the Trump Administration to cut prescription drug prices and boost domestic manufacturing investments.", "url": "https://www.forbes.com/sites/greatspeculations/2025/10/27/lly-stock-to-1100/"}}
{"date": "2025-10-27", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-27 07:31:00", "publisher": "The Motley Fool", "title": "Should You Buy Eli Lilly Stock Before Oct. 30?", "image": "https://images.financialmodelingprep.com/news/should-you-buy-eli-lilly-stock-before-oct-30-20251027.jpg", "site": "fool.com", "text": "Wall Street expects good news when Lilly announces its Q3 results on Oct. 30. Lilly's stock might not perform as you think it will, even if it beats analysts' estimates.", "url": "https://www.fool.com/investing/2025/10/27/should-you-buy-eli-lilly-stock-before-october-30th/"}}
{"date": "2025-10-27", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-27 06:45:00", "publisher": "PRNewsWire", "title": "Lilly's Omvoh (mirikizumab-mrkz) demonstrated early and sustained improvement in bowel urgency outcomes for patients with ulcerative colitis", "image": "https://images.financialmodelingprep.com/news/lillys-omvoh-mirikizumabmrkz-demonstrated-early-and-sustained-improvement-in-20251027.jpg", "site": "prnewswire.com", "text": "Phase 3b LUCENT-URGE is the first study in inflammatory bowel disease to assess bowel urgency across three measures  severity, frequency and stool deferral time  reflecting the spectrum of its burden on patients By Week 12, patients experienced a 55% reduction in daily episodes of bowel urgency from baseline, with severity reduced by more than half by Week 28 At Week 28, nearly one-third of patients were able to delay using the restroom for at least 15 minutes after feeling urgency, up from 4% at baseline INDIANAPOLIS , Oct. 27, 2025 /PRNewswire/ -- New data from Eli Lilly and Company (NYSE: LLY) showed Omvoh-treated patients with moderately to severely active ulcerative colitis (UC) and bowel urgency experienced early improvements in bowel urgency severity, frequency and stool deferral time by Week 12. These outcomes continued to improve through 28 weeks.", "url": "https://www.prnewswire.com/news-releases/lillys-omvoh-mirikizumab-mrkz-demonstrated-early-and-sustained-improvement-in-bowel-urgency-outcomes-for-patients-with-ulcerative-colitis-302594395.html"}}
{"date": "2025-10-26", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-26 08:15:00", "publisher": "Seeking Alpha", "title": "Eli Lilly: Is Another Monster Quarter Coming", "image": "https://images.financialmodelingprep.com/news/eli-lilly-is-another-monster-quarter-coming-20251026.jpg", "site": "seekingalpha.com", "text": "October 30th is the day when Eli Lilly will report its third-quarter results, including sales of its 'superstars' Zepbound and Mounjaro. Since my article was published on September 8, Eli Lilly's stock price has risen by 13.1%. On October 24th, Eli Lilly surprised me by announcing its acquisition of Adverum Biotechnologies, a developer of gene therapies for the treatment of ocular diseases, for up to $261.7 million.", "url": "https://seekingalpha.com/article/4833427-eli-lilly-is-another-monster-quarter-coming"}}
{"date": "2025-10-26", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-26 07:01:35", "publisher": "Seeking Alpha", "title": "Wall Street Week Ahead", "image": "https://images.financialmodelingprep.com/news/wall-street-week-ahead-20251026.jpg", "site": "seekingalpha.com", "text": "Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.", "url": "https://seekingalpha.com/article/4833469-wall-street-week-ahead"}}
{"date": "2025-10-26", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-26 02:40:50", "publisher": "Defense World", "title": "Pharmaceutical Stocks To Watch Now  October 24th", "image": "https://images.financialmodelingprep.com/news/pharmaceutical-stocks-to-watch-now-october-24th-20251026.jpg", "site": "defenseworld.net", "text": "Eli Lilly and Company, Wellgistics Health, Pfizer, AbbVie, and Gilead Sciences are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of companies engaged in the research, development, manufacturing, and sale of prescription drugs, biologics, and vaccines. For investors, these stocks are typically driven by factors like", "url": "https://www.defenseworld.net/2025/10/26/pharmaceutical-stocks-to-watch-now-october-24th.html"}}
{"date": "2025-10-25", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-25 11:41:00", "publisher": "Business Wire", "title": "Adverum Biotechnologies Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adverum Biotechnologies, Inc. - ADVM", "image": "https://images.financialmodelingprep.com/news/adverum-biotechnologies-investor-alert-by-the-former-attorney-general-20251025.jpg", "site": "businesswire.com", "text": "NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Adverum Biotechnologies, Inc. (NasdaqCM: ADVM) to Eli Lilly and Company (NYSE: LLY). Under the terms of the proposed transaction, shareholders of Adverum will receive $3.56 per share in cash plus one non-transferable contingent value right (CVR) entitling the holder to receive up to an additional $8.", "url": "https://www.businesswire.com/news/home/20251025519753/en/Adverum-Biotechnologies-Investor-Alert-By-The-Former-Attorney-General-Of-Louisiana-Kahn-Swick-Foti-LLC-Investigates-Adequacy-of-Price-and-Process-in-Proposed-Sale-of-Adverum-Biotechnologies-Inc.---ADVM/"}}
{"date": "2025-10-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-24 10:31:40", "publisher": "Zacks Investment Research", "title": "Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q3 Earnings", "image": "https://images.financialmodelingprep.com/news/heres-how-eli-lillys-oncology-drugs-are-poised-ahead-20251024.jpg", "site": "zacks.com", "text": "LLY's oncology portfolio, led by Verzenio, is set for double-digit growth as investors eye Q3 results beyond its obesity drugs.", "url": "https://www.zacks.com/stock/news/2776275/here-s-how-eli-lilly-s-oncology-drugs-are-poised-ahead-of-q3-earnings?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2776275"}}
{"date": "2025-10-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-24 10:11:43", "publisher": "Reuters", "title": "Eli Lilly to buy gene therapy developer Adverum in about $262 million deal", "image": "https://images.financialmodelingprep.com/news/eli-lilly-to-buy-gene-therapy-developer-adverum-in-20251024.jpg", "site": "reuters.com", "text": "Eli Lilly said on Friday it would acquire gene therapy developer Adverum Biotechnologies in a deal valued at up to $261.7 million, aiming to strengthen its pipeline with an experimental eye disease treatment.", "url": "https://www.reuters.com/legal/transactional/eli-lilly-buy-gene-therapy-developer-adverum-about-262-million-deal-2025-10-24/"}}
{"date": "2025-10-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-24 08:30:00", "publisher": "PRNewsWire", "title": "Lilly to Acquire Adverum Biotechnologies", "image": "https://images.financialmodelingprep.com/news/lilly-to-acquire-adverum-biotechnologies-20251024.jpg", "site": "prnewswire.com", "text": "Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose Acquisition aligns Lilly's genetic medicine capabilities with opportunity to expand gene therapy's potential to alleviate the burden of age-related diseases INDIANAPOLISand REDWOOD CITY, Calif. , Oct. 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy with the aim of preserving sight for life in highly prevalent ocular diseases, today announced a definitive agreement for Lilly to acquire Adverum Biotechnologies, Inc. (\"Adverum\"), including its lead product candidate, Ixo-vec.", "url": "https://www.prnewswire.com/news-releases/lilly-to-acquire-adverum-biotechnologies-302593482.html"}}
{"date": "2025-10-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-24 08:23:00", "publisher": "Benzinga", "title": "Mounjaro Maker Eli Lilly Jumps In Quality Despite Trump-Fueled Price Cut Fears", "image": "https://images.financialmodelingprep.com/news/mounjaro-maker-eli-lilly-jumps-in-quality-despite-trumpfueled-price-20251024.jpeg", "site": "benzinga.com", "text": "Eli Lilly and Co. (NYSE:LLY) has surged into the top decile of quality rankings among S&P 500 peers, achieving a percentile score of 90.25 on the latest composite quality report, despite fresh uncertainty surrounding the future pricing of its blockbuster weight loss drug, Mounjaro.", "url": "https://www.benzinga.com/markets/equities/25/10/48401923/mounjaro-maker-eli-lilly-jumps-in-quality-despite-trump-fueled-price-cut-fears"}}
{"date": "2025-10-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-24 06:46:42", "publisher": "Reuters", "title": "Eli Lilly reports promising data for alopecia and eczema drugs, eyes label expansion", "image": "https://images.financialmodelingprep.com/news/eli-lilly-reports-promising-data-for-alopecia-and-eczema-20251024.jpg", "site": "reuters.com", "text": "Eli Lilly announced on Friday safety and efficacy results from two separate late-stage studies testing its approved drugs for alopecia and eczema.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-reports-promising-data-alopecia-eczema-drugs-eyes-label-expansion-2025-10-24/"}}
{"date": "2025-10-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-24 06:45:00", "publisher": "PRNewsWire", "title": "Lilly's EBGLYSS (lebrikizumab-lbkz) delivered durable disease control when administered once every eight weeks in patients with moderate-to-severe atopic dermatitis", "image": "https://images.financialmodelingprep.com/news/lillys-ebglyss-lebrikizumablbkz-delivered-durable-disease-control-when-administered-20251024.jpg", "site": "prnewswire.com", "text": "New long-term extension data show approximately 80% of patients achieved or maintained meaningful skin improvement (EASI 75) with EBGLYSS with half the doses compared to approved monthly maintenance dosing Lilly submitted these data to the FDA for a potential label update for EBGLYSS If approved, EBGLYSS would be a first-line biologic that offers the option of monotherapy with once every eight-week maintenance dosing in moderate-to-severe atopic dermatitis uncontrolled by topicals INDIANAPOLIS , Oct. 24, 2025 /PRNewswire/ -- New results show Eli Lilly and Company's (NYSE: LLY) EBGLYSS (lebrikizumab-lbkz) sustained similar levels of skin clearance when administered as a single injection of 250 mg once every eight weeks (Q8W) compared with once every four weeks (Q4W), supporting a potential additional, less frequent maintenance dosing option for more individualized treatment of patients with moderate-to-severe atopic dermatitis. These findings from the Phase 3 ADjoin extension trial will be presented at the 2025 Fall Clinical Dermatology Conference, taking place Oct. 23-26 in Las Vegas.1 \"For people managing the persistent symptoms of eczema, hesitancy about frequent injections can add to the already heavy toll of this disease,\" said Peter Lio, M.D.", "url": "https://www.prnewswire.com/news-releases/lillys-ebglyss-lebrikizumab-lbkz-delivered-durable-disease-control-when-administered-once-every-eight-weeks-in-patients-with-moderate-to-severe-atopic-dermatitis-302593427.html"}}
{"date": "2025-10-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-24 06:45:00", "publisher": "PRNewsWire", "title": "Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial", "image": "https://images.financialmodelingprep.com/news/lillys-baricitinib-delivered-nearcomplete-scalp-hair-regrowth-at-one-year-20251024.jpg", "site": "prnewswire.com", "text": "This trial is the first and largest study specifically designed to evaluate children and adolescents with severe alopecia areata, a population often underrepresented in clinical trials New data show 71% of adolescents with severe disease treated with baricitinib 4 mg achieved successful scalp hair regrowth at one year, with continuous improvements observed throughout those 52 weeks Lilly intends to submit the BRAVE-AA-PEDS data to global regulators for a potential label update for baricitinib (commercially available as Olumiant) INDIANAPOLIS , Oct. 24, 2025 /PRNewswire/ -- New results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) showed once-daily, oral baricitinib 4 mg helped the majority of adolescent patients (ages 12 to 1 month to", "url": "https://www.prnewswire.com/news-releases/lillys-baricitinib-delivered-near-complete-scalp-hair-regrowth-at-one-year-for-adolescents-with-severe-alopecia-areata-in-phase-3-brave-aa-peds-trial-302593426.html"}}
{"date": "2025-10-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-24 05:15:00", "publisher": "The Motley Fool", "title": "2 Things Investors Should Know About Eli Lilly's $5 Billion Investment to Improve Its Drug Production Capacity", "image": "https://images.financialmodelingprep.com/news/2-things-investors-should-know-about-eli-lillys-5-20251024.jpg", "site": "fool.com", "text": "Eli Lilly's new U.S. facility will be just the first of four that it plans to build in the country. The company expects to eventually make 100% of drugs for American patients in the U.S.", "url": "https://www.fool.com/investing/2025/10/24/2-things-investors-should-know-about-eli-lillys-5/"}}
{"date": "2025-10-23", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-23 11:40:13", "publisher": "Zacks Investment Research", "title": "Lilly Up 10% in a Month: Should You Buy, Sell or Hold the Stock?", "image": "https://images.financialmodelingprep.com/news/lilly-up-10-in-a-month-should-you-buy-20251023.jpg", "site": "zacks.com", "text": "Lilly stock climbs nearly 10% in a month amid a broader recovery in the drug and biotech sector.", "url": "https://www.zacks.com/stock/news/2775453/lilly-up-10-in-a-month-should-you-buy-sell-or-hold-the-stock?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2775453"}}
{"date": "2025-10-23", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-23 11:06:19", "publisher": "Zacks Investment Research", "title": "Eli Lilly (LLY) Earnings Expected to Grow: Should You Buy?", "image": "https://images.financialmodelingprep.com/news/eli-lilly-lly-earnings-expected-to-grow-should-you-20251023.jpg", "site": "zacks.com", "text": "Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/2775305/eli-lilly-lly-earnings-expected-to-grow-should-you-buy?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_9-2775305"}}
{"date": "2025-10-23", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-23 08:00:48", "publisher": "Seeking Alpha", "title": "Eli Lilly Accelerates On Obesity Data While Novo Nordisk Retreats", "image": "https://images.financialmodelingprep.com/news/eli-lilly-accelerates-on-obesity-data-while-novo-nordisk-20251023.jpg", "site": "seekingalpha.com", "text": "Eli Lilly is a Strong Buy, driven by exceptional growth in obesity and diabetes drugs Mounjaro and Zepbound, plus pipeline innovation. LLY's diversified business mix, global reach, and proactive U.S. manufacturing investments position it well for regulatory and political developments. Despite sector headwinds and cautious market sentiment, LLY's robust earnings momentum and positive analyst revisions support continued outperformance.", "url": "https://seekingalpha.com/article/4832340-eli-lilly-stock-accelerates-on-obesity-data-while-novo-nordisk-retreats"}}
{"date": "2025-10-23", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-23 06:37:10", "publisher": "Reuters", "title": "Eli Lilly allows Cipla to sell weight loss drug under new brand in India", "image": "https://images.financialmodelingprep.com/news/eli-lilly-allows-cipla-to-sell-weight-loss-drug-20251023.jpg", "site": "reuters.com", "text": "Eli Lilly signed an agreement with Cipla , allowing the Indian drugmaker to sell its blockbuster weight-loss drug under a separate brand in the country, the companies said on Thursday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-allows-cipla-sell-weight-loss-drug-under-new-brand-india-2025-10-23/"}}
{"date": "2025-10-22", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-22 08:36:37", "publisher": "The Motley Fool", "title": "Big Money Exits: Iconic Pharma Stock Sold by High-Profile Asset Manager", "image": "https://images.financialmodelingprep.com/news/big-money-exits-iconic-pharma-stock-sold-by-highprofile-asset-20251022.png", "site": "fool.com", "text": "Sold 6,430 shares of Eli Lilly and Company; estimated transaction value ~$4.78 million Post-trade holding: 61,292 shares valued at $46.77 million Position now 1% of fund AUM, which places it outside the fund's top five holdings", "url": "https://www.fool.com/coverage/filings/2025/10/22/big-money-exits-iconic-pharma-stock-sold-by-high-profile-asset-manager/"}}
{"date": "2025-10-22", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-22 03:43:00", "publisher": "The Motley Fool", "title": "3 Things Investors Need to Know Ahead of Eli Lilly's Q3 Earnings Report", "image": "https://images.financialmodelingprep.com/news/3-things-investors-need-to-know-ahead-of-eli-20251022.jpg", "site": "fool.com", "text": "Eli Lilly is expected to present third-quarter results on Oct. 30 after the market opens. Wall Street analysts will be looking closely at sales growth for Mounjaro and Zepbound.", "url": "https://www.fool.com/investing/2025/10/22/3-things-investors-need-to-know-ahead-of-eli-lilly/"}}
{"date": "2025-10-21", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-21 16:26:08", "publisher": "MarketBeat", "title": "Got 1K to Invest? These 3 Stocks Are Still Attractive Buys", "image": "https://images.financialmodelingprep.com/news/got-1k-to-invest-these-3-stocks-are-still-20251021.jpg", "site": "marketbeat.com", "text": "But if you have $1,000 to put into the market, there are several quality names that offer significant upside even thoughin some casesthey've outperformed the market in 2025. In other words, if you're looking for long-term growth, there are opportunities available that will allow you to generate a solid return without the volatility that can come with low-priced stocks.", "url": "https://www.marketbeat.com/stock-ideas/got-1k-to-invest-these-3-stocks-are-still-attractive-buys/"}}
{"date": "2025-10-20", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-20 13:09:18", "publisher": "Proactive Investors", "title": "Eli Lilly Q3 earnings eyed for insights into drug pricing policies, obesity and diabetes drug performance", "image": "https://images.financialmodelingprep.com/news/eli-lilly-q3-earnings-eyed-for-insights-into-drug-20251020.jpeg", "site": "proactiveinvestors.com", "text": "Eli Lilly and Co (NYSE:LLY) will report its third quarter 2025 earnings next Thursday, with Bank of America analysts closely watching how the company's obesity and diabetes treatments are performing amid ongoing policy debates over US drug pricing. The firm believes the drugmaker's upcoming report could offer insight into the company's key brands while highlighting broader industry trends affecting margins and growth.", "url": "https://www.proactiveinvestors.com/companies/news/1080726"}}
{"date": "2025-10-20", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-20 11:38:23", "publisher": "Seeking Alpha", "title": "My Top 3 Pharma Stocks", "image": "https://images.financialmodelingprep.com/news/my-top-3-pharma-stocks-20251020.jpg", "site": "seekingalpha.com", "text": "Obesity, type 2 diabetes, and cancer continue to grow across the globe, but pharma stocks remain off the radars of many investors. Many of them consistently beat the Street's consensus estimates and offer dividend yields even higher than IT, as well as oil and gas stocks. In this article, I reveal my top 3 Big Pharma players.", "url": "https://seekingalpha.com/article/4831152-my-top-3-pharma-stocks"}}
{"date": "2025-10-20", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-20 10:01:16", "publisher": "Zacks Investment Research", "title": "Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-is-a-trending-stock-20251020.jpg", "site": "zacks.com", "text": "Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.", "url": "https://www.zacks.com/stock/news/2772137/eli-lilly-and-company-lly-is-a-trending-stock-facts-to-know-before-betting-on-it?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2772137"}}
{"date": "2025-10-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-19 21:55:32", "publisher": "The Motley Fool", "title": "J.L. Bainbridge Buys $45 Million in Eli Lilly Stock Despite Price-Pressure Fears", "image": "https://images.financialmodelingprep.com/news/jl-bainbridge-buys-45-million-in-eli-lilly-stock-despite-20251019.jpg", "site": "fool.com", "text": "Florida-based wealth advisory J. L. Bainbridge disclosed a purchase of Eli Lilly and Company valued at approximately $45.6 million for the quarter ended September 30, according to an SEC filing released on Friday.", "url": "https://www.fool.com/coverage/filings/2025/10/20/j-l-bainbridge-buys-usd45-million-in-eli-lilly-stock-despite-price-pressure-fears/"}}
{"date": "2025-10-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-19 19:01:04", "publisher": "The Motley Fool", "title": "Investment Advisor Goes All-In on Big Pharma Stock to the Tune of $1.07 Billion, According to Recent Filing", "image": "https://images.financialmodelingprep.com/news/investment-advisor-goes-allin-on-big-pharma-stock-to-20251019.png", "site": "fool.com", "text": "On October 17, 2025, Sapient Capital LLC disclosed a purchase of 259,392 Eli Lilly and Company (LLY -1.94%) shares, for a total transaction value of $193,028,908.", "url": "https://www.fool.com/coverage/filings/2025/10/19/investment-advisor-goes-all-in-on-big-pharma-stock-to-the-tune-of-usd1-03-billion-according-to-recent-filing/"}}
{"date": "2025-10-19", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-19 11:10:00", "publisher": "The Motley Fool", "title": "Got $5,000? 2 Stocks to Buy Now and Hold for the Long Term", "image": "https://images.financialmodelingprep.com/news/got-5000-2-stocks-to-buy-now-and-hold-20251019.jpg", "site": "fool.com", "text": "Wall Street has long rewarded patience and sound investment choices far more than market timing. Hence, buying and holding stakes in high-quality companies benefiting from powerful secular tailwinds can be one of the most effective ways to build long-term wealth.", "url": "https://www.fool.com/investing/2025/10/19/got-5000-2-stocks-to-buy-now-and-hold-for-the-long/"}}
{"date": "2025-10-18", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-18 08:00:00", "publisher": "Seeking Alpha", "title": "Our Top 10 High Growth Dividend Stocks - October 2025", "image": "https://images.financialmodelingprep.com/news/our-top-10-high-growth-dividend-stocks-october-2025-20251018.jpg", "site": "seekingalpha.com", "text": "The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rate both quantitatively and qualitatively, and select the top 10 names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and positive momentum and is suitable for investors in the accumulation phase.", "url": "https://seekingalpha.com/article/4829929-our-top-10-high-growth-dividend-stocks-october-2025"}}
{"date": "2025-10-17", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-17 16:26:23", "publisher": "Seeking Alpha", "title": "3 Price Catalysts For Eli Lilly", "image": "https://images.financialmodelingprep.com/news/3-price-catalysts-for-eli-lilly-20251017.jpg", "site": "seekingalpha.com", "text": "Eli Lilly (NYSE:LLY) is up by ~30% since I last checked on it in August, with further upside potential remaining. Three potential developments can catalyse the stock further to achieve this upside, or not. An agreement with the US government on tariffs and further positive trial results can spark a rally for LLY.", "url": "https://seekingalpha.com/article/4830868-3-price-catalysts-for-eli-lilly"}}
{"date": "2025-10-17", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-17 08:00:07", "publisher": "Investors Business Daily", "title": "Eli Lilly Makes A Bold Claim For Its Biggest Cancer Drug", "image": "https://images.financialmodelingprep.com/news/eli-lilly-makes-a-bold-claim-for-its-biggest-cancer-20251017.jpg", "site": "investors.com", "text": "Eli Lilly said Friday a combination using Verzenio reduced the risk of death by nearly 16% over two years for breast cancer patients.", "url": "https://www.investors.com/news/technology/eli-lilly-verzenio-endocrine-therapy-breast-cancer/"}}
{"date": "2025-10-17", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-17 08:00:00", "publisher": "PRNewsWire", "title": "Lilly's Verzenio (abemaciclib) prolonged survival in HR+, HER2-, high-risk early breast cancer with two years of treatment", "image": "https://images.financialmodelingprep.com/news/lillys-verzenio-abemaciclib-prolonged-survival-in-hr-her2-highrisk-early-20251017.jpg", "site": "prnewswire.com", "text": "Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2, high-risk early breast cancer Seven-year results from the Phase 3 monarchE trial also show Verzenio plus endocrine therapy demonstrated sustained benefits in invasive disease-free survival and distant relapse-free survival These data were simultaneously published in Annals of Oncology and presented as a late-breaking oral session at the European Society for Medical Oncology (ESMO) Annual Meeting INDIANAPOLIS , Oct. 17, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced results from the primary overall survival (OS) analysis of the Phase 3 monarchE trial showing that two years of adjuvant Verzenio plus endocrine therapy (ET) reduced the risk of death by 15.8% versus ET alone and resulted in sustained long-term improvements in invasive disease-free survival (IDFS) and distant relapse-free survival (DRFS), in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), node-positive, high-risk early breast cancer. These results were published in the Annals of Oncology and will be shared in a late-breaking oral presentation at the ESMO Annual Meeting today, Friday, October 17, at 2:50 PM CEST/08:50 AM ET in Berlin, Germany.", "url": "https://www.prnewswire.com/news-releases/lillys-verzenio-abemaciclib-prolonged-survival-in-hr-her2--high-risk-early-breast-cancer-with-two-years-of-treatment-302586849.html"}}
{"date": "2025-10-17", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-17 04:15:00", "publisher": "The Motley Fool", "title": "Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street?", "image": "https://images.financialmodelingprep.com/news/eli-lilly-vs-viking-therapeutics-stock-which-is-the-best-20251017.jpg", "site": "fool.com", "text": "Eli Lilly (LLY -0.97%) and Viking Therapeutics (VKTX -1.02%) offer investors the chance to invest in one of today's highest-potential industries: weight loss drugs. The market for these products, worth about $28 billion right now, is forecast to grow to $95 billion by 2030, according to Goldman Sachs Research.", "url": "https://www.fool.com/investing/2025/10/17/eli-lilly-vs-viking-therapeutics-stock-which-is-th/"}}
{"date": "2025-10-16", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-16 12:42:18", "publisher": "The Motley Fool", "title": "Chesapeake Sells 9,900 Eli Lilly (LLY) Shares Worth $7.7 Million", "image": "https://images.financialmodelingprep.com/news/chesapeake-sells-9900-eli-lilly-lly-shares-worth-77-20251016.png", "site": "fool.com", "text": "Chesapeake Asset Management LLC disclosed in its October 15, 2025, SEC filing the sale of 9,875 Eli Lilly and Company (LLY -0.19%) shares for the quarter ended June 30, 2025. The trade value was an estimated $7.68 million.", "url": "https://www.fool.com/coverage/filings/2025/10/16/chesapeake-sells-9-900-eli-lilly-lly-shares-worth-usd7-7-million/"}}
{"date": "2025-10-16", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-16 10:36:16", "publisher": "Zacks Investment Research", "title": "How Will Mounjaro and Zepbound Sales Aid Lilly's Upcoming Q3 Results?", "image": "https://images.financialmodelingprep.com/news/how-will-mounjaro-and-zepbound-sales-aid-lillys-upcoming-q3-20251016.jpg", "site": "zacks.com", "text": "Strong demand for Mounjaro and Zepbound is expected to power LLY's Q3 growth, as both drugs deepen U.S. and global market reach.", "url": "https://www.zacks.com/stock/news/2770087/how-will-mounjaro-and-zepbound-sales-aid-lilly-s-upcoming-q3-results?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2770087"}}
{"date": "2025-10-16", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-16 10:00:00", "publisher": "PRNewsWire", "title": "Lilly confirms date and conference call for third-quarter 2025 financial results announcement", "image": "https://images.financialmodelingprep.com/news/lilly-confirms-date-and-conference-call-for-thirdquarter-2025-financial-20251016.jpg", "site": "prnewswire.com", "text": "INDIANAPOLIS , Oct. 16, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its third-quarter 2025 financial results on October 30, 2025. Lilly will also conduct a conference call that day with the investment community and media to further detail the company's financial performance.", "url": "https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-third-quarter-2025-financial-results-announcement-302585549.html"}}
{"date": "2025-10-16", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-16 09:48:00", "publisher": "The Motley Fool", "title": "2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades", "image": "https://images.financialmodelingprep.com/news/2-pharmaceutical-growth-stocks-to-buy-now-and-hold-for-20251016.jpg", "site": "fool.com", "text": "Investing in pharmaceutical stocks can carry risks. It's not always clear which drugs will be successful and turn into blockbusters for their respective businesses.", "url": "https://www.fool.com/investing/2025/10/16/2-pharmaceutical-growth-stocks-to-buy-now-and-hold/"}}
{"date": "2025-10-15", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-15 09:50:08", "publisher": "Forbes", "title": "How LLY Stock Delivered $47 Billion To Shareholders", "image": "https://images.financialmodelingprep.com/news/how-lly-stock-delivered-47-billion-to-shareholders-20251015.jpg", "site": "forbes.com", "text": "In the last decade, Eli Lilly stock (NYSE: LLY) has returned $47 billion to its shareholders via dividends and buybacks. This shareholder-centric approach has delivered solid results in 2025, with the stock posting 9% year-to-date returns, despite experiencing some volatility from its peak of $937 earlier in the year, while demonstrating remarkable resilience in the face of increased competition in the diabetes and obesity treatment markets.", "url": "https://www.forbes.com/sites/greatspeculations/2025/10/15/how-lly-stock-delivered-47-billion-to-shareholders/"}}
{"date": "2025-10-15", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-15 06:45:00", "publisher": "PRNewsWire", "title": "Lilly's oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes", "image": "https://images.financialmodelingprep.com/news/lillys-oral-glp1-orforglipron-demonstrated-superior-glycemic-control-in-20251015.jpg", "site": "prnewswire.com", "text": "In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint In ACHIEVE-5,orforglipron lowered A1C by an additional 2.1% when taken with insulin glargine, meeting the primary endpoint INDIANAPOLIS , Oct. 15, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 ACHIEVE-2 and ACHIEVE-5 trials. ACHIEVE-2, the second head-to-head trial in the program, evaluated orforglipron versus dapagliflozin, an SGLT-2 inhibitor, in adults with type 2 diabetes inadequately controlled on metformin.", "url": "https://www.prnewswire.com/news-releases/lillys-oral-glp-1-orforglipron-demonstrated-superior-glycemic-control-in-two-successful-phase-3-trials-reconfirming-its-potential-as-a-foundational-treatment-in-type-2-diabetes-302584124.html"}}
{"date": "2025-10-15", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-15 03:30:00", "publisher": "The Motley Fool", "title": "New to Investing? These Are 3 Solid Blue Chip Stocks You Can Build Your Portfolio Around", "image": "https://images.financialmodelingprep.com/news/new-to-investing-these-are-3-solid-blue-chip-20251015.jpg", "site": "fool.com", "text": "Getting started with investing can be overwhelming. There are many solid stocks to choose from, but also many risky ones you'll probably be better off avoiding.", "url": "https://www.fool.com/investing/2025/10/15/new-to-investing-these-are-3-solid-blue-chip-stock/"}}
{"date": "2025-10-14", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-14 15:22:16", "publisher": "The Motley Fool", "title": "Independence Bank of Kentucky Buys Another $3.1 Million Eli Lilly (NYSE: LLY) Shares", "image": "https://images.financialmodelingprep.com/news/independence-bank-of-kentucky-buys-another-31-million-eli-20251014.jpg", "site": "fool.com", "text": "Independence Bank of Kentucky disclosed a purchase of 4,193 shares of Eli Lilly and Company (NYSE: LLY), estimated at $3.12 million based on the average price for the quarter, in its SEC filing for the period ended September 30, 2025.", "url": "https://www.fool.com/coverage/filings/2025/10/14/independence-bank-of-kentucky-buys-another-usd3-11-million-eli-lilly-nyse-lly-shares/"}}
{"date": "2025-10-14", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-14 07:49:00", "publisher": "Seeking Alpha", "title": "Wall Street Breakfast Podcast: Papa John's Delivers A Hot Slice", "image": "https://images.financialmodelingprep.com/news/wall-street-breakfast-podcast-papa-johns-delivers-a-hot-20251014.jpg", "site": "seekingalpha.com", "text": "Papa John's (PZZA) surged nearly 10% after reports of a $64/share takeover bid from Apollo Global. PZZA is up 3% premarket.", "url": "https://seekingalpha.com/article/4829749-wall-street-breakfast-podcast-papa-johns-delivers-a-hot-slice"}}
{"date": "2025-10-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-13 10:51:19", "publisher": "Seeking Alpha", "title": "Eli Lilly: The Rally Has More Room To Run (Rating Upgrade)", "image": "https://images.financialmodelingprep.com/news/eli-lilly-the-rally-has-more-room-to-run-20251013.jpg", "site": "seekingalpha.com", "text": "Eli Lilly stock has recovered resoundingly, outperforming the S&P 500, Novo Nordisk, and healthcare peers after a period of decline. LLY's robust pipeline, expansion into cardiometabolic and oncology adjacencies, and manufacturing readiness support its competitive edge over NVO. Despite near-term gross margin pressures, LLY's valuation is de-risked, and its growth strategy could bolster near-term catalysts from its diversified pipeline.", "url": "https://seekingalpha.com/article/4829516-eli-lilly-rally-more-room-to-run-rating-upgrade"}}
{"date": "2025-10-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-13 10:47:37", "publisher": "Reuters", "title": "Roche, Lilly's blood test for Alzheimer's diagnosis gets US approval", "image": "https://images.financialmodelingprep.com/news/roche-lillys-blood-test-for-alzheimers-diagnosis-gets-us-20251013.jpg", "site": "reuters.com", "text": "Roche Diagnostics said on Monday the U.S. Food and Drug Administration cleared its and partner Eli Lilly's blood test as an aid in the initial assessment for Alzheimer's disease.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/roche-lillys-blood-test-alzheimers-diagnosis-gets-us-approval-2025-10-13/"}}
{"date": "2025-10-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-13 10:10:07", "publisher": "Benzinga", "title": "Healthcare Opportunities And Risks Collide For Direxion's Eli Lilly-Focused ELIL, ELIS ETFs", "image": "https://images.financialmodelingprep.com/news/healthcare-opportunities-and-risks-collide-for-direxions-eli-lillyfocused-20251013.png", "site": "benzinga.com", "text": "As the largest publicly traded U.S. healthcare enterprise, Eli Lilly & Co. (NYSE:LLY) has historically offered investors a reliable avenue for growth. Indeed, this narrative has been particularly powerful in 2023 and 2024, which saw LLY stock rise from around $360 to approximately $960 in late summer of last year.", "url": "https://www.benzinga.com/etfs/specialty-etfs/25/10/48176169/healthcare-opportunities-and-risks-collide-for-direxions-eli-lilly-focused-elil-elis-etfs"}}
{"date": "2025-10-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-13 06:45:00", "publisher": "PRNewsWire", "title": "Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting", "image": "https://images.financialmodelingprep.com/news/lilly-to-present-new-clinical-data-for-verzenio-abemaciclib-and-20251013.jpg", "site": "prnewswire.com", "text": "Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to be presented as a late-breaking oral presentation Additional presentations showcase Lilly's robust oncology pipeline with data from studies of investigational therapies targeting FR positive ovarian cancer, KRAS G12C-mutant lung cancer, FGFR3-altered bladder cancer, and PIK3CA-mutant advanced breast cancer INDIANAPOLIS , Oct. 13, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that new data from across its oncology portfolio and pipeline will be presented at the European Society for Medical Oncology (ESMO) Annual Meeting, taking place October 17-21 in Berlin, Germany. These presentations highlight the breadth of Lilly's portfolio across treatment modalities and tumor types.", "url": "https://www.prnewswire.com/news-releases/lilly-to-present-new-clinical-data-for-verzenio-abemaciclib-and-multiple-novel-pipeline-programs-at-the-2025-european-society-for-medical-oncology-esmo-annual-meeting-302581179.html"}}
{"date": "2025-10-13", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-13 05:26:51", "publisher": "Reuters", "title": "Aspen wins approval to market Lilly's Mounjaro for weight loss in South Africa", "image": "https://images.financialmodelingprep.com/news/aspen-wins-approval-to-market-lillys-mounjaro-for-weight-loss-20251013.jpg", "site": "reuters.com", "text": "South Africa's Aspen Pharmacare said on Monday it had secured regulatory approval to market Eli Lilly's blockbuster diabetes and obesity drug, Mounjaro, for chronic weight management in the country.", "url": "https://www.reuters.com/sustainability/boards-policy-regulation/aspen-wins-approval-market-lillys-mounjaro-weight-loss-south-africa-2025-10-13/"}}
{"date": "2025-10-11", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-11 07:00:00", "publisher": "The Motley Fool", "title": "Should Investors Buy Eli Lilly Stock?", "image": "https://images.financialmodelingprep.com/news/should-investors-buy-eli-lilly-stock-20251011.jpg", "site": "fool.com", "text": "Eli Lilly (LLY -2.60%) shares jumped in the last month as investors gained confidence in its pipeline of products.", "url": "https://www.fool.com/investing/2025/10/11/should-investors-buy-eli-lilly-stock/"}}
{"date": "2025-10-10", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-10 10:15:34", "publisher": "Reuters", "title": "Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly", "image": "https://images.financialmodelingprep.com/news/next-medicine-deal-after-pfizer-analysts-shares-point-to-20251010.jpg", "site": "reuters.com", "text": "Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with Donald Trump's administration to lower drug prices last week.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/next-medicine-deal-after-pfizer-analysts-shares-point-astrazeneca-eli-lilly-2025-10-10/"}}
{"date": "2025-10-10", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-10 06:45:00", "publisher": "The Motley Fool", "title": "2 Pharmaceutical Stocks That Look Like No-Brainer Buys Right Now", "image": "https://images.financialmodelingprep.com/news/2-pharmaceutical-stocks-that-look-like-nobrainer-buys-right-now-20251010.jpg", "site": "fool.com", "text": "There are several compelling reasons to invest in pharmaceutical companies, especially when the economy isn't doing well. Since they belong to a defensive industry, drugmakers tend to perform better than most companies even in the worst economic downturns.", "url": "https://www.fool.com/investing/2025/10/10/2-pharmaceutical-stocks-that-look-like-no-brainer/"}}
{"date": "2025-10-09", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-09 10:15:09", "publisher": "Forbes", "title": "A Pricing Powerhouse, Now 30% Cheaper: Is Eli Lilly Stock A Buy?", "image": "https://images.financialmodelingprep.com/news/a-pricing-powerhouse-now-30-cheaper-is-eli-lilly-20251009.jpg", "site": "forbes.com", "text": "Eli Lilly (LLY) stock merits your attention. Why? Because it offers monopoly-like high margins at a reduced price.", "url": "https://www.forbes.com/sites/greatspeculations/2025/10/09/a-pricing-powerhouse-now-30-cheaper-is-eli-lilly-stock-a-buy/"}}
{"date": "2025-10-08", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-08 08:03:47", "publisher": "Reuters", "title": "HealthTap joins Lilly's online platform to offer diabetes management services", "image": "https://images.financialmodelingprep.com/news/healthtap-joins-lillys-online-platform-to-offer-diabetes-management-20251008.jpg", "site": "reuters.com", "text": "Telehealth company HealthTap said on Wednesday it is joining Eli Lilly's digital healthcare platform, LillyDirect, to offer virtual diabetes management services.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/healthtap-joins-lillys-online-platform-offer-diabetes-management-services-2025-10-08/"}}
{"date": "2025-10-08", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-08 06:31:00", "publisher": "The Motley Fool", "title": "These 2 AI Stocks Could Surpass Oracle in Market Cap by 2030", "image": "https://images.financialmodelingprep.com/news/these-2-ai-stocks-could-surpass-oracle-in-market-cap-20251008.jpg", "site": "fool.com", "text": "Oracle (ORCL -2.43%) quietly transformed itself over the past couple of years from an aging database giant into a critical enabler of the global artificial intelligence (AI) infrastructure buildout. With a staggering $455 billion in contracted backlog as of the end of its fiscal 2026 first quarter (which ended Aug. 31), the tech company is likely to see significant revenue expansion for several years into the future.", "url": "https://www.fool.com/investing/2025/10/08/ai-stocks-surpass-oracle-market-cap-2030-pltr/"}}
{"date": "2025-10-07", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-07 15:16:10", "publisher": "Reuters", "title": "Former FDA vaccine chief Peter Marks joins Eli Lilly, STAT reports", "image": "https://images.financialmodelingprep.com/news/former-fda-vaccine-chief-peter-marks-joins-eli-lilly-stat-20251007.jpg", "site": "reuters.com", "text": "Peter Marks, the former top vaccine regulator at the U.S. Food and Drug Administration, has joined Eli Lilly , STAT News reported on Tuesday.", "url": "https://www.reuters.com/sustainability/boards-policy-regulation/former-fda-vaccine-chief-peter-marks-joins-eli-lilly-stat-reports-2025-10-07/"}}
{"date": "2025-10-07", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-07 10:01:17", "publisher": "Zacks Investment Research", "title": "Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know", "image": "https://images.financialmodelingprep.com/news/investors-heavily-search-eli-lilly-and-company-lly-here-is-20251007.jpg", "site": "zacks.com", "text": "Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.", "url": "https://www.zacks.com/stock/news/2763455/investors-heavily-search-eli-lilly-and-company-lly-here-is-what-you-need-to-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2763455"}}
{"date": "2025-10-07", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-07 09:51:29", "publisher": "Zacks Investment Research", "title": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now", "image": "https://images.financialmodelingprep.com/news/why-investors-need-to-take-advantage-of-these-2-medical-stocks-20251007.jpg", "site": "zacks.com", "text": "Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.", "url": "https://www.zacks.com/stock/news/2763434/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|zacks_education_earnings_esp-2763434"}}
{"date": "2025-10-07", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-07 06:45:00", "publisher": "PRNewsWire", "title": "Lilly's Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 antagonist to show four years of sustained, corticosteroid-free comprehensive patient outcomes in ulcerative colitis", "image": "https://images.financialmodelingprep.com/news/lillys-omvoh-mirikizumabmrkz-is-the-first-and-only-il23p19-antagonist-20251007.jpg", "site": "prnewswire.com", "text": "Approximately 80% of Omvoh-treated patients in the LUCENT-3 study who achieved clinical remission at one year maintained long-term, corticosteroid-free clinical and endoscopic remission At four years, nearly all patients who achieved clinical remission at one year had improvements in bowel urgency, one of the most disruptive symptoms for patients INDIANAPOLIS , Oct. 7, 2025 /PRNewswire/ -- New data from Eli Lilly and Company (NYSE: LLY) showed Omvoh (mirikizumab-mrkz) is the first and only interleukin-23p19 (IL-23p19) to help patients with moderately to severely active ulcerative colitis (UC) achieve sustained, long-term outcomes through four years. The results were seen across multiple symptomatic, clinical, endoscopic, histologic and quality-of-life measures, including among patients who had previously failed a biologic or advanced therapy (27%).", "url": "https://www.prnewswire.com/news-releases/lillys-omvoh-mirikizumab-mrkz-is-the-first-and-only-il-23p19-antagonist-to-show-four-years-of-sustained-corticosteroid-free-comprehensive-patient-outcomes-in-ulcerative-colitis-302576255.html"}}
{"date": "2025-10-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-06 19:35:08", "publisher": "MarketBeat", "title": "Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal", "image": "https://images.financialmodelingprep.com/news/eli-lilly-stock-soars-on-trump-tariff-hopes-and-20251006.png", "site": "marketbeat.com", "text": "After tanking in early August, the world's most valuable pharmaceutical stock has roared back with a vengeance. That firm is Eli Lilly and Company NYSE: LLY, the maker of the wildly popular weight loss and diabetes drugs Zepbound and Mounjaro.", "url": "https://www.marketbeat.com/originals/eli-lilly-stock-soars-on-trump-tariff-hopes-and-pfizer-deal/"}}
{"date": "2025-10-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-06 15:01:12", "publisher": "Zacks Investment Research", "title": "Eli Lilly Stock Rises 16% in a Week: Here's What You Should Know", "image": "https://images.financialmodelingprep.com/news/eli-lilly-stock-rises-16-in-a-week-heres-what-20251006.jpg", "site": "zacks.com", "text": "LLY shares have jumped 16% last week as Pfizer's landmark government deal boosted investor confidence across the pharma sector.", "url": "https://www.zacks.com/stock/news/2763044/eli-lilly-stock-rises-16-in-a-week-here-s-what-you-should-know?cid=CS-STOCKNEWSAPI-FT-analyst_blog|quick_take-2763044"}}
{"date": "2025-10-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-06 14:21:31", "publisher": "MarketBeat", "title": "Trump's Drug Price Cuts: Boom or Bust for These 3 Pharma Giants", "image": "https://images.financialmodelingprep.com/news/trumps-drug-price-cuts-boom-or-bust-for-these-20251006.png", "site": "marketbeat.com", "text": "When investors hear that a company will lower prices on its products, their instinctive reaction is to expect a sequential decline in margins and profits, which is not entirely incorrect. However, sometimes these price decreases end up attracting new business, expanding market share, and more than making up for the lost ticket price in the top-line revenue.", "url": "https://www.marketbeat.com/stock-ideas/trumps-drug-price-cuts-boom-or-bust-for-these-3-pharma-giants/"}}
{"date": "2025-10-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-06 13:29:00", "publisher": "Seeking Alpha", "title": "My Top 5 Biotech Stocks Big Pharma Could Buy Next", "image": "https://images.financialmodelingprep.com/news/my-top-5-biotech-stocks-big-pharma-could-buy-20251006.jpg", "site": "seekingalpha.com", "text": "While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of Mr. Market's interest zone. Since the exclusivity of key blockbusters of 'giants', including Merck andPfizer, expires in the next 4 years, there is an urgent need to continue rejuvenating their portfolios of drugs.", "url": "https://seekingalpha.com/article/4828107-my-top-5-biotech-stocks-big-pharma-could-buy-next"}}
{"date": "2025-10-06", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-06 03:12:07", "publisher": "Reuters", "title": "Eli Lilly to invest over $1 billion in India to expand manufacturing capacity", "image": "https://images.financialmodelingprep.com/news/eli-lilly-to-invest-over-1-billion-in-india-to-20251006.jpg", "site": "reuters.com", "text": "Eli Lilly will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, as it seeks to tap into skilled workforce to bolster its global manufacturing expansion.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-invest-over-1-billion-india-expand-manufacturing-capacity-2025-10-06/"}}
{"date": "2025-10-03", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-03 18:46:24", "publisher": "Zacks Investment Research", "title": "Eli Lilly (LLY) Laps the Stock Market: Here's Why", "image": "https://images.financialmodelingprep.com/news/eli-lilly-lly-laps-the-stock-market-heres-why-20251003.jpg", "site": "zacks.com", "text": "Eli Lilly (LLY) closed the most recent trading day at $839.87, moving +2.44% from the previous trading session.", "url": "https://www.zacks.com/stock/news/2761848/eli-lilly-lly-laps-the-stock-market-here-s-why?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2761848"}}
{"date": "2025-10-03", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-03 10:47:00", "publisher": "The Motley Fool", "title": "Why Shares of Eli Lilly Soared This Week", "image": "https://images.financialmodelingprep.com/news/why-shares-of-eli-lilly-soared-this-week-20251003.jpg", "site": "fool.com", "text": "Shares in Eli Lilly (LLY 2.73%) had risen 13.2% in the week to Friday morning. The move comes at a time when peer Pfizer announced a deal with the Trump administration that gave that pharmaceutical company three years of grace from tariffs imposed on drugs it manufactures abroad and imports to the U.S..", "url": "https://www.fool.com/investing/2025/10/03/why-shares-of-eli-lilly-soared-this-week/"}}
{"date": "2025-10-03", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-03 10:46:27", "publisher": "Seeking Alpha", "title": "Top 50 High-Quality Dividend Growth Stocks For October 2025", "image": "https://images.financialmodelingprep.com/news/top-50-highquality-dividend-growth-stocks-for-october-2025-20251003.jpg", "site": "seekingalpha.com", "text": "I track a universe of 50 high-quality dividend growth stocks to identify opportune investments based on valuation and future return potential. As of October 2, 2025, 22 stocks offer attractive future return estimates of at least 10%, with 15 appearing potentially undervalued by my Free Cash Flow model. Top-ranked stocks include MKTX, RMD, MPWR, RACE, and MSCI, each offering strong projected returns driven by yield, valuation upside, and EPS growth.", "url": "https://seekingalpha.com/article/4827699-top-50-high-quality-dividend-growth-stocks-for-october-2025"}}
{"date": "2025-10-03", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-03 09:00:00", "publisher": "Business Wire", "title": "Kernal Bio Joins Lilly Gateway Labs to Accelerate In Vivo Cell Therapies", "image": "https://images.financialmodelingprep.com/news/kernal-bio-joins-lilly-gateway-labs-to-accelerate-in-20251003.jpg", "site": "businesswire.com", "text": "BOSTON--(BUSINESS WIRE)-- #AI--Kernal Bio retains strategic independence, while gaining access to shared resources, operational support and Lilly's global network of experts.", "url": "https://www.businesswire.com/news/home/20251003567884/en/Kernal-Bio-Joins-Lilly-Gateway-Labs-to-Accelerate-In-Vivo-Cell-Therapies/"}}
{"date": "2025-10-03", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-03 08:35:03", "publisher": "Forbes", "title": "Buy LLY Stock At $820?", "image": "https://images.financialmodelingprep.com/news/buy-lly-stock-at-820-20251003.jpg", "site": "forbes.com", "text": "The entire pharmaceutical sector is experiencing a rerating this week, as investors realize the adverse impact of tariffs and drug price cuts won't be as severe as previously anticipated. While most major pharma stocks have rallied, Eli Lilly stock (NYSE: LLY) warrants particular attention.", "url": "https://www.forbes.com/sites/greatspeculations/2025/10/03/buy-lly-stock-at-820/"}}
{"date": "2025-10-03", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-03 07:30:00", "publisher": "Seeking Alpha", "title": "How I Would Build An Ultra-High-Conviction Retirement Portfolio Right Now", "image": "https://images.financialmodelingprep.com/news/how-i-would-build-an-ultrahighconviction-retirement-portfolio-right-20251003.jpg", "site": "seekingalpha.com", "text": "Building a resilient retirement portfolio requires a mix of disruption-proof income from REITs, midstream energy, and high-yielding assets, plus growth stocks and ETFs. Current market challengesAI disruption, weak job market, inflation risksmake long-term planning difficult, but also highlight the need for self-reliance and diversification. Core portfolio holdings should include large, proven REITs, natural gas midstream companies, select high-yield stocks, BDCs, preferred equity ETFs, and actively managed income funds.", "url": "https://seekingalpha.com/article/4827511-how-i-would-build-ultra-high-conviction-retirement-portfolio"}}
{"date": "2025-10-02", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-02 08:20:03", "publisher": "Forbes", "title": "ABBV Stock vs. Eli Lilly & Merck", "image": "https://images.financialmodelingprep.com/news/abbv-stock-vs-eli-lilly-merck-20251002.jpg", "site": "forbes.com", "text": "AbbVie stock (NYSE: ABBV) rallied 11% in a week, largely driven by a key development that boosted the entire sector: Pfizer's agreement to lower its drug prices for Medicaid and a White House decision to grant a three-year exemption from 100% import tariffs. Since the market sees this event as broadly positive for pharmaceutical companies, ABBV's stock has risen significantly.", "url": "https://www.forbes.com/sites/greatspeculations/2025/10/02/abbv-stock-vs-eli-lilly--merck/"}}
{"date": "2025-10-02", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-02 05:27:00", "publisher": "The Motley Fool", "title": "3 Blue Chip Stocks That Have Soared 380% (and Higher) Over the Past 5 Years", "image": "https://images.financialmodelingprep.com/news/3-blue-chip-stocks-that-have-soared-380-and-20251002.jpg", "site": "fool.com", "text": "Normally when you think about earning big returns from the stock market, you're likely to remember risky investments that ended up paying off. But by no means is that the only case.", "url": "https://www.fool.com/investing/2025/10/02/3-blue-chip-stocks-that-have-soared-380-and-higher/"}}
{"date": "2025-10-02", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-02 05:05:32", "publisher": "Reuters", "title": "Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say", "image": "https://images.financialmodelingprep.com/news/novo-lilly-weightloss-drugs-should-be-first-option-obesity-20251002.jpg", "site": "reuters.com", "text": "Novo Nordisk's and Eli Lilly's blockbuster weight-loss drugs should be the first medicines doctors reach for to treat obesity and its complications, a major European medical association advised on Thursday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/novo-lilly-weight-loss-drugs-should-be-first-option-obesity-treatments-european-2025-10-02/"}}
{"date": "2025-10-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-01 13:53:30", "publisher": "Schaeffers Research", "title": "Another Surging Pharma Stock to Watch Right Now", "image": "https://images.financialmodelingprep.com/news/another-surging-pharma-stock-to-watch-right-now-20251001.jpg", "site": "schaeffersresearch.com", "text": "Pharmaceutical concern Eli Lilly And Co (NYSE:LLY ) is charging 7.2% higher to trade at $821.20 this afternoon.", "url": "https://www.schaeffersresearch.com/content/options/2025/10/01/another-surging-pharma-stock-to-watch-right-now"}}
{"date": "2025-10-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-01 13:30:44", "publisher": "Investopedia", "title": "Top Stock Movers Now: Nike, Eli Lilly, Corteva, AES, and More", "image": "https://images.financialmodelingprep.com/news/top-stock-movers-now-nike-eli-lilly-corteva-aes-and-20251001.jpg", "site": "investopedia.com", "text": "The S&P 500, Dow, and Nasdaq were little changed Wednesday afternoon, as a federal government shutdown took effect.", "url": "https://www.investopedia.com/top-stock-movers-now-nike-eli-lilly-corteva-aes-and-more-11822242"}}
{"date": "2025-10-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-01 10:49:12", "publisher": "Benzinga", "title": "Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away", "image": "https://images.financialmodelingprep.com/news/pfizers-trumprx-pact-sends-shockwaves-why-unitedhealth-lilly-and-20251001.jpeg", "site": "benzinga.com", "text": "Pfizer Inc's (NYSE:PFE) deal with Washington isn't just a handshake in the Oval Office  it's a seismic jolt to America's drug-pricing game. By agreeing to sell medicines on the government's new TrumpRx platform at steep discounts and extend \"most favored nation\" (MFN) pricing to Medicaid, Pfizer bought itself a three-year tariff reprieve and plenty of goodwill.", "url": "https://www.benzinga.com/trading-ideas/long-ideas/25/10/47971458/pfizers-trumprx-pact-sends-shockwaves-why-unitedhealth-lilly-and-cvs-cant-look-away"}}
{"date": "2025-10-01", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-10-01 08:25:02", "publisher": "Forbes", "title": "Drug-Pricing Deals And Discounted Bets: Why LLY Stock Is A Core Pick In Our Top 10", "image": "https://images.financialmodelingprep.com/news/drugpricing-deals-and-discounted-bets-why-lly-stock-is-20251001.jpg", "site": "forbes.com", "text": "Eli Lilly stock (NYSE: LLY) surged 5% yesterday, initially driven by news of a Pfizer deal with the White House to lower drug prices in exchange for tariff immunity. Following this, reports surfaced that the broader pharmaceutical companies are in active discussions with the administration regarding discounted drugs.", "url": "https://www.forbes.com/sites/greatspeculations/2025/10/01/drug-pricing-deals-and-discounted-bets-why-lly-stock-is-a-core-pick-in-our-top-10/"}}
{"date": "2025-09-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-30 15:12:24", "publisher": "CNBC Television", "title": "Eli Lilly in negotiations with Trump administration for the next pharma deal", "image": "https://images.financialmodelingprep.com/news/eli-lilly-in-negotiations-with-trump-administration-for-the-next-20250930.jpg", "site": "youtube.com", "text": "CNBC's Eamon Javers reports on news regarding the White House.", "url": "https://www.youtube.com/watch?v=fmwAvLpOvU0"}}
{"date": "2025-09-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-30 10:31:09", "publisher": "Zacks Investment Research", "title": "Is Lilly (LLY) a Buy as Wall Street Analysts Look Optimistic?", "image": "https://images.financialmodelingprep.com/news/is-lilly-lly-a-buy-as-wall-street-analysts-20250930.jpg", "site": "zacks.com", "text": "When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?", "url": "https://www.zacks.com/stock/news/2759563/is-lilly-lly-a-buy-as-wall-street-analysts-look-optimistic?cid=CS-STOCKNEWSAPI-FT-fundamental_analysis|average_broker_rating-2759563"}}
{"date": "2025-09-30", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-30 04:15:00", "publisher": "The Motley Fool", "title": "These 2 Top Dividend Stocks Are Finally Rebounding, and There Might Be More Upside Ahead", "image": "https://images.financialmodelingprep.com/news/these-2-top-dividend-stocks-are-finally-rebounding-and-20250930.jpg", "site": "fool.com", "text": "Apple (AAPL -0.43%) and Eli Lilly (LLY 0.12%) have faced significant volatility this year. However, both companies have benefited from recent positive developments, and their shares surged over the past month or so.", "url": "https://www.fool.com/investing/2025/09/30/these-2-top-dividend-stocks-are-finally-rebounding/"}}
{"date": "2025-09-29", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-29 21:06:00", "publisher": "The Motley Fool", "title": "3 Growth Stocks to Invest $1,000 Right Now", "image": "https://images.financialmodelingprep.com/news/3-growth-stocks-to-invest-1000-right-now-20250929.jpg", "site": "fool.com", "text": "Those who succeed at building wealth in the stock market often do so by buying and holding stakes in companies that have the ability to expand steadily over time. Such companies can frequently be found in the technology and healthcare sectors -- two sources of innovations that sometimes reshape our lives.", "url": "https://www.fool.com/investing/2025/09/29/3-growth-stocks-to-invest-1000-right-now/"}}
{"date": "2025-09-29", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-29 10:26:27", "publisher": "Seeking Alpha", "title": "Eli Lilly: Strong Buy On Sustained Growth, Expanding Moat, And Pipeline Depth", "image": "https://images.financialmodelingprep.com/news/eli-lilly-strong-buy-on-sustained-growth-expanding-moat-20250929.jpg", "site": "seekingalpha.com", "text": "Eli Lilly's valuation has compressed significantly from last year's highs, despite fundamentals improving faster than its share price. Industry-leading incretin treatments (Mounjaro, Zepbound) are driving rapid revenue growth, with market share gains over Novo Nordisk. Capacity expansion, U.S.-based manufacturing, and price reductions are improving accessibility while sustaining margins.", "url": "https://seekingalpha.com/article/4826597-eli-lilly-strong-buy-on-sustained-growth-expanding-moat-pipeline-depth"}}
{"date": "2025-09-29", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-29 09:35:08", "publisher": "Forbes", "title": "LLY Stock Set For A 20% Breakout?", "image": "https://images.financialmodelingprep.com/news/lly-stock-set-for-a-20-breakout-20250929.jpg", "site": "forbes.com", "text": "Eli Lilly stock (NYSE: LLY) should be on your radar. Here's why  it is presently trading within the support range ($688  $761), price points from which it has previously bounced significantly.", "url": "https://www.forbes.com/sites/greatspeculations/2025/09/29/lly-stock-set-for-a-20-breakout/"}}
{"date": "2025-09-29", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-29 02:00:00", "publisher": "Barrons", "title": "Novo, Lilly Weight-Loss Drugs May Help Alzheimer's Patients. What It Means for the Stocks.", "image": "https://images.financialmodelingprep.com/news/novo-lilly-weightloss-drugs-may-help-alzheimers-patients-what-20250929.jpg", "site": "barrons.com", "text": "The blockbuster medications could open a new frontier for the pharma giants.", "url": "https://www.barrons.com/articles/novo-lilly-stock-weight-loss-drugs-alzheimers-cf943f24"}}
{"date": "2025-09-26", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-26 16:50:24", "publisher": "CNBC Television", "title": "Many pharma companies already made U.S. investment promises, says Citi's Geoff Meacham", "image": "https://images.financialmodelingprep.com/news/many-pharma-companies-already-made-us-investment-promises-says-20250926.jpg", "site": "youtube.com", "text": "CNBC's Closing Bell Overtime team discusses President Trump's plan to impose a 100% tariff on all any branded or patented Pharmaceutical Product entering the U.S. with Geoff Meacham of Citi Research.", "url": "https://www.youtube.com/watch?v=Y8KXHmkqiCg"}}
{"date": "2025-09-26", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-26 11:35:50", "publisher": "Zacks Investment Research", "title": "LLY Gets EU Approval for Alzheimer's Drug & FDA Nod to Cancer Therapy", "image": "https://images.financialmodelingprep.com/news/lly-gets-eu-approval-for-alzheimers-drug-fda-nod-20250926.jpg", "site": "zacks.com", "text": "Eli Lilly secures EU approval for Alzheimer's drug Kisunla and gains FDA nod to breast cancer therapy Inluriyo.", "url": "https://www.zacks.com/stock/news/2757708/lly-gets-eu-approval-for-alzheimer-s-drug-fda-nod-to-cancer-therapy?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2757708"}}
{"date": "2025-09-26", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-26 10:01:12", "publisher": "Zacks Investment Research", "title": "Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock", "image": "https://images.financialmodelingprep.com/news/here-is-what-to-know-beyond-why-eli-lilly-20250926.jpg", "site": "zacks.com", "text": "Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.", "url": "https://www.zacks.com/stock/news/2757524/here-is-what-to-know-beyond-why-eli-lilly-and-company-lly-is-a-trending-stock?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|most_searched_stocks-2757524"}}
{"date": "2025-09-26", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-26 09:56:00", "publisher": "The Motley Fool", "title": "3 Strong-Buy Dividend Growth Stocks", "image": "https://images.financialmodelingprep.com/news/3-strongbuy-dividend-growth-stocks-20250926.jpg", "site": "fool.com", "text": "When it comes to investing, I am a big believer in the power of compounding dividends. I focus less on yield and more on dividend growth when analyzing dividend stocks.", "url": "https://www.fool.com/investing/2025/09/26/3-strong-buy-dividend-growth-stocks/"}}
{"date": "2025-09-26", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-26 08:30:00", "publisher": "PRNewsWire", "title": "Lilly opens newest Gateway Labs site in San Diego to boost local biotechnology ecosystem", "image": "https://images.financialmodelingprep.com/news/lilly-opens-newest-gateway-labs-site-in-san-diego-to-20250926.jpg", "site": "prnewswire.com", "text": "New 82,514 square foot facility will accommodate up to 15 biotech companies to fuel next-generation medicines Gateway Labs model provides flexible lab space and tailored scientific engagement to support early-stage biotechs INDIANAPOLIS , Sept. 26, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) today announced the official opening of its newest Lilly Gateway Labs (LGL) site in San Diego, California, expanding its network of shared innovation hubs designed to support early-stage biotechnology companies by providing lab space and opportunities to collaborate with Lilly scientists.", "url": "https://www.prnewswire.com/news-releases/lilly-opens-newest-gateway-labs-site-in-san-diego-to-boost-local-biotechnology-ecosystem-302567273.html"}}
{"date": "2025-09-26", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-26 08:15:00", "publisher": "Barrons", "title": "Eli Lilly, Pfizer Stocks Rise After Trump's 100% Pharma Tariff Threat. Here's Why.", "image": "https://images.financialmodelingprep.com/news/eli-lilly-pfizer-stocks-rise-after-trumps-100-pharma-20250926.jpg", "site": "barrons.com", "text": "Trump's threat of a 100% tariff on imported branded or patented drugs sounds dramatic, yet, pharma stocks were mostly in the green as the past few months have already seen a flurry of companies announcing plans to invest in the U.S.", "url": "https://www.barrons.com/articles/eli-lilly-pfizer-stock-trump-pharma-tariffs-2b9ddfb7"}}
{"date": "2025-09-25", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-25 18:39:00", "publisher": "PRNewsWire", "title": "Lilly's Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease", "image": "https://images.financialmodelingprep.com/news/lillys-kisunla-donanemab-receives-marketing-authorization-by-european-commission-20250925.jpg", "site": "prnewswire.com", "text": "Approved for earliest symptomatic stages of disease, demonstrating significant slowing of cognitive and functional decline Only therapy with evidence to support completing course of treatment once amyloid plaques are reduced to minimal levels INDIANAPOLIS , Sept. 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the European Commission (EC) has granted marketing authorization for Kisunla (donanemab) for the treatment of early symptomatic Alzheimer's disease (AD), in adults with mild cognitive impairment as well as those with mild dementia stages of AD with confirmed amyloid pathology who are apolipoprotein E (ApoE4) heterozygotes or non-carriers.", "url": "https://www.prnewswire.com/news-releases/lillys-kisunla-donanemab-receives-marketing-authorization-by-european-commission-for-the-treatment-of-early-symptomatic-alzheimers-disease-302567710.html"}}
{"date": "2025-09-25", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-25 14:18:14", "publisher": "Reuters", "title": "US FDA approves Eli Lilly's therapy for metastatic breast cancer", "image": "https://images.financialmodelingprep.com/news/us-fda-approves-eli-lillys-therapy-for-metastatic-breast-cancer-20250925.jpg", "site": "reuters.com", "text": "Eli Lilly said on Thursday that the U.S. Food and Drug Administration has approved its therapy for the treatment of metastatic breast cancer in patients whose disease progressed after at least one line of endocrine therapy.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-eli-lillys-therapy-metastatic-breast-cancer-2025-09-25/"}}
{"date": "2025-09-25", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-25 14:01:00", "publisher": "PRNewsWire", "title": "U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer", "image": "https://images.financialmodelingprep.com/news/us-fda-approves-inluriyo-imlunestrant-for-adults-with-er-20250925.jpg", "site": "prnewswire.com", "text": "An estimated 50% of patients with ER+, HER2 metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor In the Phase 3 EMBER-3 trial, Inluriyo monotherapy reduced the risk of progression or death by 38% versus endocrine therapy among patients with ESR1-mutated MBC INDIANAPOLIS , Sept. 25, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Inluriyo (imlunestrant, 200 mg tablets), an oral estrogen receptor antagonist, for the treatment of adults with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2), ESR1-mutated advanced or metastatic breast cancer (MBC) whose disease progressed after at least one line of endocrine therapy (ET).", "url": "https://www.prnewswire.com/news-releases/us-fda-approves-inluriyo-imlunestrant-for-adults-with-er-her2-esr1-mutated-advanced-or-metastatic-breast-cancer-302567490.html"}}
{"date": "2025-09-25", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-25 11:27:46", "publisher": "Seeking Alpha", "title": "Eli Lilly and Company (LLY) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript", "image": "https://images.financialmodelingprep.com/news/eli-lilly-and-company-lly-presents-at-bernstein-2nd-20250925.jpg", "site": "seekingalpha.com", "text": "Eli Lilly and Company (NYSE:LLY ) Bernstein 2nd Annual Global Healthcare Conference September 25, 2025 8:00 AM EDT Company Participants Lucas Montarce - Executive VP & CFO Mike Czapar - Director of Investor Relations Conference Call Participants Courtney Breen - Sanford C. Bernstein & Co., LLC.", "url": "https://seekingalpha.com/article/4825922-eli-lilly-and-company-lly-presents-at-bernstein-2nd-annual-global-healthcare-conference"}}
{"date": "2025-09-25", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-25 06:47:09", "publisher": "Reuters", "title": "Eli Lilly halts trial of experimental weight-loss drug", "image": "https://images.financialmodelingprep.com/news/eli-lilly-halts-trial-of-experimental-weightloss-drug-20250925.jpg", "site": "reuters.com", "text": "Eli Lilly has halted a study of an experimental drug, which is designed to prevent obesity patients from losing too much muscle, due to strategic business reasons, according to a U.S. registry of clinical trials.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-halts-trial-experimental-weight-loss-drug-2025-09-25/"}}
{"date": "2025-09-25", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-25 01:12:42", "publisher": "Reuters", "title": "Lilly plans to launch its experimental weight-loss pill in India, exec says", "image": "https://images.financialmodelingprep.com/news/lilly-plans-to-launch-its-experimental-weightloss-pill-in-india-20250925.jpg", "site": "reuters.com", "text": "Eli Lilly plans to bring its experimental oral weight-loss drug orforpligron in India as it sees scope for such products in the world's most populous nation, a senior executive said on Thursday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-plans-launch-its-experimental-weight-loss-pill-india-exec-says-2025-09-25/"}}
{"date": "2025-09-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-24 16:44:38", "publisher": "The Motley Fool", "title": "Does Eli Lilly's New $5 Billion Drug Manufacturing Facility Make It a Long-Term Buy?", "image": "https://images.financialmodelingprep.com/news/does-eli-lillys-new-5-billion-drug-manufacturing-facility-make-20250924.jpg", "site": "fool.com", "text": "Eli Lilly (LLY -0.59%) is a pharmaceutical manufacturer, not a construction business. And yet construction has been a focal point of late, given that it's planning a set of new factories.", "url": "https://www.fool.com/investing/2025/09/24/eli-lilly-billion-drug-manufacturing-buy-stock/"}}
{"date": "2025-09-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-24 13:25:23", "publisher": "Zacks Investment Research", "title": "LLY vs. NVO: Which Obesity Drug Stock Is the Better Buy Now?", "image": "https://images.financialmodelingprep.com/news/lly-vs-nvo-which-obesity-drug-stock-is-the-20250924.jpg", "site": "zacks.com", "text": "Eli Lilly's diversified pipeline, rapid tirzepatide growth and rising estimates give it the edge over Novo Nordisk in the obesity drug battle.", "url": "https://www.zacks.com/stock/news/2756581/lly-vs-nvo-which-obesity-drug-stock-is-the-better-buy-now?cid=CS-STOCKNEWSAPI-FT-analyst_blog|most_popular_stocks-2756581"}}
{"date": "2025-09-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-24 12:30:07", "publisher": "Schwab Network", "title": "The Big 3: AVGO, LLY, GS", "image": "https://images.financialmodelingprep.com/news/the-big-3-avgo-lly-gs-20250924.jpg", "site": "youtube.com", "text": "@Theotrade's Don Kaufman is back on Big 3  and is bearish on all of today's stocks. He points to exuberant A.I.", "url": "https://www.youtube.com/watch?v=Czv9XrmmQVY"}}
{"date": "2025-09-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-24 10:47:41", "publisher": "Finbold", "title": "2 stocks to reach $1 trillion market cap in 2026", "image": "https://images.financialmodelingprep.com/news/2-stocks-to-reach-1-trillion-market-cap-in-20250924.jpg", "site": "finbold.com", "text": "Amid the ongoing United States stock market rally, several equities have experienced increased buying pressure, pushing their valuations closer to the coveted $1 trillion market capitalization mark.", "url": "https://finbold.com/2-stocks-to-reach-1-trillion-market-cap-in-2026/"}}
{"date": "2025-09-24", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-24 04:12:26", "publisher": "Reuters", "title": "Eli Lilly's boss calls UK the 'worst' European country for drug prices", "image": "https://images.financialmodelingprep.com/news/eli-lillys-boss-calls-uk-the-worst-european-country-20250924.jpg", "site": "reuters.com", "text": "Eli Lilly Chief Executive Dave Ricks said Britain was \"probably the worst country in Europe\" for drug prices in an interview with the Financial Times, intensifying pressure on the government to improve market conditions for drugmakers.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lillys-boss-calls-uk-worst-european-country-drug-prices-2025-09-24/"}}
{"date": "2025-09-23", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-23 18:46:19", "publisher": "Zacks Investment Research", "title": "Eli Lilly (LLY) Falls More Steeply Than Broader Market: What Investors Need to Know", "image": "https://images.financialmodelingprep.com/news/eli-lilly-lly-falls-more-steeply-than-broader-market-what-20250923.jpg", "site": "zacks.com", "text": "In the closing of the recent trading day, Eli Lilly (LLY) stood at $746.98, denoting a -1.06% move from the preceding trading day.", "url": "https://www.zacks.com/stock/news/2756004/eli-lilly-lly-falls-more-steeply-than-broader-market-what-investors-need-to-know?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6-2756004"}}
{"date": "2025-09-23", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-23 13:31:00", "publisher": "WSJ", "title": "Eli Lilly to Build $6.5 Billion Ingredient-Manufacturing Facility in Texas", "image": "https://images.financialmodelingprep.com/news/eli-lilly-to-build-65-billion-ingredientmanufacturing-facility-in-texas-20250923.jpg", "site": "wsj.com", "text": "The planned site, which will be used to manufacture the company's first oral weight-loss drug, is expected to be operational within five years.", "url": "https://www.wsj.com/health/pharma/eli-lilly-to-build-6-5-billion-ingredient-manufacturing-facility-in-texas-7bc8bc23"}}
{"date": "2025-09-23", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-23 13:03:29", "publisher": "Reuters", "title": "Eli Lilly to make weight-loss pill in new $6.5 billion Texas plant", "image": "https://images.financialmodelingprep.com/news/eli-lilly-to-make-weightloss-pill-in-new-65-billion-20250923.jpg", "site": "reuters.com", "text": "Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar manufacturing plant it plans to build in Texas, the company said on Tuesday.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lilly-make-weight-loss-pill-new-65-billion-texas-plant-2025-09-23/"}}
{"date": "2025-09-23", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-23 13:00:27", "publisher": "CNBC", "title": "Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs", "image": "https://images.financialmodelingprep.com/news/eli-lilly-to-build-65-billion-texas-manufacturing-facility-20250923.jpg", "site": "cnbc.com", "text": "Eli Lilly said it will spend $6.5 billion to build a manufacturing facility in Houston, Texas, to boost production of the company's pipeline of small molecule drugs, including its closely watched experimental obesity pill. It is the second in a string of four new planned U.S. plants by the drugmaker, which will all begin making medicine within five years.", "url": "https://www.cnbc.com/2025/09/23/eli-lilly-plans-6point5-billion-texas-manufacturing-plant-for-obesity-pill.html"}}
{"date": "2025-09-23", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-23 13:00:00", "publisher": "PRNewsWire", "title": "Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Texas", "image": "https://images.financialmodelingprep.com/news/lilly-plans-to-build-a-new-65-billion-facility-20250923.jpg", "site": "prnewswire.com", "text": "The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines Company plans to create 4,615 manufacturing and construction jobs INDIANAPOLIS , Sept. 23, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that it plans to build a new $6.5 billion manufacturing facility at Generation Park in Houston, Texas.", "url": "https://www.prnewswire.com/news-releases/lilly-plans-to-build-a-new-6-5-billion-facility-to-manufacture-active-pharmaceutical-ingredients-in-texas-302563621.html"}}
{"date": "2025-09-23", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-23 08:05:00", "publisher": "GlobeNewsWire", "title": "Boys & Girls Clubs of America Receives $10 Million Grant from Lilly Endowment Inc. to Help Transform the Future of Youth Programs in and Around Native Communities", "image": "https://images.financialmodelingprep.com/news/boys-girls-clubs-of-america-receives-10-million-grant-20250923.jpeg", "site": "globenewswire.com", "text": "Funding will strengthen Boys & Girls Clubs serving youth who live on or near federal and state designated Native lands through program support, leadership development and digital transformation Funding will strengthen Boys & Girls Clubs serving youth who live on or near federal and state designated Native lands through program support, leadership development and digital transformation", "url": "https://www.globenewswire.com/news-release/2025/09/23/3154661/0/en/Boys-Girls-Clubs-of-America-Receives-10-Million-Grant-from-Lilly-Endowment-Inc-to-Help-Transform-the-Future-of-Youth-Programs-in-and-Around-Native-Communities.html"}}
{"date": "2025-09-22", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-22 21:32:30", "publisher": "Reuters", "title": "Celltrion unit pays $330 million for Eli Lilly production facility, filing shows", "image": "https://images.financialmodelingprep.com/news/celltrion-unit-pays-330-million-for-eli-lilly-production-20250922.jpg", "site": "reuters.com", "text": "Celltrion Inc. said in a regulatory filing in South Korea on Tuesday its U.S. subsidiary has acquired Imclone Systems LLC from Eli Lilly in the United States for $330 million.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/celltrion-unit-pays-330-million-eli-lilly-production-facility-filing-shows-2025-09-23/"}}
{"date": "2025-09-22", "symbol": "LLY", "type": "stock_news", "result": {"symbol": "LLY", "publishedDate": "2025-09-22 19:03:38", "publisher": "Reuters", "title": "Innovent's weight-loss drug highlights China challenge for Novo, Lilly", "image": "https://images.financialmodelingprep.com/news/innovents-weightloss-drug-highlights-china-challenge-for-novo-lilly-20250922.jpg", "site": "reuters.com", "text": "Innovent Biologics' newly launched weight-loss drug is making inroads in its home market of China, ramping up competition with its Western rivals as it pursues a marketing strategy that is gaining traction.", "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/innovents-weight-loss-drug-highlights-china-challenge-novo-lilly-2025-09-22/"}}
